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AbstractzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
This thesis describes the applications of 1,2-thiazine 1-oxides as precursors for the
synthesis of other heterocycles. The requisite 1,2-thiazine l-oxides (2) were synthesised via a
hetero-Diels-Alder reaction of the readily available dienophilezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(1).
X=S02
Y=N3, NH2
RI, R2=H, Me
,
,
t RI
c(~'i-R'
Y
, 7'
8 9
Ring opening of the l,2-thiazine l-oxides (2, Y=NH2) at the sulfur, with a Grignard
reagent gave allylic sulfoxides, which after [2,3]-sigmatropic rearrangement and desulfurisation,
furnished the unsaturated allylic alcohols (3, Y=NH2). Oxidation and ring closure via Fmoc
protection of the amine provided the 3-hydroxy-l,2,5-benzothiadiazepines (4) as the major
products. Advantageously, the use of 2-(2-azidobenzenesulfonyl)-1 ,2-thiazine 1-oxides (2, Y=N3)
led to the l-(2-aminobenzenesulfonyl)pyrrole (5, Y=NH2) via a one-pot ring contraction,
desulfurisation and aromatisation process, accompanied by concomitant same pot conversion of
the azide to a primary amine through a Staudinger reaction. Subsequent N-formylation and
Bischler-Napieralski ring closure gave pyrrolo[1,2-b][1,2,5]benzothiadiazepines (6), which were
IX
AbstractzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
good templates for 1,3-dipolar cycloaddition reactions. Furthermore, hydrolysis of (2) gave
homoallylic systems (7), which underwent iodine promoted cyclisation (Y=NH2) to give aziridino-
1,2,7-benzothiadiazocines (8) and thermolytic cyclisation (Y=N3) to furnish pyrrolo-I,2,4-
benzothiazine l,l-dioxides (9).
Finally, thermolytic cyclisations of the precursors (lOa-c) were explored. Intramolecular
I ,3-dipolar cycloaddition of azide to the nitrile or alkyne was shown to provide efficient routes to
triazolo- (llb, X=CH) and tetrazolo- (He, X=N) fused pyrrolobenzodiazepines. Intramolecular
ring closure of alkene (lOa) gave aziridinopyrrolobenzodiazepine (12) and pyrrolobenzodiazepinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
(13) as an inseparable mixture at lower reaction temperatures or hydroxy pyrrolobenzodiazepine
(14) at high temperature.
~~ _---- ~N~. ----- rY-i2."U,,-:-- OH U_ _ . 'H U,,_ H
N N3zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA.n N \Me " , X
X N~N'zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
J4 lOa: X=CH2 (alkene)
lOb: X=CH (alkyne)
JOe: X=N (nitrile)
11
13
,
Cifj"'HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN H
H "'H
12
r
c(-~
Me
X
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Introduction
Chapter 1 IntroductionzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
1 Introduction
1.1 An introduction to the pyrrolobenzodiazepineszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
The increase in cancer awareness has led to the discovery of many natural and synthetic
anticancer agents with the ability to interact with DNA, but most have little sequence-specificity
and often exhibit severe toxicity to normal tissue.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI Thus, there has been considerable interest
within molecular biology and human medicine to find small molecules that can alkylate the DNA
in a sequence-specific manner and modify the function of nucleic acids irreversibly? The tricyclic
pyrrolo[2,I-c][l,4]benzodiazepines (1) which are structurally related to the well-known 1,4-
benzodiazepine (2) pharmacore are amongst the few that have been shown to recognize and bind
to specific sequences of DNA3 (Figure 1.1). Thus, such compounds have potential as regulators of
gene expression with possible applications as therapeutic agents in the treatment of certain genetic
disorders including some cancers."
~NH
~~,13
N 2
I
2
Figure 1.1: The tricyclic and bicyclic benzodiazepine
The pyrrolobenzodiazepines represent a remarkable core structure, which has many
attributes. The most important feature is the electrophilic centre at the NlO-Cll position, and the
presence of an imine, carbinolaminel amide moiety in the central B-ring is essential for the
alkylation of the guanine residues in the minor groove DNA.s The binding to the DNA can exist
in at least three different interchangeable forms (Figure 1.2) and thus three possible mechanisms
may be envisaged for the reaction of these species with the 2-amino functionality of guanine."
Route (a) via a direct SN2 type attack of the protonated carbinolamine (3) or its II-methyl ether
(4) by the biological nucleophile.' A second mechanism (b) involving Schiff's base formation
between N2-guanine functionality and the acyclic amino aldehyde, followed by intramolecular
cyclisation'' and finally the third mechanism (c) via a direct attack of biological nucleophile on the
imine function." Molecular modelling, solution NMR, fluorimetry, and DNA footprinting
experiments indicate that PBD monomers are generally sequence-specific with a binding site
preference for 5'-puGpu (particularly 5'-AG or 5'-GA) sequences.l'' Additionally, the S-
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stereochemistry of the Clla-H gives these molecules their right-handed twist; a characteristic that
makes them isohelical with B-DNA.5
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~~'N~H~2'=G=um==in=e-=D=N=A============~
H (OR -,
(a)~ ,------------.
3:R=H
4: R=OMe
8
c(2
H NH+Guanine+DNA
d-2~
N ~: NH2'Guanine-DNA
7
Figure 1.2:DNA binding mechanism
5
6
I
Guanine-DNA
Another important aspect of the PBD skeleton is the nature of the substituents on the
aromatic A-ring. Electron donating substituents increase the electrophilicity of the NlO-CII
centre, whilst electron-withdrawing substituents attenuate biological activity arising from covalent
DNA binding.!' Bulky substituents at C9 and NIO also eliminate biological activity and DNA
binding affinity of the pyrrolobenzodiazepine. A significant increase in DNA binding affinity,
cytotoxicity and in vivo antitumour activity has been observed when there is unsaturation present
in the C-ring, specifically when C2 is Sp2 hybridised, i.e. by the inclusion of an exocyclic double
bond or a C2-C3 double bond.lla,12 However, complete unsaturation of the C-ring deactivates the
compounds because of the involvement of the NI O-C 11 centre in the conjugated system, which
leads to a decrease in the electrophilicity of this centre.lla,13
In recent years much effort has been put into extending the pyrrolobenzodiazepines so that
they span a greater number of base pairs and have enhanced sequence selectivity. One approach
has involved attaching different substituents on the pyrrolobenzodiazepines, such as
ethylenediaminetetraacetic acid (EDTA),14 epoxide," polyamide.l'' oligopyrrole, I7 and
cyc1opropylpyrroloindole (CPI) moieties," which have exhibited sequence selective DNA-
cleaving and cross linking properties. Furthermore, there have been attempts to develop more
potent compounds that could enhance the sequence selectivity as in the case of C8 diether-linked
2
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PBD dimers DSB-120,19 SJG-136 (9a),20 DRG-16 (9b)21 [Figure 1.3] and C2-C3/C2'-C3' endo
unsaturated PBD dimer_22 It has been observed that there has been extensive improvement in the
biological activity due to the cross-linking property by the presence of two imine functionalities.
One example, SJG-136 (9a) which is presently under clinical evaluation, spans six base pairs of
DNA and has a preference for a Pu-GA TC-py or Py-GA TC-Pu sequence.23,20zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
zp::::n;_~
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
9a: SJG-J36, nzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA= J
9b: DRG-J6, n = 3
Figure 1.3: Pyrrolobenzodiazepinedimer
A detailed review of the synthetic literature of the pyrrolobenzodiazepines appeared in
1994.5 The purpose of the present review is to survey the most recent developments towards the
synthesis of pyrrolobenzodiazepines. The synthesis of other classes of pyrrolobenzodiazepine
such as triltetracyclic sulphur and heterocyclic analogues will be looked at in more detail than in
the 1994 paper, since their synthesis is significant to this project. Further, in this review an effort
is being made to outline the various synthetic routes developed since 1994 with their merits and
limitations. Most of the advances that have occurred since 1994 have been in the synthesis of
"dimeric" PBDs and "hybrid" PBDs and so they will be dealt with in separate sections of this
introduction.
3
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1.2 Synthesis of pyrrolobenzodiazepines via azides
1.2.1 Aza-Wittig based synthesis of pyrrolobenzodiazepine
A number of synthetic routes have been developed for the preparation of the
pyrrolobenzodiazepines antibiotics and have met with varying degrees of success; some however
found the general problem to be the introduction of the sensitive imine at the NI O-CII position.
Since 1994, there has been considerable interest in the use of aza-Wittig reactions as a tool for the
construction of carbon-nitrogen double bonds under mild and neutral conditions. The key
intermediate iminophosphoranes have been generated from both azides and primary amines, and
their aza-Wittig reaction with a variety of carbonyl compounds provides a valuable method for the
regiospecific formation of the cyclic imine,24,25a feature often not available via the classical
amine-carbonyl group cyclisation where double bond shifts are possible.
The intramolecular aza-Wittig reaction of N-(2-azidobenzoyl) a-amino acid esters and their
application to the synthesis of benzylated DC-8I (13) as well as the natural antibiotic DC-8IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(14)
has been reported by Molina.i? and Eguchi et al.27independently. Both the groups have employed
triphenylphosphine for their intramolecular aza-Wittig reaction as illustrated in the following
scheme:
MeoJCLoj2.
I "
RO ~ N- H
° ~H20H
MeO co H I. SOCI2, benzene Me0Je(:
~ 2 reflux I~ 0
RO~N3 2. (L)-prolinol,DCMlH20 RO ~ N3
Na2C03
10 90-98% 11
PCC, DCMJ73%
r.t.
° CHO
TPP, DCM Mox;( :-
~_r.t. __ .. e I ~ 0
79-92% RO ~ N3
13: R=Bnz
14: R=H
12
Scheme 1.1
Parallel with these studies, O'Neil et al.28 prepared a series of functionalised pyrrolo[2,1-
c][I,4]benzodiazepines (18-23) bearing a variety of A-ring substituents, using a Staudinger/ aza-
Wittig sequence (Scheme 1.2). Thus, treatment of the azido aldehydes (17) with either
4
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tributylphosphine or triphenylphosphine generated the corresponding iminophosphoranes, which
underwent an in situ intramolecular aza-Wittig cycl isation to give the desired pyrrolo[2,1-
c][1,4]benzodiazepines (18-23) in up to 90% yield.
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAR
X C02H I. (COClh, DMF X« 0 P(Buh, orPPh)V refluxzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI '-':::: N t20, r.t.Y N 2. (S)-prolinol,Et3N Y .0 N 55-90%3 40-91% 3
Z Z
15 Dess-Martinperiodinane, oeM, r.t.[ 16: R=CH20H
17:R=CHO
Xy)-N,~
YYNf
Z
18: X=Y=Z=H 19: X=Z=H, Y=CI
20: X=I, Y=Z=H 21: X=Z=J, Y=H
22: X=Z=Cl, Y=H 23: X=Br, Y=Z=H
Scheme 1.2
Furthermore, the same group later reported'" the novel synthesis of C2-fluoro-substituted
pyrrolobenzodiazepines (32a-c), using the Staudingerlaza- Wittig methodology. The key strategy
was the synthesis of Boc-protected fluoro and difluoro methyl esters (Scheme 1.3). The cis-and
trans 4-fluoroproline methyl ester (25) was readily obtained from compound (24) with DAST.
Oxidation and ditluorination of compound (24) gave the 4,4' -ditluoroproline methyl ester (27).
HO DAST (2.5 eq),
~ DCM, -78°C to r.t.
N C02Me 83%
I
Soc
24
90%j(COCI)2' DMSO
Et)N,DCM
-78°C to r.t.
25
I. DIBAL-H, THF
-78°C to r.t.
R~~
HCIH OH
28a: R1=F, R2=H
28b: RI=H, R2=F
28c: RI=R2:F
2. 4M HCI in dioxane
78-82%
O~ DAST (5
0
.0eq),
( ).... DCM, -78 C to r.t.
N C02Me
I
Boc
78%
26 27
Scheme 1.3
Reduction of the esters with DIBAL-H followed by removal of the Boc-protecting group
afforded compounds (28a-c) in respectable yields. Coupling followed by oxidation of the 4-fluoro
substituted prolinol (30) afforded the desired azido aldehyde (31), which underwent a
Staudinger/aza- Wittig cyclisation upon treatment with DPPE to provide the tluoro-substituted
pyrrolobenzodiazepines (32a-c) in 71%,80% and 62% yields, respectively (Scheme 1.4).
5
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAR2
CO H 1, (COClh, DCM cl;:r= RI DPPE, THFCC 2 cat. DMF I ~ N 2 h.N 2. 28a-c, Et3N, DCM _o N
3 -780C to r.t. 3 R3
29
66-78%
D M' ' d' DCM [30: R3=CH20Hess- arnn peno mane, , T.t. 3
31: R =CHO
32a: RI=F, R2=H
32b: RI=H, R2=F
32c: RI=R2=F
Scheme 1.4
1.2.2 Azide reductive cyclisation
In addition to the ongoing research towards the synthesis of pyrrolo[2,1-
e][1,4]benzodiazepine and analogues via the azide, Kamal et al. have reported a new modified
approach based on anzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAin sit cyclisation of an amine with the pendant carbonyl through an azido
reductive process (Scheme 1.5). A wide range of reagents such as hexamethyldisilathiane.Y"
FeS04.7H201NH3,32 trimethylsilyl iodide,33 hydriodic acid (HI),34 FeCh-NaJ,35 and zinc with
ammonium formate" have been used under extremely mild conditions to successfully produce
both the pyrrolobenzodiazepine dilactam nng system and the DNA interactive
pyrrolobenzodiazepine imine, bearing the S-conformation at the chiral Clla position. The results
are summarized in table 1.0.
Scheme 1.S
6
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Entry Reagent Reaction conditions Final PBD product Yieldl%
Solvent TempfOC Time RI R2 R3 R4 35 36
HMDST MeOH r.t. 4h H H N3 H
OMe OMe N3 H 65-74 62-69
OMe OBn N3 H
2 FeS04.7H201NH3 DCM r.t 4h H H H H
OMe OH H H
90-95 68-72
Me H H H
H H H OH
3 TMSClINaI MeCN r.t. 45 min H H H H
(trimethylsilyl iodide)
H H H OH
80-85 70-75
OMe OCH2Ph H H
Me H H H
4 Hydriodic acid (HI) r.t H H H H
H H H OH
90-95 70-75
Me H H H
H Me H OH
5 FeCI3-Nai MeCN r.t. IS min H H H H
H H H OH
80-85 70-80
OMe OCHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2Ph H H
Me H H H
6 ZnlNH4C02H MeOH r.t. H H H H
OMe OBn H H 85-90 75-80
OMe OMe H H
Table 1.0
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Chandrsekaran et al.37 have reported another azido reductive cyclisation in the synthesis of
seven membered cyclic imine using benzyltriethylammonium tetrathiomolybdate. The
methodology was extended to a successful synthesis of pyrrolo[2,I-c][I,4]benzodiazepine (39a)
and also the benzylated DC-81 (39b) [Scheme 1.6].
o)c(p
3zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH20HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPO LKJIHGFEDCBA
37
::n:-52
39a: RI=R2:H
39b: R1=OMe, R2=OBn
Scheme 1.6
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1.3 Synthesis of pyrrolobenzodiazepines via oxidation and reductive
cyclisation
1.3.1 Oxidation method
An early approach of using very active manganese dioxides for the oxidation of the readily
prepared pyrrolobenzodiazepine secondary amine (40) to its corresponding imine has been subject
to little scrutiny due to lack of control to selectively achieve oxidation at only the NlO-CII
position (Scheme 1.7), the isolated product being the fully unsaturated productzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(41).
2// _M_n---=o~=-,:..::2e.:..:..;_ze_ne_ctN,"jzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~N~ 7m N~
H
40 41
Scheme 1.7
Similarly, Rault et al. reported the use of thionyl chloride38 in the presence of base to
readily aromatise 2-hydroxypyrrolo[2, l-c ][1,4]benzodiazepines (42) into 11-chloropyrrolo[2, I-
c][1,4]benzodiazepines (43a-d) in high yield. The chloroimine moieties are interesting analogues
to the imine and carbinolamine found in the antitumour antibiotic DC-81. Thus, the chlorine
group at the CII position could reinforce the electrophilic character and enhance the ability to
react with nucleophiles, whilst on the other hand the chloroimine could also act as a scaffold for
the preparation of numerous tricyclic derivatives by substitution.
oR1xX-gOH SOCI2,PyridineI '-':::: reflux 2h
R2 ~ N H 62-70%
H 0
42
R'yJ-N::)
R2UN~
Cl
43a: RI=R2=H
43b: RI=H, R2=CI
43c: Ri=H, R2=Me
43d: Ri=R2=methylene dioxy
Scheme 1.8
However, Kamal et al.39 have reported a new mild oxidant, TPAP in the presence of N-
methylmorpholine N-oxide as a co-oxidant, which can selectively oxidise the secondary amine to
the imine without over oxidation and without any racemisation at the Clla position. This
9
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methodology has many advantages, but the most significant is that it is devoid both of side
products and aqueous work-up for the sensitive imine moiety. Also, in this study the
pyrrolobenzodiazepine secondary amine was synthesized by a new approach involving the
reductive desulfurisation of the pyrrolobenzodiazepine-5-one-ll-thione by Raney nickel (Scheme
1.9).
Furthermore, the same workers showed that oxidation of the cycl ic secondary amine (49)
using activated Me2S040 gave the desired pyrrolobenzodiazepine in the imine form (50) in 40-45%
yield.
47 "" ~~wesson's
~gent
Raney nickel,
EtOH, tJ. 5-6h
49zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA48
Scbeme 1.9
1.3.2zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAReductive cyclisation
Reductive cycIisation of acyclic nitro aldehydes has been by far the most important
approach of synthesizing the pyrrolobenzodiazepine imine. However, earlier studies have showed
that using such routes generally gave large amounts of the secondary amine along with the desired
carbinolamine, methyl ether or imine in moderate yield. Current studies by Kamal et al. havezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
10
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showed that reduction of the nitro aldehyde (54) using iron powder" in acetic acid, results in the
formation of the desired pyrrolobenzodiazepine imine (55) in high yield with no by products
(Scheme 1.10). The limitation in this methodology has been that the pyrrolobenzodiazepine imine
is produced with an optical rotation value somewhat lower than the product obtained though other
routes. This is believed to be a direct result of racemisation taking place in acidic reaction
conditions. Further, the method was extended towards the synthesis of 5-thio
pyrrolobenzodiazepine imine derivatives. Thus thiation of nitro aldehyde (54) with Lawesson's
reagent resulted in (56) and reductive cyclisation with iron and acetic acid in THF afforded the
desired 5-thio PBD imines (57) in good yields.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
54j (P-CH30C6H4PS2hToluene, 6 2-3 h
RI SzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Fe/CH3C02H R2~.~
THF, r.t. 3-6 h 3V....rr NrR N02CHSzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
56zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Scheme 1.10
In addition, a new one-pot reductive cyclisationf of the acyclic nitro aldehyde in the
synthesis of benzylated DC-SI and the natural product DC-SI has been reported by the same
group. Thus, reduction of (2S)-N-(2-nitrobenzoyl)pyrrolidin-2-carboxaldehyde (58) with ferric
chloride hexahydrate and N,N-dimethylhydrazine resulted in the corresponding methylether of the
pyrrolobenzodiazepine carbinolamine (59), via a hydrazone intermediate, which upon column
chromatography (silica gel, chloroform:methanol. 9.S:0.2) afforded the pyrrolobenzodiazepine
imine (60a-c) [Scheme 1.11].
] 1
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(CH3hNNH2, 0 Si02
Id .~ FeCI3·6H20 RIJCt:R CHCI3:MeOH
R 1"'-'::: N0 MeOH,70°C,6-8h 1"'-'::: N _...:....{9_.8_:0_.2"'-)__
R2 // NO:' R2 // N H
2CHO HOMezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
5958 60a:RI=R2=H
60b:RI=OCH2Ph,R2=OMe
60c:RI=OH,R2=OMe
Scheme 1.11
A new class of heterocyclic quinone (64) from 3,6-dimethoxy-2-nitrobenzoic acid (61) has
been reported by Tapia et al ..43 Thus treatment of (61) with thionyl chloride and subsequent
reactions of the resulting acid chloride withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(L)-proline methyl ether furnished the amide (62) as a
I: I mixture of syn and anti rotamers. Reductive cyclisation of compound (62) with iron(II)
sulphate and ammonium hydroxide yielded the pyrrolobenzodiazepine (63) in 86% yield.
Oxidative demethylation of (63) with ammonium cerium(lV) nitrate afforded the
pyrrolobenzodiazepinequinone (64) in 75% yield [Scheme 1.12].
¢COMe ~:~L~~~OlinemethYI¢(OMeO~hMe ¢(OMe0:9C02H ester, Et3N "'-'::: N0 FeS04 "'-'::: N., (NH4hCe(N03)6NO 81% I // 86% I // 'H 75%2 N~ N
OMe OMe OMeH 0
61 62 63
«~o H 0
64
Scheme 1.12
1.3.3 Synthesis of C2-substituted endo-exo unsaturated pyrrolo[2,1-
c] [1,4]benzodiazepines
Ongoing investigations into the chemistry and structure activity relationship (SAR) of the
pyrrolobenzodiazepine ring systems have established that compounds possessing endo-exo
unsaturation in their C-rings combined with conjugated planar C2-substituents, such as the
acrylamide side chain found in anthramycin, have the greatest cytotoxicity and DNA binding
affinity. It is also well known in the literature that C-ring hydroxy substitution plays an important
role in biological activity, examples being naturally occurring pyrrolobenzodiazepines such as
chicamycin A and B, neothramycin A and B, and abbeymycin."s,7,44 On the basis of these studies
Kamal et al. reported an elegant and efficient solid-phase synthesis'" ofNIO-CII imine containing
pyrrolobenzodiazepines and the dilactam with C2-hydroxy substituents via a reductive cyclisation
procedure. Thus, the Wang trichloroacetamidate resin (66) was coupled with Fmoc-protected 4-
]2
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hydroxyproline methyl ether (67). The product, after Fmoc deprotection using 20% piperidine/
DMF, was coupled with 2-azidobenzoic acid in presence ofDCC and DMAP to provide the amide
(71). Reductive cyclisation of (71) using TPP afforded the pyrrolobenzodiazepine-5,lI-dione
(75), which upon cleavage from the resin yielded 2-hydroxy-7,8-substituted
pyrrolobenzodiazepine-5, l l-dione (76). Furthermore the reduction of (71) by DIBAL-H followed
by reductive cyclisation and cleavage afforded 2-hydroxy-7,8-substituted pyrrolobenzodiazepine
imine (74) (Scheme 1.13).
DBU,DCM
OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA+ Cl3CCN
OH
+ Me02c,,·Q
I
FmoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6765
o
Me02CI,.Q
H
69
o
DCC,DMAPj ~OH
DCM,OoC RV~,
NJ
70
o
RO:>~O
N3 C02Me
71
PPh3 j
Toluene
o
RC(~O
H 0
75
TFAlDCMj(I :3)
oRc(gOH
H 0
76
66
20% piperidine
DMF
j
BF3.0Et2 or
CF3S03H,DCM
o
Me02c,,·Q
I
Fmoc
68
o
DIBAL-H,DCM ..cC C(0
-78°C2 h I ~ NR-
I ~ :
N3 CHO
72j PPh3Toluene
R~N'IO
~N~
73
jTFAlDCM(1 :3)
R~N'IOH
~N~
74
Scheme 1.13
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Thurston et al.46 have reported a simple coupling reaction in the synthesis of a C2-vinylic
pyrrolobenzodiazepine imine. Thus, the pre-formed C-rings (7S) were coupled to the nitrobenzoic
acid fragment (77) using oxalyl chloride in presence of potassium carbonate to provide compounds
(79). Reduction followed by treatment with 4-nitrobenzyl chloroformate and pyridine of the
resultant amine (SO) afforded the NlO-protected intermediates (SI), which were cyclised with
TPAPINMO to give (S2). Removal of the NI0-protecting group resulted in the C2-vinylic
pyrrolobenzodiazepine imine (83).
o
M'O~OH
BnOzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI ,? N02
77
o
Meod~RI N0
BnO ,? NH ~
~G "OH
8Ia: R=H,H
8Ic: R=CHMe
78a: R1=H, H; R~H 79a: R1=H, H; R2=H
78b: R1=CHMe; R2=TBDMS 79b: R1=CHMe;R2=TBDMS
TBAF. THF. ooce 79c: R1=CHMe;R~H
For 80c: SnCI2 j For80a: RaneyNi
MeOHd NH2NH2
MeOH .1
o
4-nitrobenzylchloroformate, Od ~R
pyridine,DCM,O°C Me I "': N0
,? :
BnO NH2 =
"OH
80a: R=H, H
80c: R=CHMe
(COClh, DMF,MeCN ~ RI
24 h then 78a or 78b Mea ~"Tr NCJ
BnO N02 ~
"OR2
jTPAP'NMO4A molecular sieves,DCMlMeCN(3:1)
Me0:cL,?, c-, 0 gR Meod'''- O}!R" Activation -czyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
--------------~
BnO N H BnO ,? N- H
~G OH
82a: R=H,H
82c: R=CHMe
838: R=H,H
83c: R=CHMezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Scheme 1.14
Another approach reported'" by the same group involves the use of the Suzuki reaction to
introduce the C2-aryl substituents (Scheme 1.15). Thus, the pre-formed C-ring (S5) was coupled
to 4,5-dimethoxy-2-nitrobenzoic acid (S4) to provide compound (S6). Reduction followed by
cyclisation of the resultant amine provided the pyrrolobenzodiazepine dilactam (87). Protection of
the C2 alcohol as the TBDMS ether (SS), followed by treatment with SEM-CI under strongly basic
conditions provided the SEM substituted analogue (89). Selective deprotection of the C2-TBDMS
14
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ether, followed by Swern oxidation of (90) furnished the C2 ketone (91), which was converted to
the C2-C3 enoltriflate (92) using trifluoromethanesulfonic anhydride in the presence of pyridine.
Suzuki reactions on the enoltriflate (92) with various arylboronic acids provided C2-substituted
analogues (93-95). Reduction of the dilactam in the presence of the NIO-SEM group with sodium
borohydride, followed by spontaneous cleavage of the unstable NIO-SEM protected carbinolamine
in presence of wet silica gel afforded C2-aryl pyrrolobenzodiazepines (96-98) in their imine form.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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SchemezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1.15
In continuation, Thurston et al. reports" the use of Stille coupling in the synthesis of C-
ring endo-exo unsaturated C2-substituted pyrrolo[2, I-c][1 ,4]benzodiazepines. Thus, the key
enoltriflate (92) was coupled to a number of commercially available organotin reagents under
Stille conditions to provide vinyJic, acetylenic and heteroaromatic moieties at the C2 position of
the pyrrolobenzodiazepine dilactams (99a-d). Reduction of the dilactam with sodium borohydride
afforded the SEM-protected carbinolamine intermediate, which converted to the
15
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pyrrolobenzodiazepine imineszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(toOa-d) upon exposure to moist silica gel. An attempt to convert
the enoltriflate to the more versatile trimethylstannyl alkene failed and instead afforded the simple
unsubstituted endo-2,3-unsaturated product (101) in 41% yield.
o
Meo~g'.::::: OTf RSnBu3IPd[PPh314U,,_ THF/retlux
MeO .0 N H
SEMO
92
STI2MeJPd[PPh314J
THF/reflux
M'o2N:'j
MeO~N~H
SEMO
101
99a-d
J
I.NaBH4, EtOHlH20
2. Silica gel EtOHlH20
MeO~N\~R
MeO~Nh
lOOa:R=~ lOOb:R=~
lOOe: R= Ph lOOd: R=J)
Scheme 1.16
The same group later reported'" an alternative synthetic strategy where
trifluorosulfonationl Suzuki coupling are carried out prior to the B-ring closure (Scheme 1.17).
Thus, coupling of 4-(L)-trans-hydroxyproline (102) with 4,5-dimethoxy-2-nitrobenzoic acid to
give (103) followed by oxidation with BAIB/TEMPO resulted in compound (104) in 90% yield.
Triflation of compound (104) with NaHMDS afforded almost exclusively the 1,2-unsaturated
product (105), which underwent Suzuki coupling in presence of arylboronic acid to give
compound (106) in high yield, but needed heating, unlike the Suzuki reaction involving the
dilactam-based enoltriflate reported above. Reduction of the nitro and protection of the resultant
amine (107) gave compound (108). TBDMS group removal and oxidation of (109) with
BAIB/TEMPO achieved B-ring closure to compound (110) in 80% yield. Finally, removal of the
allyl carbamate afforded the C2-aryl substituted 1,2-unsaturated pyrrolobenzodiazepine imine
(111) in 80% yield. The advantages of this synthetic route in comparison to the one mentioned
above is that it avoids a reductive step, thus removing the risk of NlO-Cll secondary amine
formation and allows a reduction sensitive group to be included on the C2-aryl ring.
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OTBC-S0HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI,
'"
N
HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Scheme 1.17
More recently, Mori et al. reported'? a novel synthesis of an anthramycin derivative via
reductive cyclisation of a pyrrolidine (Scheme 1.18). The key strategy includes the ring closing
enyne metathesis and cross metathesis via the use of ruthenium carbene complex. Thus, enyne
metathesis of compound (112) and 5 mol% of ruthenium carbene complex at room temperature
under ethylene gas gave pyrrolidine (113) in 76% yield. Condensation of the deprotected
pyrrolidine with 2-nitro-3-benzyloxy-4-methyl-benzoyl chloride (114) afforded compound (115),
which upon reduction with zinc in acetic acid and treatment with dilute hydrochloric acid gave
(116) in 86% yield. Cross metathesis of (116) with ethyl acrylate using (117) followed by
treatment of the resultant (118) with RhCh.3H20 in ethanol resulted in the formation ,of the double
bond shifted compound (119). Debenzylation followed by protection of the resultant phenol (120)
as a benzylidene acetal gave (121), which was reduced via NaBH4 to give aminal (122), the final
product.
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1.4 Synthesis of pyrrolobenzodiazepine dimers
Recently, there has been tremendous interest in the design and synthesis of DNA
interstrand cross-linking agents that are likely to enhance the sequence selectivity and which in
turn could increase selectivity for tumour cells/" In this context a large number of PBD dimers
have been designed and synthesized with a view to exploring their DNA cross-linking ability and
their sequence selectivity.f These PBD dimers have been joined through different positions such
as A-CS/A-CS',53 A-C7/A-C7', C-C2/C-C2' and A-CS/C-C2. Amongst these, A-CS/A-CS' linked
PBD dimers have shown promising cytotoxicity and efficient cross-linking properties.f
1.4.1 Synthesis of C8-linked pyrrolo[2,I-c][I,4]benzodiazepine dimer via
dethioacetalisation
An efficient convergent synthesis of the CS-linked pyrrolobenzodiazepine dimer via a
versatile approach of joining two vanillic acid units with n.ro-dihaloalkanes has been reported by
Thurston and co-workers.f Thus, refluxing vanillic acid (123) with diiodoalkanes of varying
length in the presence of aqueous sodium hydroxide afforded the dimer acids (124a-d) in 60-S4%
yield. Following conversion to their corresponding methyl esters (USa-d), nitration using
SnCIJHN03 in DCM proceeded smoothly at -20°C to provide the corresponding arylnitro esters
(U6a-d) in 65-75% yield. Mild hydrolysis of the esters followed by coupling of the
corresponding nitro acids (127a-d) with (2S)-pyrrolidinecarbaxaldehyde diethyl dithioacetal
afforded the bis-amides (USa-d). Reduction of the nitro thioacetal intermediates and cyclisation
of the resultant aryl amino thioacetal (U9) with HgCh/CaC03 gave the target CS-linked dimers
(130a-d) in 60-S3% yield (Scheme 1.19).
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Scheme 1.19
Kamal et al., have reported" an improved and versatile route to the DC-8I dimer via a less
expensive starting material, i.e., vanillin instead of vanillic acid. The use of this approach means
that the additional step of esterification and deesterification of the vanillic acid has been eliminated
which in turn reduces the number of steps, as well as improving the yields. Thus, vanillin (131)
was dimerised with dibrorno-alkanes followed by the nitration with SnC14IHN03 to obtain the
nitroaldehyde dimers (132). Oxidation of the aldehydes with NaCI02 gave the nitro acids (133) in
78-84% yield. Treatment of nitro acids (133) with thionyl chloride and coupling of the resultant
acid chloride with (S)-proline gave compound (134), which upon esterification followed by
reduction of the ester (135) with DIBAL gave the aldehyde (136). Treatment of the aldehyde
(136) with TMSiCI and EtSH provided the advanced intermediate (137). Reduction of this nitro
thioacetal intermediate and cyclisation of the resultant amino thioacetal (138) with HgCI2/CaC03
afforded the DSB-120 (139a: n=3) and other DC-8I dimers (139b-c) in 22-25% yields (Scheme
1.20).
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Scheme 1.20
The same group later reported 55 a simple procedure for the conversion of the thioacetals
(138a-c) to the carbonyl compounds using FeCl3.6H20 and have further demonstrated subsequent
cyclisation to give OSB-120 (139a; n=3) and other DC-S1 dimers in IS-22% yield (Scheme 1.21).
n° :ceO FeCI3·6H20 Rn°zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA°dO 52N OMe MeO I '-'::N0 OCM, r.t. 30min ,,' N I '-'::OMe Me I: N9H,N O--{CH,lnO '" NH, --'R 18·22% H -N '" O--{CH,>;,O N- H
138a: R=CH(SEt)z;n=3, b: n=4, c: n=5 139a-c
Scheme 1.21
1.4.2 Synthesis of CS-linked pyrrolobenzodiazepine dimer via reductive cyclisation
of ro-azido/nitrocarbonyl compounds
A further method has been reported for the synthesis of PBO dimers involving reductive
cyclisation of ro-nitrocarbonyl compounds by samarium Iodide." Thus, alkylation of precursor
(140) with dibromo-alkanes (141) generated oi-nitroester dimer (142), which upon reduction with
DIBAL-H afforded the to-nitroaldehyde (143). Reductive cyclisation of compound (143) with
samarium iodide gave DC-S1 dimers (144a-c) in 55-63% yield (Scheme] .22).
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Scheme 1.22
Very recently, Kamal et al. synthesized and tested a new sequence selective imine-amide
pyrrolobenzodiazepine dimer,57 comprised ofDC-81 and dilactam of the DC-8I subunits tethered
to their C8 positions through alkanedioxy linkers. Thus, oxidation of vanillin followed by
benzylation and nitration provided the starting material (145). Coupling of the (L)-proline methyl
ester and debenzylation of the resultant (146) with BF3.0Et2-EtSH afforded compound (147),
which upon hydrogenation over a palladium catalyst gave the dilactam precursor (148).
Esterification of vanillic acid methyl ester (149), followed by nitration, ester hydrolysis and
coupling with (2S)-pyrrolidinecarboxaldehyde diethyl thioacetal afforded the other precursor (153)
(Scheme 1.23).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o
MeO C02R Br(CHZ)nBr, KZCOJ M.eO CO R M°xX 0CH COCH fl :er Z oc, OMF. e I ~........... N ". J J, re ux I -c "HO X 82,86% ~ THF, HzOBr(CHZ)nO XzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAn Br(CH2)nO NOz CH(SEth
149: X=H, R=Me E150a-c: X=H, R=Me N "CH(SEth 153a-c
SnCI4i HN03, OCM, -ZSOC 151a-c: X=NOz, R=Me H
1M LiOH, THF, MeOH, H20 (3:1:1), r.t. 152a-c: X=NOZ' R=H
Scheme 1.23
Linking compounds (147) and (153) resulted in the key intermediate (154), while the
alternative key intermediate (155) has been prepared by linking (153) and (148). Reduction of
both compound (154) and (155) with tin (II) chloride provided (156), which upon treatment with
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HgCh/CaC03zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAgave the target C8-linked dimers (157) containing the imine and dilactam moiety in
55-61% yield (Scheme 1.24).
Compound147,K2C03~
CH3COCH3,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAreflux 85-90%
o 0G<:CC°zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAM' M,od>o
RI 02N O-(CH)i10 N02 'R2
154: RI= C02Me, R2=CH(SEth
I
153a:n=3,b:n=4,c:n=5
I
SchemezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1.24
Similarly, the same group later reported'" the synthesis of the mixed imine-amine PBD
dimers employing compound (146). The key step involves the synthesis of compound (160)
which was obtained in moderate yield via reduction to alcohol (158) and subsequent oxidation to
give aldehyde (159) followed by hydrogenation and ring closure. Linking compound (160) and
(153a-b) resulted in the key intermediate (161), which upon reduction to compound (162) and
treatment with HgCh/CaC03 gave the target C8-linked dimers (163) containing the imine and
amine moiety in 50-51% yield (Scheme 1.25).
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Me0)Cl,° ~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI N0
BnO .0 N02 k
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Scheme 1.25
1.4.3 Synthesis of pyrrolobenzodiazepine dimers through a piperazine side armed
alkane spacer
During the last decade, many piperazine derivatives have been synthesized as useful
chemotherapeutic agents for various diseases. Bis-l,4-dialkyl-piperazines have been extensively
investigated and have been reported as anti-bacteriaI59,6o and antineoplastic agents.S9,61,62 Michejda
and co-workers'" reported symmetrical bifunctional agents as a promising antitumour class of
compounds with remarkable selectivity against colon cancers that possess a piperazine moiety in
its linker spacer. Recently, Kamal et al. synthesised and tested a series pyrrolobenzodiazepine
dimers linked through a piperazine moiety." Access to the pyrrolobenzodiazepine dimer linked
through piperazine (166) was accomplished via an initial dimerisation of the compound (153a-d)
with piperazine in the presence of potassium carbonate in refluxing acetone to access dimer (164),
followed by reduction to (165) and treatment withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAHgCh/CaC03 to urnish the target C8-
piperazine linked dimers (166a-d) in 61-65% yield (Scheme 1.26).
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166a:n=2,b:n=3,c:n=4,d: n=5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Scheme 1.26zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Lown and co-workers'< adopted a similar method for the synthesis of pyrrolo[2,1-
c][1,4]benzodiazepine dimers (174) linked with pyrrole and imidazole polyamides. Thus, the key
intermediate (169) was obtained in 70% yield from compound (167) via a condensation reaction
with [2-[N-(benzyloxycarbonyl)amino]ethyJ]amine and subsequent deprotection of the Cbz group
in intermediate (168). Access to the alternative precursor (172) was accomplished via an initial
coupling reaction between compound (167) and (170) followed by hydrolysis of intermediate
(171) with sodium hydroxide (Scheme 1.27). Additional coupling of compound (169) and (172) in
the presence of EDcr and HOBt afforded compound (173), which upon reduction and treatment
withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAHgCh/HgO cycl sed to afford the desired bis-PBD-pyrrole and imidazole dimer (174) in 40-
45% yield.
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAM'°xXN~
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Scheme 1.27
1.4.4 Synthesis of C2/C2'-exo unsaturated pyrrolobenzodiazepine dimer
In an attempt to further extend base-pair span and recognition behavior, Thurston et al.
investigated the inclusion of C2/C2' substituents and reported a novel synthesis of SJG_13666,67
(189), a C2/C2' exo-methylene analogue of DSB-120. Thus, the key PHD C-ring coupling
fragment (182) was prepared in seven high yielding steps (via 176......181) from trans-4-hydroxy-L-
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proline (175) as shown in Scheme 1.28. Subsequent coupling to compound (183) provided the
bis-nitro-amide (184) in 74% yield, which under mild conditions using TBAF to rapidly remove
the TBDMS protecting group afforded the bis-nitro-alcohol (185) in 94% yield. Reduction of the
nitro group followed by Alloc protection and oxidation with TPAPINMO resulted in ring closure
to provide compound (188) in moderate 32% yield. Cleavage of the Alloc protecting group with
Pd(PPh3)4/PPh3/pyrrolidine afforded the desired PBD dimer (189) in 77% yield. Alternatively,
under Swern's conditions, compound (187) oxidised to give compound (190) and upon Alloc
deprotection gave the dilactam dimer (191). The same group further extended the study to include
the synthesis of the homologous diether-linked dimers (i.e. -O-(CHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2)n-O- where n=3 and 5) via a
similar route."
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Scheme 1.28
In addition, Kamal et al. have reported a series of C2-exo-fluorounsaturated
pyrrolobenzodiazepine dimers employing the deprotective cyclisation of an amino thioacetal
approach.69,7o Thus, etherification of 4-fluorosubstituted pyrrolidine-2-carboxaldehyde diethyl
thioacetal (192) with dibromoalkanes provided compound (193). Reduction of compound (193)
with SnCh.2H20 resulted in the corresponding amino diethyl thioacetal (194), which upon
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deprotection via HgCh/CaC03 cyclised to give C2/C2' -exo-fluorosubstituted PBD dimers (195a-
c) in 60-70% yield (Scheme 1.29).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o
M'O:CC>O'X
HO N02 CH(SEth
192: X=For =CF2
dibromoalkanes,K2C03 j 89-9) %
acetone, reflux 36-48 h
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0X'G<XXOM' M'Orr<),X
(EtShHC R O--{CH)i10 R CH(SEth
C 193: R=N02, X=For =CF2SnCI2·2H20, MeOH, reflux 2 h 194:R=NH2, X=For=CF2
HgCI2, CaC03 j 65-70%
MeCN/H20 12 h 0
X'S{~O JCl0)? ,XN ~ OMe MeO ~ N .
H'" -N I a O--{CHinO I a N- H
195a-c: X=F or =CF2
n=3, 4 and 5
Scheme 1.29
1.4.5 Synthesis of A-C8/C-C2 linked pyrrolo[2,1-c] [l,4]benzodiazepine dimers
Recently, Thurston and co-workers have reported" the first example of A-C8/C-C2 amido-
linked pyrrolobenzodiazepine dimers via convergent routes involving C8-amino and C2-
methylenecarboxy pyrrolobenzodiazepine monomers. Thus, N-protection of the commercially
available 4-nitroanthranilic acid (196) as its allyl carbamate (197) followed by coupling to (S)-( +)-
2-pyrrolidinemethanol provided compound (198). Reduction of the nitro using SnCb in refluxing
methanol and treatment of the resultant amine (199) with 9-fluorenylmethyl chloroformate in the
presence of aqueous sodium carbonate resulted in compound (200). Swern oxidation of (200)
provoked B-ring cyclisation to give compound (201), which upon treatment with N,N-
dimethylamine in methanol removed the Fmoc protecting group to provide the key C7-des-
methoxyaniline (202). The desired A-C8/C-C2 amide-linked PBD dimers (205) were prepared by
coupling compound (202) with compound (203) and subsequent treatment of compound (204)
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with palladium in the presence of pyrrolidine cleaved the Alloc protecting group to give the novel
NI O-C 11 imine PBD dimer (205) in 70 % yield (Scheme 1.30).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
TBTU 0 0
(s)-2-pyrrOlidinemethanold'~ (COCI)2,DMSOd2
DTPEA,DMF I '-': NW Et3N,DCM,-45°C I '-":: N
75% I 0 : 76% RI 0 RR NH :: N
I ---OR I OH
Alloe Alloe
196: RI=NO.R2=H 198' RI=NO 201: RI=NHFmoe
AlIoc-CI,Pyridine,OCM,c-cc:197: RI=NO~;R2=Alloe SnCI2·H20,MeOH,t.E 199; RI=NH~ HNM~, MeOHC:202: RI=NH2
Fmoc-Cl, aq. N82C01,THF 200: RI=NHFmoe
~N\~
o ~ DlC, HOBt,DCM dO ~ NHUW-(H
MeO '-': i['C02H O°Cthen202 DCM MeO ,'- gr I OHI " I <c 0 Alloe
MeO 0 N H MeO 0 N H 204
I OH I OH
Alloe ~ Alloe
203 70% Pd(PPh3)4,PPh)
o pyrrolidine,DCM
o NHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAd5?
MeO -N_~ N
MeO N~ 0 205
Scheme 1.30
The synthesis ofa new A-C8/C-C2 alkoxyamido-linked pyrrolo[2, l-c][1,4]benzodiazepine
dimer has been described by Kamal et al..zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA72 The key A-C8 components (208a-c) were prepared by
etherification of compound (206) with methyl bromoalkanoates, followed by basic hydrolysis of
the resultant esters (207a-c) to give the desired intermediate acids (208a-c) .in78% yield (Scheme
] .31).
o 0 IMLiOH 0
Meod'~ methylbromoalkanoateMeod .~ THF-MeOH-H20Meod ~I '-': NW K2C03,DMF,r.t.24h I '-': NW r.t. 12h I '-":: NW
0: 90% 0: 78% 0:
HO N02 CH(SEth R N02 CH(SEth R N02 CH(SEth
206 207: R=O-(CH2)nC02Me 208: R=O-(CH2)nC02H
a:n=l;b:n=3;c:n=4
Scheme 1.31
The other key C-C2 amino components were prepared via a coupling reaction between
compound (209) and trans-4-hydroxy-L-proline methyl ester hydrochloride to give the nitro ester
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(210). Treatment with TBDMS-CI followed by reduction with DIBAL-H produced the
corresponding aldehyde (212), which upon protection with EtSH/TMS-CI resulted in the
protection of the aldehyde and deprotection of the TBDMS in the same step to give compound
(213). Mesylation upon C2 hydroxy group gave compound (214), followed by azidation to
compound (215) and reduction of the azide to afford compound (216). Reaction of compound
(208a-c) and compound (216) gave coupled product (217), which after reduction with SnCh.2H20
in methanol gave (218a-c). Deprotection of the diaminothioacetal precursor usingzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAHgCIz/CaC03
afforded the PBD dimers (219a-c) in 56-60% yield (Scheme 1.32).
1. SOCI2,benzene
HO
2.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAh 0 0
MeOXXC02H N "C02Me Meod .~R2 TPP, THFINH40H Meod ~.\NH2I '-': H HCI I '-': N0 r.t.: h I '-': Ny
B 0 ~ NO H20, r.t. 2 h ~: 72 Yo B ° ~ NO :.
n 2 75% BnO N02 RI n 2 CH(SEth
209 TBDMSCI imidazole DCM r.t. 8 h~ 210: RI=C02Me, R2=OH 216
, " 211: R1=C02Me, R2=OTBDMS j
DIBAL·H, DCM, ·78°C I h 212: R1=CHO, R2=OTBDMS HOBt, EDCI
EtSH, TMSCI, DCM, r.t. 8 h 2.13: R1=CH(SEt)2,R2=OH 55.59% compound. 208
Et3N, MsCl, DCM, O°C 5 h 214: R'=CH(SEth, R2=OMs DCM/H20
NaN3, DMF, 60
0
C '6 h 215: RI=CH(SEt)2,R2=N3 r.t. 8 h
o H M'O~":I 0 H M'O~N8
MeoBL~·"\Nrr4'oAANYa ~ag~o.l~MeO~N~·'Nrr4'oAJlR 'R'
I 0 MeCN/H20 ~n ~ 0
BnO 0 N- H r.t.12h BnO R RI
219a-c 56-60% r217a-c: R=N02, R'=CH(SEth
n=l, 3, and 4 SnCI21H20, MeOH, reflux 2h L.218a-c: R=NH2•R'=CH(SEth
Scheme 1.32
In a variation on this procedure, intermediates (224a-c) were prepared by coupling
compounds (208a-c) with compound (223) prepared as shown in Scheme 1.33, which upon
reduction gave the aminothioacetal precursors (22Sa-c). Treatment with HgCh/CaC03 provided
the imine-dilactam PBD dimers (226a-c) in 51-55% yield.
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
M'0x::L(yR
BnO N-lH
H 0
NaN DMF 60°C 16hE 221: R=OMe3.. 222: R=N3
TPP. THFIH20. r.t. 8 h 223: R=NH2
j
HOBt, EDCI
63-65% compound 208a-c
DCMIH20
r.t. 8 h
0:8A~:d-}2HgCI, x::L0:8 ,A;:d-N?,MeO N n" N CaCO MeO ~ N II" R
o 3 I 0
H MeCNIH20.o H
BnO ~ r.t.12h BnO N
o 51-55% H 0
226a-c LI224a-c: R=N02, R'=CH(SEth
n=l, 3, and 4 SnC121H20. MeOH. reflux 2"L.225a-c: R=NH2, R'=CH(SEth
Scheme 1.33
Moreover, the same group have reported the first example of A-C8/C-C2-exo unsaturated
alkoxyamido linked pyrrolo[2,I-c][1,4]benzodiazepine dimer." Thus, debenzylation of precursor
methyl 4-benzyloxy-5-methoxy-2-nitrobenzoate (227) with BF3.0Et2-EtSH gave compound (228),
which upon etherification with Boc-protected bromoalkylamine provided (229a-b). Hydrolysis
and subsequent coupling of acid (230) with (2S)-pyrrolidinecarboxaldehyde diethyl thioacetal gave
(231a-b) and Boc deprotection with tritlouroacetic acid provided the key C8 alkoxyamine
intermediate (232a-b) (Scheme 1.34).
Boc-protected
bromoalkylamine
K2C03,OMF, r.t. 24 h
C 227: R=OBnEISH-BF30EI2. DCM. r.t, 12 h 228: R=OH
MeO~R
Boc'N-B"..O~N02
H
. C 229a: R=C02Me; n=l, b: n=2
1M LIOH. THFIH20fMeOH, r.t. 2 h 230: R=C0
2
H
2-(S)-pyrrolidinecarboxaldehydediethyl thioacetall 60-65%
EDCI/HOBt, DCM/H20, r.t. 24 h t
o
MeovVN0
~".Jr ~
R N02 CH(SEth
85-88%
C 231: R=O-(CH2kNH-BocTFA, DeM. r.t. 8 h 232a: R=O-(CH2kNH2; n=l, b: n=2
Scheme 1.34
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The C-C2-exo unsaturated acid components (240) required for coupling to (232) were
synthesized via an initial coupling reaction between 4-benzyloxy-5-methoxy-2-nitrobenzoic acid
(233) and trans-4-hydroxy-(L)-proline methyl ester hydrochloride to afford compound (234).
Protection of the hydroxy group with TBDMS-CI followed by reduction of the resultant (235) with
DIBAL-H gave aldehyde (236). Subsequent treatment with EtSH/TMS-CI resulted in the
protection of aldehyde and deprotection of the TBDMS group in one step to provide compound
(237). Oxidation followed by treatment of the resultant product (238) with methyl diethyl
phosphonoacetate resulted in compound (239), which upon hydrolysis yielded the corresponding
acid (240). Amidation of compound (240) with (232) yielded the key intermediate (241a-b),
which upon reduction with SnCh.2H20 gave the amino diethyl thioacetal (242a-b) and
deprotection of the amino diethyl thioacetal with HgCh/CaC03 provided the target molecules
(243a-b) and (244a-b) (Scheme 1.35).
I. SOCI2, benzene
2.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAHOh 0 TPAPINMO
MeOXXC02H N' 'C02Me Meox;( ~R3zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBADCM/MeCNI H HCI I N0 r.t. 2.S h
RiO h NO Et3N, H20, THF RiO h NO ~ 76·78%
200C 1 h 2 R2
233 ~ 234: R2=C02Me, R3=OH
TBDMS-C1.DCM.r.t. 12h 235' R2=CO Me R3=OTBDMS
DIBAL-H.DCM.-78°C4S min : L 2 'J-
EtSHTMS-CIC Cl 8 h 236. R -CHO, R -OTBDMS
. . H 3. r.t. I 237: R2=CH( Eth, R3=OH
o
M~x;(NcrO
R 0 N02 CH(SEth
238
/OyO jNaH' THF
0,) OoC 2 h
'p
/"""-0' 'o_) 80·84%
EDCI, HOBt
o compound 232 0
o H Me°:(J(1 N:) D;t~£:t MeO~NJ):°R
xX .~N. A ::::,.,. '--"';'S':";';'4-=-.6"';'OO:":"'Yo-I ~ ....tr: 0MeO I '-':: N~ -:7' ~ "-""'1fti'O R tH(SEt)2 R 0 N02 CH(SEthRiO .0 R - r- 239: R=Me
CH(SEth 1MLiOH.THFIH20lMeOH.r t. 2hL,. 240: R=H
SnCI2.2H20.MeOH.reflux3 h r- 241a: R=N02; n=l, b: n=2L,. 242a: R=NH2; n=l , b: n=2
HgCI2, caCO~48'SS% 0
MeCN/H20 ~
xXr.t.12ho}(r.~~:V"N')?MeO NRiO N- H ~43a: RI=Bn; n=l, b: n=2
244a: RI=Me; n=I, b: n=2
Scheme 1.35
Further, the group also prepared the PBD dimer (250a-b) with amide and imine
functionality at the NlO-CII positions." Thus, amidation of compound (240) from above withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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(247) prepared as shown below, and subsequent reduction of coupled product (248) followed by
deprotection of the diethyl thioacetal group in intermediate (249) afforded the imine/ dilactam
PBD dimer (250a-b) in 51-53% yield (Scheme 1.36).
TFA,DCM
r.t. 8 h
o
;'
oOzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAdN8
H2N 0 N02c02Me
247Boo-protectedbromoalkylaminer- 245: R=OH
K2CO), DMF, r.t. 24 h L. 246: R=O-(CH2kNH-Boc
j
EDCI, HOBt
65-67% compound 240zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
DCMJH20
r.t. 24 h
o
Me0:oLN~
o H I 0
N~ ~ :
MeO N?8 no N02CO2Me
BnO N02CH(SEth 248
76-78%) SnCI2·2H20,MeOH
reflux 3 h
MeorrO~
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH I
Meod .~N~O ~ N HI ~ N0 ~ H 0
~: 249
BnO NH2 CH(SEt)2 j HgCI2' CaC0351-53% MeCNIH20r.t. 12 h
MeorrO.~o H I}0N~ ~ HMeO N 7" nON. 0 H 0
BnO N- H n;~O:~2
,
Scheme 1.36zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
1.5 Synthesis of pyrrolobenzodiazepine hybrids
The development of conjugates and hybrid molecules between two types of cytotoxic
moieties represent a new approach in the discovery of new antitumour agents, as they possess not
only high potency but also different alkylating sites, with both the aspects being useful for tumour
treatment. Thus in the past few years, several active moieties of known antitumour compounds
leading to novel hybrids tethered to pyrrolobenzodiazepines have been designed, synthesized and
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evaluated for their biological activity. Thurston and coworkers74 have synthesized PBD analogues
with an epoxide group attached at the CS position with an objective of producing PBD system with
DNA cross-linking activity. In this method a 9-fluorenylmethylcarbonyl (Fmoc) group has been
employed to protect the amino intermediate (253) before dithioacetal deprotection to allow the
Fmoc-protected carbinolamine (254) to be formed in order to carry out epoxidation on the C8-
propenoxy group withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAm-CPBA. Finally, the Fmoc is cleaved by tetrabutyl-ammonium fluoride in
DMF to produce the NlO-Cll imine while leaving the epoxide intact, thus affording the target
expoxide-PBD (256) in 79% yield (Scheme 1.37).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
MoO~~1
~OUN~
o
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
DCCDCM 1X SnCI202H20 =cL
Me0'(YC0
2
H Lt:4 h ~:O I: NO. Me04H9'~/ot1' 3 h ~:O I~ NO.
~0~N02 (EtShH~ -...;/ '0 NO 7( ~, //
2 CH(SEt)2 0 NH2CH(SEth
251 HN8 252 253
I. Dioxane,aq. Na2C03'FmOC-Clj
OOC4 h, then rot. 24 h
20HgCI2,CaC03,MeCNIH20
o 0
DMF,TABF Meorr::R m-CPBA,DCM Meorrx.
rot. 15 min -::?' I rot. 72 h -::?' I
79% ~O ~ N H 55% ~O ~ N H
o PmocOH FmocOH
256 255 254
Scheme 1.37
The same group has also focused on the development of a GC-specific agent, due to the
sequence being a major site of action of a number of clinically useful antitumour drugs, such as
nitrogen mustard and mitomycin." Consequently, an EOTA (cleaving moiety) conjugated
pyrrolobenzodiazepine has been synthesized via the thioacetal cyclisation route." The crucial
strategy includes the attachment of the EOTA moiety to the pyrrolobenzodiazepine skeleton prior
to the unstable electrophilic NI0-CI1 imine. The key to this was compound (259) which was
accessed by coupling acid (258) to a diethyl thioacetal. Next, deprotection of compound (259)
with Me3SiI, followed by attachment of the EDTA triester through its free carboxylic group using
CDI afforded the nitro amide (261)0 Reduction of compound (261) through catalytic
hydrogenation provided the amine (262), which cyclised upon treatment with HgCb/CaC03 to the
desired EDTA-DC-S1 (263) in 12% yield (Scheme 1.38). The EDTA moiety was then exploited
to produce, for example, the iron complex (264).
34
Chapter 1 IntroductionzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
EDTA triester, COl, DMF
260: R1=N02, R2= H2C.......,NH2zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
H
261: R1=N02, R2=H2C,-,NyEDTAEtJ
o
H2,IO%Pd-C
9~ M,ox:{°:Q
O~N:3 H I
O-Fe~N~N~ ~ _ H
6,) ~ ° N
~ 264
°
1, Hydrolysis
2,Fell
263
Scheme 1.38
The synthesis of pyrrolobenzodiazepine ring systems linked to methanesulphonate, which
IS an alkylating part of busulphan, used in treatment of chronic myeloid leukemia, has been
described by Kamal and coworkers." Thus etherification of compound (265) with bromoalkanols,
followed by mesylation of the resultant (266) provided the desired precursors (267). Reduction
and subsequent treatment of the amine (268) withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAHgCh/CaC03 in aqueous acetonitrile resulted in
the deprotection of the thioacetal group to provide the target compound (269a-b) (Scheme 1.39).
MeO~N\1
Me02S0~oUN~
° °Meo)C(.~ bromoalkanol K2C03 M orr ~I ~ N0 DMF,r.t.24h e ~ I N0
o ~ 94-96% ~ ~ ~
HO N02 CH(SEth HO nO N02 CH( Eth
265 266
MeO2 I, t3Nj 90-91')1
D M, o-c 8 h 0
°HgCI2• HgO rr
aq. MeCN, r.t. 12 h MeO ~ I N0
68-71% MeO SO~O ~ R :.
2 n CH(SEth
269a-b
n=2,3
[267: R=N02SnCI2·2H20. MeOH, reflux 4 h 268: R=NH2
Scheme 1.39zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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A series of novel pyrrolobenzodiazepine analogues (277-280) resulting from conjugation to
cyclic amines, such as pyrrolidine, piperidine, indoline and isoindoline, via a standard coupling
approach has been reported by Thurston and coworkers." Thus, the key core building block (276)
was obtained from an initial etherification of compound (270) with benzyl alcohol andzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAp-
toluenesulfonic acid to provide the nitro monoester (271). Treatment of (271) with oxalyl chloride
generated the acid chloride which readily coupled to (2S)-( + )-pyrrolidinemethanol in presence of
triethylamine to give compound (272), which upon reduction, followed by treatment of the
resultant amine (273) with di-t-butyl dicarbonate, gave the Boc-protected amine (274). Oxidation
with pyridinium dichromate resulted in the ring closure to compound (275) and finally removal of
the benzyl ester protecting group provided the target building block (276), which was conjugated
to each of the four amines using standard coupling methodology (EDCIIDMAP). Removal of the
Boc group and accompanying dehydration gave the target analogue (277-280) (Scheme lAO).
PhCH20H
cat.p-TsOH
Me0l(YC02H __ to_lu_e_ne___ 0 Me0YyC02H
H02C~O~N02 66% ~O~O~N02zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
270 ~ 271
1.(COCI)z,OMFzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAj
OCM, 18 h
2. Et3N,-50°Cto r.t.
n OH.,'/
~ 0
PCC,OCM 0 MeoXJC, N'~4 A sieves I h / 0
60% ~O~O ~ R ~
~ "OH
eO fl 1 I E272: R=N02SnCI2·2H20, M H, re ux 1 273: R=NH2(BochO. THF, reflux, 18 h 274: R=NHBoc10%Pd/C/H2j98%
16psilEtOH 0
I. EDCr, DMAP, DMF
o thenpyrrolidine °
Me0n--:R pi~ridi~e, indoline M on-52
-7 , Isotndoltne 0 e -7
H02C~O ~ N H 2. 95%CF3C02H, -10°C R~O ~ I N- H
~oc OH
276
277: R= -N8
279:R=~
~NI
\
278:R=CN-
280:R=Q:N-zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Scheme 1.40
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With the aim of finding novel anticancer agents Kamal et al. synthesized numerous PBD
hybrids and conjugates that exhibited not only good DNA binding affinity, but also represented
promising in vitro anticancer activity. The key step involves the initial etherification of (2S)-N-(2-
nitrobenzoyl)pyrrolidine-2-carboxaldehyde diethyl thioacetal derivatives (281, substrate in Tables
1.2a-b) with the DNA interactive moieties such as benzlmidazole," anthraquinone.Y
fluoroquinolone.t' flavone,82 naphthalirnide.V chrysene," acridone/acridine." and pyrene'"
through different alkyl chain spacers to give the C8-linked nitro thioacetal intermediate (282).
Reduction of the nitro to its corresponding amine (283) and subsequent deprotection of the
thioacetal group provided the desired PBD hybrids (284) [Tables 1.2a-b].
Meov.J .~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I M",rN~ + HYBRID
R 0 N02 CH(SEth
281
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
xX: 1.deprotection :eLy.etherification MeO I "'-'::: NCJ 2. cyclisation MeO I "'-'::: N
.& 2 • HYBR[D-O .& N- HHYBRlD-O R CH(SEth
reduction C 282: R~N02 284
283: R2=NH2
SchemezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1.41: General reaction
Entry Substrate Hybrid Reaction conditions Final PBD product
o
Me0xXN~ ~~~ I. KzCO).DMF.r.t.I 0 I/,,,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAII OH 2. SnClz·2HzO
Br.-(?;;.O ".;::. NO ., R ~ N MeOH. reflux
z CH(SEth 3. HgClz/HgO
R=H Me N/HzO. r.t
R=N-methylpiperazine
2
°
° HN~Br
I. Kz 0), acetone. reflux
2. Sn Iz.2HzO. MeOH. reflux
3. Hg Il/Ca 0). Me N/HlO.r.t
°
3
°
FIDOlEt
I".;::. I
F N
~Br
I. KlCO). acetone. reflux
2. SnClz.2HzO. M.OH, reflux
3. HgCIl/Ca 0), MeCN/HlO.r.t
Table 1.2a
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Entry Substrate Hybrid Reaction conditions Final PBD product
° ° °
Me°xX<)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~OH
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° °
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Table 1.2b
The same group also reported the synthesis of C2 and C2-C8 linked
pyrrolobenzodiazepine-naphthalimide hybrids87a,87b to explore its DNA binding potential.
Synthesis of the C2 linked PBD-naphthalimide hybrids have been carried out via the deprotective
cyclisation of an amino thioacetal approach to introduce the sensitive NlO-CIl rrmne, Thus,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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treatment of the nitro ester (285) with TBOMS-CI resulted in the protection of the hydroxy group.
Reduction of compound (286) with DIBAL-H, followed by protection of the corresponding
aldehyde (287) with EtSH/TMS-CI gave compound (288) in 72% yield. Oxidation of the C2
hydroxy group with TPAPINMO provided compound (289), which upon treatment with methyl
(diethyl phosphono) acetate afforded compound (290). Subsequent treatment with 1M LiOH gave
compound (291). Amidation of compound (291) with corresponding naphthalimide (292)
provided the key intermediate (293), which upon treatment with SnCh.2H20 afforded the
corresponding amino diethyl thioacetal (294). Deprotection of amino diethyl thioacetal withzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
HgCh/CaC03 provided the target C2 linked PBD-naphthalimide (295) in 56-58% yield (Scheme
1.42).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2
Meorr ~RI N0
h- .
BnO N02 RI
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DCMJMeCN Mearr /'-..f'a
r.t. 2.5 h I -....:::::N0
78% h-:
BnO N02 CH(SEth
TBDMS-CI'imidazole'DCM,r.t.12h~ 285: RI=C02Me, R2=OH
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Scheme 1.42
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Synthesis of the C2-C8 linked PBO_naphthalimide87a,87b involved a similar approach, but
employing compound (296) as starting material. Thus protection with TBOMS-CI, reduction of
the resultant intermediate (297) followed by ethanethiol protection of intermediate (298) afforded
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compound (299). Coupling of this compound with 1,8-naphthalimide afforded the intermediate
(300), which gave compound (301) upon oxidation. Treatment with methyl (diethyl phosphono)
acetate and ester hydrolysis of the resultant intermediate (302) gave compound (303). Further
amidation of compound (303) with amine (304) provided compound (305). Subsequent reduction
gave the amine (306) which followed by deprotection of the diethyl thioacetal group provided the
desired C2-C8 linked PBD-naphthalimide (307) in 52% yield (Scheme 1.43).
o
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Scheme 1.43
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Furthermore, Baraldi et al. have reported the synthesis of a new hybrid,88 a combination of
a PBD and the naturally occurring antitumour agent distamycin A. Thus, the key
pyrrolobenzodiazepine (315) was prepared via a new general route involving oxidative cyclisation
of the NI 0-Troc-protected intermediate (314), which was readily made available through coupling
of nitro monoester (311) and (2S)-(zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA+)-pyrrolidinyl ethanol, followed by catalytic hydrogenation
of compound (312) and subsequent protection of the resultant amine (313) with Troc-CI. The final
assembly of the desired hybrids (318) was achieved in two steps involving acid hydrolysis of the
ester (315) to give acid (316), which was then coupled with deformyl distamycin in the presence
of EDCI as condensing agent to provide Troc protected hybrid molecule (317a-d). Deprotection
of the Troc afforded the free NlO-CII imine moiety of the target molecule (318a-d) (Scheme
1.44).
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SchemezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1.44
Similarly, Lown et al. have reported a convenient strategy for the design and synthesis of
the first example of a pyrrolobenzodiazepine conjugated with a lexitropsin hybrid.89 The precursor
carboxylic acid (322) was assembled from vanillin (319) as shown in Scheme 1.45. Coupling of
carboxylic acid (322) with (2S)-pyrrolidine-2-carboxaldehyde diethyl thioacetal via the acid
chloride resulted in the nitro ester (323). Hydrolysis produced nitro acid (324), which was then
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coupled with the amine moiety of lexitropsin to give compound (325). Hydrogenation of the nitro
lexitropsin hybrid (325) to the corresponding amine (326), followed by deprotection of the
thioacetal group with HgCbIH20 in aqueous acetonitrile afforded the desired imine (327) in 40%
yield together with the methoxy derivative (328).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o
Meox;rCHO K2C03, THF MeO RI MeoXJ( .~I '::::: Br(CH2hC02Et ~ 1. SOCI2, benzene ?' I N0
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M"N H 'L!(1l" 0 R CH(SE'h
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2 326a:R=NH2; n=l, b: n=2,c: n=3
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+
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~N':-, 0 I
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Me2N . N H 0 H3
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Scheme 1.45
Finally in this section, Hurley et al. have designed a new PHD hybrid (UTA-6026 n=3; see
entry 1, table 1.3) containing two alkylating moieties with the potential to alkylate G and A
sequence tracts of DNA.9o To achieve this a similar methodology to that discussed above was
used whereby DC-SI was combined to (+ )-cyclopropapyrroloindole [(+)-CPJ], which is a DNA-
DNA alkylating moiety that selectively alkylates N3 of adenine.91 The key strategy involved
synthesizing the NI O-Fmoc protected PBD analogue first and coupling it to (+ )-seco-CPI-indole
42
Chapter 1 IntroductionzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
with EDCIIDMA and removing the Fmoc group in the final step to introduce the sensitive PBD
imine bond (entry 1) [Table 1.3]. A similar approach was also undertaken by Tercel and
coworkers'? to combine thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAseco-l ,2,9.9a-tetrahydrocyclopropa[ c]benz[ e]indol-4-one (seco-CBI)
and PBD units to construct a new class of unsymmetrical minor groove cross linking agents (entry
2-5) [Table 1.3].
Entry Substrate Final PBD productHybrid Reaction conditionszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Table 1.3
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1.6 Synthesis of pyrrolobenzothiadiazepines
Recent searches for novel anti-HIV agents endowed with low toxicity has led to the
synthesis of the tricyclic derivatives possessing a 7-membered diazepine ring, which is
representative of a novel class of non-nucleosidic reverse transcriptase inhibitora." Amongst the
benzodiazepine derivatives, the first non-nucleoside reverse transcriptase inhibitors with clinical
potential have been tetrahydroimidazobenzodiazepinone (TIBO, 329),94 followed by the
dipyridodiazepine nevirapine (330) and nevirapine-like tricyclic pyrido- (331) or benzo- (332)
derivatives.f Analogues of nevirapine and TIBO with thiadiazepine moieties have attracted
numerous interest. The related pyrrolo (333) derivatives have also attracted attention as
thiadiazepines with the potential to act as non-nucleosidic reverse transcriptase inhibitors. This,
together with their structural relationship to the antitumour antibiotic pyrrolobenzodiazepines'" has
made the pyrrolobenzothiadiazepines attractive targets, and thus a brief review of methods used to
synthesise them follows.
tzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
CI'G(N
I .0 w_tMe
HN-{ RI
S
329: Rl=H2 330: X=Y=N
331: X=N,Y=CH
332: X=Y=CH
Figure 1.4: Novel classes ofnon-nucleosidic reverse transcriptase inhibitors
333
With a view to investigating pyrrolobenzodiazepines as anti-HfV agents Artico and
coworkers97,98 reported the synthesis of pyrrolobenzothiadiazepines using reductive cyclisation of
a nitro in the presence of a pendant carbonyl functionality. Thus, condensation reaction of 2-
nitrobenzenesulfonyl chloride (334) with compounds (335a-b) using potassium tert-butoxide and
18-crown-6 provided the key compounds (336a-b), which upon reduction with iron powder in the
presence of acetic acid furnished the aminoaldehyde intermediate with concomitant ring closure to
the desired pyrrolobenzothiadiazepines (337a-b) in 92-100% yield (Scheme 1.46).
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336b: R=COC02Et
337a: R=H
337b: R=C02Et
Scheme 1.46
Artico et al. further extended their studies and synthesized compound (337a) via a
phosphorus oxychloride mediated Bischler-Napieralski cycJisation reaction of the formylated
precursor 1-(2-formamidobenzenesulfonyl)pyrrole (339),97,99 which was quantitatively derived
from the reaction of acetic formic anhydride with 1-(2-aminobenzenesulfonyl)pyrrole (338), which
in turn was readily made available from a condensation reaction between the corresponding
sulfonyl chloride and pyrrole (Scheme 1047).
0)( CHO 0 O"?-pzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI 0""0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACC~N::(XS'N~ \ (XS'N~ POCI3COMe
100% 47%
NH2 ~ NHCHO N
338 339 337a
Scheme 1.47
Recent studies by Artico and coworkers'I" described the synthesis of pyrrolo[1,2-
b][1,2,5]benzothiadiazepin-4-one l,l-dioxides via an intermolecular cyclisation'l" of an ester.
Thus, reduction of the nitro compound (340) on heating in the presence of iron in acetic acid
afforded the key amino ester compound (341) in high yield, which upon treatment with 2-
hydroxypyridine as a bifunctional catalyst resulted in the intramolecular cyclisation of the amino
ester to provide pyrrolobenzothiadiazepin-4-one (342) in 42-54% yield. Additionally, treatment of
the ester (341) with hydrazine resulted in the 1-(2-amino-5-chlorobenzenesulfonyl)pyrrole-2-
carbohydrazide (343), which underwent loss of hydrazine upon heating with 2-hydroxypyridine in
acetic acid to provide compound (342) in 38% yield (Scheme 1048).
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o~ezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Scheme 1.48
An approach to the cyclopropyl and benzyl substituted pyrrolobenzothiadiazepines (348a-
b) has been established in high yields101a via intermolecular cyclisation of the corresponding fluoro
carboxyamides. Thus, coupling 2-ethoxycarbonyl-IH-pyrrole with 2-fluorobenzenesulfonyl
chloride (344) resulted in the ester (345), which upon alkaline hydrolysis with KOH gave the acid
(346). Treatment of the acid (346) with cyclopropylamine and benzylamine in the presence of
EDe and DMAP and subsequent treatment of corresponding amides (347a-b) with sodium
hydride/cuprous iodide provided the 5-cyclopropyl- (348a) and 5-benzyl- (348b) substituted
pyrrolobenzothiadiazepine, respectively, in 80-94% yield (Scheme 1.49).
0-..
(XSO,CI I.B"O~,18.:::" (X°'1N~
~ F 82% F ~
344 [345: RI= OzEt
KOH (aq), EIOH,THF 346:RI= 02H
51.71%) EDNH6~p
NaH, DMF, Cu.l (X,....IO~~N~
80-94% -c ~
F CONHR
348a-b 3478:R=cyclopropyl
347b: R=benzyl
Scheme 1.49
An example of a saturated pyrrole (i.e. pyrrolidine) derivative (351) was prepared from 2-
ethoxycarbonyl-l-(2-nitrobenzenesulfonyl)pyrrolidine (349) and reported by Artico and
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coworkers. lOla Thus, reduction of the nitro (349) to the corresponding amino ester (350) with iron
powder, followed by treatment of compound (350) with 2-hydroxypyridine on heating afforded the
pyrrolo[ IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA,2-b][ I ,2,5]benzothiadiazepin-I, I-one 5,5-dioxide (351) (Scheme 1.50).
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACl0"" N 0
(YS'N~ Ph20,~800C, 18 h
~ ~ 64%
R C02Et
F A OH 60°C 2 h[349: R=NOz
e, c, , 350: R=NH2
d:i2
H 0
351
Scheme 1.50
1.6.1 Synthesis of other pyrrolobenzothiadiazepine analogues
In the course of investigations into the synthesis of cyclic sulfones, Silvestri et al.102
synthesized a series of novel pyrrolobenzothiazepine I,l-dioxide derivatives (355) and (358) via
oxidation of the corresponding pyrrolobenzothiazepines. Thus, coupling of 2-aminothiophenol
(352) with IH-pyrroJe in the presence of iodine and potassium iodide gave a mixture of 2-(2-
aminobenzenesulfenyl)-IH-pyrrole (353) and 3-(2-aminobenzenesulfenyl)-lH-pyrrole (356),
which upon treatment with triphosgene in the presence of triethylamine afforded
pyrrolobenzothiazepines (354) and (357). Oxidation of compound (354) and (357) with hydrogen
peroxide provided the desired dioxides (355) and (358) (Scheme 1.51).
R
\
N
O:N~
H 0
354
o R
O~" N
H,O,_o::~
H 0
355
Scheme 1.51
The same group also adopted a similar approach 103 in the synthesis of diester
pyrrolobenzothiadiazepine (363). Thus, coupling of 2-nitrobenzenesulfenyl chloride (359) with
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IH-pyrrole in presence of potassium tert-butoxide and I8-crown-6 furnished 1-(2-
nitrobenzenesulfenyl)-lH-pyrrole (360), which upon reduction with iron powder gave the
corresponding amino derivative (361). Condensation of compound (361) with diethyl oxalacetate
resulted in the cyclised precursor (362), which was then oxidised to the desired dioxide in the
presence of 3-chloroperoxybenzoic acid (Scheme 1.52).
(XSCIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
N02
/-BuOK
18-crown-6
55%zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
359zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
J)"
benzene
r.t. 2 h
26%
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1.6.2 Synthesis of tetracyclic pyrrolobenzothiadiazepines
On studies into the new antidepressant agent, aptazapine, Artico and coworkers"
synthesized a novel tetracyclic pyrrolobenzothiadiazepine (367) via cyclisation and double amide
reduction. Thus, reaction of the unsubstituted pyrrolobenzothiadiazepine (364) with
bromoacetylbromide furnished 1O-bromoacetyl-l 0, 11-dihydro-l1-ethoxycarbonylpyrrolo[1 ,2-
b][J ,2,5]benzothiadiazepine-5,5-dioxide (365), which in the presence of benzylamine provided the
precursor N5-substituted pyrrolobenzothiadiazepine (366). Treatment of precursor (366) with
lithium aluminium hydride resulted in cyclisation and amide reduction to afford the desired
tetracycJic pyrrolobenzothiadiazepine (367) (Scheme 1.53).
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364 1365: R=COCH2BrPhCHzNHz t.._366: R=COCH2NHCH2Ph
Scheme 1.53
The same group also demonstrated the conversion of compound (365) into a series of
useful tetracyclic pyrrolobenzothiadiazepine derivatives, namely (368),103,105 (369)103,105 and
(371).104 The former derivatives (368) and (369) resulted through treatment of 10-bromoacetyl-
ll-ethoxycarbonyl-l 0, 11-dihydropyrrolo[ 1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA,2-b][1 ,2,5]benzothia iazepine (365) with an equimolar
amount of aqueous methylamine in the presence of triethylamine. The latter dioxopiperazinyl
derivative (371) was accomplished through thermal cyclisation of the benzylaminoacetyl
intermediate (370), which was in tum attained by reacting compound (365) with benzylamine
(Scheme 1.54).
O~S~2'-':::equimol NH2MezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAQ _ Et3N
N
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H2N'-Oj
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HNi
370 Ph
O'~?"S-N '-':::V - 368
N C02Et
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15%
19%
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Scheme 1.54
Alternatively, treatment of compound (365) with sodium hydrogen carbonate allowed a
high yielding access to the tetracyclic ~-Iactam derivative (368). Opening of the ~-lactam ring
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with excess methylamine furnished the bis-amide (372),103which underwent ring closure in the
presence of 2-hydroxypyridine to provide the spiro pyrrolobenzothiadiazepine derivative (373) in
50% yield (Scheme 1.55).
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Scheme 1.55
Access to the imidazolo-fused tetracyclic system (377) via cycloaddition of tosylmethyl
isocyanide (TosMIC) to the NI0-Cl1 imine of pyrrolobenzothiadiazepine (337a) in the presence
of butyllithium has also been established by the same author." Such tetracyclic systems were
envisaged as sulfonyl analogues of flumazenil, which has found clinical and commercial success
as a cognition enhancer. The same tetracycle (377) has also been synthesized in 39% yield
through oxidation of the dihydroimidazole precursor (376), which was in turn obtained from
treatment of the aminomethyl derivative (375) with triethyl orthoformate. The aminomethyl
derivative (375) was obtained from the reaction of pyrroJobenzothiadiazepine (337a) with
nitromethane and subsequent Raney nickel reduction of the intermediate nitro compound (374)
(Scheme 1.56).
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1.7 1,2-Thiazine I-oxides
In the context of our interest in the synthesis of pyrrolobenzodiazepines,
pyrrolobenzothiadiazepines and analogues, including other tricycles, some tetracycles and even
bicycles, this introduction will conclude with a brief introduction to the synthesis and chemistry of
1,2-thiazine ]-oxides, as the major aim of this thesis is to synthesise pyrrolobenzodiazepines,
pyrrolobenzothiadiazepines and analogues from 1,2-thiazine ]-oxides.
1.7.1 Chemistry of 1,2-thiazine I-oxides
1,2-Thiazine l-oxides'r" are cyclic six-membered ring compounds containing an SoN bond,
which emanate from the [4+2] cycloaddition reaction of N-sulfinyl dienophile (378) with a
conjugated I ,3-diene (379), in a Diets-Alder fashion.I07 In principle the N-sulfinyl nitrogen-sulfur
double bond, embraced with four electrons, is very similar to the carbon-carbon double bond, and
thus has sufficient polarity to enter into conjugative interaction with adjacent n-electron
systems.l'" Subsequently, the hetero Diels-Alder reaction of nitrogen-sulfur double bonds in a
variety of N-sulfinyl compounds (378; R=Ar, S02Ar, C02R, COR, CN, SR2, PO(OR)2) has
provided a valuable method for the synthesis of 3,6-dihydro-] ,2-thiazine I-oxides (380) [Figure
] .5].109-110
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Diels-AlderzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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R'N ) R'N.....A) Diels-Alder R_ )reaction N IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA+" + ------. +" \.: - +1
-O",S
-O",S~
-o"'S
378 379 380
Figure 1.5: Diels-Alder and hetero Diels-Alder reaction of N-sulfinyl dienophiles
Since the discovery of this reaction by Wichterle and Rocek in 1953,107a number of Die Is-
Alder cycloadditions have been reported for a variety of N-sulfinyl compounds bearing electron-
withdrawing groups on the nitrogen and generally proceed rapidly at relatively low
temperatures.I07-I08,111-116Conversely, in the absence of an electron-withdrawing group these
reactions are slow and require high pressure conditions or Lewis acids to proceed efficiently.l'" In
general these Diels-Alder reactions show excellent regio- and stereospeciflcity.l'" A few
examples of asymmetric hetero Diels-Alder reactions, using either chiral N-sulfinyl dienophiles or
chiral dienes, have been reported to proceed with high diastereoselectivities, while the application
of chiral Lewis acid complexes as catalysts has been demonstrated to give excellent chiral
induction.i'"
1.7.2 Reactivity of I,2-thiazine J-oxides
Although 3,6-dihydro-1,2-thiazine l-oxides are stable enough to be handled and isolated,
the N-S bond is very easily cleaved with variety of nucleophiles. This reactivity is, in fact, a very
important and useful aspect of 3,6-dihydro-1 ,2-thiazine chemistry given that they can, in turn, be
transformed into a variety of useful structures, such as allylic sulfoxides, 110-115sulfenate esters,'!"
115 allylic alcohols,109-115,119homoallylic amines,109-"5 pyrroles,109-115,120-122sultams,109-IISzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN-
unsubstituted thiazine derivatives 110-115and other important compounds as shown below in Figure
1.6.
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Figure 1.6: Synthetic transformations of the 3,6-dihydro-1,2-thiazine l-oxide nucleuszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
(i) Homoallylic amines
The acid- or base hydrolysis of 3,6-dihydro-1 ,2-thiazine l-oxides results in the formation
of the unsaturated amine derivatives via the S-N bond cleavage (Figure 1.6, route a).I09-115Based
on deuterium labeling experiments, Mock and Nugent!" propose that such a conversion involves a
concerted retro-ene reaction of the allylic sulfinic acid, derived from ring opening of the thiazine
ring, generating the corresponding homoallylic amines via extrusion of S02.114
(ii) Allylic alcohols
The conversion of 3,6-dihydro-l,2-thiazine I-oxides to allylic alcohols proceeds via a
sequence of steps by the use of carbon nucleophiles. The bond rupture with a Grignard reagent
initially affords the allylic sulfoxide (Figure 1.6, route b), which later undergoes a reversible [2,3]-
sigmatropic rearrangement to produce the sulfenate esters (Figure 1.6, route c). Upon treatment
with a thiophilic reagent (e.g trimethyl phosphitej.v" the sulfenate esters produce the
corresponding allylic alcohols (Figure] .6, route d).I08-116
(iii) 4-amino-2-alkenyldisulfanes
Reaction of 3,6-dihydro-l ,2-thiazine I-oxide cycloadducts of TosNSO with PhSH in an
alkaline medium yields 4-amino-2-alkenyldisulfanes (Figure 1.6, route e).125
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(iv) 4-amino-2-alkenesulfonicacid derivatives
Treatment of the cycloadducts of TosNSO with base, followed by oxidation with hydrogen
peroxide and acidification provides the 4-amino-2-alkenesulfonic acid (Figure 1.6, route f).125
(v) 3,6-dihydro-[2H]-I,2-thiazine I-oxides
N-Unsubstituted derivatives of 3,6-dihydro-I,2-thiazine I-oxides can be obtained via the
reduction of the cycloadducts of CChCH202CNSO with zinc in refluxing I-BuOH (Figure 1.6,
route g).125-127
(vi) 3,6-dihydro-I,2-thiazine I,I-dioxides (sultams)
Oxidation of 3,6-dihydro-l ,2-thiazine I-oxides tends to be complicated since oxidation can
occur at both the carbon-carbon double bond, as well as at the sulfur. Usually, oxidation at sulfur
is accomplished with milder oxidising agents, such as m-CPBA (peracid) to afford 3,6-dihydro-
I,2-thiazine-I,I-dioxides (sultams) (Figure 1.6, route h). However, a stronger oxidising agent,
such as trifluoroperacetic acid, can lead to oxidation at both centres to produce epoxysultams.Y"
115
(vii) 3,6-dihydro-I,2-thiazines
N-Aryl-3,6-dihydro-I,2-thiazine I-oxides can be reduced to the corresponding 3,6-dihydro-
I,2-thiazines by treatment with lithium aluminium hydride in ether (Figure 1.6, route i). However,
3,6-dihydro-l,2-thiazine oxides that have a strong electron-withdrawing group on nitrogen yield
only products derived from N-S bond cleavage.109-116
(viii) pyrroles
Heating the 3,6-dihydro-I,2-thiazine I-oxide in a strong alkaline methanolic solution
appears to be a complex process. Nevertheless there is literature precedent.l'" which shows that
3,6-dihydro- I ,2-thiazine I-oxides can be transformed into pyrroles. More recent precedence has
shown an alternative route, which makes use of triethylamine/ trimethylphosphite in methanol to
convert the cycloaddition adduct via ring contraction to the corresponding pyrrole (Figure 1.6,
route j). 109-115,122
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2.1 Aims of research projectzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
As can be seen from the introduction, considerable effort continues to be focused on the
chemistry of pyrrolobenzodiazepines and the related pyrrolobenzothiadiazepines. Due to the
immense biological importance of these tricyclic systems, there is always scope to discover new
synthetic routes and modified ring systems with new potential pharmacokinetic properties.
Consequently, in this thesis novel approaches to PBDs/ PBTDs and related analogues using 1,2-
thiazine I-oxide chemistry will be discussed.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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The first part of this research is focused on exploiting route "b" of Figure 2.1 to gain access
to the allylic alcohol (383) via a ring-opening! [2,3]-sigmatropic rearrangement! desulfurisation
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sequence of the starting 1,2-thiazine I-oxide precursor (382)109,128-130.1,2-Thiazine I-oxides are
easily made by intermolecular hetero Diels-Alder reaction of the N-sulfinyl precursor (381) with
1,3_diene109,128-130as shown in Figure 2.1 route "a". Oxidation of the corresponding allylic
alcohols prior to N-protection followed by deprotection and an intramolecular ring closure should
furnish the bicyclic system (384), a useful target in itself, but also useful as a template for further
reaction to form analogues of the PBDs/ PBTDs such as structure (385).
The next aim of the project was to use similar chemistry to routes "a" and "b" as an
approach to some novel tricyclic systems involving intramolecular cyclisation. The concept of this
strategy, as depicted in Figure 2.1 route "e", relies upon the initial construction of cyclisation
precursor (386). Treatment of compound (386) with thionyl chloride and pyridine should generate
the N-sulfinyl dienophile, which is anticipated to undergo intramolecular hetero Diels-Alder
cycloaddition to provide the key tricyclic I,2-thiazine I-oxide fused system (387), a useful target
in itself, as an interesting tricyclic benzodiazepine and benzothiadiazepine. Furthermore,
compound (387) may serve as an excellent template for a variety of chemistry, and importantly a
route through to PBDs! PBTDs (389) via ring contraction-sulfur expulsion reaction,122 or through
ring opening and subsequent cyclisation of the corresponding allylic alcohol (388).
Almost all reported syntheses of the PBDs/ PBTDs rely upon proline as the source of the 5-
membered ring,5,29,34,66,78,96,93with only a few methods relying upon a de novo pyrrole construction
methodology,4C,5,130-132and no methods which construct the pyrrole from a diene. Although
relatively unexploited, the synthesis of simple (unfused) pyrroles from dienes has proven its
importance to the synthetic chemist. 122,133In the view of this, the synthesis of PBTD through 1,2-
thiazine I-oxide precursors is the next aim of this research. We envisioned exploiting route "d"
which should allow access to the pyrroles (390) via a ring contraction-sulfur explusion
reaction 122,134of the 1,2-thiazine l-oxides, followed by a ring closure procedure to propagate the
tricyclic PBD/ PBTD nucleus (389).
The next route to be explored was to utilise a third reaction of 1,2-thiazine I-oxide, that of
homoallylic amine (391) formation via hydrolysis109-11Sas shown in Figure 2.1 route "e". The idea
here was to close the homoallylic systems to form a pyrrole (392) and then study ring closure
possibilities for the system, with a view to generating analogues of PBDs! PBrDs.
Finally, the thesis describes work that will look at the extension of the tricyclic PBrDs to
their tetracyclic analogues (393) via performing a final cycloaddition reaction on the reactive NI 0-
C II imine bond as shown in Figure 2.1 routezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA"f", As discussed previously in the introduction,
such tetracyclic systems are of enormous potential utility. For this reason significant effort was
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put into exploring route "g" of Figure 2.1, whereby the azides (394) are closed onto alkenes,
nitriles and alkynes derived from proline to give the tetracycles (393) via "click" ring closure, a
method hitherto unknown for the synthesis of thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAPBD/ PBTD nucleus.
2.2 Synthesis of 1,2,5-benzothiadiazepine 1,1-dioxide via I,2-thiazine I-oxides
As stated in the aims, the initial plan of this project involved the synthesis of 1,2,5-
benzothiadiazepine I,l-dioxides via a novel 1,2-thiazine I-oxide based approach. The target is
represented by structure (395) [Figure 2.2]. 1,2,5-Benzothiadiazepines are 1,4-benzodiazepine
analogues possessing a sulfonyl moiety' at the 5-position of the 7-membered benzothiadiazepine
ring, and have attracted attentionl35-140as analogues of the benzodiazepines because of their
CNS,135 diuretic,135a hypolipidemic.!" and antiarrhythmic'V activities, their ability to inhibit
metalloproteinases and famesyl protein transferase enzymes,':" and their activity as potent tumour
necrosis factor-azyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(TNF-a) converting enzyme (TACE) inhibitors.139 Some typical examples are
the antiarrythmic agents (396)137 and the TACE inhibitors (397),139 as shown in Figure 2.3.
Although target (395) is useful in its own right, our intention was, however, to further explore its
utility as a precursor for tricyclic systems. In the event, the bicyclic compound (395) was not
formed, but some interesting chemistry, producing a I,2,5-benzothiadiazepine I ,I-dioxide resulted
nonetheless and will be discussed in this chapter.
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R2--«n 0
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAR
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Figure 2.2
The concept of this strategy, as depicted in Scheme 2.1, relies upon the conversion of the
I,2-thiazine l-oxide functionality into the amino ketone (408) and its subsequent intramolecular
cyclisation to generate the target compound (395). Access to the required amino ketone precursor
(408) was to be accomplished via a hetero Diels Alder reaction of the N-sulfinyl dienophile (399)
produced in situ from the 2-azidobenzenesulfonamide (398) by treatment with thionyl chloride in
the presence ofpyridine.109-115 The reduction of the azide via a Staudinger reactionl41-144provides
the amine (402), followed by treatment with a Grignard reagent to afford the allylic sulfoxide
(403), which upon subsequent heating with methanolic trimethyl phosphite, would furnish the
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allylic alcohol (405) via a [2,3]-sigmatropic rearrangement! desulfurisation sequence.I09-115It was
observed previously!" that direct oxidation of such allylic alcohols was unfeasible with a variety
of oxidants and, therefore, protection of the amine group was essential, a process that had been
performed previously in the group, but was not optimized.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIt was, theref re, the preliminary aim
of this project to improve upon this route, and, in addition, to investigate the ring closure reaction
to allow access to target (395) and hopefully therefore to tricyclic analogues of the PBTDs. This
work will now be discussed in detail in this chapter.
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Scheme 2.1: Reagents and conditions: (i) SOCI2, pyridine, THF, rt, 4h; (ii) RICH=CH-CR3=CHR?, THF, rt,
I8h; (iii) PPh3, THF, rt; (iv) H20, THF, reflux; (v) PhMgBr, THF, -40°C; NH4CI(aq); (vi) P(OMeh
MeOH, 60°C;(vii) Protection; (viii) Oxidation; (ix) Deprotection; (x) Cyclisation.
2.2.1 Synthesis of N-sulfinyl dienophiles
The N-sulfinylamines containing a quadrivalent dicoordinate sulfur atom are highly
reactive heterocumulenes,':" which have attracted many interests a starting material for the
synthesis of a diverse range of organic compounds.lo8-116,146-lsoOf particular interest are the
products from their reactions with dienes, which are readily formed and can, in turn, be used for
the preparation of a series of acyclic and heterocyclic compounds as discussed previously. 110-15,134
The classical means of preparing these hetero dienophiles are via sulfinylation of compounds
containing an NH2 group or a 'masked' NH2 group with thionyl chloride in the presence ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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pyridine.I08-116 The resulting N-sulfinyl derivatives can often be distilled or crystallized, but are
water sensitive and are usually prepared in sitU.116
Accordingly, the generation of N-sulfinyl dienophile through sulfinylation of the
commercially available 2-aminobenzenesulfonamide was examined first. It was observed that the
2-amino nitrogen of 2-aminobenzenesulfonamide (409) has the greater reactivity towards thionyl
chloride. Consequently, the 2-amino nitrogen was converted into its corresponding azide, with a
view to the subsequent conversion of the azide back to the amine at a later stage in the synthesis.
Thus, diazotization 151-154of 2-aminobenzenesulfonamide (409) in aqueous hydrochloric acid
solution at OoCresulted in the corresponding diazonium chloride (410), which was used without
isolation in an azidation reaction with sodium azide in aqueous sodium acetate solution at OoCto
give a reproducible 90% yield of the 2-azidobenzenesulfonamide (398) [Scheme 2.2]. The
structure of the product was confirmed by NMR, IR and MS spectroscopic analysis, with IR
showing the characteristic azide band atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax 2135 c ".
NaN°z,OOCa S02NH2__ H_C_I_Ca_q)___...
NH2
409 410zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA398
Scheme2.2
Under these conditions the diazotization takes place with an initial attack of the protonated
nitrosating agent (HN02) by the free aromatic amine nitrogen, followed by proton loss from the
NH2 + group, transfer of a proton onto the oxygen and subsequent loss of water to provide the
diazonium salt (410). Finally, a nucleophilic displacement of N, by an azide ion gave access to
the 2-azidobenzenesulfonamide (398), as shown in the scheme below:
+w .. a,,-,:: S02NH2 _ _____''''r(Y+S02NH2
-w o·~ + ~N-N=OH N=N-OH
I ~ I ..
H H1 \...,.
----[cr~'l----a;:H'---H-2-0-a~:H'
N~ 410
Scheme 2.3: Mechanism of diazotization/azidation of primary amine
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Sulfinylation of the 2-azidobenzenesulfonamide (398) with thionyl chloride using
rigorously dry conditions in the presence of pyridine, proceeds rapidly at OoC, to provide the
desired N-sulfinyl-2-azidobenzenesulfonamide (399), which was used without purification in a
Diels Alder reaction, as described in the following section. One should note that the pyridine is
required in large excess under these conditions. Pyridine functions as both a nucleophilic catalyst
and as a scavenger to trap the liberated hydrogen chloride and precipitates it as the hydrochloride
salt and thus the following mechanism is envisaged (Scheme 2.4).
No
Scheme 2.4: Mechanism of sulfinylation of sulfonamides in the presence of pyridine
2.2.2 Synthesis of 1,2-thiazine 1-oxides via hetero Diels-Alder reaction
Embarking on the synthetic methodology set out in Scheme 2.1, we examined the hetero
Diels-Alder reaction of the N-sulfinyl-2-azidobenzenesulfonamide (399), which was generated in
situ, as discussed in the previous section, with isoprene to produce the 1,2-thiazine I-oxide (400b).
The cycloaddition reaction was carried out by employing an excess of diene and was allowed to
proceed to completion by stirring at O°C for 16 hours, whilst being monitored by TLC (Scheme
2.5).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
399
o
CCo~/_~~S__/--MeN //30
400b
Scheme2.5
In the event of purification by column chromatography of the crude reaction mixture, it
was found that two major product fractions were isolated. The structure of both compounds were
confirmed by spectroscopic analysis and were found to the homoallylic amine (50tb) [seezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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discussion-part IV] formed in 23% yield and the desired 1,2-thiazine ]-oxidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(400b) is lated in
75% yield.
Specifically, thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIH NMR spectrum of compound (400b) provided evidence of
cycloaddition of the diene by the occurrence of the methyl peak at bH 1.83 ppm (3H, s, CH3), the
presence of the axial and equatorial protons of the thiazine ring as four pairs of doublets of
rnultiplets, in the region of bH 3.20-4.1 0 ppm [3.24 (lH, dd, J 16.2, 1.8, CH2S=O), 3.56-3.67 (1H,
dt, J 16.2,1.1, CH2S=O), 3.75-3.85 (lH, dm, J 16.8, CH2N), 4.05-4.15 (IH, dm, J 17.1, CH2N)].
The vinylic CH appeared more deshielded at bH 5.65 (lH, d, J 1.9, MeC=CH), indicating coupling
with the adjacent CH proton. Lastly, four aromatic protons were present, as expected in the region
of8H 7.20-8.l0 ppm [7.28 (lH, t,J7.4, ArH), 7.34 (lH, d, J8.0, ArH), 7.65 (1H, td, J7.9, 1.3,
ArH), 8.01 (lH, dd, J 8.0, 1.3, ArH)]. Furthermore, the J3C NMR spectrum of the molecule
showed a single CH3 group at be 22.1 ppm and two CH2 groups at eSc39.3, 54.2, while the vinylic,
aromatic and quaternary carbon atoms appeared more downfield at 8clI7.6-139.6 ppm. These
data combined with IR spectroscopy [N3 absorption at Vmax 2131 ern"], MS [m/z (ESI+): [M+Ht,
3] 3] and correct accurate mass measurement supported the structure assignment.
The symmetrical 1,3-butadiene was next selected to react with N-sulfonyl-2-
azidobenzenesulfonamide (399) [Scheme 2.6]. 1,3-Butadiene is highly volatile and readily
evaporates at room temperature. Consequently, a large excess of 1,3-butadiene was condensed at
low temperature «-lOOC) and was subsequently introduced to the cooled reaction mixture
containing the dienophile. The cycloaddition was found to proceed readily and the 1,3-butadiene
adduct (400a) was obtained in 75% yield after purification via column chromatography.
~
0",0, 11. T)f{F, O°C 0, ,0,
, cr"S-~s~n'YS'N=S-O- ,9 ;J
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399 400a
Scheme2.6
The structure of the product was confirmed by the presence of the two CH2 groups in the
IHNMR spectrum (400 MHz), shown as four complex sets of signals in the region of bH 3.45-4.17
ppm, with the more downfield CH2 being, presumably, next to the more electronegative nitrogen
atom. Furthermore, the appearance of two multiplets at DH 5.77-5.97 ppm as the two complex
vinylic CH groups, each split both by their neighbouring CH2 and vinylic CH group, confirmed the
assignment. Spectroscopic analysis by J3C NMR (100 MHz) [(DEPT-135) Dc 39.0, 50.6 ppm
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(2xCH2)] and IR spectra [N3 absorption (strong) atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax 2137 c "], along with a consistent MS
[m/z (ESI+):[M+~t, 316] and accurate mass measurement further supported the desired
structure.
The mechanism of such cycloaddition reactions is open to debate. Mock and Nugentl23
proposed a non-concerted, stepwise mechanism, whereas, later, Hanson and Stockbum ISSproposed
that such cycloadditions were concerted processes in accord with Frontier Molecular Orbital
theory.l'" Both proposals can rationalize the observed regioselectivity of these reactions, such as
that observed above with isoprene. The mechanistic situation is further complicated by the fact
that there is no clear evidence as to whether thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(E)- or (Z)-sulfinyl ienophile (Figure 2.3) is
involved.109-110,112,130
+S",-O
II
N'R
(Z)-isomer
+S/O-
II
R/N
(E)-isomer
Figure 2.3: (Z)- and (E)-isomers of N-sulfinyl compounds
Whilst investigating the regioselectivity of the Diels-Alder reaction of N-sulfinyl-p-
toluenesulfonamide with several unsymmetrical dienes, Kresze and WagnerlS7 observed that the
cycloaddition with 2-substituted dienes yields only the 5-substituted dihydrothiazine oxides,
whereas in the case of l-substituted dienes the regiochemistry of the adduct is dependent on the
reaction temperature; at low temperatures, 3-substituted dihydrothiazine oxides are usually
formed, but at higher temperatures the 6-substituted heterocycles are produced (Scheme
2.7).109,129,157
~
R
Scheme 2.7
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Based on their finding, Kresze and Wagnerl57 offered a mechanistic model for the [4+2]-
cycloadditions of N-sulfinyl dienophiles to rationalise the kinetically formed regioisomeric
products. They proposed a concerted reaction mechanism via a transition state which has dipolar
character. For 2-substituted dienes, transition states A and B may be considered (Scheme
2.8).109,129,157If R is an electron-donating group, which stabilises the cationic center, a 5-
substituted product will result. Thus, the isoprene used above, behaves entirely as predicted, a
prediction that was confirmed by subsequent reactions (see later in this chapter). A similar
argument can be made for l-substituted and more complex dienes (Scheme 2.8).109,129,157
B
Scheme2.8
2.2.3 Synthesis of amines via an in situ Staudinger reaction
The reduction of azides to amines is an important reaction for the synthesis of variety of
organic compounds.r" Amongst the large number of methods reported, the Staudinger/hydrolysis
reaction remains one of the more extensively used approaches owing to its simplicity, high
selectivity and mild conditions.l'" Developed in 1919 by Staudinger and Meyer,159athe reaction
engages a primary imination reaction of an azide (412) and tertiary phosphine (411) to form
phosphazide. Interestingly, phosphazides are sometimes isolable or stable, or can be trapped either
via intermolecular reactions, or through formation of a transition metal complex. However, as a
rule they lose nitrogen at ambient temperature or at even lower temperatures to give the
corresponding iminophosphoranes (418)159b,159cin practically quantitative yields (Scheme 2.9).
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Mechanistic studies on the Staudinger reaction revealed that the nucleophilic attack of the
tertiary phosphine on the azide occurs with the formation of an E-phosphazide (413) which
possesses zwitterionic character. Isomerisation of the E-phosphazide gives the Z-phosphazide
(415)/intermediate (416), the formation of which results in cyclisation to (417) and then
elimination of nitrogen and formation of the iminophosphorane (418).159b,159c,160-161zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
[
N-R'
R P:~N=N-N-R' _ N=tP
3 '...; VI 2R31'zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
411 412 413
E-phosphazide
N=N ]R;P' N-R'
415
Z-phosphazide
418
[R3~~-R']N=N
417
~
[
R3P,----,N-R']
N=N
416
Scheme2.9
While iminophosphoranes (418) are powerful synthetic intermediate for aza-Wittig
reactions, they can also be rapidly hydrolysed to the corresponding amine (419)159,162under
acidicl63-165and basic166-167conditions as shown below.
Scheme 2.10
In this respect, both 2-(2-azidobenzenesulfonyl)-I,2-thiazine ]-oxides (400a-b) were
treated with triphenylphosphine in anhydrous tetrahydrofuran at ambient temperature. The
resultant iminophosphorane intermediates (401a-b) were employed in situ in a hydrolysis reaction
in refluxing tetrahydrofuran in the presence of a slight excess of water (Scheme 2.] 1). In both
cases the hydrolysis step proceeded readily, yielding the amines (402a-b) in almost quantitative
yields (98-99%).
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402a:zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBARI=R2::H
402b: RI=H, R2=Me
400a-b
Scheme 2.11
Spectroscopic analysis by IH and J3C NMR of the 2-(2-aminobenzenesulfonyl)-3,6-
dihydro-l,2-thiazine I-oxides (402) confirmed their proposed structure. In particular, the presence
of an amine group was manifested by the appearance in the IH NMR spectrum (400 MHz) of a
broad signal integrating to two protons at bH -4.91-5.06 ppm. Further analysis by IR spectroscopy
revealed the disappearance of the azide band, together with the existence of two broad NH stretch
peaks, the primary band appearing at Vrnax -3432-3476 cm" and the secondary band at Vrnax -3338-
3373 ern", while the NH bending absorption appeared at Vrnax -1560-1598 cm'. Both J3CNMR
(lOO MHz) and MS (ESI+), as well as accurate mass measurements were consistent with the
structure of the products.
2.2.4 Synthesis of allylic alcohols via amino allylic sulfoxides
Following the synthetic methodology shown in Scheme 2.1, the next step involved the
generation of the alIyJic alcohol 168-169 via cleavage of the 1,2-thiazine I-oxide ring by a Grignard
reagent to produce an allylic sulfoxide, which would furnish the allylic alcohol via [2,3]-
sigmatropic rearrangementI70-172 and subsequent desulfurisation in the presence of a thiophile, as
outlined in Scheme 2.12.
R, )
+11 I
- ",8
o ~o-
Ph,o+
MgBr
H
R'N)
",8 I
0-1
Ph
H H - R_ .r-r P(OMe)3 R, ;r
R'N~O ...Hf-- __ R'N; ...°I--__ -NS~ MeOH,1l f©
~ ~ Ph/' (~ -dh
\__:p(OMeh
Scheme 2.12
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Accordingly, the 2-(2-aminobenzenesulfonyl)-1,2-thiazine I-oxides (402a-b) were treated
at -78°C with an ethereal solution of phenylmagnesium bromide in anhydrous tetrahydrofuran
under rigorously dry conditions (Scheme 2.13). The reaction was allowed to proceed to
completion by stirring at -50°C, whilst being monitored by TLC. Thiazine bond rupture proceeded
very cleanly under these conditions to give the crude aJlylic sulfoxides (403a-b), which were
heated with trimethylphosphite in refluxing methanol to give the desired N-(2-
aminobenzenesulfonyl)-1,2-vicinal amino alcohols (405a-b). The allylic alcohols (405) were
purified by column chromatography and were obtained in excellent yields (80-89%). The
structures of the products were confirmed by spectroscopic analysis.
402a-b 403a-b 405a: RI=R2=H
405b: RI=H, R2=Me
Scheme 2.13
More specifically, the IH NMR spectrum of the N-(2-aminobenzenesulfonyl)-t ,2-vicinal
amino alcohol (405b) showed the methyl peak at OH 1.61 (3H, s, CH3), together with a
characteristic signal for the two protons next to the sulfonamide (S02NCH2) group which were
split by each other and the neighbouring CH and NH groups as two sets of doublets of double
doublets at OH 2.84zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(IH, ddd, J 13.0, 8.5, 4.3, CH2NH), and 3.09 (tH, ddd, J 13.1, 6.9, 3.8,
CH2NH). The resonance of the alcohol appeared as a broad singlet at 3.02 (1H, s, br, OH) and its
neighbouring CH-OH appeared as doublet of doublets 4.02 (I H, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.1, 3.0, CHOH), indicating
coupling with the adjacent two CH protons. In the vinylic region of the 'H NMR, the vinylic CH2
group appeared as two separate singlets at OH 4.86 (lH, s, MeC=CH2), and 4.95 (1H, s,
MeC=CH2), followed by a broad singlet intregrating at two, which corresponded to the NH2 at OH
4.97 (2H, s, br, NH2). Evidence for a successful ring opening was provided by the presence of a
broad peak at OH 5.59 ppm (lH, quartet, J 4.1, S02NH), corresponding to the sulfonamide NH
proton. Lastly, four aromatic protons were present, as expected in the region of OH 6.70-7.70 ppm
[6.78 (lH, d, J 7.7, ArH), 6.79 (lH, t, J7.8, ArH), 7.31 (lH, td, J 7.7, lA, ArH), 7.69 (1B, dd, J
7.9, lA, ArH)]. Furthermore, the 13C NMR (100 MHz) supported the assignment, showing,
amongst other peaks, the vinylic CH2 present at Oc 112.2 ppm (DEPT-l3S). The IR spectrum also
showed two broad bands at Vmax 3474 ern" (OH stretch) and Vmax 3378 ern" (NH stretch) and a NH
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bend atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVrnax 1522 cm", which, together with a consistent MS analysis (ESI+) and accurate mass
measurement, confirmed the anticipated structure.
2.2.5 Synthesis of N-Fmoc protected amino alcohol
As mentioned in the introduction to this chapter, previous work in this group145 showed
that a direct oxidation of the hydroxy group in the allylic alcohol proved unsuccessful under a
variety of conditions (for example, Dess-Martin, Swern, TPAP, Corey's reagent, and Mn02)
possibly due to a competing reaction of the primary amine. Protection of the amino group was
essential in order to carry out the subsequent oxidation step. Therefore, an investigation on amine
protecting groups that could apply to our synthesis was undertaken. The protecting group chosen
would need to protect the amine in the presence of the alcohol group.
Fortunately, recent work by Wijkmans et 01.173 into the investigation of the cyclisation
strategies for the construction of the 3-methoxycarbonyl-2-N-methyl-1 ,2,5-benzothiadiazepine 1,1-
dioxide (424) via an aniline derivative (423), demonstrated the use of 9-fluorenylmethyl
chloroformate as a protecting group for the generation of the Fmoc-protected aniline (421), a
species which, like compound (405), contains an alcohol. Thus, in Wijkman's work treatment of
the amine (420) with 9-fluorenylmethyl chloroformate in the presence of sodium bicarbonate
afforded the Fmoc-protected compound (421) in 45% overall yield (Scheme 2.14). At the
deprotection step, these workers anticipated that removal of the Fmoc-group of the a,~-unsaturated
ester (422) using standard conditions, such as piperidine in DMF, would rapidly lead to the
formation of the piperidyl adduct (425), the product of Michael addition. Therefore, alternative
conditions for the deprotection of Fmoc derivative (422) were studied. It was found that refluxing
a mixture of (422) in a I: 1 solution of dichloromethane and N.N-diisopropylethylamine (OlEA)
afforded aniline derivative (423) in 70% yield. 173Cyclisation of compound (423)with sodium tert-
butoxide in THF furnished the desired benzothiadiazepine dioxide (424).
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Accordingly, the allylic alcohols (405a-b) were treated with 9-tluorenylmethyl
chloroformate and sodium hydrogen carbonate in anhydrous dichloromethane at ambient
temperature under nitrogen (Scheme 2.15). In both cases the protection proceeded readily and the
purification of the crude mixture yielded the Fmoc-protected arylamino alcohols (406a-b) in 63-
71% yields.
Fmoc-CI
NaHC03
DCM,r.t.
405a-b
Scheme 2.15
The incorporation of the Fmoc group was confirmed by IH and I3C NMR spectroscopic
analysis of the products. Significantly, in each case, the IH NMR spectrum (400 MHz) indicated
the additional presence of the 9-tluorenylmethoxycarbonyl CH and CH2 groups, split by each other
as a triplet at bH ~4.33 ppm (lH, t, J7.l Hz, CHCH20CONH) and a doublet at OH ~4.52 ppm (2H,
d, J 7.2 Hz, CHCH20CONH), respectively. In the aromatic region, the tluorenyl CH groups
appeared in the region of OH ~7.36-7.44 ppm and OH ~7.65-7.8] ppm, while, more downfield in the
spectrum, a broad signal at OH ~8.70 ppm verified the presence of the deshielded carbamate NH
group. Additionally, I3C NMR spectra (lOO MHz) of the products showed the 9-
fluorenylmethoxycarbonyl CH and CH2 groups in the region of Oc ~46.9-54.2 ppm and Oc ~67.6
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ppm, respectively, together with the expected fluorenyl carbons in the aromatic region and the
deshielded carbamate c=o group at ()c ~ 153.2 ppm. Further evidence of the carbamate protection
was provided by the occurrence, in the IR spectrum of each of the products, of azyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAc=o st etching
absorption at Vmax 1738 ern", while analysis by MS (ESI+) and accurate mass determination were
in full agreement with the proposed structures.
2.2.6 Synthesis of N-Boc protected amino alcohol
Having, successfully, protected the allylic alcohol with a base-labile Fmoc protecting
group, our next aim was to improve the yield of the protection with the use of an alternative
protecting group. Among the various protecting groups, we became interested in the acid labile
tert-butyl carbamate (Boc) group,174.177which has been the most utilized protecting group for 1°
and 2° amines in the literature.174-177 Various different reagents with a general structure Boc-X
(426) have been synthesized for introducing the Boc group onto the amines (Figure 2.4).
However, owing to the instability of the corresponding tert-butyl chloroformate (429) and the
explosive properties of the tert-butylazido formate (428), the di-tert-butyl carbonate (430, Boc20)
reagent is the most widely used for protecting the amines.174-178
Figure2.4
The conventional means of introducing the tert-butoxy carbonyl group usmg Boc20
involve treatment of the parent amine with Boc anhydride in the presence of triethylamine, a
procedure which well documented in literature.174-177However, the efficiency and selectivity of
such conditions depends very much on the nature of the compound which is being protected, as
described by Hassner et al.179 whilst investigating the reaction of Boc20 in the presence and
absence ofDMAP as a route to protecting primary aliphatic and aromatic alcohols, amino alcohols
and aminothiols. The study showed that the reaction of di-tert-butyl dicarbonate (Boc20) with
amines or alcohols, in the presence or absence of DMAP leads to N-Boc protected amines orzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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alcohols, usually in high yield (Scheme 2.16). Furthermore, in the presence of triethylamine,
aromatic amines can be converted to their N-Boc derivatives.i "
DMAP RNHBoc
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
+ Jl + RN=C=O
RHN NHR
ROH + B0C:!0
DMAP RoJok
Scheme 2.16
Accordingly, compound (405h) was initially treated with a solution of BOC20 and
triethylamine in anhydrous acetonitrile at ambient temperature under nitrogen (Scheme 2.17).
However, several attempts to perform the amine protection were unsuccessful, yielding only the
starting allylic alcoholzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(405b).
Scheme 2.17
Consequently, the reactivity of compound (405a) with BOC20 in the presence and absence
of DMAP and triethylamine was carefully examined under different conditions. Several attempts
to form the N-Boc protected amine (431h), led to the formation of the N,O-diBoc product (432h)
as a result of the concomitant protection of the OH group. The best conditions leading to the
highest yield of the desired N-Boc protected amine (431h) were found to be when the reaction was
carried out at low temperatures «-lOoe, Scheme 2.18) inzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBADMAPI MeCN, although, even then the
ratio of the N-Boc product (431h) to the N,O-diBoc product (432h) was just less than 1:I. The
desired N-Boc protected amine (431h) was easily separated by column chromatography in 50%
yield.
o OH OH
O~s'_ r-< DMAP, MeCN o~/9 r-<.
r(Y ~ ,t-Me BoC:!O r(Ys-N ,t-Me +zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~_ <-10°C lA_
NH2 NH
I
Boc
405b 431b
O-Boc
O~/9 r-<Cl: -~ ,t-Me
NH
I
Boc
432b
Scheme 2.18
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The incorporation of the Boc group was confirmed byzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIH and J3CNMR spectroscopic
analysis of the products. Significantly, in each case, the IH NMR spectrum (400 MHz) indicated
the additional presence of the tert-butyl carbonyl (CH3)3 groups as a singlet, integrating as 9
protons in the region of bH ~1.35-1.38 ppm (9H, s, (CH3)3). Evidence of the N,O-diBoc product
(432b) was provided by the disappearance of the OH group in the IH NMR of compound (432b),
which is present in the N-Boc compound (43tb) at bH ~2.81 ppm (lH, s, OH). Additionally, J3C
NMR spectra (100 MHz) of both products showed the tert-butyl carbonyl (CH3)3 and the
carbamatezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAc=o group in t e region of eSc~27.7 ppm and be ~151.0-153.3 ppm, respectively,
together with the expected doubling of the carbamate peak in the J3CNMR of compound (432b),
which is indicative of two Boc groups in the product. Further evidence of the carbamate
protection was provided by the occurrence, in the IR spectrum, of a c=o stretching absorption at
Vmax 1738 cm', while analysis by MS (ESI+) and accurate mass determination were in full
agreement with the proposed structures.
2.2.7 Synthesis ofN-Fmoc protected amino ketones via Dess-Martin oxidation
Having successfully synthesised the N-protected Fmoc and Boc allylic alcohols, the next
step involved the generation of a ketone via an oxidation. The oxidation of allylic alcohols to the
corresponding ketones can be achieved using a variety of oxidising reagents, with the most
common being Dess-Martin period inane, 180TPAP,181Corey's reagentl82 and Mn02,183, as well as
Swern oxidation.184-185The ease of use and ready availability made Dess-Martin period inane the
first reagent to be tried. Furthermore, its use as an effective oxidant for similar conversions had
already been established in previous work by this group.145
Therefore, a solution of the Fmoc protected allylic alcohols (406a-b) in dry
dichloromethane was added to a suspension of Dess-Martin period inane in dry dichloromethane at
room temperature under nitrogen (Scheme 2.19). In both cases the oxidation proceeded smoothly
and the desired ketone (407a-b) was isolated in 80-90% yield.
Dess-Martin
DeM, r.t.
o rl_0d'S-~r=
NH
I
Fmoc
406a·b 407a: R2=H
407b: R2=Me
Scheme2.19
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The mechanism of such oxidation processes is not known for certain, but it is considered to
involve an initial exchange of an acetate ligand on the iodine with the alcohol functionality to give
an intermediate (433)180, which then collapses to form the carbonyl functionality as outlined in
Scheme 2.20.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~
~ J
AeO OAe AeO OAe,-,H
"'_"OAe ~"(~O-C\-R2
'0 _.. I 0 RI _..
-HOAe.o -HOAe
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
433
Scheme 2.20
The structural assignment of the Fmoc-protected amino ketones (407a-b) was performed in
view of their IH NMR, 13CNMR, MS and IR spectroscopic analysis. In both cases (407a-b) the IH
NMR spectrum (400 MHz) indicated a dramatic change in the CH2 group adjacent to the NH
proton, which appeared as a doublet split by the adjacent NH proton in the region of OH ~4.05-4.17
ppmzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(J ~4. 7 Hz). The disappear nce of both CH and OH groups (CH-OH) and the presence of the
ketone moiety in the 13C NMR spectra (100 MHz) in the region of ~ 192.1-193.3 ppm confirms
successful oxidation. Additionally, the disappearance of the CHOH group and the presence of a
new carbonyl C=O stretch in the range of Vmax ~1733-1740 ern" of the IR spectra gave further
confirmation of the desired structure, while analysis by MS (ESJ+) and accurate mass
determination were in full agreement with the proposed structures.
2.2.8 Synthesis of N-Boc protected amino ketone via Dess-Martin oxidation
The effectiveness of the Dess-Martin periodinane in oxidising the allylic alcohols was also
examined on the N-Boc-protected allylic alcohol (431b). Thus, a solution of the N-Boc protected
allylic alcohols (431b) in dry dichloromethane was added to a solution ofDess-Martin periodinane
in dry dichloromethane at room temperature under nitrogen. Similarly, the reaction proceeded
smoothly and the reagent successfully oxidised the alcohol to give the corresponding N-Boc-
protected ketone (434b) in 94% yield (Scheme 2.21).
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Scheme 2.21
Specifically, the IH NMR spectrum evidence of oxidation of the alcohol was indicated by
the dramatic change in the nature of the CH2 group adjacent to the NH proton, which appeared as a
singlet at OH S.03 ppm (2H, s, CH2CO). The disappearance of both CH and OH groups (CH-OH)
and the presence of the ketone moiety in the I3C NMR spectra (100 MHz) at Oc 193.9 ppm
confirms successful oxidation. Additionally, the disappearance of the CHOH group and the
presence of a carbonyl C=O stretch in the range of Vmax 1692 crn' of the IR spectra provided
further confirmation for the desired product, while analysis by MS (ESJ+) and accurate mass
determination were in full agreement with the proposed structures.
2.2.9 Synthesis of 1,2,5-benzothiadiazepines by Fmoc deprotection/cyclisation
Following the successful oxidation of the Fmoc-amino alcohols to the corresponding
ketones, the final requirement was to cleave the Fmoc functionality and generate the amino ketone
cyclisation precursor for the synthesis of 1,2,S-benzothiadiazepines.
In general, Fmoc deprotection proceeds readily in mildly basic conditions by means of a
variety of ]0, 2° and some 3° amines, most rapidly via unhindered secondary amines, such as
piperidine.186-188The amine serves two purposes in this reaction, initially to drive the reaction by
removing the acidic l3-proton of the fluorenyl ring to generate a cyclopentadienyl anion, which
undergoes elimination reaction to form dibenzofulvene (DBF) and the desired amine via the loss
of carbon dioxide from the carbamate anion precursor.186 Secondly, the purpose of the amine is its
function as a scavenger to trap the liberated DBF via a Michael type addition thereby ruling out
competing reaction with the product aminel89 as illustrated in the Scheme 2.22.
73
Chapter 2 Discussion-PartzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIzyx vutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
DBF
1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
!
O;P
"" HI
NHR
Scheme2.22
H
R-NH, Q_~
I
ezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN)X=CH2, 0, NR, S
X
fr()
--.~ +
Preliminary studiesl45 in our group have shown that the standard Fmoc deprotection
methods (using secondary amines such as diethylamine, dicyclohexylamine and piperidine) were
unsuccessful in cleaving the Fmoc group and instead led to the formation of the product of
Michael addition to the a,r:l-unsaturated ketone. Such competing reaction has also been noted by
Wijkmans et al.140 whilst attempting to remove the 9-fluorenymethyloxycarbonyl group with
piperidine in the presence of a Michael acceptor. Subsequently, the bulky and sterically hindered
N,N-diisopropylethylamine (DIEA) was employed in an attempt to circumvent the potential
difficulties of piperidine acting as a Michael donor.140,186-188
Thus, heating the Fmoc ketone (407b) in a 1:1 solution of N,N-diisopropylethylamine and
dichloromethane resulted in the isolation of two new products, which were not the deprotected
compound (408) nor the expected cyclisation product (395), but were in fact 3-hydroxy-l,2,5-
benzothiadiazepine (435) and, tentatively assigned epoxybenzothiadiazine (436), obtained in 24%,
and 23% yield, respectively (Scheme 2.23).
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Scheme 2.23
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The structures of all products were assigned on the basis of IH NMR, I3CNMR, MS, IR
spectroscopy and further supported by an accurate mass measurement. Specifically, the IH NMR
spectrum (400 MHz) of the 3-hydroxy-I,2,5-benzothiadiazepine I,l-dioxide (435) showed the two
methyl groups split as doublets at OH 0.80 ppm (3H, d, J 6.8, CH3) and 1.01 (3H, d, J 6.9, CH3)
together with a quartet of quartets at OH 2.25 ppm (lH, quartquart, J 6.8, 3.4, Me2CH), diagnostic
of the isopropyl group. The two methyl groups appeared as two doublets, as a result of their
diastereoisotopic nature by virtue of the chiral centre. Further enlightment was given by the
presence ofa Sp3CH group atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAbH 4.28 (lH, d, J3.2, CHOH), which is consistent with the chemical
shift expected of the CH-OH grouping. In addition, I3C NMR spectra (100 MHz) showed a
methine (CHOH) carbon together with a resonance at Oc 160.8 ppm, diagnostic of an imine, which
was also inferred by inspection of the IR spectrum via the presence of a C=N stretching absorption
at Vmax 1602 cm". The presence of an OH group was also indicated in the IR spectrum (vmax 3475
ern") and further confirmation of the proposed structures was provided by MS analysis and
accurate mass measurement.
With regards to a possible mechanism, the 3-hydroxy-l ,2,5-benzothiadiazepine (435) may
arise as a result of a series of tautomerisms involving an initial base catalysed enolisation of the
starting ketone (407b), followed by enamine/imine tautomerism to provide the imine tautomer
(438) and further enol tautomerism to reveal the crucial isopropyl grouping present in compound
(439), as illustrated in Scheme 2.24.
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407bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA437 438 439
Scheme 2.24
With the isopropyl grouping now in place, deprotection of the Fmoc functionality and
subsequent cyclisation of the corresponding free amine (440) under the basic reaction conditions
would produce the carbinolamine (441), which could then give the isolated 3-hydroxy-I,2,5-
benzothiadiazepine (435), possibly via an intermolecular process involving the intermediate
epoxide (442) as outlined in Scheme 2.25.
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The structure of the final product (436) was tentatively assigned on the basis of IH NMR,
I3C NMR, MS, IR spectroscopy and further supported by an accurate mass measurement.
Specifically, the IH NMR spectrum (400 MHz) of the epoxybenzothiadiazepine (436) showed the
methyl groups as two singlets at eSH1.80-1.90 ppm, indicative of the gem dimethyl group. In
addition, I3C NMR spectra (100 MHz) showed a resonance at eSc]50. 7 ppm, diagnostic of a
carbonyl, which was also inferred by inspection of the lR spectrum via the presence of a C=O
stretching absorption at Vmax 1767 em-I. Further evidence for the proposed structure was provided
by MS analysis and accurate mass measurement, which, critically, showed the presence of an extra
carbonyl group (28 mass units) over that expected for simple loss of Fmoc.
With reference to the mechanistic details, it is thought that the extra C=O unit is
incorporated via the carbamate carbonyl by the sulfonamide nitrogen, to give an intermediate
(443), which then collapses to cleave the remainder of the Fmoc functionality to reveal
benzothiadiazine (445) and compound (446) as illustrated in the scheme below.
Scheme2.26
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Compound (445), could then undergo a senes of rearrangements, involving an initial
keto/enol tautomerism to give intermediate (447), which further undergoes an enamine/imine
tautomerism to reveal the crucial dimethyl group present in compound (448). Further
intermolecular rearrangement would give the isolated product (436). Attempts to grow crystals of
compound (436) in order to confirm this unusual structure were unsuccessful.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
[
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Scheme 2.27
It was thought that the vigorous conditions employed (N,N-diisopropylamine,
dichloromenthane, 1:1, 48 hrs at reflux) might be responsible for the failure to isolate the
deprotected amine (408) [see Scheme 2.23, above]. Hence, a number other tertiary amines were
investigated as replacements for diisopropylamine. In the event, triethylamine turned out to be the
best base, as its use led to a single product in reasonable yields. Thus, treatment of the Fmoc
ketones (407a-b) with excess triethylamine in anhydrous dichloromethane at reflux resulted in the
isolation, in each case, of a major new product. Again the new products were not the deprotected
free amines, but were in fact the 3-hydroxy-l,2,5-benzothiadiazepines (435a-b) which were
isolated in 57-69% yield. With triethylamine as base, no other products were isolated (Scheme
2.28), and these represent the best conditions for the deprotection and cyclisation of the Fmoc-
amine (407).
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2.2.10 Attempted deprotection/cyclisation of N-Boc protected amino ketone
Next, the deprotection/cyclisation of the Boc-protected ketone (434b) was investigated.
Unlike the Fmoc group, the Boc group is stable towards hydrolysis under basic conditions as well
as to many nucleophilic reagents. Thus, deprotection generally proceeds readily in mildly acidic
conditions'{' by means of a variety of acidic reagents, including eerie ammonium nitrate,190
Hel/dioxane (4M) solution,'?' BF30Et2/4A sieves,"? acetyl chloride193 and most commonly
TFA.194 It is considered that under acidic conditions, protonation of the carbonyl oxygen of the
tert-butyl carbamate results in degradation to initially produce the unprotected amine, carbon
dioxide, and the highly reactive tert-butyl cation,175a,195-196which can decompose to
isobutylene175a,197in the absence of suitable trapping reagents (Scheme 2.29).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
H,OzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAMe
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Scheme 2.29
However, several attempts to perform the deprotection using Hel/dioxane (4M)191 or
BF30Et2/4A sieves,l92 proved unsuccessful in yielding either the desired cyclised product, or the
deprotected amine. When TFA 194was used, the deprotected product (408) was isolated in 68%
yield (Scheme 2.30). Unfortunately, no cyclisation was observed under these conditions. It was
found, however, that the amine (408) underwent widespread degradation to give a multi-spot TLe
profile. Given this difficulty, together with the successful Fmoc results and the long synthetic
procedure to produce compound (434b), this route was not pur ued further.
434b 408 395
Scheme 2.30
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2.3 ConclusionzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
The alcohols (405a-b) were easily produced from the 1,2-thiazine 1-oxides (402a-b) in a
good yielding, reproducible and facile manner. The failure of the alcohols (405a-b) to undergo
oxidation meant that protection of the aniline nitrogen was necessary prior to oxidation as it
appeared that N-oxidation was the problem. Fmoc and Boc groups were successfully introduced,
where the former was selective for the nitrogen and the latter gave mixtures of N-Boc and di-Boc
products.
On attempted deprotection, Fmoc again showed itself the best group, allowing reasonable
yields of 1,2,5-benzothiadiazepine to be obtained, although isolation of the deprotected amine
proved impossible. Conversely, Boc allowed the deprotected amine to be isolated, but did not
result in any cyclisation.
It is of note that compound (395), the target of this section of the work, and the target from
which tricyclic systems would be built was not obtained. Consequently, this thesis will now
describe some other routes by which attempts to produce tricyclic systems were made.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Chapter3 Discussion-Part IIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
3.1 Attempted synthesis of tricyclic 1,2-thiazine T-oxldes
As described in the previous section, the attempt to use the Fmoc-amino ketone
deprotection-cyclisation strategy as a route to making tricyclic benzothiadiazepines was not
successful, due to the involvement of some complex rearrangement reactions in the final step of
the synthesis leading to 5-hydroxy-I,2,5-benzothiadiazepine I, I-dioxides, which are not suitable
building blocks for tricyclic systems. In the view of this finding and our continuing quest to
develop novel synthetic strategies for the synthesis of tricyclic systems, including the
pyrrolobenzothiadiazepine and pyrrolobenzodiazepine heterocycles, we embarked upon a
modified route, which relies upon the incorporation of a pyrrole moiety via intramolecular 1,2-
thiazine I-oxide formation, followed by conversion to the pyrrole, either via ring opening of the
I,2-thiazine ring to form the allylic alcohol (388),168-169which then closes to pyrrolo-fused system
(453) or via a direct ring contraction processzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA122 to give (452), as shown in Scheme 3.1.
We began this part of our investigation with the aim of applying the 1,2-thiazine I-oxide
methodology employed previously, to the synthesis of pyrrolobenzothiadiazepine, starting from
the readily available 2,4-hexdienal (449). The idea was to construct the tricyclic 1,2-thiazine 1-
oxide system (387) via an in situ intramolecular hetero Diels-Alder reaction of the corresponding
N-sulfinyl dienophile, generated from the cyclisation precursor (386) upon treatment with thionyl
chloride (Scheme 3.1). Access to the cyclisation precursor (386) would be accomplished in three
steps from the commercially available dienal (449) involving reduction, followed by halogenation
and finally a coupling reaction of the resultant l-bromo-2,4-hexadiene (451) with 2-
aminobenzamide in presence of triethylamine. Ring contraction of the 1,2-thiazine I-oxide ring
(387) would give the desired pyrrole (452), whereas opening to allylic alcohol (388) and closure
via an SN2' process would hopefully afford (453).
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOH
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3.1.1 Synthesis of hex-2,4-dien-l-01
Br
Me~~
451
OX'NH. 2N~Me
H
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The initial requirement was to reduce the aldehyde functionality to the corresponding
alcohol, which would subsequently be used to produce the l-bromohexa-2,4-diene. The reduction
of carbonyl groups to the corresponding alcohol is an important reaction for the synthesis of
variety of organic compounds.!" Amongst the large number of reagents reported, sodium
borohydride remains one of the most frequently used owing to its ease of use under mild
conditions. I99.200
Accordingly, the 2,4-hexadienal was treated with a milky fine suspension of sodium
borohydride and sodium methoxide in methanol at oDe. The reaction wa found to have proceeded
smoothly and upon purification of the crude mixture yielded the desired alcohol in 74% yield
(Scheme 3.2).
o NaBH4/NaOMe OH
~ II MeOH 0° to r.t. ~ L_H
Me~H Me~H
449
Scheme3.2
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3.1.2 Synthesis of the cyclisation precursor via I-bromo-2,4-hexadiene
Following the successful reduction of the aldehyde to the corresponding primary alcohol,
the next requirement was to replace the alcohol group with a halide atom to produce the desired
alkenyl halide. Primary alcohols can be converted to the corresponding alkyl halide (HX) with
several reagents.i'" the most common of which are halogen acids, inorganic acid and halides such
as SOCb, PBrs, PBr3, POBr3, and so PBr3 was used. The mechanism as outlined in Scheme 3.3,
involves initial activation of the alcohol oxygen by the electrophilic phosphorus (to form a good
leaving group), followed by an SN2 substitution at the alcohol carbon (Scheme 3.3).
H .. ~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
'0: '\zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA~J
R~ :p~
H H Br' BrzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
OH
I
+ ,P~B
Br" r
Scheme3.3
Accordingly, phosphorus tribromide was selected and reacted with the hexa-2,4-dien-I-ol
(450) in anhydrous ether at O°C under an atmosphere of dry nitrogen, to give I-bromo-2,4-
hexadiene (451) [Scheme 3.4], one spot pure by TLC , which was used without purification at the
next stage.
OH
Me~H
PBr), ether Br
QOC, I hr , I~H
-_;--"Me~H
450 451
Scheme3.4
Subsequently, the crude l-bromo-2,4-hexadiene (451) was added to a solution of 2-
aminobenzamide in anhydrous dichloromethane in presence of triethylamine and DMF and
furnished the desired coupled cyclisation precursor (386), presumably via a simple ubstitution
reaction (Scheme 3.5).
Scheme 3.5
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The reaction proceeded smoothly and the cyclisation precursor (386) was isolated, after
purification by column chromatography in 32% yield. The structure of the compound was
confirmed by NMR, JR, and mass spectroscopy. Specifically, the IH NMR spectrum provided
evidence by the presence of the methyl peak split into a doublet atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAbH 1.76 pp (3H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.7, CH3)
and the presence of the CH2 at bH 3.86 ppm (2H, d, J 5.5, NHCH2) split into doublets indicating
coupling to the neighbouring group. The four vinylic CH groups appeared more deshielded in the
region of bH 5.62-6.27 ppm, together with the four aromatic protons as expected in the region of OH
6.56-7.41 ppm. Lastly, both the NH2 group and the NH group were present and appeared as broad
singlets at bH 5.97 ppm and bH 7.92 ppm respectively. Furthermore, the I3C NMR spectra (100
MHz) of the product showed the 2,4-hexadiene CH3 and CH2 groups at be 18 ppm and be 44.6
ppm, respectively, together with the four expected vinyl CH group in the aromatic region and the
deshielded C=Q group at oe 172.3 ppm. These data combined with JR spectroscopic, which
indicated the existence of three broad N-H stretch peaks at Vmax -3486-3340 cm", and the presence
ofa C=Q stretching absorption at Vmax 1735 ern", together with MS [m/z (ESI+): [M+Ht, 217]
further supported the structure assignment.
3.1.3 Attempted synthesis of tricyclic 1,2-thiazine I-oxide
Following the synthetic plan shown in Scheme 3.1, we proceeded to the attempted
synthesis of the tricyclic 1,2-thiazine 1-oxide (387) via an intramolecular cyclisation reaction,
adopting the N-sulfinyl dienophile. Thus, preparation of the N-sulfinyl dienophilelO8-109 (454) was
attempted via sulfinylation of the cyclisation precursor (386) with thionyl chloride under our
standard pyridine conditions. Unfortunately, this proved unsuccessful in generating the desired
tricyclic product (387), and resulted only in the recovery of the starting cyclisation precursor
(386). In the quest for successful cyclisation, a variety of di fTerent conditions were explored as
shown in Scheme 3.6. However, despite the initial disappearance of the starting material, no
identifiable product was obtained under a variety of times, concentrations and reactant ratios. This
is perhaps because compound (454) does form, does not cyclise, but rather hydrolyses back to
compound (386) on attempted isolation.
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THF
Scheme 3.6zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
3.2 Conclusion
The above synthetic plan proved to be unsuccessful in providing the desired tricyclic 1,2-
thiazine I-oxide template for the construction of pyrrolobenzodiazepines and
pyrrolobenzothiadiazepines. The failure to produce the desired 1,2-thiazine l-oxide by
intramolecular cycloaddition meant that the SN2' route and the direct ring contraction route to
pyrrolobenzodiazepines and pyrrolobenzothiadiazepines could not be attempted. The next strategy
for synthesizing the desired pyrrolobenzodiazepine and pyrrolobenzothiadiazepine that was
attempted was to perform the pyrrole ring formation on a 1,2-thiazine formed in an intermolecular
sense and this is described in the next section.
84
Discussion-Part III
ChapterzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA4 Discussion-Part IIIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.1 Synthesis of pyrrolobenzothiadiazepines using ring contraction
approachzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
As depicted in the previous chapter, attempted intramolecular cyclisation reaction to
acquire the corresponding tricyclic 1,2-thiazine I-oxide template as a precursor to the
pyrrolobenzodiazepines had failed. In continuation of our pursuit to develop novel synthetic
strategies for the synthesis of the pyrrolobenzothiadiazepine and pyrrolobenzodiazepine
heterocycles, we thought to explore the possibility of using 2-(2-azidobenzenesulfonyl)-3,6-
dihydro-l,2-thiazine I-oxides in a ring contraction reaction to access the pyrrole moiety, with a
view to generate the pyrrolobenzothiadiazepines. The modification of utilizing 2-(2-
azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine 1-oxides was envisaged as a means to circumvent
the difficulties encountered in the previous chapter, where intramolecular construction of the 1,2-
thiazine l-oxide ring was unsuccessful. The methodology is illustrated in Scheme 4.1.
Scheme 4.1: Reagents and conditions: (i) SOCI2, pyridine, THF, rt 4h; (ii) CH=CR'-CR2=CH, THF, rt,
I8h; (iii) PPh3, THF, rt; (iv) H20, THF, reflux; (v) Et3N, P(OMeh, MeOH, 2h; (vi) acetic anhydride, formic
acid, DCM; (vii) POCI3, dichloroethane,Ll.
In summary, access to the 1,2-thiazine 1-oxide (400), was accomplished via a hetero Diels-
Alder reaction of a sulfinylamine (399) produced in itu from the 2-azidobenzenesulfonamide
(398) by treatment with thionyl chloride. Treatment of the 1,2-thiazine l-oxide (400) with an
equimolar mixture of triethylamine/trimethylphosphite in methanol furnished the desired pyrrole
(455), whilst subsequent N-formylationzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA97 using a preformed mixture of acetic anhydride and
formic acid provided the N-formylated product (456). Finally, ring closure reaction using the
Bischler-Napieralski approach'" gave the desired pyrrolobenzothiadiazepine (457). ApproacheszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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viazyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAthe amine (402) through an iminophosphorane (401) also successfully gave the pyrrole (455).
The detail of this route will be discussed in the remainder of this chapter.
4.1.1 Synthesis of 1,2-thiazine I-oxides via the N-sulfinyl dienophile
The initial requirement was to synthesize I,2-thiazine l-oxides via the hetero Diels-Alder
cycloaddition, as established in section 2.2.2 of this thesis. We initially explored this methodology
using 2,3-dimethylbutadiene as the diene. Accordingly, treatment of the N-sulfinyl-2-
azidobenzenesulfonamide, which was generated in situ as discussed in section 2.2.1, with excess
2,3-dimethylbutadiene produced the desired 1,2-thiazine ]-oxide (400c), which was isolated upon
purification via column chromatography in 77% yield (Scheme 4.2).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o 0 SOCI2
CC~~....pyridineNH2 THF
N3zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
398
Scheme 4.2
The structure of the product was confirmed by the presence of the two CH2 groups in the
IHNMR spectrum (400 MHz), shown as four sets of doublet signals in the region of OH -3.23-3.86
ppm, with the more downfield CH2 being, presumably, next to the more electronegative nitrogen
atom. Furthermore, the appearance of two singlets at DH .1.71 ppm and 1.79 ppm as the two CH)
groups, confirmed the assignment. Spectroscopic analysis by l3C NMR (100 MHz) [(DEPT-135)
Dc ] 6.9, 19.7 (2x CH3) and Dc 42.9, 55.5 (2x CH2)] and lR spectra [azide (N3) absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax
2134 cm"], along with a consistent MS [mlz (ESI+): [M+Ht, 326] and accurate mass
measurement further support the proposed structure.
Having successfully established the I,2-thiazine l-oxide (400c) using the 2,3-
dimethylbutadiene, a further two examples (400a) and (400b) were synthesized u ing butadiene
and isoprene via the same route.
86
Chapter 4 Discussion-Part IIIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.2 Synthesis of pyrroles via ring contraction of the 1,2-thiazine I-oxides
Amongst the various methods developed for the synthesis of pyrroles (461), the use of 1,2-
thiazine I-oxide as a source of the five membered ring via a ring contraction approach has proven
its use in the synthesis of simple (un fused) pyrro)es,121-122,134although the method seems little
used. The method for this ring contraction transformation requires base catalyzed ring opening of
the I,2-thiazine l-oxide, and was classically achieved by simply heating the 1,2-thiazine l-oxides
(458) in a strong alkaline methanolic solution.V' However, this procedure was only applied to
derivatives of I,2-thiazine l-oxides, where the 2-position is substituted by an ester group, hence
limiting it to pyrroles (459). Conversely, various other 2-substituted ] ,2-thiazine l-oxides were
shown to exclusively yield homoallylic amines (460) under alkaline hydrolysisI08,121,130(Scheme
4.3). Subsequent to this work, Harrington 122showed that a tertiary amine base in the presence of
trimethylphosphite furnished good yields of pyrroles (461) without the need for ester group
substitution.
R, )NzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI MeOH
O~S Et3N
458 P(OMeh
Me~
KO~.Htl -.
-H OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
R-N~
461
Scheme 4.3
4.2.1 Synthesis of pyrroles from 2-(aminobenzenesulfonyl)-3,6-dihydro-I,2-tbiazine
I-oxides
In the context of our interest in the application of the 1,2-thiazine l-oxide methodology to
heterocyclic synthesis, particularly directed towards the synthe is of pyrrolobenzothiadiazepines,
we envisioned a versatile synthetic approach utilizing a similar methodology to that above, via the
conversion of 1,2-thiazine l-oxide to a pyrrole. It is thus the aim of th is section of the work to
explore more fully this interesting transformation, utilizing 2-(aminobenzenesulfonyl)- and 2-
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(azidobenzenesulfonyl)-3,6-dihydro-I,2-thiazine I-oxides (402) and (400) [see Scheme 4.1, pp.
86], respectively for the construction of the pyrrole moiety.
To test the feasibility of this process a solution of 2-(aminobenzenesulfonyl)-3,6-dihydro-
1,2-thiazine I-oxide (402c) in methanol was treated with a 1:1 molar equivalent mixture of
triethylamine:trimethylphosphite in methanol, under an atmosphere of nitrogen at room
temperature, and monitored by TLC. The reaction was found to have proceeded readily, and was
complete in two hours, with TLC indicating two new products. After purification by column
chromatography of the crude reaction mixture, the upper product, the desired pyrrole (455c), was
isolated in 21% yield, whilst the lower product, compound (462c), was obtained in 38% yield
(Scheme 4.4). The structure of both compounds was confirmed by spectroscopic analysis.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
402c 455czyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~'EN~('
~_ Me
NH
I
O=P,-OMe
OMe
462c
Scheme 4.4
Specifically, the IH NMR spectrum (400zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAMHz) of the 1-(2-aminobenzenesulfonyl)pyrrole
(455c) showed the two CH3 groups as one singlet at OH 1.91 ppm (6H, s, 2x CR3) and also the two
pyrrole CH groups appeared as one singlet at OH 6.84 ppm (2H, s, 2x pyrrole-H), thus indicating a
symmetrical pyrrole. Further enlightment was given by the presence of the NH2 group at OH 4.60
ppm (2H, br, s, NR2). In addition, the I3C NMR spectrum (100 MHz) showed five CH resonances
in the aromatic region (oc 117.4-135.0 ppm), diagnostic of the presence of the pyrrole and the
aromatic ring. The presence of the NH2 group was further verified by the IR spectrum, which
indicates two NH stretching absorptions at Vrnax 3457 and 3377 ern". MS (ESI+) and accurate
mass measurements were in full agreement with the proposed structure.
Similarly, in the case of the second product (462c), the structure wa confirmed by the IH
NMR spectrum as the N-phosphoramidate. This time, the presence of two extra sets of CH3 a
singlets at DH 3.71 ppm (3H, s, OCR3) and 3.74 ppm (3H, s, OCR3) and the disappearance of the
NH2 functionality and the appearance of the NH group as a broad singlet at OH 6.57 ppm OH, s, br,
NH), allowed the assignment of the structure (462c). The product was also analysed by I3CNMR
(lOO MHz) with the DEPT-135 showing the extra CH3 resonances as expected. Further
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confirmation was gained from the IR spectrum which indicates P=O absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVrnax 1280 c ",
together with MS (ESI+) showing the expected mass peak.
With regards to a possible mechanism, the N-phosphoramidate (462c) may have arisen as a
result of the nucleophilic amine reacting with the phosphate, PO(OMe)3, the side product of the
pyrrole formation reaction, as shown in Scheme 4.5 below.
R-N?
CSH-Q-
,,-----,:P(OMeh
R-N? - R-N? - R-N:J + O=P(OMehzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
r-'s SH
Hl9,
+P(OMeh
o
II~
H ~P\OMe
Ar- ~l MeO OMe
I
H
H 0
I II
Ar-N-P
/ '-MeO OMe
Scheme 4.5
Although the necessary ring contraction reaction of the 2-aminobenzenesulfonyl-3,6-
dihydro-l,2-thiazine l-oxides with triethylamine in the presence of trimethylphosphite proved
successful, the yields of the desired pyrrole were low. The observed reaction of the amino
nitrogen with phosphorus species formed during the reaction is clearly problematic, and for this
reason we turned attention to the use of the azides (400), with the hope that it would behave
differently.
4.2.2 Synthesis of pyrrole from 2-(azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine
I-oxides
The modification of utilizing 2-azidobenzenesulfonyl-3,6-dihydro-1 ,2-thiazine l-oxides
was envisaged as a means to circumvent the difficulties mentioned above, which was blamed upon
the presence of the nucleophilic amine functionality in the structure. Intriguingly, treatment of the
2-(azidobenzenesulfonyl)-3,6-dihydro-I,2-thiazine ] -oxide (400c) with a 1.: 1 molar equivalent
mixture of triethylamine:trimethylphosphite in methanol, under an atmosphere of nitrogen at room
temperature, resulted in a one-pot ring contraction, accompanied by concomitant same pot azide
reduction to provide the desired amino pyrrole (455c) in 11% yield (Scheme 4.6). A second
product was isolated, which was identified as the N-phosphoramidate (462c) which was formed in
39% yield. Recovered starting material accounted for the balance of product.
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400c 455czyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~~N~(zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~_ Me
NH
I
O=P,-OMe
OMe
462c
Scheme 4.6
With reference to the mechanism, it is considered that this interesting one-pot dual
transformation proceeds via the ring contraction, desulfurisation and aromatization process as
depicted in Scheme 4.3, shown previously. This is accompanied by concomitant same pot
conversion of the azide functionality into the corresponding amine via the hydrolysis of
intermediate iminophosphorane (464) formed after Staudinger reactionl41-142of the azide (463)
with the phosphite as shown in Scheme 4.7. The formation of the N-phosphoramidate (465) could
have arisen as a result of partial basic hydrolysis of the iminophosphorane (464) via route 'a' in
Scheme 4.7, or via reaction of the final amine product, (466), with the PO(OMe)3 as per route 'b'.
-[M.~.~~'p----N-Rl- [M~~~'P~-R]/, ,. M 0/ I'" IMeO N=N .. e N=N
J -N2 H
[
H H+H 1 :0011 MeO,(/O 'd Route MeO ~" 'HMeO I '8' ,f
MeO~P-~-R __ Meo-~-~. -R ~ MeO~P=N-R -- MeO~P=N-R
MeO H H MeOl
465 464
Route! l
M~~~P=:'+:~~:-[:::o.o~lfL~ ::::g;ti-R]- M~~;t;~~-H
MeO MeO HI MeO MeO
466 .
463
Scheme 4.7
Based on these findings, we became interested in optimizing the yield ofpyrrole (455c) as
it could potentially provide a route through to the desired pyrrole in two fewer steps than our
original plan. Having examined many potential conditions for the concomitant azide
reduction/ring contraction reaction of the 2-azidobenzenesulfonyl-3,6-dihydro-l ,2-thiazine l-oxide
(400c), optimal results were obtained by using a ]:2 molar equivalent mixture of
triethylamine:trimethylphosphite In methanol, followed by a basic aqueous work up with 2M
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sodium hydroxide. It was found to be most important to purify the crude product by
chromatography with eluent containing 10% triethylamine. These conditions produced the desired
amino pyrrole (455c) in 50% yield.
Having established the efficiency of the ring contraction reaction of the 2-
azidobenzensulfonyl-3,6-dihydro-I,2-thiazine f-oxide, the value of the new optimized conditions
using I,2-thiazine l-oxides derived from isoprene and butadiene was next examined.
Accordingly, 2-azidobenzenesulfonyl-3,6-dihydro-I,2-thiazine l-oxides (4008) and (400b) were
treated with a 1:2 molar equivalent mixture oftriethylamine:trimethylphosphite in methanol under
nitrogen. In both cases the ring contraction proceeded readily, yielding the desired amino pyrrole,
which was again isolated upon work-up with 2M sodium hydroxide solution and purification by
column chromatography using 10% triethylamine in the eluent mixture. The products (4558) and
(455b) were isolated in good yields (50-73%) and the results are presented in Table 4.1.
Entry RI R2 Method Yield of 455 Yield of 462zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(%) (%)
8 H H Et3N, P(OMe)3 (1:2), MeOH, r.t. 50 23
b H Me Et3N, P(OMe)3 (1:2), MeOH, r.t. 73 10
c Me Me Et3N,P(OMe)3(I:2), MeOH, r.t. 50zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA18
Table 4.1: % yields of the amino pyrroles (455a-c) and the N-phosphoramidatepyrroles (462a-c)
4.3 Formylation of the pyrrole
With the desired pyrroles (455) in hand, the next task of our synthetic strategy was to
establish cyclisation of the amino pyrrole system to the desired seven-membered ring with the
imine functionality at the NIO-CII position. Potentially, there are two key sites available in our
compound where the extra carbon needed to bring about such a ring closure can be introduced,
namely via the formylation of the electron-rich pyrrole or of the nucleophilic amine. Either route
in effect could then afford the desired tricyclic pyrrolobenzothiadiazepine, bearing the imine bond
that is so essential to the biological activity" of several similar compounds in the literature. Our
first approach to the synthesis of the formylated precursor involved the introduction of the formyl
group on the pyrrole, an obvious choice, which is well documented in the literature.202
One of the most common methods of formylating activated aromatic rings, such as
pyrroles, is via the Vilsmeier-Haack reaction.202 The reaction proceeds with the combination of an
N.N-dimethylamide and phosphorus oxychloride to form an iminium cation (467). Subsequent
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reaction of the reactive carbon electrophile with pyrrole results in the formation of a stable
iminium salt (468), which upon work-up with aqueous sodium bicarbonate hydrolyses to the
desired formylated pyrrole (469) as illustrated in Scheme 4.8.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
HyQ ..H20 H~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I I Io R M ......N:+- R
e Me
--zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
469 468
Scheme 4.8
Initially, we decided to test the methodology using the N-phosphoramidate pyrrole (462c),
in order to avoid any possible side reactions of the amine group that is present in compound
(455c). Once the formylation proved to be efficient, the intention was to remove the phosphorus
grouping from the nitrogen using HCl203 and to then cyclise the ring in a one-pot reaction to form
the desired tricyclic system (457). Accordingly, a solution of the N-phosphoramidate pyrrole
(462c) in dry dichloromethane was added at O°C to a mixture of N,N-dimethylformamide and
phosphorus oxychloride in anhydrous dichloromethane. The mixture was gradually allowed to
attain room temperature and was stirred for 18 h. Work-up with aqueous sodium hydroxide,
followed by purification via column chromatography, resulted in the isolation of the desired
product (470c) and the unexpected N-[o-(N',N'-dimethylformamidinyl)benzenesulfonyl]
formylated pyrrole (471c) in 38% and 43% yields, respectively (Scheme 4.9).
~j_{::(,
~ Me
NH
I
O=P,-OMe
OMe
462c
DMF,POCI3
DCM,r.t.
O",? :Ay. MeCCS-Nr~ +NH CHOMe
I
O=P,-OMe
OMe
470c
O"'~N.Ay. MeCC r~N CHOMe
·M· jJe ....N
I
Me
47Jc
Scheme 4.9
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The incorporation of the formyl group in the case of the desired product (470c) was
confirmed with IH NMR (400 MHz) which indicated the additional presence of the aldehyde
proton as a singlet at OH 10.1 ppm (lH, s, CHO). In addition, the !3CNMR spectrum (lOO MHz)
also confirmed this with the CHO resonance at oe 179.0 ppm, diagnostic of the deshielded
aldehyde carbonyl, together with the presence of a C=O stretching absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAUmax 1662 ern" in
the IR spectrum. Concurrently, analysis by MS (ESI+) and accurate mass determination were in
full agreement with the proposed structure.
The IH NMR spectrum (400 MHz) of the N,N-dimethylformamidyl product (471c) showed
two pyrrole CH3 groups as separate singlets at OH 1.99 ppm (3H, s, CH3) and OH 2.28 ppm (3H, s,
CH3), indicating a non symmetrical pyrrole. Evidence of the successful formylation was provided
by the presence of a peak at OH 9.98 (lH, s, CHO), diagonistic of the aldehyde. The disappearance
of the NH group and the appearance of two extra sets ofCH3 groups at OH 3.01 ppm (3H, s, CH3)
and OH 3.02 ppm (3H, s, CH3), together with a peak at OH 7.42 ppm (1H, s, N=CH) in the vinylic
region further confirmed the structure. The !3CNMR (100 MHz) further supported the assignment
by the presence of four CH3 groups at Dc 9.50, 10.9, 34.4, 40.3 ppm and the CHO group at Dc
180.5 ppm, while the vinylic, aromatic and quaternary carbon atoms appeared more deshielded in
the region ofoe 120.6-152.8 ppm and showed the presence of the extra CH resonance attributed to
the CH=N. This structural determination was verified by JR spectroscopy with the presence of a
C=O stretching absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax 1710 ern". Th se data, in combination with a consistent MS
[m/z (ESI+): [M+Ht, 334] and accurate mass measurement of the desired molecular ion assisted
towards the structural determination of the N,N-dimethylformamidyl compound (471c).
In terms of mechanism, it is proposed here that loss of the phosphoramidate functionality
results in the formation of the amine in the first step, a process which is known to be affected by
the presence HCI.203 The second step involves reaction of the Vilsmeier salt with the free amine to
give the N,N-dimethylformamidyl compound (471c) as illustrated in Scheme 4..10.
R_
NB HC) H------.... c_)
o=p-OMe ~ R-N:/ .~ .Me
'OMe \ 'H H ~
OMe Me
O=~-OMe
ClzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
R-N
'1
....N'MMe e
Scheme 4.10
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Attempted synthesis of the 1-(2'aminobenzenesulfonyl)-2-formylpyrrole (472c) via thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN-
(arylamino) pyrrole (440) under Vilsmeier conditions resulted in a similar reaction with the
desired 1-(2'aminobenzenesulfonyl)-2-formylpyrrole (472c) obtained in 31zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA% yield, together with
the N,N-dimethylformamidinyl compound (471c) in 49% yield (Scheme 4.11).
DMF,POC13
DCM,r.t.
o
O~II ~MeCCS-N -c- +
.0 NH2 CHOMezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
455c 472c 471c
Scheme 4.11
The observed isolation of the N,N-dimethylformamidinyl compound (471c) in this case is
presumably due to the direct reaction of the Vilsmeier salt with the amine, accompanied by
formylation of the pyrrole ring.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.4 Synthesis of 1-(2-formamidobenzenesulfonyl) pyrroles
Although the Vilsmeier reaction discussed in the preceding section resulted in the isolation
of the desired 1-(2'aminobenzenesulfonyl)-2-formylpyrrole (472c) in a moderate 31% yield, in the
event, it was found that this would not cyclise to the desired tricyclic pyrrolobenzothiadiazpine,
probably due to the deactivation of the aldehyde by delocalisation into the pyrrole. Fortunately,
Artico et al." in their pursuit of heterocycles with benzothiadiazepine moieties, reported the
synthesis of pyrrolobenzothiadiazepines utilizing 1-(2-formamidobenzenesulfonyl)pyrroles. Thus,
according to Artico'" treatment of the ] -(2-aminobenzenesulfonyI)pyrrole (455a) with acetic-
formic anhydride resulted in the formylation of the amine. Subsequent treatment of the ]-(2-
formamidobenzenesulfonyl)pyrrole (456a) with phosphorous oxychloride re ulted in cyclisation
via a Bischler-Napieralski reaction" to provide the tricyclic pyrrolobenzothiadiazepine (457a)
[Scheme 4.12].
OI,CHO 0 0
_C_O_M_e. cC~-{:J
NHCHO
4568 4578
Scheme 4.12
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Thus, treatment of 1-(2-aminobenzenesulfonyl) pyrroles (455a-c) with a preformed
mixture of acetic anhydride and formic acid gave the N-formylated products (456a-c) in high
yields (77-98%) after purification via column chromatography (Scheme 4.13).
O~/? C(R' ~CHO o~,? C(R'
r(YS-N '-':::: COMe ITYS-N '-'::::zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
l(A_ - R2---l(A_ - R2
NH2 NHCHO
455a-c 456a: R'=R2=H
456b: R'=H, R2=Me
456c: R'=R2:Me
Scheme 4.13
Spectroscopic analysis of the N-formylated pyrrole (456a-c) confirmed their proposed
structure. In particular the presence of the formyl group was confirmed by the appearance of a CH
group in the I3CNMR spectra at Dc~ 159 ppm (CHO) and the presence of an extra CH resonance
in the IH NMR spectra at DH ~ 8.55 ppm (tH, s, CHO) accompanied by loss of the NH2 resonance
and the appearance of a new NB resonance at DH ~9.45 ppm (IH, s, NHCHO). The IR spectra
showed the new C=O at Vmax ~ 1700 ern" in all cases and mass spectroscopic analysis confirmed
the assignments with matching M+peaks.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.5 Synthesis of pyrrolobenzothiadiazepines
Having established a straightforward and high yielding route for the conversion of the ] -(2-
aminobenzenesulfonyl) pyrroles to the corresponding N-formylated pyrrole, as presented above,
the final task was to cyclise the formyl onto the pyrrole via the Bischler-Napieralski reaction.97
Accordingly, solutions of 1-(2-aminobenzenesulfonyl) pyrroles (456a-c) were heated at
reflux in dichloroethane in the presence of phosphorus oxychloride for 3 hours (Scheme 4.14).
4S6a-c 457a-c
Scheme 4.14
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In all cases the reaction proceeded readily yielding the desired pyrrolobenzothiadiazepines
(457a-c), which were purified by column chromatography and isolated in the yields shown in
Table 4.2.
EntryzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBARI R2 Method Yield 0(457(%)
a H H POCh, DCM, ~ 55
b H Me POCh, DCM, ~ 59
c Me Me POCh, DCM, ~ 43
Table 4.2:% yields of the pyrrolobenzothiadiazepines
The structures of the pyrrolobenzothiadiazepines (457a-c) were, in each case, assigned on
the basis of IH NMR, l3C NMR, MS, and IR spectroscopic analysis, together with an accurate
mass measurement for the desired ion. In all cases, evidence for successful cyclisation was
provided by IHNMR (400 MHz), which showed the disappearance of the deshielded aldehyde CH
group and the appearance of a new CH group in the aromatic region at OH -8.62-8.66 ppm,
diagnostic of the imine. Additionally, the presence of the imine carbon was demonstrated in the
I3C NMR (100 MHz) spectra of the products by the appearance of a peak in the region of Oc
-148.5-150.0 ppm, which was also inferred by inspection of the IR spectra via the presence of a
C=N stretching absorption at Umax 1603 cm", These data, along with consistent mass spectra and
accurate mass measurement further supported the proposed structures.
4.6 Synthesisof tetra cyclicsystems
Whilst the synthesis and biological applications of the pyrrolobenzodiazepine and
pyrrolobenzothiadiazepine pharmacore continues to attract considerable attention in the literature,
current interest has turned to the synthesis of analogues having additional heterocyclic rings fused
to the diazepine ring. As described in the introduction of this thesis, such tetracyclic systems are
of enormous potential utility, particularly bretazenil (473)97.IOlb which possesses an imidazole
moiety at the NlO-Cll position of the pyrrolobenzodiazepine (Figure 4.1), which has found
clinical and commercial success as an anxiolytic agent.204-20SzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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6(NQozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~~ 1--zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
N 0\
473zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Figure 4.1
On these grounds, we envisaged our compounds would be extremely useful in the synthesis
oftetracyclic systems via the 1,3-dipolar cycloaddition reaction.206-2o8In an attempt to investigate
this transformation further and with a view to generating novel heterocycles comprising the five
membered 1,2,4-oxadiazoline, we chose to incorporate the nitrile oxides.208-2o9The route that we
investigated is shown in Scheme 4.] 5 and relies upon a 1,3-dipolar cycloaddition of benzonitrile
oxide, which is readily available from benzohydroxyimoyl chloride (476) using Huisgen's2lo base-
induced dehydrochlorination process to generate the desired 1,2,4-
oxadiazolopyrrolobenzothiadiazepine 5,5-dioxide (477). Access to the benzohydroximoyl
chloride (476) was accomplished via chlorination of the corresponding benzaldoxime (475),
derived from commercially available benzaldehyde (474).
474 475 476 477
Scheme 4.15: Reagents and Conditions: (i) NH20H.HCI, NaOAc, tOH, r.t.; (ii) NCS, CHCI3,
pyridine, r.t.; (iii) Et3N, THF, pyrrolobenzothiadiazepine (457a-c).
Following our proposed methodology shown in cherne 4.15 the initial requirement was to
synthesis the nitrile oxide, which would react with the NIO-Cl1 imine bond in the
pyrrolobenzothiadiazepine in a ] ,3-diploar cycloaddition to generate the desired 1,2,4-
oxadiazoline. Nitrile oxides208-2o9are in general highly reactive and thu unstable 1,3-dipoles, and
although some aryl nitrile oxides can be quite stable, they generally undergo dimeri ation in the
absence of dipolarphiles to give the corresponding 1,2,5-oxadiazole-2-oxides (478).
Consequently, in order to eliminate competitive dirnerisation, they are commonly generated in situ
in the presence of dipolarophiles.208-2o9 Among several methods developed for the in situ
generation of nitrile oxides, the dehydration of primary nitro derivatives (Mukaiyama procedure
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for aliphatic nitrile oxidesr'!' and the base-induced dehydrohalogenation of hydroximoyl chlorides
(Huisgen's methodology for aromatic nitrile oxides)2lo have been extensively used. In this thesis,
generation of the nitrile oxides was performed using the base catalysed dehydrochlorination of
benzohydroximoyl chlorides.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
H
I
R -CH2X --- R-y- N02
H
R-CHO --- R-C=NOH --- R-C=NOH
I I
H X
~ ~ R R
---I R-C=N-OzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI ~ N~'Q
478
Scheme 4.16zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.6.1 Synthesis of benzaldoxime
The condensation of the carbonyl compounds with hydroxylamine constitutes one of the
most valuable reactions in preparing oximes.212-214Accordingly, benzaldehyde (474) was treated
with hydroxylamine hydrochloride in ethanol in presence of sodium acetate. The oximation
proved very efficient, generating the desired benzaldoxime (475) in 84% yield (Scheme 4.17).
NH20H.HCI
EtOH, NaOAc, r.t.
474 475
Scheme 4.17
The reaction mechanisrn/!" begins with a nucleophilic addition of the hydroxylamine to the
carbonyl moiety to form an unstable intermediate, which upon protonation and dehydration results
in the corresponding oxime as illustrated in the Scheme 4.18.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Scheme 4.18
4.6.2 SynthesiszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAof benzohydrox moyl chloride
Having successfully generated the oxime via the condensation reaction of aldehyde and
hydroxylamine, the next requirement was to chlorinate the oxime to make the benzohydroximoyl
chloride precursor, which would subsequently dehydrohalogenate in the presence of base to give
the desired benzonitrile oxide in the next step.
Hydroximoyl chlorides can be prepared via chlorination of the respective aldoximes using
a wide variety of reagents including Ch,215NCS,216NBS,217NaOCI,218 tert-butyl hypochlorite.i'"
chloramine-T,22o and benzyltrimethylammonium tetrachloroiodate (BTMA TCIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA4).221The ease of
use and ready availability made NCS222the first reagent to be tried.
Thus, treatment of benzaldoxime (475) with a solution of N-chlorosuccinimide in dry
chloroform in the presence ofpyridine, gave the desired benzohydroximoyl chloride (476), which
upon purification via column chromatography was isolated in 76% yield (Scheme 4.19).
'-'::: ".~OH NCS, pyridineVN CHeI3• r.t.
475
I
~N-OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
476
Scheme 4.19
With regards to a mechanism, it is believed that the N-chlorosuccinimide initially breaks
down to form a succinimidyl radical and chlorine radical.223 The reaction is, then, propagated by
hydrogen atom abstraction by the chlorine radical, and finally terminated with the replacement of
the methine hydrogen by chlorine as illustrated in the scheme below.
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~N-OH
476
Scheme 4.20
4.6.3 Synthesis of 1,2,4-oxadiazolopyrrolobenzothiadiazepine 5,5-dioxide via 1,3-
dipolar cycloaddition reaction
Following the synthetic methodology shown in Scheme 4.15, the final step involved the
generation of the benzonitrile oxide via dehydrochlorination of the benzohydroximoyl chloride
using Huisgen's approach'"? and subsequent in situ 1,3-dipolar cycloaddition of the corresponding
benzonitrile oxide with pyrrolobenzothiadiazepines.
The transformation of the hydroximoyl chloride into nitrile oxides is an extremely rapid
process and can be readily achieved in the presence of a basic reagent. Consequently, in order to
avoid possible competitive dimerisation,208-21oslow addition of base such as triethylamine or
pyridine to the mixture of the dipolarophiles and dipole precursor is essential.
Accordingly, the 1,3-dipolar cycloaddition precursor, benzohydroximoyl chloride (476)
and the pyrrolobenzothiadiazepines (457b-c) were reacted together, with a view to synthesising
the desired 1,2,4-oxadiazoline-annulated pyrrolobenzothiadiazepine (477a-b). The cycloaddition
reaction conditions involved the addition of a solution of the benzohydroximoyl chloride (476) in
anhydrous tetrahydrofuran to a solution of the pyrrolobenzothiadiazepine (457b-c) in anhydrous
tetrahydrofuran in the presence of triethylamine (Scheme 4.21).
I.Et3N1 THF
cc
o~s~x~RI _2_.b_e_nZ_O_hY_d_rO_Xi_m_OY_I_Ch_IO_ri_de_rr_H.._FccO)?:r:N ~ RI(dropwise addition), r.t.
- R2 - R2
N- N
PhANP
477a: RI=H, R~Me
477b: RI=R2=Me
457b: RI=H, R~Me
457c: R I=R2=Me
Scheme 4.21
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In all cases the in situ cycloaddition proceeded readily, generating, after purification by
column chromatography, the desired 1,2,4-oxadiazoline annulated pyrrolobenzothiadiazepines
(477a-b) in 47% and 69% yields, respectively.
The incorporation of the benzonitrile oxide in both products (477a-b) was confirmed by IH
NMR (400 MHz) which indicated the additional presence of 5 protons in the region of cSzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH ~7.20-
7.94 ppm. More importantly, the incorportation of the oxadiazoline moiety in the molecules was
manifested by the occurance in the 13C NMR spectra of an additional deshielded quarternary
carbon atom at Dc155.6 ppm and at Dc155.9 ppm for compounds (477a) and (477b), respectively,
together with the appearance of the extra expected aromatic carbons, and the new Sp3methine
carbon. The presence of an imine was also evident by IR analysis, which showed a band of
medium intensity at Vrnax ~1585 cm". These data, in combination with consistent MSzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA[m/z (ESIt:
[M+Ht, 366] and [rn/z (ESIt: [M+Ht, 380] for compound (477a) and (477b), respectively,
together with accurate mass measurement of the desired molecular ion assisted the structural
determination of both cyc1oadducts.
Following the success of the above methodology for the construction of 1,2,4-oxadiazoline
annulated pyrrolobenzothiadiazepines, we decided to implement this strategy with other nitrile
oxides. Consequently, the preparation of 1,2,4-oxadiazoline derivatives via the readily available
ethylchloroximidoacetate was next attempted, using pyrrolobenzothiadiazepines (457b-c). In all
cases the 1,3-dipolar cycloaddition proceeded smoothly, generating, after purification by column
chromatography, the desired 1,2,4-oxadiazoline annulated pyrrolobenzothiadiazepines (479a-b) in
47% and 69% yields, respectively (Scheme 4.22).
I. t3N1 THF 0O~/?r.Rl2. ethylchloroximidoacetate/THF O~I'r.Rl
CCS-N ~ (dropwi e addition), r.t. CC -N "-'::R2 ---------. I ~ - R2zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN- NzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
AP
Et02 N
479a: Rl=H R2:M
479b: Rl=R2:Me
457b: R1=H; R2=Me
457c: Rl=R2=Me
Scheme 4.22
The incorporation of the ethyl ester grouping was confirmed by IH and 13C NMR
spectroscopic analysis of the products (479a-b). Significantly in each case, the 'H NMR
spectrum (400 MHz) indicated the additional presence of the CH2 and CH3 groups, split by each
other as a multiplet at OH ~4.25 ppm (2H, m, C02CH2CH3) and a triplet at OH ~ J .28 ppm (3H, t, J
7.1, C02CH2CH3), respectively. Additionally, I3C NMR spectra (100 MHz) of the products
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showed the ethyl ester CH2 and CH3 groups at DH 62.7 ppm and DH 13.8 ppm, respectively, together
with the deshielded quarternary carbon atoms atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBADc -147.8 ppm and at Dc 156.6 ppm, values
distinctive for the resonance of the C=N and C=O groups, respectively. Further evidence of the
proposed structure was provided by IR spectra of the products, which showed a band of medium
intensity in the region Vmax -1574-1582 ern", corresponding to the imine, together with a sharp
carbonyl band in the region Vmax -1733-1736 cm -I. These data, in combination with consistent MSzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
[m/z (ESI+): [M+Ht, 362] and [m/z (ESI+): [M+Ht, 376] for compounds (479a) and (479b),
respectively, together with accurate mass measurements of the desired molecular ions confirmed
the structures of both cycloadducts.
With regards to the mechanism of the 1,3-dipolar cycloadditions, it is proposed that initial
proton abstraction by triethylamine, and thus, removal of Hel, provides the reactive nitrile oxide,
followed by a 1,3-dipolar cycloaddition, leading to the formation of a 1,2,4-oxadiazoline ring, as
illustrated in Scheme 4.23.
[ ("+ - +-]zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAR-C=N-O .__. R-C=N-O
Step 2
R'= Ph or O2 t
RI.R2:H. Me
Scheme 4.23zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.3 Conclusion
In conclusion, the attempt to formulate a novel synthetic approach to
pyrrolobenzothiadiazepine heterocycles was fruitful. Generation of the 1,2-thiazine f-oxides was
performed routinely, starting from the commercially available 2-aminobenzenesulfonamide.
Advantageously, the use the 2-(2-azidobenzenesulfonyJ)-I,2-thiazine l-oxides in a ring
contraction reaction led to the desired arylpyrrole (455a-c) via a one-pot ring contraction,
desulfurisation and aromatization process, accompanied by concomitant same pot conversion of
the azide to a primary amine through a Staudinger reaction. Formylation of the arylpyrrole proved
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problematic as the desired amino pyrrole was only obtained in low yields. However,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN-
formylation was successful and a subsequent Bischler-Napieralski reaction yielded the
pyrrolobenzothiadiazepines (457a-c) in moderate yields. Access to tetracylic systems via a 1,3-
dipolar cycloaddition using nitrile oxides proved successful, and four 1,2,4-oxadiazoline-annulated
pyrrolobenzothiadiazepines were obtained in good yields.
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5.1 Synthesis of aziridinobenzothiadiazocines and pyrrolobenzothiadiazines
Following the successful synthesis of the pyrrolobenzothiadiazepine 1,1-dioxides via the
ring contraction process122 of 1,2-thiazine I-oxides, we embarked upon an alternative to the route
described in the preceding section and sought to take advantage ofthe fact that the 1,2-thiazine 1-
oxide nucleus (402), upon hydrolysis,109-115should yield a sulfinic acid, which, after spontaneous
retro-ene type loss of sulfur dioxide would furnish a homoallylic sulfonamide (480). We
anticipated that a 5-endo-trig iodocyclisation+" would then yield the corresponding pyrrolidine
system (481), which would serve as a useful precursor for the synthesis of the
pyrrolobenzothiadiazepine nucleus, as shown in Scheme 5.1. Access to the tricyclic
pyrrolobenzothiadiazepine (457) could be accomplished in four further steps involving loss of HI,
followed by oxidation to pyrrole (455).225 N-formylation followed by Bischler-Napieralski ring
closure'" using an acetic anhydride/formic acid mixture would complete the synthesis. Also
possible via this route would be an exploration of the use of the precursor (481) to furnish
compound (482), an interesting analogue of the usual [2,1-c] fused pyrrolobenzodiazepine
systems.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
RI RI
o 0 c)- 0 0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAr)- 0 °RI 0 0 I
~/I \\ ~II ~/I 2(' "II c:(R
CCS-N '\ R2 i CCS-N I. R2 ii CCS-N I iii CCS-, N's ~ I H /1 .---- I 2 ,---._ I .--:II _o. _o. R _o. R2
NH20 NH2 NH2 NH2
402 480 " 481 455
,,~i,/
o "
O~II )J
CC:~R'zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
H R2
482
~iV
457 456
Scheme 5.1: Reagents and conditions: (i) acid hydrolysis; (ii) iodocyclisation; (iii) HI
elimination/oxidation; (iv) N-formylation; (v) Bischler-Napieralski cyclisation; (vi) cyclisation.
5.1.1 Synthesis of homoallylic sulfonamides via hydrolysis of 1,2-thiazine I-oxides
Recently, Weinreb and co_workersl13-115 have exploited some of the known reactions of the
1,2-thiazine 1-oxides, along with new transformations, in the selective preparation of some
104
Chapter 5 Discussion-Part IVzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
complex nitrogen-containing molecules, One useful transformation of these adducts is the
hydrolysis/retro-ene elimination of sulfur dioxide shown in Scheme 5.2, Thus, treatment with acid
of the two epimeric cycloaddition adducts ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(E,E)- and (E,Z)-tetramethylbutadiene, (483) and
(486), resulted in hydrolysis to produce allylic sulfinic acids (484) and (487), which suffered a
retro-ene reaction via the chair-like conformation shown to give the desired E-erytho (485) and E-
h (488)' ic h 11I' IJ:: id 106 III 113-115zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAt' I I' h ht reo rsomenc omoa y IC su ronarru es, " respec tve y, t IS t oug t that this
transformation arises due to the methyl group on the sulfur-bearing carbon occupying a quasi-
equatorial position, which directs intramolecular protonation to one of the diasteroisotopic faces of
the double bond to establish (E)-geometry in the newly formed double bond,
E-erythro
isomer
483 484 485
£Me- 1.5% NaOH[ rffiMe Me+s-o] Me NHTsMe .±"..O 2. 5%HCI Me _// IS ~I s r H Me ~ £-threoN f:iO -----i... Me isomerMe . 'Ts H = NHTs Me
Me Me
486 487 488
Scheme 5.2
In an adaptation of this method, the 2-(2-aminobenzenesulfonyl)-] ,2-thiazine I-oxides
(402a-c) were heated at reflux in tetrahydrofuran in the presence of aqueous Het. Upon
completion, the reaction was neutralized with aqueous sodium hydroxide generating the desired
homoallylic sulfonamides (480a-c), presumably via the intermediate sulfinic acids (489a-
)106111113-115(Sh· 53) T II th ti dd dil ' ,.c ,. c erne , , .n a cases . e reac Ion procee e rea t y yielding the homoallylic
sulfonamides (480a-c) which were purified by column chromatography and isolated in the yields
shown in Table 5,1,
aq. HCI
THF,t.
402a-c 489a-c 480a-c
Scheme 5.3
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Entry RI R2 Yieldof480zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(%)
a H H 47
b H Me 51
c Me Me 58
Table S.l: % yields of the homoallylic sulfonamide
The structure of the homoallylic sulfonamides (480a-c) was, in each case, assigned on the
basis of IH NMR, 13CNMR, MS, and IR spectroscopic analysis, together with an accurate mass
measurement for the desired ion. In all cases, evidence for a successful ring opening was provided
by IH NMR (400 MHz), which showed the presence of a broad peak at OH -4.82-5.63 ppm,
corresponding to the sulfonamide NH proton. In the vinylic region, compound (480a) showed
three protons around OH -4.99-5.13 ppm, as a complex mutiplet, corresponding to the vinyl CH]
and vinyl CH groups. This was further confirmed by 13CNMR (100 MHz) [(DEPT -135)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOc 117.7
(CH), 118.0 (CH2)]. As, expected, the IH NMR spectrum of compounds (480b,c) revealed two
protons in the vinylic region, which showed up clearly as a CH2 in the 13CNMR, together with the
quaternary carbon bearing the CH3 group. The presence of one methyl group at OH 1.53 ppm for
compound (480b), together with the presence of two methyl groups in compound (480c), helped to
confirm the assignments. In each case IR spectra [3x NH absorption at Vmax -3285-3479 cm"],
along with consistent mass spectra and accurate mass measurement further supported the proposed
structures.
5.1.2 Attempted synthesis of pyrrolidine via 5-endo-trig iodocyclisation
With the homoallylic sulfonamides in hand, the next objective was to synthesize the
corresponding pyrrolidine via an lodocycllsatlon.i" Electrophile-induced 5-endo-trig cyclisations
are now well established as a viable and often highly stereoselective approach to
tetrahydrofurans.226-228 In the light of these studies, Knight et al.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA224c have shown that similar
cyclisations of the (E)-homoallylic sulfonamides (490) by treatment with excess iodine in the
presence of anhydrous potassium carbonate or sodium bicarbonate leads to the 2,5-trans-iodo-
pyrrolidines (491). Additionally, access to the 2,5-cis-isomers (492) was accomplished by
treatment of the same sulfonamides (490) with iodine (Scheme 5.4).
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I
R1,c)"'R2N
IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
TszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
491
jm, 12, MeCNDOC, 0.5 h
3 eq. 12, MeCN J
DoC, 0.5 h ,-{
L-----:-[a-:ci-::di-c c":""o-nd:-:-it-:-io-ns7]~ RI"...£.,_N)-._R2
I
Ts
492
3 eq. 12, K2C03o MeCN, DoC, 0.5 h
RI--Z..NH 'I.._ R2 [basic conditions]
+s -90% [>15:1]
490
Scheme 5.4
This general transformation of homoallylic sulfonamides (490) into a 5-membered ring, is
considered to be electrophile driven, involving a chair-like transition state (493), wherein an
equatorial positioning of substituents R2 is the controlling feature (Scheme 5.5).
1KCOl +H] r2, 2 3 I,MeCN 'zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI RI
R'~R' - R'~ - R'~"'R'
Ts H Ts Ts
490 493
Scheme 5.5
491
Based upon this finding, the 5-endo-trig iodocyclisation process was adopted for the
attempted conversion of homoallylic sulfonamides (480a-c) to the corresponding aryl
iodopyrroIidines (481a-c). Accordingly, the homoallylic sulfonamides (480a-c) were treated with
iodine in anhydrous acetonitrile in presence of sodium bicarbonate at ambient temperature
(Scheme 5.6). In two cases [(480b) and (480c)] apparent evidence of successful 5-endo-trig
iodocyclisation was provided by the appearance of a new major product. This was in contrast to
the homoal1ylic sulfonamide derived from 1,3-butadiene (480a), which yielded no identifiable
product. Intriguingly, in both cases, the major products of the attempted 5-endo-trig
iodocyclisation were neither the desired aryl iodopyrrolidine (481), nor the de-iodo products
derived therefrom (494) and (495), nor the possible further cyclised product (482).
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RIOr)-O 0 RI 0 0 RIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
O~II 12,NaHC03 ~I/ ex ~I/ ex
as-N R2 MeCN r t as-N I as-N IHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAj .------'-~. I -------- I~ ~ ~ ~NH2 NH2 , NH2
480 RI, R2=H, Me 481" " 494
,
,
,,
0)(
C(~R'
H R2
482
,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
'", 0
c('S-<:('
NH2
495
Scheme 5.6
In both reactions the major product were assigned on the basis of their IH NMR, l3C NMR,
IH,IH_COSY, IH,l3C-COSY, MS, IR spectra and accurate mass measurements. Specifically, two
dimensional IH NMR (400 MHz) studies of the product derived from compound (480b) showed
the absence of the NH2 group protons and confirmed the presence of the distinct sulfonamide NH
group at OH 5.25 ppm (l H, t, J 6.2, NH(h) [see Figure 5.1]. The sulfonamide NH(h) was coupled to
the methylene group (Cl) at OH 3.80 (lH, m, br, NHCH-H(g), which in turn in the expansion, was
coupling to H(b)on the same carbon. Furthermore, H(g)was coupling to H(c)of a second methylene
unit (C2), together with H(c) coupling with H(t} The C2 methylene unit was attached to a
quaternary but sp3 carbon which in turn was attached to a methyl group and also to a further
methylene group. This final methylene unit had no further carbon or hydrogen coupling, and
showed a clear and distinct singlet for each of its two hydrogens at OH 2.11 ppm and 2.31 ppm.
This together with the two hydrogens being non-equivalent and unable to couple to each other led
to the assignment of the structure as the aziridine fused benzothiadiazocine (496b). Such a pattern
is very distinctive of aziridine CH2 groups by virtue of the geometric constraints in the ring, as
shown in the Iiterature.229 Further evidence was given by the I3CNMR spectrum (100 MHz) of
the molecule, which showed (DEPT-US) the three CI:I2 groups at Qc 35.8, 39.2, 40.2 ppm, and a
methyl group at Qc 20.2 ppm. The C3 quaternary carbon appeared as expected at 44.0 ppm, while
the aromatic and the two aromatic quaternary carbon atoms appeared more downfield at Qc 12l.7-
147.8 ppm. These data combined with IR spectroscopic analysis [NH absorption (strong) at 3101
ern"], MS [m/z (ESI+): [M+Ht, 239] and accurate mass measurement supported the structural
assignment. The stereochemistry at nitrogen was not established, but the product was one
diastereoisomer.
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Figure 5,1: IH_IH COSY ofaziridine fused benzothiadiazocine (496b)
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Compound (480c) behaved in a similar fashion to give the aziridine fused
benzothiadiazocine (496c) which, as well as showing all of the expected connectivities by 2D
NMR, was also formed as a single diastereoisomer. NOE studies showed that the two methyl
groups in compound (496c) were trans (or anti) to one another, a feature implied by a relatively
strong correlation between the hydrogen on C4 of the 1,2,6-benzothiadiazocine ring and the CS
methyl substituent, indicating that the C4 hydrogen and the C5 methyl were cis (or syn) to each
other. Again the stereochemistry at the aziridine nitrogen was not determined. Yields of
compounds (496b) and (496c) were 49% and 30%, respectively (Scheme 5.7).
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Scheme 5.7
With regards to a possible mechanism, it is thought that the arylamino nitrogen and not the
sulfonamido nitrogen is the participating nuc1eophile in the iodocyc1isation, thereby giving the
thiadiazocine ring (497). Formation of the aziridine (496) then follows from cyclisation onto the
primary alkyl iodide (Scheme 5.8), paralleling well known methods for the synthesis of
aziridines.229b-229c,23o
°0,11
~C(N)"R'
Nx<"R2
r-t H
496497
Scheme 5.8
It is of note that compounds (480) are able to adopt conformations, such as that shown in
structures (498) or (499) in Scheme 5.9, that favour cyclisation via the arylamino nitrogen rather
than the alternative 5-endo-trig sulfonamido nitrogen cyclisation, although the latter process whilst
disfavoured by Baldwin's rules, is known to occur.224a It is of further note that compound (480a;
R'=R2= H) is able to offer less stability, having no methyl group, to the proposed iodonium
intermediate than that offered by compounds (480b; R'=H, R2=Me) and (480c; R'=R2=Me) and
this may explain its failure to react. Finally, it seems that a possible explanation for the trans
relationship of the two methyl groups in compound (496c) is that the RI and R2 groups in
conformers (498) or (499) occupy the two pseudo equatorial positions shown in the six membered
ring transition state, leading to the observed trans stereochemistry (Scheme 5.9).
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Scheme 5.9
Despite the failure of the 5-endo-trig iodocyclisation to generate the aryl iodopyrrolidine,
the somewhat serendipitous discovery of a iodocyclisation+" in the synthesis of an aziridine fused
1,2,6-benzothiadiazocine is of interest due to the difficulties encountered in constructing both the
eight- and three-membered rings and, thus, yields of 49% and even 30% are, in this context,
respectable. Furthermore, this transformation is of particular interest as benzodiazoc.ines have
attracted attention as analogues of the 1,4-benzodiazepines,231 as novel antibacterialzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAcompounds+"
and as positive inotropic calcium sensitizing agents.233 The corresponding 1,2,6-
benzothiadiazocines are attractive as sulfur analogues of this system and have also received
particular interest as potential NNRTIs,98 whilst aziridine fused systems are of general and
widespread utility as DNA alkylating agents and potential antitumour agents.i"
5.2 Synthesis of pyrrolidine via 5-endo-trig iodocyclisation
As described above, the attempt to use the (2-aminoaryl)allylic sulfonamides (480) as
precusors to making the aryl iodopyrrolidine was not successful, due to the involvement of the
arylamine nitrogen undergoing 8-exo-trig iodocyclisation to furnish aziridino fused 1,2,6-
benzothiadiazocines. Therefore to overcome this problem, we embarked upon a modified route
and investigated the use of2-azido, 2-iminophosphoranyl and 2-nitroaryl allyJic sulfonamide, each
of which has a non-nucleophilic nitrogen. The idea was to convert these homoallylic systems to
their corresponding pyrrolidine via iodocyclisation, and subsequent reduction of the 2-arylnitrogen
functionality would then give access to the desired cyclisation precursor (481) [Scheme 5.10].
Scheme 5.10
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5.2.1 Acid hydrolysis of 2-(2-[iminophosphoranyl]benzenesulfonyl)- and 2-(2-
azidobenzenesulfonyl)-1,2-thiazine I-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Following this revised synthetic strategy, the synthesis of 2-azido and 2-
iminophosphoranyJ homoallyJic suJfonamides was explored first. Accordingly, the 2-(2-
azidobenzenesulfonyl)-I,2-thiazine l-oxide (400b) and iminophosphorane (40tb) were heated at
reflux in tetrahydrofuran in the presence of aqueous HCl. In both cases the reaction proceeded
readily yielding the homoallylic sulfonamides (50tb) and (502b), which were purified by column
chromatography and isolated in 55% and 65% yield, respectively (Scheme 5.11).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
400b
aq. Helj
THF,A
o r)-RIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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r(Ys-t:j ;/ R2
~-
N3
b: RI=H,R2:Me
50tb
Scheme 5.11
The structure of the homoallylic sulfonamides (50tb) and (502b) was, in each case,
assigned on the basis of IH NMR, !3C NMR, MS, and IR spectroscopic analysis, together with an
accurate mass measurement for the desired ion. As an example, the IH NMR spectrum (400 MHz)
of the homoallylic sulfonamide (50tb), revealed the presence of methyl group at OH1.52 ppm (3H,
s, CH3) and two sets of CH2 in the region of OH2.10-2.95 ppm, with the more downfield CH2
being next to the more electronegative nitrogen atom. In the vinyJic region, the vinyl CH2
appeared as two sets of doublets at OH 4.62-4.75 ppm and further downfield a broad triplet at OH
5.21 (lH, t, br, J 5.9, NB) indicated the presence of the secondary sulfonamide. In the !3C NMR
spectrum (lOO MHz) of the same product, evidence of the alJylic CH2 group was given by DEPT-
135 analysis, where the CH2 appeared at Oc 112.4 ppm, wh ile the two sets of CH2 and the CH3
appeared at Oc 40.5,36.7 ppm and 21.3 ppm, respectively. Analysis by IR spectroscopy showed
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the presence of a broad N-H stretch band at VzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAma -3308 c " and N-H bending absorption at Vmax
-1575 ern", while MS [m/z (ESI+):[M+Ht, 267] further supported the structure of the product.
Similarly, in the case of the homoallylic sulfonamide (502b), IH NMR (400 MHz) revealed
the presence of methyl group at OH 1.52 ppm (3H, s, CH3) and two sets of CH2 in the region of OH
2.02-2.93 ppm, with the more downfield CH2 being next to the more electronegative nitrogen
atom. In the vinylic region, the vinylic CH2 this time appeared as a singlet at OH 4.40 ppm and
down field of the aromatic region, a broad singlet at OH 6.65 ppm indicated the presence of the
secondary sulfonamide. Further enlightment was given by the presence of additional IS protons in
the aromatic region, which is diagnostic of the triphenyl functionality. This data, together with
spectroscopic analysis by 13CNMR (lOO MHz) [(DEPT-135) 22.1 (CH3), 37.4, 41.5 (2x CH2) and
] 11.9 (CH2)] and IR spectra [N-H absorption at -3020 ern" and a N-H bending absorption at 1585
cm"], along with a consistent MS [m/z (ESI+):[M+Ht, 501] and accurate mass measurement
supports the proposed structure.
In the event, the attempted iodocyclisationv'" of compounds (50tb) and the corresponding
iminophosphorane (502b) proved unsuccessful under a number of conditions, yielding only some
unchanged starting material together with significant multi-spot TLC degradation (Scheme 5.12).
We reasoned that the azide or iminophosphorane functionality present in compound (50tb) or
(502b) might be intolerant of the iodo based methodologies. Considering this we moved onto
synthesize the nitro analogue in order to attempt further iodocyclisation.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
501b 503b
Scheme 5.12
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5.2.2 Synthesis of 2-nitroaryl allylic systems via 2-(2-nitroaryl)-1,2-thiazine I-oxide
Access to the 2-(2-nitroaryl)-1,2-thiazine I-oxides was accomplishedzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAvia the hetero Diels-
Alder cycloaddition, as established in Chapter 2 of this thesis. We initially explored this
methodology starting from commercially available 2-nitrobenzenesulfonamide (505a: X=S02) and
2-nitrobenzamide (505b: X=CO) using isoprene as the diene. Accordingly, sulfinylation of the 2-
nitrobenzenesulfonamide (505a) and 2-nitrobenzamide (505b) with thionyl chloride using
rigorously dry conditions in the presence of pyridine proceeded rapidly at O°C to provide the
desired N-sulfinyl-2-nitrobenzenesulfonamide (506a), and N-sulfinyl-2-nitrobenzamide (506b),
which were used without purification in a Diels-Alder reaction with excess isoprene to furnish 2-
(2-nitrobenzenesulfonamide )-1 ,2-thiazine l-oxide (507a) and 2-(2-nitrobenzamide )-1 ,2-thiazine 1-
oxide (507b) in 77% and 67% yields, respectively (Scheme 5.13).
505a-b
rC(N=S-O-]zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAl N02
506a-b
CCx-~~S__/--Me//
N020
507a: X=S02
507b: X=CO
SOCl2
X . pyridineQ 'NH2 THF
N02
Scheme 5.13
The structures of the products were confirmed by the presence of the two CH2 groups in
the 1H NMR spectrum (400 MHz), shown as four sets of doublet signals in the region of OH ~ 1.86-
3.70 ppm, with the more downfield CH2 being, presumably, next to the more electronegative
nitrogen atom. The vinylic proton in both cases appeared more deshielded at OH ~5.68-5.73 ppm
and finally the appearance of the four aromatic protons in the region of OH ~7.71-8.19 ppm
designated the presence of an ortho-disubstituted benzene ring. The 13CNMR (100 MHz) further
supported the assignment by revealing one O-h group at Oc ~24.3-25.0 ppm, two CH2 groups at Oc
-38.5-54.2 ppm and finally the vinylic, aromatic and quaternary carbon atoms more downfield of
the spectrum in the region of Oc -117.6-148.3 ppm. Furthermore, the structural determination was
verified by IR spectroscopy, MS and accurate mass measurements.
Having successfully synthesized the 2-(2-n itrobenzenesul fonam ide)-1 ,2-th iazine l-oxide
(507a) and 2-(2-nitrobenzamide)-1 ,2-thiazine l-oxide (507b), we then moved on to transform the
thiazine rings to their corresponding homoallylic system via acid hydrolysis. Accordingly,
compounds (507a-b) were heated at reflux in tetrahydrofuran in the presence of aqueous HCt. In
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both cases the acid hydrolysis proceeded smoothly and upon purification, yielded the (2-
nitroaryl)allylic sulfonamide (508a) and (2-nitroaryl)allylic amide (508b) in 65% and 55% yield,
respectively (Scheme 5.14).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
C(~~J-M'zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA_~q_HF~~_~~ceX-{)-M'
N020 N02
507a: X=S02
507b: x-co
508a-b
Scheme 5.14
Evidence of successful ring opening of the thiazine ring in both cases was provided by lH
NMR, which showed the presence of the new vinylic CH2 group as pairs of singlets in the region
of BH -4.69-4.85 ppm. As expected the CH2 next to the nitrogen now appeared as a quartet at BH
-3.25-3.58 ppm, due to coupling with the adjacent NH and neighbouring allyl CH2 group, which
subsequently appeared as a triplet at BH -2.25-2.35 ppm. Further enlightment was the diagnostic
presence of a broad signal at BH -5.35-6.00 ppm, corresponding to the sulfonamide or amide NH
proton. Analysis of both products by l3C NMR (lOOMHz) revealed the presence of two relatively
shielded CH2 groups at Be -36.9-45.1 ppm and more importantly the new deshielded CH2 group at
Be -112.5-113.4 ppm. These data, combined with consistent IR spectra verified the structural
assignment.
5.2.3 Synthesis of 1-(2'-nitroaryl)-3-iodopyrrolidine via 5-endo-trig iodocyclisation
Following the new synthetic plan as outlined in Scheme 5.10, the next task involved the
generation of the iodopyrrolidines (500;Y=N02) via the 5-endo-trig iodocyclisation.P"
Encouragingly, treatment of the homoallylic benzamide (508b) with iodine and sodium hydrogen
carbonate in anhydrous acetonitrile at ambient temperature resulted in a smooth cyclisation to
generate the iodopyrrolidine (509b) in 91% yield. Conversely, the homoallylic
benzenesulfonamide (508a) underwent a slow reaction and, after purification via column
chromatography resulted in the desired iodopyrrolidine (509a) and recovered starting material in
53% and 25% yields, respectively (Scheme 5.15).
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
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Scheme 5.15
The structure of the 2-nitroaryl iodopyrrolidines (509) was assigned on the basis of 'n and
13CNMR spectroscopic analysis. Specifically, in each case, the lH and 13CNMR spectrum (400
MHz), showed the expected three relatively shielded CH2 groups, with each proton being different
environmentally, hence appearing as six different CH's in the region of OH ~1.81-3.86 ppm. The
disappearance of both the NB and the allylic CH2 group further supported the proposed structure,
which was verified by mass spectrometry which confirmed the presence of the single iodine.
Unfortunately, all attempts to reduce the N02 group present in (509a-b) were unsuccessful
and to date we have been unable to isolate the desired products (481a-b), or any recognizable
product.
C({~:,--7Jj,_~]___,~~C(~,
NOz NHz
5098: x-so, 481a: x=SOz
509b: X=CO 48] b: X=CO
Scheme 5.16
Finally, the unexpected success of the iodocyclisation in the synthesis of the aziridino-
1,2,6-benzothiadiazocine discussed earlier in this section, naturally led us to attempt the
transformation of the analogous 2-(aminoaryl)homoallylic amide (510), derived via reduction of
(508b) using Pd/C,39 to the corresponding aziridine fused 8-membered ring. In the event,
iodocyc1isation of 2-(aminoaryl)homoallylic amide (510) led to a multi spot reaction by TLC.
Nevertheless, purification of the crude mixture yielded one major identifiable product, which was
assigned by NMR, MS and IR spectra as the 1-(2'-amino-4'-iodoaroyl)-3-iodo-3-
methylpyrrolidine (511), the product of an unexpected over-iodisation (Scheme 5.l7). Attempts to
cycJise compound (511) were unsuccessful.
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ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0N-~j-Me 3 et~2c~~~203~N~J
llA_ 35% I)lA- MezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
NH2 NH2
510 511
Scheme 5.17
The unsuccessful attempts to prepare a 1-(2-aminoaryl)-3-iodopyrrolidine (481) from the
corresponding 1-(2-nitroaryl)-3-iodopyrrolidine (509), together with the failure of 2-aminoaryl
homoallylic amide (510) to undergo ring cyclisation to the desired aziridino fused 8-membered
ring meant that possibilities for the synthesis of pyrrolobenzothiadiazepines via this route were
exhausted. With a reliable, but unexpected, synthesis of the aziridino benzothiadiazocines in
hand, our attention now turned to exploring alternative avenues to produce such aziridine fused 8-
membered ring heterocycles with the further intension to verify this unusual structure by
alternative synthesis.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
5.3 Attempted alternative synthesis of aziridine fused benzothiadiazocines
Recently, Ciufolini et al.235 have demonstrated the utility of the tethered alkenic aryl azide
(512) for the synthesis of N-aryl aziridine (SI4), by simply refluxing compound (SI2) in toluene,
followed by dediazoniation of the corresponding triazoline (SI3)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAvia irradiati in benzene at
room temperature (Scheme 5.18).
OH
ccJTMS Toluene. A,3 h90%N3
OH Benzene OH
r.t.15min ~I~
I R™S-7-7%-0 ..... 'AN7HTMS
N"N
513 5]4512
Scheme 5.18
In the context of our interest in the application of 1,2-thiazine l-oxide based
methodologies in heterocyclic synthesis, together with the intention to synthesis aziridine fused 8-
membered ring heterocycles, we envisaged a synthetic approach utilizing a similar methodology to
that above. In this respect, the plan was to heat homoallylic sulfonamido arylazide (SOl), derived
from 2-(2-azidobenezenesulfonyl)-1,2-thiazine l-oxides (400) via acid hydrolysis, to generate the
triazoline intermediate (SIS) via a 1,3-dipolar cycloaddition process, which upon extrusion of
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nitrogen would furnish the desired aziridine (496) [Scheme 5.19]. This would confirm the
structural assignment made in section 5.1.2, above, and offer a more straightforward route to
compound (496).
496
Scheme 5.19
5.3.1 Thermolysis of homoallylic sulfoamido aryJazide
Following the synthetic plan, we attempted to transform the homoallylic sulfonamido azide
(SOla) into the corresponding aziridinobenzothiadiazocine (496a) using DMF. Intriguingly,
heating a solution of homoallylic sulfonamido arylazide (SOla) in DMF resulted in the isolation of
one new product, which, was not the triazole (SlSa), nor the aziridine (496a), but was, in fact, the
pyrrolo-I,2,4-benzothiazine l.J-dioxide (S16a) [Scheme 5.20], obtained in 18% yield.
o
ce'S-{l
N3
SOh
Scheme 5.20
The structure of the product was assigned on the basis ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIH NMR, I3C NMR, IH_IH_
COSY, IH-13C-COSY, MS, IR spectra and accurate mass measurements. The appearance of a
broad peak at OH 4.28 ppm, corresponding to the aryl NH group, together with the disappearance
of the azide, vinylic CH2 group and the NH group of the sulfonamide. Two dimensional IH_13C
correlation spectrum allowed a definite assignment of the resonance due to the chiral CH group,
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whose carbon resonance occurred at an expected position around Dc 71.2 ppm, while the proton
resonance was shifted to the region of DH 5.48 ppm, indicating its being next to the two
electronegative nitrogen atoms. The IH_IH COSY spectrum allowed all of the other proton
resonances to be assigned and showed that the chiral methine was coupling to the NH and to a
methylene group, which in turn was coupling to a second methylene group, which was then
coupled to a third methylene, whose protons appeared more downfield at DH 3.20 ppm and 3.57
ppm, corresponding to being next to the more electronegative nitrogen atom. The fact that the two
dimensional NMR shows a clear NHCHCH2CH2 linkage, rules out the alternative eight membered
ring triazoline and aziridine fused system, where we would expect a CH2-CH-CH2-CH2 linkage.
These data combined with JR spectroscopic analysis [NH absorption (strong) at VzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAmax 3363 er "],
MS [rn/z (ESI+): [M+Ht, 225], high resolution mass spectra and X-ray crystallographic analysis
(figure 1.2) confirmed the structural assignment.
Figure 5.2: X-ray crystal structure of 1,2,7-pyrrolobenzothiazine-l, I-dioxide (516a)
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With regards to mechanism it was thought, given the use of DMF at reflux as solvent, that
initial nitrene formation is followed by ring closure to a nine membered ring, free radical
migrations and closure to a 6,5-fused system, perhaps akin to that shown in Scheme 5.21.
0)(CC::ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
H
516a
-
Scheme 5.21
In order to verify this proposed mechanism, a further two examples of homoallylic
sulfonamido azides (SOtb: RI=H, R2=Me) and (SOle: R1=R2=Me), were heated at reflux in DMF.
In both cases thermolysis proceeded readily, however, in each case, the major products isolated
were not the expected pyrrolo-l,2,4-benzothiazine 1.l-dioxides (S16b) and (S16e), but were in fact
the differently substituted pyrrolo-l,2,4-benzothiazine-l,l-dioxides (S17b) and (517e),
respectively (Scheme 5.22). This indicates a more complex mechanism to that proposed In
Scheme 5.21, whereby a rearrangement of the carbon backbone must occur (see later).
d~P-R'
H R2
517b-c
Scheme 5.22
Again, the structures of the products were assigned on the basis of their IH NMR, l3C
NMR, IH,IH_COSY, IH,13C-COSY, MS, IR spectra and accurate mass measurements. In both
cases these data contrasted markedly with those expected for the supposed products (S16b) and
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(516c). In the case of compound (517b), the most notable feature was a clear CH2-CH2-CH2
chain, thus ruling out structure (516b) in which the expected CH-CH(Me)-CH2-CH2 linkage was
not present. Further enlightment was given by the presence of the methyl group at OH 1.78 ppm,
appearing as a singlet, giving a strong indication that the methyl group is on the bridgehead, and
further ruling out structure (516b), where the methyl is expected to be split into a doublet by the
neighbouring methine. A deshielded quaternary carbon atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOc 79.0 ppm would seem to correspond
to the deshielded bridgehead carbon.
Similarly, a detailed analysis of compound (517c) by IH_13C COSY, now showed the
presence of two methyl groups, whose resonance occurred at Oc 18.7 ppm and 28.3 ppm. In the
IH_lH COSY spectrum these methyl groups appeared as a doublet at OH 1.07 ppm (3H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.6,
CH3CH), as a result of coupling to the adjacent CH group, while the other appeared as an unsplit
singlet at 1.78 ppm (3H, s, CCH3), indicating its position on the bridgehead, and evidently ruling
out the (516c) structure. As expected, the CliMe group appeared more complex [OH 2.36-2.53
ppm (IH, m, CH2CliMeCH2), as a result of the coupling with the methyl group and with the
neighbouring methylene groups, that are present on each side of the CHMe group. The CH2 next
to the nitrogen appeared more deshielded at OH 3.58 ppm (IH, dd, J 9.7,9.7 NCH-H) and OH 3.23
ppm (IH, dd, J 10.3, 7.0, NCH-H), while the CH2 between the two chiral centre appeared
relatively shielded at c5H 2.21 ppm (IH, dd, J 13.0, 7.1, CMeCH-HCHMe) and 1.88 ppm (IH, dd, J
12.9, 10.3, CMeCH-HCHMe). Furthermore, IH_IH COSY clearly showed the CH2CHMeCH2
linkage, together with an IR spectrum that supported the structural determination by showing the
NH stretch absorption at Vmax -3366 cm", while the mass spectrometry (ESI+) and accurate mass
measurement verified the structural assignment.
As discussed above, the mechanism put forward in Scheme 5.21 for compound (516a)
cannot apply here, as the products expected [516b and 516c] do not form. An alternative
mechanism, which would explain the formation of (517a) as well as that of (517b) and (517c) is
shown in Scheme 5.23 and involves a rearrangement of the carbon backbone.
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Scheme 5.23zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
5.4 Conclusion
A novel synthetic route to aziridino-l,2,7-benzothiadiazocines (496) was established via an
homoallylic arylamino sulfonamide iodocyc1isation strategy. Advantageously, the use of 2-(2-
aminobenzenesulfonyl)-1,2-thiazine-I-oxides, obtained in excellent yields via a Staudinger/
hydrolysis sequence of the corresponding azides, allowed access to the required homoallylic
arylamino sulfonamides (480). Attempted synthesis of iodopyrrolidines via the azide or
iminophosphorane, proved to be problematic. These difficulties were addressed by the use of the
corresponding nitro compound where iodocyc1isation yielded the 1-(2'-nitroaryl)-3-
iodopyrrolidine (509), through 5-endo-trig iodocyclisation. However, these later failed to be
reduced to the corresponding amine. Interestingly, in the case of the analogous homoallylic
arylazido sulfonamides (501), it was found that thermolysis in DMF proved to be a good method
for the synthesis of pyrrolo-I,2,4-benzothiazine Ll-dioxides (517), a process that occurs via an
unusual mechanism involving a rearrangement of the carbon backbone.
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6.1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAAttempted synthesis of aziridinopyrrolobenzodiazepines and
pyrrolobenzodiazepines
As part of our interest in the synthesis of pyrrolobenzothiadiazepines and
pyrrolobenzodiazepines, we have so far, in this thesis, explored the 1,3-dipolar cycloaddition
reaction of nitrile oxides to pyrrolobenzothiadiazepines and further, in the previous section,
described the intramolecular azide cycloaddition to alkenes. In a continuation of our pursuit tozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
.
develop a novel synthetic strategy for the synthesis of tetracyclic pyrrolobenzothiadiazepine and
pyrrolobenzodiazepine heterocycles, this final chapter is to unite these two themes by exploring
'click chemistry,236 approaches to these heterocycles: Currently, the term click chemistry has
become synonymous with the Huisgen 1,3-dipolar cycloaddition between a terminal alkyne and an
azide,236a and has found many applications in organic chemistry."? drug discovery.v"
bioconjugations.r" materials science.i" and the synthesis of natural product derivatives.i'" and
polymers.242
The concept of this strategy, as depicted in Scheme 6.1, relies upon the synthesis of a C-
ring (the pyrrole) that is substituted with the 1,3-dipolarophile (518), which in tum, would be
coupled to a pre-formed A-ring azidic component to provide access to the desired backbone
containing both the azide dipole and the alkene, alkyne or nitrile dipolarophiles as shown in
compound (520). Subsequent intramolecular 1,3-dipolar cycloaddition would, hopefully, furnish
the novel tetracyclic heterocycles (521). This chapter will describe the synthesis and uses of
alkene, alkyne and nitrile in the synthesis of target compounds (521).
0, '~x-[0,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA~x]- Np-ct()
I I N3 ", N-r-RH" , 'xX N~ ,
N
Xs=CH2 (alkene), CH (alkyne)
or N (nitrile)
R= Fmoc, C02Et or Boc
518 519 520
Scheme 6.1
521
The route that we investigated first is shown in Scheme 6.2 and relies upon the generation
of 2-ethylene pyrrolidine (526), which is readily available from Fmoc protected ethylene
pyrrolidine (525). Access to the Fmoc protected ethylene pyrrolidine (525) would be
accomplished via a Wittig reaction243 of the corresponding aldehyde (524), derived from N-
protection of the commercially available (S)-prolinol (522), followed by oxidation of the Fmoc
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protected prolinol (523). Deprotection of the Fmoc protected ethylene pyrrolidine (525) and in
situ condensation reaction of the resulting free amine (526) to 2-azidobenzoyl chloride, derived
from a diazotization and chlorination sequence from anthranilic acid,245would generate the desired
cyclisation precursor (527).
Fmoc-CI
NaHC03
~ DCMzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
B OH
522zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~ .a, ~CHO Ph3P=CH2 ~
tmoc OH tmoc Fmoc
523 524 525
1
1:1(V/V)
Et3N, DCM DIEAIDCM
o OCOCI d
c(f~b N,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA[Y;]
527
Scheme 6.2
526zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.1.1 Synthesis of N-Fmoc protected (S)-prolinol
Following the proposed methodology in Scheme 6.2, the initial requirement was to protect
the nitrogen of (S)-prolinol with Fmoc.173 Accordingly, a solution of (S)-prolinol (522) was
treated with 9-fluorenylmethyl chloroformate and sodium hydrogen carbonate in anhydrous
dichloromethane at ambient temperature under nitrogen (Scheme 6.3). The reaction was found to
proceed readily and the purification of the crude mixture yielded the Fmoc-protected (S)-prolinol
(523) in 82% yield.
Fmoc-CI
NaHC03
~ DCM
B OH
522
c:»
't:'oH
523
Scheme 6.3
The incorporation of the Fmoc group was confirmed by IH and I3C NMR spectroscopic
analysis of the products. Significantly, the IH NMR spectrum (400 MHz) indicated the additional
presence of the 9-fluorenylmethoxycarbonyl CH and CH2 groups, split by each other as a triplet at
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bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH ~4.30 ppm a d a doublet at bH ~4.50 ppm, respectively. In the aromatic region, the fluorenyl
CH groups appeared in the region of bH ~7.25-7.45 ppm and bH ~7.55-7.80 ppm, together with the
expected fluorenyl carbons in the aromatic region of the l3C spectrum and the deshielded
carbamatezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAc=o group at be 156.3 ppm. Further evidence of the carbamate group was provided by
the occurrence in the IR spectrum ofa C=O stretching absorption at Vmax 1681 ern".
6.1.2 Synthesis of N-Fmoc protected (S)-prolinal via oxidation
Having successfully protected the nitrogen of the (S)-prolinol, the next objective was to
synthesise the corresponding aldehyde via an oxidation. The use of Dess-Martin period inane was
examined first due to its mild conditions and ease of use.180 Accordingly, the N-Fmoc prolinol
(523) was treated with Dess-Martin period inane in anhydrous dichloromethane at ambient
temperature under nitrogen (Scheme 6.4). The oxidation proceeded smoothly yielding the desired
aldehyde (524) in 96% yield, after purification by column chromatography (Scheme 6.4).
Dess-Martin
periodinane
~ DeM, r.t. 1hr
IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOHFmoc
523 524
Scheme 6.4
The successful oxidation of the alcohol was confirmed with IH NMR (400 MHz) which
indicated the additional presence of the aldehyde proton as a singlet at OH 9.57 ppm (IH, s, CHO).
Additionally, the presence of the carbonyl moiety was demonstrated in the 13C NMR spe~tra (100
MHz) of the products by the appearance of a deshielded aldehyde CHO peak at be 199.8 ppm,
together with the disappearance of the CH20H group. Further confirmation of the desired
structure was obtained from the IR spectrum, which showed the presence of a carbonyl C=O
stretch in the range of Vmax 1732 em-I.
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6.1.3 Synthesis of the (2S)-N-(9'-fluorenylmethoxycarbonyl)-pyrrolidine-2-ethenzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAe
via a Wittig reaction
The Wittig reaction, a process by which phosphorus ylides convert aldehydes and ketones
to alkenes, is one of the most important reactions in organic chemistry and is widely used as a key
step in many natural product synthesesi'" as well as in industrial processes.r" The phosphorus
ylides (Wittig reagent) are usually prepared in two step process involving an SN2reaction between
an alkyl halide and triphenylphosphine, followed by deprotonation of the corresponding
alkyltriphenylphosphonium salt with a strong base such as n-BuLi, NaH, or t_BuOK.247 Although,
the ylides can be isolated, they are usually produced and used as reagents immediately, and
consequently, exposure to aldehydes or ketones, results in a nuleophilic addition of the phosphorus
ylide (528) to the carbonyl compound to form an unstable oxaphosphetane ring (529), which
promptly fragments to give the desired alkene (530) and triphenylphosphine oxide as side
product.247a
-- (PhhP=CH2]
Scheme 6.5
Accordingly, the synthesis of the desired alkene (525) was attempted via the Wittig
reaction of the Fmoc protected carbonylpyrrolidine (524) with triphenylphosphonium methyl ide
(Scheme 6.6), where the latter was generated from the readily available
methyltriphenylphosphonium bromide by deprotonation using butyllithium in anhydrous
tetrahydrofuran.
Ph3P=CH2zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA[)! THF
N CHO
I
Fmoc
~
Fmoc
524 525
Scheme 6.6
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However, it was found that the Wittig reaction afforded the desired alkene (525) only in
low yields (20%). The structure of the product was confirmed by IH NMR (400 MHz) which
indicated the disappearance of the aldehyde proton and the appearance of three vinylic protons in
the region ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAbH 4.90-5.90 ppm [4.90-5.15 ppm (2H, m, =CH2) and 5.77 ppm (lH, m, br, =CH)].
Additionally, the presence of the vinylic CH and CH2 groups was demonstrated in the l3C NMR
spectra (100 MHz) of the products by the appearance of peaks at be 137.9 and 114.2 ppm,
respectively, together with the disappearance of the CHO group.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.1.4 Attempted synthesis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-ethene
The low yield of the alkene was attributed to competitive base induced cleavage of the
Fmoc protecting group in both the product and starting material. In the event, the attempted
coupling of the C-ring component via deprotection of N-Fmoc alkene (525) and subsequent
addition of the 2-azidobenzoyl chloride to the reaction mixture resulted in a multi-spot TLC
(Scheme 6.7). Purification of the crude product yielded only the unchanged 2-azidobenzoyl
chloride. Consequently, we moved on to explore alternative means to bring about the synthesis of
the desired compound (527).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
525 526 527
Scheme 6.7
Fortunately, work by Ikeda248on the construction of optically active pyrrolizidinone ring
systems (536) via the c-chlcrosulfldes (535), involved the use of (S)-prolinol (522) for the
generation of the (S)-(-)-2-ethenyl-l-ethoxycarbonylpyrrolidine (533). Thus, in Ikeda's248 work N-
protection of (S)-prolinoI (522), followed by oxidation of the corresponding (S)-N-
ethoxycarbonylprolinol (531) with sulfur trioxide (S03)-pyridine in dimethyl sulfoxide gave the
aldehyde (532) in 74% yield. Access to the alkene (526) was accomplished by means of the
Wittig reaction of the aldehyde (532) using triphenylphosphonium methylide, followed by
hydrolysis of the corresponding N-protected alkene (533) with potassium hydroxide/ hydrazine
hydrate in refluxing ethylene glycol. Treatment of the resultant amine (526) with phenylthio- or
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methylthio-acetyl, followed by chlorination of the resultant acetamides (534) with N-
chlorosuccinimide furnished the u-chlorosulfides (535).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4MNaOH
~ EtC02Cl
I'I OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
522
S03·PY
!\N .."HH _D_M_SO_ [);!! Ph3P=CH2
'N~ N CHO
C02Et OH C02Et
531 532
ex
_H'Me
° SR
BU3SnH
(1:1 eq)
AIBN Y1
O~Cl
SR
NCS Y1
O~
SR
534
Y1
C02Et
533
I KOH
• NH2NH2
RSCH~OCI [y;1
536 535 526
Scheme 6.8
Based on this finding, the above method was utilized as an approach to access the desired
C-ring component (526) as discussed below.
6.2 Synthesis of aziridinopyrrolobenzodiazepines and pyrrolobenzo-
diazepines via N-ethyl ester
6.2.1 Synthesis of (S)-(-)-I-ethoxycarbonylpyrrolidine-2-methanol
Following the method outlined in Scheme 6.8, the initial requirement was to protect the
prolinol nitrogen. Accordingly, (S)-prolinol (522) was treated with ethyl chloroformate in 4M
sodium hydroxide at o-c. The reaction was found to have proceeded smoothly and upon
purification of the crude mixture yielded the desired N-protected prolinol (531) in 93% yield
(Scheme 6.9).
4MNaOH
~ EtC02CI
I'I OH
522
Scheme 6.9
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6.2.2 Synthesis of (S)-(- )-1-ethoxycarbonylpyrrolidine-2-carbaldehyde
With the success of the N-protection, the next objective was to synthesize the
corresponding aldehyde via an oxidation. Amongst the various oxidizing agents available, the use
of pyridinium chlorochromate''" was examined first.
Pyridinium chlorochromater'" (pee) is a useful reagent for the facile and efficient
oxidation of primary and secondary alcohols to the corresponding aldehydes and ketones,
respectively. The reagent is usually prepared easily and safely by adding one equivalent of
pyridine to a solution of one equivalent of chromium(VI) oxide and concentrated hydrochloric
acid.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Hel + er03 -- G -~Hero3el --.. NH Or-Cr+ClII
o
Scheme 6.10
The mechanism by which the pyridinium chlorochromate oxidation takes place engages
two steps. The first step involves the formation of a chromate ester. Once the chromate ester is
formed, it undergoes an elimination reaction to generate the carbonyl group as outlined in Scheme
6.11.
RI 0
>= IIo + er-OH + H-Base
R2 ~
Scheme 6.11
Accordingly, a solution of (S)-(-)-1-ethoxycarbonylpyrrolidine-2-methanol (531) in
dichloromethane was treated with pyridinium chlorochromate at ambient temperature and
monitored by TLe. The reaction was found to be slow but was complete in three hours, with TLe
indicating one new product. Workup with ether, followed by purification via column
chromatography, resulted in the isolation of the desired aldehyde (532) in 56% yield. Although
the necessary oxidation had occurred, isolation of the product from the sticky tar deposit of the
chromium byproduct proved problematical on many occasions, and for this reason we turned
attention to the use of Swern conditionsl84-185and sulfur trioxide pyridine complex248,250as
alternative oxidants, with the hope to improve the yield and to find an oxidizing reagent which was
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easy to use and handle. In the event, it was found that the use of sulfur trioxide pyridine complex
turned out to be the best oxidant, as its use led to the desired product in high yields as shown in
Table 6.1.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIt is also notable that Ike a248 reports that this oxidant leads to no racemisation, in
contrast, for example, to Swern oxidation.
n
N
.."HH_[_0]_ /\ ,H
-,N~ "NAcHO
C02Et OH C02Et
531 532
Scheme 6.12
a PCC, DCM, r.t., 3 hrs
b Et3N, DMSO, S03-pyridine complex, DoC,2 hrs
c (COCI)2, DMSO, DCM, DIEA
56zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
83
76
Entry Method Yield of 532(%)
Table 6.1: % yields of the aldehyde
6.2.3 Synthesis of (S)-( -)-2-ethenyl-l-ethoxycarbonylpyrrolidine
Having established an efficient route through to the aldehyde (532), the next objective was
to convert the aldehyde to the corresponding alkene moiety via the Wittig reaction. Initially, we
decided to implement the Wittig conditions as described by Ikeda et al.248using sodium hydride in
DMSO to generate the phosphorus ylide from the readily available methyltriphenylphosphonium
bromide. Accordingly, a preformed mixture of methyltriphenylphosphonium bromide in DMSO
in the presence of NaH was treated with a solution of aldehyde (532) in DMSO at room
temperature and stirred for 1 hour (Method A). Work-up with a mixture of water and hexane,
followed by purification of the crude mixture via column chromatography, resulted in the isolation
of the desired product (533) in 50% yield as a mixture of rotamers. It was also found that treating
the methyltriphenylphosphonium bromide using n-butyllithium as base (Method B) generated the
phosphorus ylide, and subsequent reaction with the aldehyde (532) afforded the alkene (533) in
49% yield.
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A
NaH, hexanezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA[')!: DMSO, (PhhP+-CH3Br-
N CHO n-BuLi, THF
C02Et (Ph»)P+-CH3Br-
532 B
Scheme 6.13
The structure of product (533) was assigned on the basis of 'H NMR, l3C NMR, MS, IR
spectroscopic analyses and accurate mass measurement. Specifically, 'H NMR showed evidence
of the incorporation of an alkene by the occurrence of the vinylic methine and methylene peaks at
DH 5.74 ppm (lH, s, br, =CH) and 5.09 ppm (2H, m, =CH2), respectively. The three pyrrolidine
CH2 groups appeared as broad multiplets in the region of DH 1.70-3.50 ppm. As expected the
chiral methine appeared more deshielded at DH 4.32-4.39 ppm (1H, m, br, NCH), due to the
neighbouring electronegative nitrogen. Lastly, the presence of a methyl group at DH 1.24 ppm (3H,
m, br, CH3) together with the relatively deshielded peak at DH 4.13 ppm, indicated the ethyl ester
still intact. These data combined with spectroscopic analysis by l3C NMR (100 MHz) [(DEPT-
135) Dc 22.4/23.3,31.1131.8,46.1146.3 (3x CH2) and 113.71114.0, 138.11138.4 (vinylic Cl-h and
CH, respectively) as mixture ofrotamers], IR spectroscopic [alkene absorption at Vmax 1698 ern"],
MSzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA[m/z (ESI+): [M+Ht, 170] and correct accurate mass measurement supported the structure
assignment.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.2.4 Synthesis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-ethene
With the alkene in hand, attention turned to the use of potassium hydroxide and hydrazine
in refluxing ethylene glycol as the literature248 conditions to generate the free amine (526), which
would be reacted in situ with 2-azidobenzoyl chloride, derived from chlorination of 2-
azidobenzoic acid with thionyl chloride, to gain access to the desired cyclisation precursor (527).
Accordingly, a solution of carbamate (533) in ethylene glycol was heated at reflux in the presence
of potassium hydroxide and hydrazine hydrate. Upon completion, the reaction mixture was
cooled, quenched with aqueous sodium hydroxide and extracted with diethyl ether. Subsequent
treatment of the ethereal solution with triethylamine and a solution of 2-azidobenzoyl chloride in
diethylether, afforded the desired coupled precursor (527) as a rotameric mixture in 49% yield
after work up and purification by column chromatography (Scheme 6.14).
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y; zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
C02EtzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
533zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA526 527
Scheme 6.14
The structural assignment of the coupled precursor (527) was performed in the view of the
IH NMR, I3CNMR, MS, IR and accurate mass measurement. The IH NMR spectrum (400 MHz)
established a rotameric mixture, with the doubling of the desired peaks. Evidence of successful
coupling reaction was confirmed by the appearance of four aromatic protons in the region of OH
6.90-7.50 ppm [6.94-7.23 (3H, m, ArH); 7.21-7.34 OH, m, ArH)] corresponding to the ortho-
disubstituted benzene ring, the presence of the distinctive pyrrolidine signals, together with the
disappearance of the methyl and methylene groups that were diagnostic of the ethyl ester in the
protected pyrrolidine. The structure of the product was further confirmed by I3CNMR (100 MHz)
[(DEPT-135), which showed the presence of three CH2 groups in the region of be 20.5-49.5 ppm,
a CH resonance at 57.9 and 60.6 ppm (rotamers) and the vinylic, aromatic and quaternary carbon
atoms more downfield at be 113.9-166.9 ppm. These data combined with IR spectroscopic
analysis [N3 absorption (strong) at Vmax 2128 cm-I and C=O absorption at Vmax 1718 cm"], MS
[m/z (ESI+): [M+Ht, 243] and accurate mass measurement supported the structural assignment.
6.2.5 Synthesis of the pyrrolobenzodiazepine targets
With precursor (527) in hand, the final requirement was to explore the synthesis of
tetracyclic pyrrolobenzodiazepines via intramolecular 1,3-dipolar cycIoaddition. Thus, a solution
of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-ethene (527) in DMF was heated at reflux, whilst being
monitored carefully by TLC. Purification by column chromatography of the crude reaction
mixture gave one major product. The structure of the compound was assigned by spectroscopic
analysis as the hydroxypyrrolobenzodiazepine (539) formed in 38% yield (Scheme 6.15).
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539
Scheme 6.15
The structure of the hydroxypyrrolobenzodiazepine (539) was assigned on the basis of IH
NMR (400 MHz) spectrum, where the OH group was evident as a broad singlet at OH 5.24 ppm, a
feature confirmed by infra-red analysis, while the methyl group on the adjacent carbon was present
at OH 1.52 ppm as a singlet. Significantly, one of the C-3 protons of the pyrrolidine ring appeared
at OH 3.18 ppm (lH, td, J 14.5,3.0, CH-H), while the other resonated at 4.68 ppm (lH, dt, J 10.4,
3.7, CH-H), being shifted more downfield due to the presence of the electronegative OH group at
C-4. The pyrrolidine C-l and C-2 protons appeared in the region of OH 1.90-2.72 ppm [1.90-2.05
(lH, m, CH-H), 2.08-2.19 (lH, m, CH-H) and 2.70 (2H, q, J 8.6, 5.0, CH2)], with the more
downfield CH2 being next to the more electronegative nitrogen atom. Further support for the
proposed structure was provided by 13CNMR (100 MHz) (DEPT-135), which revealed the
presence of three relatively shielded CH2 groups at Oc 22.2, 35.6 and 37.5 ppm, and a deshielded
quaternary carbon at Oc 75.1 ppm, indicative of the C-4 attached to OH. IR analysis also
confirmed the presence of alcohol by the occurrence of a relatively broad OH absorption at Vmax
3315 cm". These data combined with a consistent MS spectrum [m/z (ESI+): [M+Ht, 231] and
accurate mass measurement, verified the structural assignment, and beyond doubt confirmed that
the molecule contained an unexpected extra oxygen atom.
Mechanistically, this transformation might proceed via the mechanism shown in Scheme
6.16, whereby high temperature free radical formation from the triazoline leads to loss of nitrogen
and rearrangement of the resultant methylene radical to a tertiary carbon radical. Oxygen insertion
(the reaction was not done under an inert atmosphere or in degassed solvent) followed by cleavage
of thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0-0 bond in the peroxide would then give the proposed product. Similar mechanisms
involving initial nitrene formation can also be written and cannot be discounted at this
temperature.
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Scheme 6.16
Although, the thermolysis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-ethene (527) proved
interesting in generating a tricyclic pyrrolobenzodiazepine analogue (539), it was clear that the
high temperature associated with DMF was problematic. Subsequently our attention next turned
to the use of acetonitrile, as it was envisaged that the use of a solvent with a lower boiling point to
that of DMF may reduce the chance of free radical formation and thus, (2S)-N-(2-azidoaroyl)-
pyrrolidine-2-ethene (527) could cyclise to achieve the desired tetracyclic pyrrolobenzodiazepine
(537). In the event, heating (2S)-N-(2-azidoaroyl)-pyrrolidine-2-ethene (527) in acetonitrile at
reflux, resulted in the isolation of an inseparable mixture of two new products. The structure of
the products were confirmed by spectroscopic analysis and were found to be the
aziridinopyrrolobenzodiazepine (538) and pyrrolobenzodiazepine (540) in a 3:] ratio, respectively.
Interestingly, heating the precursor (527) in dichloromethane afforded the same products, however
this time in a 1:1 ratio.
ceO;?"
c'f ~::~Z'N 'HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
. ~ 537
"H
N3",7 ° °
ceiJ·."H +cL~N N
" Me
H 'H
527
538
Scheme 6.17
540
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Diagnostic signals in thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIHNMR were the methyl group of (540) together with a doublet
for each of the aziridine methylene protons where these protons coupled to the neighbouring
methine but not to each other (typical of such aziridines).229 Mass spectroscopic analysis
confirmed the loss ofN2, i.e. the triazoline (537) was not isolated.
With regards to mechanism, it is believed that the initial 1,3-dipolar cycloaddition does
take place (nitrene being unlikely at the lower temperature) to form the triazoline, which then
undergoes extrusion of nitrogen by two different routes to yield the two products (538) and (540)
as shown in Scheme 6.18.
Scheme 6.18
Interestingly and concurrent with the work in this thesis, Brogglnl+" has recently shown
that compound (527) [which he constructed by a different route] gives the triazoline (537) as the
only product in refluxing carbon tetrachloride. A personal communication from Broggini
indicated that the formation of aziridine (538) or imine (540) was not observed.
Finally in this section, it is worth mentioning that attempts to convert the prolinol coupled
product (541) into the alkene (527) via oxidation followed by Wittig olefination (Scheme 6.] 9),
failed at the Wittig stage, possibly due to nucleophilic attack of the yJide at the azide.
aq. KOH,DCM(),COCI 0 0 0
~OH
.0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
c(~ pcc clN9 Ph,PoCH, cl8N) , ~ NN \ ~ I ~ "'HIH 3 OH N3 ~ N3 ~
522 541 542 527
Scheme 6.19
135
Chapter 6 Discussion-Part VzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.3 Synthesis of triazolopyrrolobenzodiazepines via alkyne
Having established the validity of an intermolecular 1,3-dipolar cycloaddition between an
azide and a terminal alkene within this system, we next explored the feasibility of the process
using an alkyne as the dipolarphile, a process considered to be the classic "click" reaction.i" This
process was anticipated to be easier than the alkene, in that cycloaddition leads to 1,2,3-triazoles
which are stable and are isolated as the single products. In this respect, the idea was to convert the
aldehyde (532) to the corresponding alkyne (544), via the Corey-Fuchs approach,252-253and in tum
couple it to 2-azidobenzoyl chloride after deprotection. This would generate the key cyclisation
precursor (546), containing the azidic dipole and terminal alkyne. Ring closure would then give
the triazole (547) which, besides being a tetracyclic pyrrolobenzodiazepine analogue, is an
interesting analogue of the anxiolytic drug bretazenil, as discussed before. As discussed above,
Wittig type reactions on the aldehyde (542) derived from 2-azidoaroyl prolinol (541) are not
successful (Scheme 6.19), and hence routes from aldehyde (542) were not investigated further.
The focus in this section is therefore on the synthesis and coupling of alkyne (545) as the route to
cyclisation precursor (546).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
547 546 545
Scheme 6.20
6.3.1 Corey-Fuchs approach to the alkyne
The conversion of aldehydes into alkynes is a key challenge. One solution, and the one
used here, is the so called Corey-Fuchs approach252-253whereby an aldehyde is transformed into
the corresponding alkyne in two steps. The first step is comparable to a Wittig reaction and leads
to a dibromoalkene (549) via the ylide (548).
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R BrzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
+ >=<
H Br
549
Scheme 6.21
In the second step a lithium base (BuLi, LOA) generates a bromoalkyne (550) intermediate
via dehydrohalogenation, which undergoes metal-halogen exchange under the reaction conditions
and yields the terminal alkyne (551) upon work-up (Scheme 6.22).
Br H - t.
.\_!!::./ "-" Bu: IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
er=Br R
549
H = R
550 551
Scheme 6.22
In a recent example of this, Rassat254 described the synthesis of alkynes via 1,l-dibromo-l-
alkenes from aromatic and aliphatic aldehydes (Scheme 6.23). These dibromo compounds were
prepared by the condensation of aldehydes with dibromomethylenetriphenylphosphorane
generated in situ from dibromomethyltriphenylphosphonium bromide (2 equiv.) and t-BuOK (2
equiv.) in THF at ambient temperature.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
+ -
Ph3PCBr2·Br
(-BuOK
THF,r.t.
(-BuOK
=<
Br THF, -780CR-<f-
H Br
R-C=C-HR-CHO
Scheme 6.23
Based on this finding, the initial requirement was to generate dibromomethyltriphenyl-
phosphonium bromide. Accordingly, a solution of triphenylphosphine in anhydrous
dichloromethane was treated with carbon tetrabromide at ambient temperature and monitored by
TLC. The reaction was very fast and was complete in 30 minutes, after which workup with
aqueous dichloromethane, followed by precipitation using acetonitrile, resulted in the isolation of
the desired salt in excellent yield (Scheme 6.24).
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Scheme 6.24
The following step involved an in situ generation of the ylide and its concomitant reaction
with the aldehyde (532) to form the 1,l-dibromoalkene (543). Therefore, treatment of the
dibromomethyltriphenylphosphonium bromide with t-BuOK in anhydrous tetrahydrofuran at
ambient temperature resulted in a yellow-brown reaction mixture, indicating the formation of the
yJide. The aldehyde (532) was added to the mixture at ambient temperature and stirred for 2
hours. The reaction was found to have proceeded smoothly, and the desired l,l-bromoalkene
(543) was isolated as a mixture of rotamers in 65% yield after workup and purification by column
chromatography (Scheme 6.25).
532 543
Scheme 6.25
The structure of the product (543) was confirmed by spectroscopic analysis. Specifically,
the 'n NMR spectrum (400 MHz) showed the disappearance of the aldehyde proton and the
appearance of one vinylic proton in the region ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA()H ~6.15 ppm. The three CH2 groups of the
pyrroJidine ring resonated in the region of BH ~ 1.50-3.30 ppm, with the more downfield CH2
being, presumably, next to the more electronegative nitrogen atom. The chiral CH group appeared
more deshielded at BH 4.22 ppm, while the methyl and methylene groups of the ethyl ester were
also present and appeared at BH 1.03 ppm (3H, t, J 5.7, CH2CH3) and 3.88 ppm (2H, q, J 7.1,
CH2CH3), respectively. The 13CNMR (100 MHz) further supported the assignment by the
presence of four CH2 groups at Be 21.9/22.8, 29.4/30.1, 43.9/45.0, 57.5/58.5 ppm and two CH
groups at Be 54.4/55.0, 137.71137.9 ppm. These data, in combination with consistent MS [m/z
(ESI+): [M+Ht, 328] confirmed the structure of the l,l-dibromoalkene (543).
Following the Rassat et al.254 approach, the l,l-dibromoalkene (543) was next treated with
t-BuOK in anhydrous tetrahydrofuran (Scheme 6.26). It was observed that the dehaiogenation
reaction proceeded readily at ambient temperature to provide the desired alkyne (544) in 100%
yield, again as a rotameric mixture.
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t-BuOKzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
THFzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
543
Scheme 6.26
6.3.2 Synthesis of (2S)-N-(2-azidoaroyl)-2-ethynylpyrrolidine
With the alkyne (544) in hand, the next objective was to cleave the carbamate and couple
the corresponding free amine (545) in situ to 2-azidobenzoyl chloride to generate the key
cyclisation precursor (546). Accordingly, alkyne (544) in ethylene glycol was heated at reflux in
the presence of potassium hydroxide and hydrazine hydrate. Upon completion, the reaction
mixture was cooled, quenched with aqueous sodium hydroxide solution and extracted with diethyl
ether. Subsequent treatment of the ethereal solution with triethylamine and a solution of 2-
azidobenzoyl chloride in diethyl ether afforded the desired compound (546) as a rotameric mixture
in only 11% yield, after workup and purification by column chromatography.
NH2NH2
~ KOH,~
I
C02Et
544 545 546
Scheme 6.27
Evidence of a successful deprotectionlcoupling sequence of the (S)-(-)-1-
ethoxycarbonylpyrrolidine-2-prop-l-yne (546) was provided by IH NMR, which showed the
expected pyrrolidine methylene and methine protons together with the additional presence of the
four aromatic protons in the region of eSH 7.00-7.50 ppm, while more downfield in the spectrum,
the presence of a signal at eSH 4.63 ppm (lH, s, alkyne-CH) verified the presence of the alkyne.
Additionally, I3C NMR spectra (100 MHz) of the product showed the alkyne quaternary carbon
and CH resonances at eSc 114.6 ppm and 118.51119.6 ppm, respectively, together with the expected
aromatic carbons in the region of eSc ~ 124.0-134.0 ppm and the deshielded carbonyl C=O group at
Oc 167.8 ppm. The IR spectrum of the product showed a C=O stretching absorption at Vmax 1717
cm", and the diagnostic presence of absorptions at 3394 ern", 2435 ern" and 2127 cm",
139
Chapter 6 Discussion-Part VzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
corresponding to the alkyne C-H and carbon-carbon triple bond stretch and N3 stretch,
respectively.
6.3.3 Synthesis of (S)-(-)-1-t-butoxycarbonylpyrrolidine-2-(1,1-dibromoprop-l-ene)
Although the necessary deprotection/coupling sequence of the alkyne (544) with 2-
azidobenzoyl chloride in refluxing ethylene glycol proved successful, the yields of the desired
cyclisation precursor were low. The reason for this is uncertain; however the instability of the
intermediate (545), together with the use of high temperature during the deprotection of the
carbamate might be contributing factors. In considering alternative strategies, we turned to the use
of a Boc protecting group and hoped that it would behave differently. Accordingly, a solution of
dibromomethylenetriphenylphosphorane in anhydrous tetrahydrofuran, generated in situ from
dibromomethyltriphenylphosphonium bromide and t-BuOK, was treated with the readily available
N-Boc-prolinal (552) at ambient temperature whilst being monitored by TLC (Scheme 6.28).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Br
~Br
N
1
Boc
552 553
Scheme 6.28
In the event, purification by column chromatography of the crude reaction mixture resulted
in the isolation of one major product. The structure of the product was confirmed by spectroscopic
analysis and was found to be the desired N-Boc I, l-dibromoalkene (553) formed in 69% yield. as a
mixture of rotamers. Specifically, the IH NMR spectrum of the product showed evidence of
successful Wittig reaction by the occurrence of the vinylic proton at OH 6.37 ppm and the
disappearance of the aldehyde proton. The three CH2 groups of the pyrrolidine ring resonated in
the region of OH -1.70-3.50 ppm, with the more downfield CH2 being, presumably, next to the
more electronegative nitrogen atom. The chiral CH group appeared more deshielded at OH -4.35
ppm, while the tert-butyl group appeared as a singlet at OH 1.47 ppm (6H, s, (CH3)3). Further
enlightment was given by the l3C NMR (100 MHz), which showed as expected three CH2 groups
at Oc 22.8, 31.2, 46.2 and two CH groups at 60.4, and 140.2 ppm, while the tert-butyl methyls
appeared more shielded at Oc29.3 ppm.
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6.3.4 Synthesis of (S)-(-)-1-t-butoxycarbonylpyrrolidine-2-prop-l-yne
We next examined the efficacy of t-BuOK in the conversion the N-Boc 1, l-dibrornoalkene
(553) to the corresponding alkyne (554). Thus, a solution of N-Boc 1, l-dibrornoalkene (553) in
anhydrous tetrahydrofuran was treated with t-BuOK at ambient temperature under an atmosphere
of dry nitrogen. The reaction proceeded smoothly and the t-BuOK successfully dehalogenated the
N-Boc 1, l-dibromoalkene (553) to give the desired N-Boc protected alkyne (554) in quantitative
yield (Scheme 6.29).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Br
[WBr
N
I
BoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I-BuOK
THF (K
I
BoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
553 554
Scheme 6.29
The structure of the product (554) was confirmed by spectroscopic analysis, specifically,
the IH NMR spectrum of the molecule showed the disappearance of the vinylic proton and the
appearance of a characteristic signal for the alkyne proton at OH 5.34 ppm. The resonance of the
tert-butyl group appeared as a singlet at OH 1.27 ppm, while the three methylene groups and one
methine group appeared as expected in the region of -1.50-3.30 ppm. Furthermore, the I3C NMR
spectrum of the product showed three sets of CH2 groups at Oc 22.8/23.6, 32.2/32.9,44.7/45.1 and
two CH groups at Oc 80.9, 119.3 with the more upfield being the alkyne CH. These data combined
with IR spectroscopy [alkyne CH absorption at 3292 ern" and alkyne carbon carbon triple bond
absorption at 2202 cm"] and MS [m/z (ESI)+: [M+Ht, 196] supported the structure assignment.
6.3.5 Synthesis of (2S)-N-(2-azidoaroyl)-2-ethynylpyrrolidine
With the new protecting group in place, attention turned to the deprotectionlcoupling of the
N-Boc alkyne (554) to the 2-azidobenzoyl chloride. Accordingly, a solution of N-Boc alkyne
(554) was treated with trifluoroacetic acid in dichloromethane.l'" Upon completion, the reaction
mixture was quenched with aqueous sodium hydroxide solution, neutralised with hydrochloric
acid and extracted with dichloromethane. Subsequent treatment of the dichloromethane extract
with triethylamine and a solution of 2-azidobenzoyl chloride in dichloromethane afforded the
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required cyclisation precursor (546) as a rotameric mixture in 37% yield over two steps (Scheme
6.30).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
TFA
~ DCM,r.t
I
BoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
547 544 546
Scheme 6.30
The incorporation of the 2-azidobenzoyl group was confirmed by 1H and 13C NMR
spectroscopic analysis of the product. Significantly, the 1HNMR spectrum (400 MHz) indicated
the additional presence of the four aromatic protons in the region of bH -7.00-7.60 ppm. The three
CH2 groups were present and appeared in the region of bH -1.60-3.90 ppm as complex signals,
together with the CH group at 4.35 ppm. More importantly, the alkyne CH remained intact and
appeared at bH 4.65 ppm. In the 13CNMR spectrum (100 MHz) of the same product, evidence of
the alkyne CH group was given by DEPT-135 analysis, where the CH appeared at be 118.5/119.6
ppm, whilst the three CH2 groups appeared at be 22.2/24.3, 28.0/29.6, 45.8/48.8 and one CH
appeared at be 56.3/58.4 ppm. These data combined with a consistent IR spectrum [alkyne CH
absorption at Vrnax 3394 ern", alkyne carbon carbon triple bond at 2435 ern", azide absorption at
2127 cm" and C=O stretch at 17] 7 cm"] further verified the structural assignment.
6.3.6 Synthesis of 1,2,3-triazolopyrrolo [2,1-c][1,4] benzodiazepine
Having established an efficient route through to the cyclisation precursor, the final
requirement was to cyclise the azide onto the terminal alkyne. Subsequently, a solution of the
cyclisation precursor (546) was heated at reflux in toluene whilst being carefully monitored by
TLC (Scheme 6.31).
546
C¢<2
,i'H
N':-N
547
Scheme 6.31
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Gratifyingly, the cycloaddition reaction was very clean and yielded the desired tetracycle
(547) as the only product in 16% yield. The structure of the product (547) was confirmed by lH
NMR, l3C NMR, lH_1H COSY, lH_13CCOSY, IR, MS and accurate mass measurements. This
time, the non-occurrence of a rotameric mixture, together with the presence of a characteristic
singlet at OH 7.64 ppm, diagnostic of the triazole CH, were significant evidence of the proposed
structure. The chiral CH appeared as doublet of doublets at OH 4.76 ppm, whilst the three CH2
groups appeared in the region of OH ~2.1 0-4.00 ppm, with the more downfield CH2 being next to
the more electronegative nitrogen atom. Lastly, four aromatic protons were present, as expected,
in the region of OH ~7.50-8.30 ppm. Furthermore, the l3C NMR spectrum of the molecule showed
three CH2 group at Oc 23.7, 29.4, 47.6 ppm and a CH group at Oc 49.6 ppm, while the five
aromatic protons and four quaternary carbons appeared more downfield at Oc 122.9-164.0 ppm.
These data combined with IR spectroscopy, MS [m/z (ESI+): [M+Ht, 241] and correct accurate
mass measurement supported the structural assignment.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.4 Synthesis of tetrazolopyrrolobenzodiazepines via the nitrile
Having made the tetracyclic triazolopyrrolobenzodiazepine from the intramolecular 1,3-
dipolar cycJoaddition reaction of an azide with a terminal alkyne, it seemed sensible to attempt the
corresponding nitrile-azide cycloaddition in order to access tetrazolopyrrolobenzodiazepines,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
• .&: I I f b '197101b Nitril ful . di .agam useru ana ogues 0 retazenil.": I n es are very use mterme rates m synthetic
organic cbemlstry " and can be obtained readily from primary amines,256 aldehydes.f" or from
d h drati f id 258 d Id' 259e y ration 0 ami es an a oximes.
Recently, Togo et al.26o reported a direct oxidative conversion of primary alcohols to the
corresponding nitriles in a one-pot procedure, using molecular iodine in ammonia water. Thus, in
Togo's260 work heating a mixture of 3-phenypropanol (555) and ammonia water in the presence of
iodine at 60°C afforded the 3-phenylpropionitrile (556) in 91% yield (Scheme 6.32).
12/ aq. NH3
~OH 60oC,24 h VC5!N
555 556
Scheme 6.32
The mechanism suggested for this transformation is given in Scheme 6.33.
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Scheme 6.33
Based on this finding, we envisaged a synthetic approach utilizing the above method to
access the nitrile. In this respect, the plan was to treat (S)-(-)-1-ethoxycarbonylpyrrolidine-2-
methanol (531) with iodine in ammonia to generate the nitrile (557). Subsequent deprotection of
the carbamate, followed by an in situ coupling of the free amine (558) with 2-azidobenzoyl
chloride would furnish the desired cyclisation precursor (559), and thus a straightforward route to
compound (560) as outlined in Scheme 6.34.
531 557 558zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
560 559
Scheme 6.34zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.4.1 Oxidative conversion of alcohol to nitrile
Following the synthetic methodology shown in Scheme 6.34, the initial requirement was to
oxidise the alcohol (531) to the corresponding nitrile (557). Accordingly, a solution of (S)-(-)-1-
ethoxycarbonylpyrrolidine-2-methanol (531) in aqueous ammonia was heated at 70°C in presence
of finely powdered iodine for 20 hours (Scheme 6.35). The reaction was found to be very clean
and the desired nitrile (557) was isolated in good yield, after work up and purification by column
chromatography.
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Izlaq. NH3
70°C, 20 hrszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
531 557
Scheme 6.35zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.4.2 Synthesis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-carbonitrile
With the nitrile (557) in place, attention next turned to the deprotection of the carbamate
and in situ coupling reaction of the corresponding free amine (558) with 2-azidobenzoyl chloride.
Thus, a solution of nitrile (557) in ethylene glycol was heated at reflux in the presence of
potassium hydroxide. Upon disappearance of the starting material, the mixture was cooled and
extracted with dichloromethane. The free amine (558) was immediately alkylated with 2-
azidobenzoyl chloride to give the required cyclisation precursor (559) in a disappointingly low
yield «10%), which could not be improved upon (Scheme 6.36).
557 558 559
Scheme 6.36
In an alternative approach for the synthesis of the cyclisation precursor (559) containing
the nitrile dipolarphile, it was envisaged that the nitrile could be synthesized by a direct oxidation
of (2S)-N-(2-azidoaroyl)-2-hydroxymethylpyrrolidine (541), derived from the reaction of the
readily available (S)-prolinol (522) with 2-azidobenzoyl chloride. Accordingly, (2S)-N-(2-
azidoaroyl)-2-hydroxymethylpyrrolidine (541) was treated with finely ground iodine in aqueous
ammonia and the mixture was heated at 70°C. Upon completion the reaction mixture was cooled,
quenched with an aqueous solution of sodium sulphite and extracted with diethyl ether.
Gratifyingly, purification of the crude product via column chromatography resulted in the isolation
of the desired cyclisation precursor (559) in 36% yield, as a mixture ofrotamers (Scheme 6.37).
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541 559zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Scheme 6.37
Evidence of successful transformation of the alcohol to nitrile was provided by 'H NMR,
which showed the appearance of only three CH2 groups in the region of OH ~2.00-3.90 ppm,
together with the disappearance of the OH group and the remaining CH2 group. The chiral
methine was present and appeared at OH 4.86 ppm, while the four aromatic protons appeared in the
region of OH ~7.00-7.50 ppm. Analysis of the same product by 13C NMR (lOO MHz) revealed the
presence of the three CH2 groups at Oc 23.0/24.8, 30.2132.0, 45.6/47.7 ppm, one CH group at Oc
46.0/48.6 ppm, and more importantly a new deshielded quaternary carbon at Oc ] 18.1 ppm,
diagnostic of the nitrile carbon. These data, combined with IR spectroscopy [nitrile absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Vmax 2242 cm", azide absorption atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax 2131 cm" an c=o stretch at Vmax 1645 cm"] and
consistent MS [m/z (ESI+): [-N2+Na+], 236] further verified the structural assignment.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.4.3 An alternative synthesis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-carbonitrile
During the course of our studies in the design and synthesis of the (2S)-N-(2-azidoaroyl)-
pyrrolidine-2-carbonitrile (559), it occurred to us to explore further efficient and convenient
methodologies for the preparation of the nitrile. Recently, tosyI chloride with pyridine has been
used by Ley and co-workers'?' for the conversion of a prolinamide (562) to the corresponding
nitrile (563) [Scheme 6.38].
l-hydroxybenzotriazole040 EDCI, NH3, THF, r.t. 24 hrs
t OH
561
p- TsCI, pyridine040 DCM, r.t., 72 hrs
t NH2
562
[J:..H
N C"N
I
Z
563
lO%PdJC, H2
AcOH/H20,r.t. 4 hrs Q4,H K
N "N IIt HN-N
566 565 564
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Scheme 6.38
Based on this development, we envisioned a synthetic approach utilizing the above method
to access the nitrile. In this respect, the plan was to couple the readily available (L)-prolinamide
(567) to 2-azidobenzoyl chloride to generate the coupled product (568) containing the amide.
Subsequent dehydration of the amide (568) moiety using tosyl chloride and pyridine would then
give access to the desired cyclisation precursor (559).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I. aq. K2C03/DCM
2.DCM
r:»zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBANH2_CC_~_ _;:~'4C~'d. <~_~~l~~~d-N~
'~/1 N3 t~H2 N3 I~
ozyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN
559567 568
Scheme 6.39
However, in the event, the treatment of L-prolinamide (567) with an aqueous solution of
potassium carbonate in dichloromethane, followed by reaction with 2-azidobenzoyl chloride,
resulted in the isolation of the one new product, which was not the amide (568), but was, in fact,
the desired (2S)-N-(2-azidoaroyl)-pyrrolidine-2-carbonitrile (559), obtained in 48% yield (Scheme
6.40).
567 559
Scheme 6.40
The structure of the product (559) was assigned on the basis of IH NMR, I3C NMR, MS,
and IR spectra. The appearance of the pyrrolidine protons together with the presence of four
additional protons in the in the region of OH ~7.10-7.70 ppm, confirmed the successful coupling of
the 2-azidobenzoyl chloride. More importantly, the incorporation of the nitrile moiety in the
molecule was manifested by the occurrence in the IR spectra of an characteristic nitrile absorption
at Vmax 2242 cm", together with the non existence of the two amide protons in the IH NMR and the
loss of one of the amide carbonyls in the I3CNMR spectrum.
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Mechanistically it is thought that the initial coupled product, the amide (568) reacts with
the aroyl chloride to afford the intermediate (569) shown in Scheme 6.41 below. Dehydration then
occurs to give the nitrile (559) together with 2-azidobenzoic acid (570), the presence of which was
confirmed by chromatography. In fact, this is just a variation on the tosyl chloride assisted
dehydration.i'" with 2-azidobenzoyl chloride in place oftosyl chloride.
559 570
Scheme 6.41
6.4.4 Synthesis of 1,2,3,4-tetrazolopyrrolo[2,1-c] [1,4]benzodiazepine
With reliable syntheses of the cyclisation precursor (559) in hand, the final requirement
was to cyclise the azide onto the nitrile. Gratifyingly, heating a solution of the precursor (559) in
toluene at reflux resulted in a successful cyclisation and the desired tetrazolopyrrolo-
benzodiazepine (560) was obtained in almost quantitative yield (99%) as seen in Scheme 6.42.
Scheme 6.42
Evidence of successful cycJoaddition was provided by IR spectroscopy, which showed the
disappearance of an azide and the nitrile absorption peak, which were present in the cyclisation
precursor at Vrnax 2130 cm" and 2245 ern", respectively, together with the appearance of an imine
absorption at 1606 ern". The IHNMR spectrum (400 MHz) of the [1,2,3,4]-tetrazolopyrrolo[2,1-
c][1,4]benzodiazepine (560) showed the three CH2 groups in the region of OH -2.10-4.00 ppm,
with the more downfield CH2 being next to the more electronegative nitrogen atom. The chiral
CH appeared as a doublet of doublets at OH 4.83 ppm, while the four aromatic protons were present
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in the region of OH -7.59-8.25 ppm. In addition, the J3CNMR spectrum of the molecule showed
as expected threezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACI-h grou s at Oc23.5, 28.2, 48.2 ppm and a CH group at Oc49.7 ppm, while the
four aromatic protons and four quaternary carbons appeared more downfield at Oc 122.5-163.4
ppm. These data combined, MS [rn/z (ESI+): [M+Ht, 242] and correct accurate mass
measurement supported the structural assignment.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
6.5 Conclusion
This section has described work that demonstrates that intermolecular 1,3-dipolar
cycloaddition of azides to nitrites and alkynes offers an efficient route to access triazolo- and
tetrazolo- fused pyrrolobenzodiazepines. Intramolecular ring closure onto an alkene was less clear
cut, giving either a hydroxy pyrrolobenzodiazepine (i.e. no fourth ring) at high temperature or
pyrrolobenzodiazepines and aziridinopyrrolobenzodiazepines as inseparable mixtures at lower
reaction temperatures.
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Experimental Section
General InformationzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Unless otherwise stated, all reactions were conducted using oven-dried glassware under
nitrogen, dried through 4A molecular sieves and silica gel and delivered to the reaction through a
gas manifold. Workup procedures were done in air. All solvents were purchased from either
BDH or Fisher chemicals and were of analytical grade. Petroleum ether used for chromatography
was of the 40-60°C boiling point range. All anhydrous grade solvents, commercially available
starting materials and reagents were purchased from Sigma-Aldrich and used without additional
drying or further purification.
All reactions were monitored by thin-layer chromatography (TLC), which was carried out
on 0.25 mm Merck silica gel-60 F254precoated plates and visualisation of the plates was achieved
using ultraviolet light and/ or vanillin stain. Flash column chromatography was performed on
flash grade silica gel (70-230 mesh; 60A) using eluents described in the experimental protocol.
The NMR spectra were recorded either on a Bruker DPX-400 instrument, operating at 400
MHz for IH and 100 MHz for J3C channels, respectively, or on a Bruker Avance 500 with
multinuclear probe, operating at 500 MHz for IH and 125 MHz for J3C, respectively. All NMR
spectra were obtained at 25°C using TMS as internal reference and the chemical shift are
expressed in parts per million (ppm). The list of coupling constants (.1) are reported to the nearest
0.1 Hertz (Hz) and the splitting patterns were designated as s (singlet), d (doublet), t (triplet), q
(quartet), m (multiplet), br (broad) or a suitable combination. Assignment of signals in J3CNMR
was based on the H-decoupled experiments and, in most cases, on DEPT-135 and DEPT-90
experiments.
IR spectra were recorded on a Perkin Elmer paragon 1000 FT-IR instrument as thin film
between NaCI plates (oil) or as KBr disks (solids) and are reported using the following
abbreviations: s (strong), m (medium), w (weak) or br (broad).
Low resolution mass spectra were recorded on a Micromass Quattro II Triple Quadrupole
mass spectrometer operating at a positive ion mode under electron impact (El), chemical ionisation
(Cl), or electrospray ionisation (ESI) methods. Molecular ions are reported as their mass, with the
percentage abundance quoted in brackets. High resolution mass spectra were recorded on a
Finnegan MAT 900 XTL instrument operated by the EPSRC National Mass Spectrometry service
at the University of Swansea.
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Experimental- Part I
7.1.1 Synthesis of 2-azidobenzenesulfonamidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
409 410 398zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
To a suspension of 2-aminobenzenesulfonamide (409; 0.800 g, 4.65 mmol, 1.0 eq) in
concentrated hydrochloric acid (10 ml) and water (10 ml) atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAoDe was added, with vigorous stirring,
a solution of sodium nitrite (0.380 g, 5.57 mmol, 1.2 eq) in water (10 ml), dropwise over 20
minutes. The resulting mixture was further stirred for 1 hr at o-c and was added dropwise to an
ice-cooled mixture of sodium azide (0.360 g, 5.57 mmol, 1.2 eq) and sodium acetate (15.0 g,
185.83 mmol, 40 eq) in water (50 ml). The white precipitate so-formed was filtered, washed
thoroughly with water (3x 25 ml) and dried in the oven (-lOODe) overnight to give 2-
azidobenzenesulJonamide (398; 0.73 g, 79% yield) as a beige solid, m.p: 189-190 De (lit. m.p: 191
DC).262
t>H (400 MHz, cncr,» 3.35 (2H, s, br,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBANH2), 7.32 (lH, t, J 7.7, ArB), 7.52 (lH, d, J 8.0,
ArB), 7.66 (IH, t, J7.3, ArB), 7.84 (lH, d, J7.4, ArB). t>c (lOO MHz, coci,» 120.6 (CH), 124.6
(CH), 128.0 (CH), 133.4 (CH), 133.8 (q), 136.9 (q). Vmax (thin film ern"): 3357 (s), 3255 (s), 3096
(m), 2137 (s), 1578 (s), 1472 (s), 1337 (s), 1285 (s), ] 157 (s), 770 (s), 657 (s). EI+ mass spectrum
(m/z, %): 199 ([M+Ht, 2%), 198 ([M]+, 7%), 172 (10%), 155 (15%), 105 (40%), 91 (15%),77
(100%),64 (25%),52 (25 %), 39 (30%), 28 (40%).
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7.1.2 Synthesis of 2-(2-azidobenzenesulfonyl)-3,6-dihydro-I,2-thiazine I-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
SOC12
so NH pyridine
(): 2 2 THF, r.t.
N3
398 399 400a: Rl=R2=H
400b: R1=H, R2=Me
400c: Rl=R~Me
To a solution of 2-azidobenzenesulfonamide (398; 1.0 eq) and thionyl chloride (0.46-0.55
ml, 1.0 eq) in anhydrous tetrahydrofuran (15-30 ml) at DoC,under an atmosphere of dry nitrogen,
was added a solution of anhydrous pyridine (0.51-0.61 ml, 2.0 eq) in anhydrous tetrahydrofuran
(5-10 ml) over a period of 3 hr. Maintaining the temperature at DoC,the stirring was continued for
a further 1 hr, followed by dropwise addition of the appropriate 1,3-diene (1.6 eq), and the whole
was allowed to warm up to ambient temperature over 20 hours. In the case of the 1,3-butadiene
adduct (400a), the diene was condensed at low temperature (-20°C) and subsequently added to the
mixture, maintaining the low temperature of the reaction for 4-6 hr. After completion of the
reaction, the solvent was removed in vacuo and the crude product was purified by flash column
silica chromatography (eluent PE:EtOAcl 3:2). The 2-(2-azidobenzenesuljonyl)-3,6-dihydro-i,2-
thiazine i-oxides were obtained as follows:
2-(2-Azidobenzenesuljonyl)-3,6-dihydro-i,2-thiazine l-oxide (400a) was obtained as a
yellow solid (1.150 g, 61% yield) from 2-azidobenzenesulfonamide (398; 1.250 g, 6.31 mmol) and
1,3-butadiene (large excess, -10eq).
t5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 3.45 (lH, ddd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 16.5,6.2,2.3, CH2S=O), 3.61 (tH, dddd, J 16.5,
10.0, 4.8, 2.5, CH2S=O), 3.83 (lH, dddd, J 17.4, 9.5, 4.7, 2.3, CH2N), 4.11-4.17 (lH, m, CH2N),
5.73-5.79 (lH, m, HC=CH), 5.96-6.01 (lH, m, HC=CH), 7.28 (IR, td, J 7.8, 0.9, ArH), 7.34 (lH,
dd, J 8.0, 0.8, ArH), 7.66 (IH, td, J 7.8, 1.5, ArH), 8.01 (lH, dd, J 8.0, 1.5, ArH). t5c (100 MHz,
CDCh): 39.0 (CH2), 50.6 (CH2), 114.6 (CH), 120.3 (CH), 124.3 (CH), 124.6 (CH), 127.7 (q),
131.6 (CH), 135.1 (CH), 139.1 (q). Vrnax (thin film cm"): 3010 (w), 2919 (w), 2133 (s), 1575 (m),
1470 (s), 1433 (m), 1352 (s), 1282 (s), 1170 (s), 1103 (s), 1060 (s), 1003 (m), 868 (m), 771 (s),
653 (m). EI+ mass spectrum (m/z, %): 298 ([Mt, 4%), 282 (l %), 270 (2%), 250 (3%), 172 (5%),
156 (10%), 116 (25%), 104 (20%), 90 (40%),76 (35%), 64 (50%),54 (30%),39 (100%). CI+
mass spectrum (m/z, %): 316 ([M+NH4t, 100%), 299 ([M+Rt, 6%). HRMS (ESI+): found
[M+NH4t 316.0534, CIOHION403S2requires 316.0538.
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2-(2-Azidobenzenesuljonyl)-3, 6-dihydro-5-methyl-i, 2-thiazine l-oxidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(400b) was obtained
as a yellow solid (1.980 g, 84% yield) from 2-azidobenzenesulfonamide (398; 1.500 g, 7.57 mmol)
and isoprene (1.51 ml, 15.14 mmol).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
dH (400 MHz, CDCh): 1.85 (3H, s, CH3), 3.24 (IH, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 16.2, 1.8, CH2S=O), 3.56-3.67
(1H, dt, J 16.2, 1.1, CH2S=O), 3.75-3.85 (lH, dm, J 16.8, CH2N), 4.05-4.15 (lH, dm, J 17.1,
CH2N), 5.65 (IH, d, J 1.9, MeC=CH), 7.28 (lH, t, J7.4, ArH), 7.34 (lH, d, J8.0, ArH), 7.65 (lH,
td, J 7.9, 1.3, ArH), 8.01 (1H, dd, J 8.0, 1.3, ArH). t5e (100 MHz, CDCh): 24.4 (CH), 39.3 (CH2),
54.4 (CH2), 117.7 (CH), 120.3 (CH), 122.7 (q), 124.6 (CH), 127.8 (q), 131.6 (CH), 135.1 (CH),
139.1 (q). Vmax (thin film ern"): 2135 (s), 1575 (m), 1473 (s), 1444 (m), 1349 (s), 1293 (m), 1172
(s), 1103 (s), 916 (m), 832 (s), 763 (m), 735 (m), 655 (m), 626 (s). EH mass spectrum (mlz, %):
312 ([Mt, 2%), 296 (1%), 284 (3%), 264 (1%), 183 (5%), 171 (10%), 156 (15%), 130 (10%), 108
(15%), 104 (15%), 90 (55%), 84 (45%), 76 (35%), 68 (100%). CH mass spectrum (mlz, %): 330
([M+NH4t, 97%), 313 ([M+Ht, 15%), 284 (M-N2t, 90%). HRMS (ESH): found [M+Ht
313.0416, CIIHI2N40)S2 requires 313.0424.
2-(2-AzidobenzenesuljonylJ-3,6-dihydro-4,5-dimethyl-i,2-thiazine l-oxide (400c) was
obtained as a yellow solid (1.890 g, 77% yield) from 2-azidobenzenesulfonamide (398; 1.500 g,
7.57 mmol) and 2,3-dimethyl-l,3-butadiene (1.71 ml, 15.15 mmol).
t5H (400 MHz, CDCh): 1.71 (3H, s, CH3), 1.79 (3H, s, CH3), 3.23 (IH, d, J 15.9, CH2),
3.63 (IH, d, J 14.2, CH2), 3.68 (IH, d, J 14.2, CH2), 3.86 (lH, d, J 16.2, CH2), 7.28 (IH, t, J 7.8,
ArH), 7.34 (IH, d, J 8.0, ArH), 7.66 (lH, dt, J7.8, 1.1, ArH) 8.01 (lH, dd, J 8.0,0.9, ArH). de
(lOOMHz, CDCh): 16.9 (CH), 19.7 (CH3), 42.9 (CH2), 55.5 (CH2), 115.0 (q), 120.3 (CH), 123.5
(q), 124.6 (CH), 127.5 (q), 131.6 (CH), 135.1 (CH), 139.0 (q). Vmax (chloroform ern"): 3006 (w),
2918 (w), 2134 (s), 1585 (m), 1575(m), 1472 (s), 1444 (m), 1351 (s), 1291 (m), 1171 (s), 1102 (s),
885 (m), 758 (s), 614 (m). EH mass spectrum (mlz, %): 326 ([M+Ht, 9%), 298 (12%), 278
(10%), 156 (10%), 116 (25%), 104 (20%), 90 (40%), 76 (35%), 64 (50%), 54 (30%), 39 (100%).
HRMS (ESH): found [M+Ht 327.0587, C12H14N40)S2requires 327.0585.
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7.1.3 Synthesis of 2-(2-aminobenzenesulfonyl)-3,6-dihydro-I,2-thiazine I-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
PPh3
THF,r.t.
400a: Rl=R2::H
400b: R'=H, R2=Me
400c: Rl=R2=Me
402a: Rl=R2=H
402b: R'=H, R2=Me
402c: R'=R2=Me
General Procedure:
A solution of triphenylphosphine (1.0 eq) in anhydrous tetrahydrofuran (10-20 ml) was
added dropwise over a period of 1 hr to a stirring solution of the 2-(2-azidobenzenesulfonyl)-3,6-
dihydro-Lz-thiazine l-oxide (400a-c; ~3-6 mmol, 1.0 eq) in anhydrous tetrahydrofuran (10-20 ml)
under an atmosphere of dry nitrogen. The reaction mixture was stirred for 4 hr at ambient
temperature and water (~l6 eq) was added to the mixture and the whole was heated at reflux for
15-18 hours. The reaction mixture was allowed to cool to ambient temperature and the solvent was
removed in vacuo. The crude product was purified by column chromatography (eluent:
PE:EtOAcl 3:2) to yield the 2-(2-aminobenzenesulJonyl)-3,6-dihydro-I,2-thiazine l-oxides (402a-
c), as follows:
2-(2-AminobenzenesulJonyl)-3,6-dihydro-I,2-thiazine l-oxide (402a) was obtained as a
yellow oil (1.190 g, 87% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-I,2-thiazine I-oxide
(400a; 1.500 g, 5.03 mmol, 1.0 eq).
t>H (400 MHz, CDCb): 3.33 (lH, ddd, J 16.5, 6.4, 2.2, CH2S=O), 3.55 (1H, dsext, J 16.5,
2.7, CH2S=O), 3.80 (IH, dsext, J 17.2,2.3, CH2N), 3.94-4.02 (lH, dm, J 17.2, CH2N), 5.33 (2H, s,
br, NH2), 5.65 (lH, tquart, J 8.5, 2.1, HC=CH), 5.87-5.94 (lH, m, HC=CH), 6.67-6.75 (2H, m,
2xArH), 7.25 (lH, td, J 7.7, 1.4, ArH), 7.41-7.43 (lH, m, ArH). t>c (lOO MHz, CDCh): 38.8
(CH2), 50.3 (CH2), 114.3 (CH), 117.0 (CH), 117.1 (q), 117.9 (CH), 124.1 (CH), 129.8 (CH), 132.7
(q), 135.2 (CH). Vmax (thin film ern"): 3470 (m), 3372 (m), 2983 (m), 2892 (m), 1622 (s), 1600 (s),
1567 (m), 1484 (s), 1455 (s), 1438 (s), 1389 (m), 1319 (s), 1144 (s), 1120 (s), 1016 (s), 1002 (m),
881 (s), 753 (s), 723 (s), 696 (s). EI+ mass spectrum (rn/z, %): 273 ([M+Ht, 3%), 272 ([Mt,
15%), 224 (15%), 218 (30%), 172 (5%), 156 (40%), 140 (10%), 116 (10%), 108 (30%), 92
(100%), 65 (80%), 54 (10%). CI+ mass spectrum (m/z, %): 290 ([M+NH4t, 100%), 273
([M+Ht,60%). HRMS (ESI+): found [M+Ht 273.0367, ClOHI2N203S2requires 273.0367.
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2-(2-AminobenzenesulJonyl)-3,6-dihydro-5-methyl-I,2-thiazine l-oxidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(402b) was
obtained as a yellow oil (0.810 g, 88% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-5-
methyl-I,2-thiazine l-oxide (400b; 1.000 g, 3.21 mmol, 1.0 eq).
~ (400 MHz, CDCh): 1.83 (3H, s, CH3), 3.22 (lH, dd, J 16.2, 1.9, CH2S=O), 3.61 (IH, dt,
J 16.2, 1.2, CH2S=O), 3.80 (lH, dsext, J 16.6,2.1, CH2N), 4.00 (IH, dt, J 16.6,2.1, CH2N), 5.14
(2H, s, br, NH2), 5.67 (lH, s, MeC=CH), 6.75 (IH, dd, J 8.1, 0.6, ArH), 6.80 (lH, dt, J 7.6, 0.8,
ArH), 7.35 (lH, td, J 7.7, 1.4, ArH), 7.70 (IH, dd, J 8.1, lA, ArH). Oc (100 MHz, CDCh): 24.3
(CH3), 39.3 (CH2), 54.3 (CH2), 117.6 (CH), 117.8 (CH), 117.9 (q), 118.0 (CH), 122.6 (q), 130.2
(CH), 13504 (CH), 146.1 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin fil cm"): 3462 (m), 3338 (m), 2961 (m), 2928 (s), 1625
(m), 1598 (m), 1483 (s), 1438 (s), 1343 (s), 1158 (s), 1093 (s), 1027 (w), 927 (m), 758 (s), 668 (s).
EI+ mass spectrum (m1z,%): 286 ([M]+' 4%), 238 (8%), 218 (15%),172 (10%),156 (30%),140
(10%), 108 (35%), 92 (100%), 65 (25%). ESI+ mass spectrum (m1z,%): 309 ([M+Nat, 8%), 287
([M+Ht,20%). HRMS (ESI+): found [M+Ht 287.0524, CIIHI4N203S2 requires 287.0524.
2-(2-AminobenzenesulJonyl)-3, 6-dihydro-4,5-dimethyl-I,2-thiazine l-oxide (402c) was
obtained as a yellow oil (1.000 g, 83% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-4,5-
dimethyl-Lz-thiazine l-oxide (400c; 1.000 g, 3.06 mmol, 1.0 eq).
OH (400 MHz, CDCh): 1.59 (3H, s, CH3), 1.67 (3H, s, CH3), 3.14 (lH, d, J 16.1, CH2S=O),
3.55 (IH, d, J 16.3, CH2S=O), 3.67 (2H, s, CH2N), 5.25 (2H, s, br, NH2), 6.65-6.71 (2H, m,
2xArH), 7.24 (IH, t, J 7.6, ArH), 7.69 (IH, d, J 8.4, ArH). Oc (lOO MHz, CDCh): 16.7 (CH3),
19.2 (CH3), 42.9 (CH2), 55.2 (CH2), 114.8 (q), 116.7 (CH), 116.8 (q), 117.7 (CH), 123.5 (q), 129.6
(CH), 134.9 (CH), 146.2 (q). Vmax (thin film cm"): 3473 (s), 3347 (s), 2916 (m), 1624 (s), 1601
(s), 1564 (m), 1485 (s), 1454 (s), 1345 (s), 1157 (s), 1095 (s), 962 (m), 913 (m), 881 (m), 835 (s),
731 (m), 617 (s), EI+ mass spectrum (m/z, %): 300 ([Mt, 3%), 252 (5%), 218 (15%), 108 (25%),
92 (100%), 77 (35%). HRMS (EI+): found [M+Ht 301.0675, CI2HI6N203S2requires 301.0680.
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7.1.4 Synthesis of (2-aminobenzenesulfonamidyl)alkenols via phenyl allylic
sulfoxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o RI 1. PhMgBr
O~SI 0 THF, -78°C
CC -N,s_Y-R2 2. NH4Cl(aq)
"NH20
402a: RI=R2=H
402b: RI=H, R2=Me
RI
O~S~ r-\ 2 P(OMehCC ~~~R MeOH,~
NH2Ph 0
403
RIOH0); ri---CCS-~ i/RzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAZ
NHz
405a: R'=R2=H
405b: R'=H, R2=Me
To a stirring solution of 2-(2-aminobenzenesulfonyl)-3,6-dihydro-5-methyl-l,2-thiazine 1-
oxide (402a-b; 1.450 g, 5.06 mmol, 1.0 eq) in anhydrous tetrahydrofuran (25 ml) was added
dropwise a solution of phenyl magnesium bromide (3M in ether; 3.4 ml, 21.26 mmol, 2.0 eq) at-
78°C, under an atmosphere of dry nitrogen. The resulting mixture was further stirred for 3 hr at -
50°C, quenched at -20°C with saturated ammonium chloride solution (25 ml) and allowed to warm
to ambient temperature. The mixture was extracted with ethyl acetate (3x 15 ml) and washed with
brine (l0 ml). The organic phase was collected, dried (MgS04), filtered and the solvent was
removed in vacuo to yield the crude phenyl allylic sulfoxide (403). To a solution of the crude
allylic sulfoxide (403) in anhydrous methanol (25 ml) was added trimethyl phosphite (2.2 ml,
18.65 mmol, 2.0 eq), under an atmosphere of dry nitrogen, and the whole was heated under reflux
for 18 hr. The solvent was removed in vacuo and the crude product was purified by flash column
chromatography (eluent: PE:EtOAcl 3:2) to yield 4-(2-aminobenzenesuljonamidyl)-2-methyl-but-
l-en-3-o1 (405b; 1.170 g, 90% yield) as a yellow oil.
bH (400 MHz, CDCh): 1.61 (3H, s, CH3), 2.84 (lH, ddd, J 13.0, 8.5, 4.3, CH2NH), 3.02
(lH, s, br, Ol!), 3.09 (lH, ddd, J 13.1, 6.9, 3.8, CH2NH), 4.02 (IH, dd, J 8.1, 3.0, CHOH), 4.86
(lH, s, MeC=CH2), 4.95 OH, s, MeC=CH2), 4.97 (2B, s, br, NH2), 5.59 (IH, quartet, J 4.1,
S02Nl!), 6.78 (IH, d, J 7.7, ArH), 6.79 (lB, t, J 7.8, Arl!), 7.31 (1H, td, J 7.7, 1.4, Arl!), 7.69
(tH, dd, J7.9, 1.4, ArH). bc (lOOMHz, CDCh): 18.3 (CH3), 47.0 (CH2), 73.3 (CH), ] 12.2 (CH2),
117.7 (CH), 117.8 (CH), 121.3 (q), 129.4 (CH), 134.2 (CH), 144.0 (q), ] 45.0 (q). Vmax (thin film
cm"): 3477 (br, m), 3376 (br, m), 2986 (m), 1622 (m), 1600 (m), 1573 (m), 1483 (s), 1455 (s),
1319 (s), 1143 (s), 1024 (m), 754 (s). EI+ mass spectrum (m/z, %): 256 ([Mt, 12%), 185 (15%),
168 (10%),156 (41%),108 (31%), 92 (100%),84 (20%), 65 (40%). CI+ mass spectrum (m/z, %):
274 ([M+NH4t, 30%), 257 ([M+Ht, 100%). HRMS (ESI+): found [M+Ht 257.0953,
CIIHI6N203S requires 257.0954.
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4-(2-AminobenzenesulJonamidyl)-but-l-en-3-olzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(405a) was obtained in the same fashion as
a yellow oil (0.612 g, 86% yield) from 2-(2-aminobenzenesulfonyl)-3,6-dihydro-l,2-thiazinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1-
oxide (402a; 0.800 g, 2.937 mmol, 1.0 eq).
bH (400 MHz, CDCI3): 2.85 (lH, ddd, J 13.1,8.0,5.2, CH2NH), 3.08 (lH, ddd, J 13.1, 7.6,
3.7, CH2NH), 4.15-4.17 (lH, m, CHOH), 4.75 (2H, s, br, NH2), 5.17 (lH, dt,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 10.5, 1.0,
HC=CH2), 5.28 (IH, dt, J 17.2, 1.2, HC=CH2), 5.44 (lH, t, br, J 5.9, S02NH), 5.73 (lH, ddd, J
17.1, 10.6,5.7, H2C=CH), 6.78-6.84 (2H, m, 2xArH), 7.34 (IH, td, J 7.7, 1.5, ArH), 7.71 (IH, dd,
J 8.0, 1.4, ArH). be (100 MHz, CDCh): 48.2 (CH2), 71.1 (CH), 117.0 (CH2), 117.8 (CH), 117.9
(CH), 121.5 (q), 129.6 (CH), 134.3 (CH), 137.0 (CH), 145.0 (q). Vmax (thin film cm"): 3476 (br,
m), 3377 (br, m), 2987 (m), 2928 (m), 1620 (m), 1600 (m), 1573 (w), 1483 (s), 1456 (s), 1332 (s),
1156 (s), 1073 (m), 896 (m), 747 (s). EI+ mass spectrum (m/z, %): 242 ([Mt, 5%), 224
([M-H20t, 2%), 185 ([M-(CH2=CH-CHOH)t, 35%), 168 ([C6H4S02NHCHt, 15%), 156
([C6H4S02NH2t, 50%), 108 ([(C6H4)St, 35%), 92 ([C6H4NH2t, 100%), 65 ([CsHst, 100%), 57
([CH2=CH-CHOH)t,90%). CI+ mass spectrum (m/z, %): 260 ([M+NH4t, 95%), 243 ([M+Ht,
100%). HRMS (ESI+): found [M+Ht 243.0804, CIOHI4N203Srequires 243.0803.
7.1.5 SynthesiszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAof {o-[ (9'-fluorenylmethoxycarbonyl)amino] benzenesulfonamidyl}
alkenols
4050: RI=R2=H
40Sb: RI=H, R2=Me
d~{-):R'
NH
I
Fmoc
4060: RI=R2=H
406b: RI=H, R2=Me
To a solution of the 4-(2-aminobenzenesulfonamidyl)-2-methyl-but-l-en-3-ol (405a-b;
0.330 g, 1.28 mmol, 1.0 eq) in anhydrous dichloromethane (10 ml) was added sodium hydrogen
carbonate (0.230 g, 2.69 mmol, 2.1 eq) and 9-fluorenylmethyl chloroformate (0.701 g, 2.69 mmol,
2.1 eq) under an atmosphere of dry nitrogen. The reaction mixture was stirred at ambient
temperature for 18 hr, and distributed between dichloromethane/water (1: 1; ]0 ml) and extracted
with dichloromethane (3x 5 ml), dried over MgS04, and filtered under gravity. Evaporation of the
solvent gave the crude product as a orange oil, which was purified by flash chromatography
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(eluent: PE:EtOAc/ 3:2) to yield 4-{o-[(9'-fluorenylmethoxycarbonyl)aminoJbenzenesuljon-
amtdyll-Z-methyl-but-l-en-Brol (406b; 0.440 g, 71% yield) as a colourless oil.
~ (400 MHz, CDCb): 1.58 (3H, s, CH3), 2.28 (IH, d, J 2.9, OH), 2.91 (tH, ddd, J 12.7,
8.5,4.2, CH2NH), 3.16 (IH, ddd, J 12.3,8.4,4.2, CH2NH), 3.94 (IH, t, J 3.9, CHOH), 4.31 (tH, t,
J 7.2, CHCH20CONH), 4.50 (2H, d, J 7.2, CHCH20CONH), 4.86 (IH, s, HC=CH2), 4.92 (tH, s,
HC=CH2), 5.30 (tH, t, J 4.2, S02NH), 7.20 (tH, td, J 8.0, 0.8, ArH), 7.35 (2H, td, J 7.4, 1.0,
2xArH), 7.44 (2H, t, J 7.4, 2xArH), 7.56 (IH, t, J 7.5, ArH), 7.65 (2H, d, J 7.4, 2xArH), 7.80 (2H,
d,J7.5, 2xArH), 7.90 (IH, dd,J8.0, 1.4, ArH), 8.13 (tH, s, ArH), 8.75 (IH, s, C02NH). Jc (100
MHz, CDCb): 18.2 (CH3), 46.7 (CH2), 46.8 (CH), 67.7 (CH2), 73.1 (CH), 112.5 (CH2), 120.0
(CH), 122.1 (CH), 123.4 (CH), 125.0 (CH), 127.2 (CH), 127.8 (CH), 129.3 (CH), 134.2 (CH),
136.0 (q), 141.3 (q), 143.5 (q), 143.8 (q), 153.3 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVrnax (thin film ern"): 3502 (br, w), 3349 (br,
m), 2949 (m), 1737 (s), 1588 (s), 1531 (s), 1444 (s), 1326 (s), 1291 (m), 1249 (m), 1216 (s), 1152
(s), 1132 (m), 1083 (m), 1048 (m), 910 (s), 755 (s), 740 (m). ESI+ mass spectrum (m/z, %): 979
([2M+Na]+, 5%), 957 ([2Mt, 15%),501 ([M+Nat, 20%), 479 ([Mt, 70%). C,H,N(%): found C
65.5, H 5.4, N 5.9; C26H26N20sSrequires C 65.2, H 5.5, N 5.9.
4-{o-[(9 '-fluorenylmethoxycarbonyl)amino JbenzenesuljonamidyIJ-but-l-en-3-ol (406a)
was obtained as a colourless oil (0.120 g, 63% yield) from 4-(2-aminobenzenesulfonamidyl)-but-
l-en-3-o1 (405a; 0.10 1 g, 0.413 mmol, 1.0 eq).
JH (400 MHz, CDCb): 2.90 (IH, ddd, J 12.8,8.0,4.7, CH2NH), 3.15 (IH, ddd, J 11.7,8.0,
3.7, CH2NH), 3.57 (tH, s, br, OH), 4.05-4.12 (IH, m, CHOH), 4.33 (IH, t, J 7.1,
CHCH20CONH), 4.52 (2H, d, J7.2, CHCH20CONH), 5.02 (IH, quart, J 5.7, S02NH), 5.18 (tH,
d, J 10.5, HC=CH2), 5.25 (IH, d, J 17.3, HC=CH2), 5.71 (tH, ddd, J 17.1, 10.8,5.7, H2C=CH),
7.22 (IH, t, J7.7, ArH), 7.36 (2H, t, J7.5, 2xArH), 7.45 (2H, t, J 7.5, 2xArH), 7.59 (lH, t, J 7.8,
ArH), 7.65 (2H, d, J 7.4, 2xArH), 7.81 (2H, d, J 7.5, 2xArH), 7.90 (1H, dd, J 8.0, 1.0, ArH), 8.15
(lH, d, br, J 7.8, ArH), 8.69 (IH, s, br, C02NH). Jc (lOO MHz, CDCh): 46.9 (CH), 47.9 (CH2),
67.7 (CH2), 70.9 (CH), 111.3 (CH2), 117.5 (q), 118.0 (q), 120.1 (CH), 122.3 (CH), 123.5 (CH),
125.1 (CH), 127.2 (CH), 127.9 (CH), 129.4 (CH), 134.3 (CH), 136.8 (CH), 141.4 (q), 143.6 (q),
153.3 (q). Vrnax (thin film ern"): 3512 (br, w), 3355 (br, m), 2925 (m), 2853 (m), 1735 (s), 1588
(s), 1530 (s), 1469 (m), 1458 (s), 1329 (s), 1291 (m), 1250 (m), 1154 (s), 1132 (m), 1082 (m),
1047 (m), 933 (w), 757 (s), 668 (m). ESI+ mass spectrum (mlz, %): 487 ([M+Nat, 55%), 465
([M]+' 20%). HRMS (CI+): found [M+NHtt 482.1747, C2sH24N20sS requires 482.1750.
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7.1.6 Synthesis of {o-[ (9' -fluorenylmethoxycarbonyl)amino] benzenesulfonamidyl}
aiken ones
o r)-R10H
O~II .
azyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAs-N. R2 Dess-MartinH /; oeM, r.t..0
NH
I
Fmoc
° r-1..
0d'S-II I/R'
NH
I
Fmoc
406a: RI=R2=H
406b: RI=H, R2=Me
407a: R2=H
407b: R2=Me
To a stirring solution of 4-{0-[(9' -fluorenylmethoxycarbonyl)amino ]-benzenesulfon-
arnidylj-z-methyl-but-l-en-j-ol (406b; 0.340 g, 0.710 mmol, 1.0 eq), in anhydrous
dichloromethane (10 ml) was added finely powdered Dess-Martin periodinane (0.331 g, 0.782
mmol, 1.1 eq) under an atmosphere of dry nitrogen. The mixture was stirred at ambient
temperature for 12hr and the solvent was removed in vacuo to give the crude product as a yellow
suspension, which was purified by flash column chromatography (eluent: PE:EtOAcl 3:1) to yield
4-{0-[ (9'-fluorenylmethoxycarbonylJamino ) benzenesulJonamidylj-2-methyl-but-l-en-3-one (407b;
0.280 g, 80% yield) as a pale yellow solid.
t5H (400 MHz, CDCh): 1.84 (3H, s, CH3), 4.17 (2H, d, J 4.6, CH2NH), 4.36 (IH, t, J7.4,
CHCH20CONH), 4.50 (2H, d, J 7.4, CHCH20CONH), 5.79 (lH, t, J 4.5, S02NH), 5.83 (2H, dd,
J6.1, 1.6, MeC=CH2), 7.19 (tH, t, J8.1, ArH), 7.37 (2H, td, J7.5, 0.8, 2xArH), 7.45 (2H, t, J7.4,
2xArH), 7.58 (IH, t, J 8.5, ArH), 7.68 (2H, d, J7.4, 2xArH), 7.81 (2H, d, J7.5, 2xArH), 7.90 (lH,
dd, J 8.0, 1.4, ArH), 8.24 (lH, d, J 7.9, ArH), 8.86 (lH, s, br, C02NH). t5c (100 MHz, CDCb):
17.2 (CH3), 46.8 (CH), 47.5 (CH2), 67.8 (CH2)' 120.0 (CH), 121.8 (CH), 123.1 (CH), 125.1 (CH),
125.8 (q), 126.3 (q), 127.2 (CH), 127.8 (CH), 129.2 (CH), 134.4 (CH), 136.4 (q), 141.2 (q), 14·1.8
(q), 143.5 (q), 153.0 (q, C02NH), 193.3 (q, C=O). Vrnax (thin film ern"): 3348 (br, m), 2925 (s),
2853 (m), 1739 (br, s), 1687 (s), 1587 (s), 1531 (s), 1470 (m), 1444 (s), 1329 (s), 1291 (m), 1216
(m), 1154 (s), 1134 (m), 1083 (m), 1059 (m), 910 (s), 759 (s), 738 (m). ESI+ mass spectrum (m/z,
%): 499 ([M+Nat, 65%), 478 ([M+Ht, 6%). C,H,N (%): found C 65.7, H 5.0, N 6.0;
C26H24N20SSrequires C 65.5, H 5.1, N 5.9.
4-{0-[(9'-fluorenylmethoxycarbonyl)aminoJbenzenesulJonamidyIJ-but-l-en-3-one (407a)
was obtained as a pale yellow oil (0.047 g, 78% yield) from 4-{o-[(9'-fluorenylmethoxycarbonyl)-
amino]benzenesulfonamidyl}-but-l-en-3-ol (406a; 0.060 g, 0.1292 mmol, 1.0 eq).
159
Chapter 7 Experimental Part IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
bHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(400 MHz, CDC ): 4.05 (2H, d, J 4.7, CH2NH), 4.36 (lH, t, J 7.3, CHCH20CONH),
4.52 (2H, d, J 7.4, CHCH20CONH), 5.73 (IH, t, br, J 4.5, S02NH), 5.93 (IH, dd, J 9.8, 1.5,
H2C=CH), 6.21-6.34 (2H, m, HC=CH2), 7.19 (IH, t, J7.6, ArH), 7.37 (2H, t, J7.4, 2xArH), 7.45
(2H, t, J 7.4, 2xArH), 7.58 (IH, t, J 7.8, ArH), 7.77 (2H, d, J 7.4, 2xArH), 7.81 (2H, d, J 7.5,
2xArH), 7.89 (lH, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.0, 1.3, ArH), 8.23 (lH, d, br, J 8.1, ArH), 8.82 (lH, s, br, C02NH). be
(100 MHz, CDCh): 46.9 (CH), 49.2 (CH2), 67.7 (CH2), 120.0 (CH), 121.9 (CH), 123.1 (CH),
125.1 (CH), 125.9 (q), 127.2 (CH), 127.8 (CH), 129.2 (CH), 130.8 (CH2), 132.7 (CH), 134.5 (CH),
136.4 (q), 141.3 (q), 143.6 (q), 153.1 (q), 192.1 (q). Vrnax (thin film cm"): 3355 (br, m), 2920 (s),
2850 (s), 1735 (s), 1589 (s), 1529 (s), 1470 (m), 1459 (s), 1330 (s), 1291 (m), 1240 (m), 1155 (s),
1133 (m), 1079 (m), 1048 (m), 756 (s), 667 (m). ESI+ mass spectrum (m/z, %): 485 ([M+Nat,
40%),480 ([M+NH4t, 50%).
7.1.7 Synthesis of 2,3-dihydro-3-hydroxy-l,2,5-benzothiadiazepine l,l-dioxides
o r)-0 Route A 0
O~II DlEA/DCM O~II(yS-~ /; R2 __ I :1...:;..'d____,~CC~S-J;_NHOH +
~_ Et3NIDCM,-/
~H 1:I,d N Me
Fmoc Route B R2
4358: R2=H
435b: R2:Me
4078: R2=H
407b: R2=Me
Route A
To a solution of the 4-{o-[(9'-fluorenylmethoxycarbonyl)amino]benzenesulfonamidyl}-2-
methyl-but-l-en-Lone (407b; 0.230 g, 0.483 mmol, 1.0 eq) in anhydrous dichloromethane (5 ml),
was added N,N-diisopropylethylamine (0.17 ml, 0.965 mmol, 2.0 eq) and the mixture was heated
at reflux in an atmosphere of dry nitrogen for a total of 21 hrs, whilst being monitored by TLC.
Upon completion of the reaction the solvent was evaporated off and the crude residue was purified
by flash column chromatography (eluent: PE:EtOAc/ 1:1) to yield the 2,3-dihydro-3-hydroxy-4-(i-
propyl)-1,2,5-benzothiadiazepine I,l-dioxide (435b; 0.032 g, 26%) as a yellow oil.
bH (400 MHz, CDCI3): 0.80 (3H, d, J 6.8, CH3), 1.01 (3H, d, J 6.9, CH3), 2.25 (IH,
quartquart, J 6.8,3.4, Me2CH), 4.14 OH, m, br, CHOH), 4.28 (lH, d, J3.2, CHOH), 7.23 (lH, d,
J 8.2, ArH), 7.39 (IH, t, J7.7, ArH), 7.52 (lH, td, J 8.4, 1.2, ArH), 7.87 (lH, d, J 7.9, ArH), 9.78
(IH, s, S02NH). be (lOO MHz, CDCh): 15.3 (CH3), 19.0 (CH3), 32.8 (CH), 75.1 (CH), 117.2
(CH), 121.6 (q), 124.5 (CH), 127.1 (CH), 133.0 (CH), 133.6 (q), 160.8 (q). Vrnax (thin film cm"):
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3477 (br, m), 3261 (br, m), 2965 (m), 2930 (m), 1602 (m), 1560 (w), 1523 (m), 1482 (m), 1442
(w), 1297 (s), 1260 (s), 1161 (s), 1082 (s), 1028 (s), 800 (s), 756 (m). EI+ mass spectrum (m/z,
%): 254 ([Mr, 2%), 237 (4%), 212 (25%), 196 (20%), 147 (70%), 119 (50%), 108 (15%), 91
(45%), 77 (15%), 64 (25%). ESI+ mass spectrum (mlz, %): 785 ([3M+Nat, 4%), 763 ([3M+Ht,
2%), 531 ([2M+Nat, 35%), 509 ([2M+H]+, 10%),277 ([M+Nar, 35%), 255 ([M+Ht, 100%).
HRMS (ESI+): found [M+Ht255.0803, CllHI4N203S requires 255.0803.
Epoxybenzothiadiazine (436b) was similarly obtained as a yellow oil (0.033 g, 24% yield)
from the same reaction.
t5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDC!): 1.82 (3H, s, CH3), 1.84 (3H, s, CH3), 5.32 (IH, s, br, NH), 6.23
(1H, s, NCH), 7.22 (1H, t, J7.7, ArH), 7.48 (IH, t, J7.9, ArH), 7.74 (IH, d, J 8.0, ArH), 7.95 (1H,
d, J 8.4, ArH). t5c(100 MHz, CDC!): 17.3 (CH3), 67.4 (CH), 115.8 (q), 120.6 (CH), 124.5 (CH),
125.3 (CH), 127.2 (q), 131.9 (q), 132.7 (q), 133.5 (CH), 150.7 (q). Vmax (thin film cm"): 3252 (br,
m), 2923 (m), 1767 (s), 1724 (s), 1595 (m), 1575 (m), 1482 (m), 1450 (m), 1395 (s), 1374 (s),
1346 (s), 1299 (s), 1262 (m), 1213 (s), 1178 (s), 1150 (s), 1054 (m), 1001 (m), 955 (m), 909 (s),
839 (s), 810 (s), 760 (s). EI+ mass spectrum (m/z, %): 280 ([M]+, 4%), 182 (5%), 134 (5%), 118
(10%), 106 (3%), 98 (40%), 90 (100%), 70 (42%), 64 (40%). HRMS (ESI+): found [M+NH4r
298.0862, C12H16N304Srequires 298.0856.
Route B
A solution of the {0-[(9' -fluorenylmethoxycarbonyl)amino ]benzenesulfonamidyl }alkenone
(407; 0.151 g, 0.322 mmol, 1.0 eq) in a mixture of triethylamine (0.23 ml, 1.58 mrnol, 5.0 eq) and
anhydrous dichloromethane (10 ml) was heated at reflux in an atmosphere of dry nitrogen whilst
being monitored by TLC. Upon completion (approx. 15 hours) of the reaction, the solvent was
evaporated off and the crude residue was purified by flash column chromatography (eluent:
PE:EtOAcl 1:1) to yield the 1,2,5-benzothiadiazepine 1,l-dioxides (435) as follows:
4-Ethyl-2,3-dihydro-3-hydroxy-I,2,5-benzothiadiazepine I, I -dioxide (435b) was obtained
as a light yellow oil which solidified on standing (0.053 g, 69% yield), mp: 89-92 "C.
t5H(400 MHz, CDC13): 1.06 (3H, t, J 7.4, CH3), 1.87 (1H, dq, J 7.4, 3.8, MeCH2), 2.08
(1H, m, MeCH2), 3.6-3.8 (IH, s, br, OH), 4.49 (IH, d, J 3.8, CHOH), 7.12 (1H, d, J 8.2, ArH),
7.45 (lH, t,J7.7, ArH), 7.57 (lH, t,J7.7, ArH), 7.96 (1H, d,J8.0, ArH). t5c(100 MHz, CDCh):
9.1 (CH3), 28.5 (CH2), 72.3 (CHOH), 117.0 (CH), 121.6 (q), 124.7 (CH), 127.2 (CH), 132.9 (CH),
133.6 (q), 160.4 (q), Vmax (thin film cm"): 3475 (br, m), 3277 (br, m), 2963 (m), 2927 (m), 1604
(m), 1560 (w), 1525 (m), 1481 (m), 1440 (w), 1297 (m), 1261 (s), 1158 (s), 1079 (s), 1020 (s), 801
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(s), 759 (s). ESI+ mass spectrum (m/z, %): 743 ([3M+Nat, 5%), 503 ([2M+Nat, 30%), 481
([2M+Ht, 6%), 263 ([M+Nat, 70%), 241 ([M+Ht, 100%). HRMS (ESI+): found [M+Ht
241.0642, CJQHI2N203Srequires 241.0647. C, H, N (%): found C 49.9, H 5.1, N 11.9;
CJQH12N203Srequires C 50.0, H 5.0,N 11.7.
2,3-Dihydro-Bshydroxy-e-ti-propyli-l, 2,5-benzothiadiazeptne I, l-dioxide (435a) was
obtained as a yellow solid (0.0129 g, 62% yield), mp: 117-119 °C fromzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA4-{o-[(9'-
fluorenylmethoxycarbonyl)aminobenzenesulfonamidyl}-but-l-en-3-one (407a; 0.391 g, 0.82
mmol).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
dH (400 MHz, CDCh): 0.87 (3H, d, J 6.9, CH3), 1.07 (3H, d, J 6.9, CH3), 2.34 (IH, qq, J
6.8, 6.7, Me2CH),3.4-3.5 (IH, s, br, OH), 4.33 (IH, d, J 3.3, CHOH), 7.13 (IH, d, J 8.2, ArH),
7.43 (IH, t, J7.6, ArH), 7.54 (lH, t, J7.8, ArH), 7.92 (IH, d, J7.9, ArH), 9.40 (lH, s, br S02NH).
de (100 MHz, CDCh): 15.3 (CI-h), 19.0 (CH3), 32.8 (CH), 75.1 (CH), 117.2 (CH), 121.6 (q),
124.5 (CH), 127.1 (CH), 133.0 (CH), 133.6 (q), 160.8 (q). Vrnax (thin film cm"): 3477 (br, m),
3261 (br, m), 2965 (m), 2930 (m), 1602 (m), 1560 (w), 1523 (m), 1482 (m), 1442 (w), 1297 (s),
1260 (s), 1161 (s), 1082 (s), 1028 (s), 800 (s), 756 (m). EI+ mass spectrum (mlz, %): 254 ([Mt,
2%),237 ([M-OHt, 4%), 212 ([(M-CHMe2)+Ht, 25%), 196 (20%), 147 (70%), 119 (50%), 108
(15%),91 (45%), 77 (15%), 64 (25%). ESI+ mass spectrum (m/z, %): 785 ([3M+Nat, 4%), 763
([3M+Ht, 2%),531 ([2M+Nat, 35%), 509 ([2M+H]\ 10%),277 ([M+Nat, 35%), 255 ([M+Ht,
100%). HRMS (ESI+): found [M+Ht 255.0803, CllH14N203Srequires 255.0803. C, H, N (%):
found C 51.8, H 5.6,N 10.8;CllH14N203Srequires C 52.0, H 5.5, N 11.0.
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7.1.8 Synthesis of 4- [(o-tert-butoxycarbonylamino )benzenesulfonamidyl] -2-methyl-
but-l-en-3-o1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
OH OH
0~/9zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAr-< DMAP,MeCN 0)( r-<zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
(XS-~ rMe B_O_.:C2~0,_<_.I_O°C.(XS-~ rMe +
NH2 NH
I
Soc
405b 431b
dF-~~::'
NH
I
Boc
432b
To a solution of 4-(2-aminobenzenesulfonamidyl)-2-methyl-but-1-en-3-01 (405b; 0.041 g,
0.159 mmole, 1.0 eq) in anhydrous acetonitrile (2 ml) was added 4-dimethylaminopyridine (0.002
g, 0.0159 mmol, 0.1 eq), followed by di-tert-butyldicarbonate (0.16 ml, 0.159 mmol, 1.0 eq) at
O°Cunder an atmosphere of dry nitrogen. The mixture was further stirred for 20 minutes at O°C
and the solvent was removed in vacuo to give the crude product as a brown oil, which was purified
by flash column chromatography (eluent: PE:EtOAcl 3: I) to yield 4-[(o-tert-butoxycarbonyl-
amino)benzenesulJonamidyIJ-2-methyl-but-l-en-3-ol (431b; 0.028 g, 50% yield) as yellow oil.
bH (400 MHz, CDCh): 1.35 (9H, s, 3xCH3), 1.83 (3H, s, CH3), 2.81 (1H, s, OH), 3.98 (2H,
d, J 7.4, CH2NH), 4.43 (IH, s, CHOH), 4.97 (lH, s, BocNH), 5.10 (2H, s, C=CH2), 5.14 (lH, s,
S02NH), 7.20 (IH, td, J 8.0, 0.8, ArH), 7.35 (2H, td, J 7.4, 1.0, 2xArH), 7.44 (2H, t, J 7.4,
2xArH), 7.56 (IH, t, J7.5, ArH), 7.65 (2H, d, J7.4, 2xArH), 7.80 (2H, d, J7.5, 2xArH), 7.90 (lH,
dd, J 8.0, 1.4, ArH), 8.13 (IH, s, ArH), 8.75 (lH, s, C02NH). be (lOO MHz, CDCh): 18.2 (CH3),
46.7 (CH2), 46.8 (CH), 67.7 (CH2), 73.1 (CH), 112.5 (CH2), 120.0 (CH), 122.1 (CH), 123.4 (CH),
]25.0 (CH), 127.2 (CH), 127.8 (CH), 129.3 (CH), 134.2 (CH), 136.0 (q), 141.3 (q), 143.5 (q),
143.8 (q), 153.3 (q, C02NH). Vmax (thin film cm"): 3502 (br, w), 3349 (br, m), 2949 (m), 1737 (s),
1588 (s), 153] (s), 1444 (s), ]326 (s), 1291 (m), 1249 (m), 1216 (s), 1152 (s), 1132 (m), 1083 (m),
]048 (m), 910 (s), 755 (s), 740 (m). ES+ mass spectrum (m/z, %): 713 (45%),603 (21%),358
(16%),357 (90%), 301 (100%),283 (20%),174 (31%). HRMS (ESI+): Found [M+Ht 357.1483,
C'6H2s0sN2S requires 357.1479.
The O-Roc derivative (432b) was similarly obtained as yellow oil (0.028 g, 50% yield)
from the same reaction.
bH (400 MHz, CDCI3): 1.38 (9H, s, 3xCH3), 1.49 (9H, s, 3xCH3), 1.84 (3H, s, CH3), 3.98
(IH, dd, J 14.7,4.8, NHCH2), 4.16 (lH, dd, J 14.7,8.4, NHCH2), 5.03 (IH, s, CH3CCH2), 5.04
(2H, s, br, 2xNH), 5.14 (IH, s, CH3CCH2), 5.32 (1H, q, J 6.6, CH2CHOBoc), 6.69 (1H, d, J 8.3,
ArH), 6.73 (1H, t, J 7.7, ArH), 7.30 (lH, t, J 7.7, ArH), 7.67 (lH, d, J 8.1, ArH). be (100 MHz,
]63
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CDCb): 18.3 (CH3), 27.7 (2x(CH3)3), 48.4 (CH2), 77.6 (CH), 82.1 (q), 84.4 (q), 114.4 (CH2),
116.8 (CH), 117.5 (CH), 120.8 (q), 130.8 (CH), 134.5 (CH), 140.7 (q), 146.3 (q), 151.0 (q), 152.7
(q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin fil ern"): 3493 (br, s), 3386 (s), 2981 (s), 1738 (s), 1623 (s), 1567 (m), 1486 (s),
1456 (s), 1254 (m), 1157 (s), 991 (m), 913 (s), 843 (s), 731 (s). ES+ mass spectrum (m/z, %): 457
(22%), 401 (14%), 397 (21%), 379 (22%), 357 (87%), 301 (100%), 283 (15%), 239 (16%), 232
(14%), 174 (34%), 150 (6%), 128 (II %), 102 (10%), 84 (5%). HRMS (ESI+): Found [M+Ht
457.2002, C21H3307N2Srequires 457.2003.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.1.9 Synthesis of 4-[(o-tert-butoxycarbonylamino )benzenesulfonamidyl]-2-methyl-
but-l-en-3-one
o 0 r)-0H
~II . . Dess Martin
r(YS-N M
~_ H j e DeM, r.t.
NH .
I
Boc
o ~OdS'-~ !1M,
NH
I
Boc
431b 434b
To a solution of 4-[(o-tert-butoxycarbonylamino )benzenesulfonamidyl]-2-methyl-but-l-en-
3-01 (431h; 0.061 g, 0.172 mmol, 1.0 eq) in anhydrous dichloromethane (5 ml) was added finely
powdered Dess-Martin periodinane (0.150 g, 0.350 mmol, 2.1 eq) at ambient temperature under an
atmosphere of dry nitrogen for 1 h. Evaporation of the solvent gave a residue, which was purified
by flash column chromatography (eluent PE:EtOAcl 3:2). The 4-[(o-tert-butoxycarbonylaminoJ-
benzenesuljonamidylj-2-methyl-but-l-en-3-one (434h) was obtained as yellow oil (0.055 g, 92%
yield).
c5H (400 MHz, CDCI3): 1.33 (9H, s, 3xCH3), 1.95 (3H, s, CH3), 5.03 (2H, s, CH2CO), 5.24
(2H, s, br, 2xNH), 5.90 (lH, s, C=CH2), 6.03 (IH, s, C=CH2), 6.71 (lH, d, J 8.3, ArH), 6.78 (lH,
t, J7.5, ArH), 7.32 (lH, t, J8.4, ArH), 7.81 (lH, dd, J8.2, 1.1, ArH). be (100 MHz, CDCI)): 17.7
(CH3), 27.7 ((CH3)3), 51.3 (CH2), 84.6 (q), 116.8 (CH), 117.5 (CH), 120.2 (q), 125.4 (CH2), 131.0
(CH), 134.7 (CH), 141.5 (q), 146.5 (q), 150.8 (q), 193.9 (q). Vmax (thin film cm"): 3470 (s), 3381
(s), 2928 (m), 1724 (s), 1692 (s), 1632 (s), 1485 (m), 1456 (m), 1348 (s), 1156 (m), 1066 (m), 908
(s), 735 (s). EI+ mass spectrum (m/z, %): 355 (18%), 354 (100%), 156 (12%), 92 (35%), 84
(30%), 69 (39%), 57 (100%), 41 (37%). HRMS (EI+): Found [M+t 354.1242, C16H220sN2S
requires 354.1244.
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7.1.10 Synthesis of 2-aminobenzenesulfonamidyl-2-methyl-but-l-en-3-one
Or}OzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAO~IIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBATFA, DCMo:s-tizyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAII Me O°Cto r.t.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
NH
I
Boe
434b 408
To a stirring solution of 4-[(o-tert-butoxycarbonylamino)benzenesuljonamidylJ-2-methyl-
but-l-en-3-one (434b; 0.018 g, 0.050 mmol) in anhydrous dichloromethane (2 ml) was added
trifluoroacetic acid (0.071 ml, 0.599 mmol) at O°C under an atmosphere of dry nitrogen. The
stirring was continued for 7 hrs, during which time the reaction mixture was allowed to warm up
to ambient temperature. The reaction mixture was washed with aqueous NaOH (2 ml) and
extracted with ethyl acetate (3 x 5 ml). The organic phase was dried over anhydrous MgS04,
filtered undergravity and the volatiles were removed in vacuo. The crude product was purified by
flash chromatography (eluent PE:EtOAc/ 3:2) to yield the 2-aminobenzenesuljonamidyl-2-methyl-
but-l-en-S-one (408; 0.0083 g, 68%) as a yellow oil.
bH (400 MHz, CDCh): 1.84 (3H, s, CH3), 4.15 (2H, d, J 4.7, NHCH2), 4.94 (2H, s, br,
NH2), 5.78 (lH, m, br, NH), 5.85 (lH, s, C=CH-H), 5.90 (1H, s, C=CH-H), 6.76 (IH, d, J 8.1,
ArH), 6.80 (1H, t, J 7.3, ArH), 7.33 (1H, t, J 7.0, ArH), 7.70 (IH, d, J 8.1, ArH). be (lOO MHz,
CDCh): 17.5 (CH3), 50.3 (CH2), 83.5 (q), 115.2 (CH), 116.8 (CH), 124.2 (CH2), 121.5 (q), 129.6
(CH), 133.5 (CH), 140.2 (q), 191.8 (q). Vmax (thin film ern"): 3421 (br, m), 3377 (br, m), 3337 (br,
m), 2924 (s), 2889 (s), 1730 (s), 1686 (s), 1620 (s), 1484 (s), 1456 (s), 1319 (m), 1145 (s), 1060
(s), 809 (m), 735 (m). EI+ mass spectrum (m/z, %): 255 ([M+Ht, 70%), 219 (8%),205 (8%), 183
(6%), 157 (3%), 129 (10%), 96 (4%). HRMS (EH): Found [M+Ht 255.0796, CIIHIs03N2S
requires 255.0798.
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Experimental- Part II
7.2.1 Synthesis of hex-2,4-dien-l-0120 IbzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
o NaBR4/NaOMe OR
~ II MeOH,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAoDe to r.t. ~ I
Me~H Me~HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
449 450
To a stirring suspension of sodium methoxide (2.36 g, 43.69 mmol, 2.8 eq) and sodium
borohydride (4.72 g, 124.83 mmol, 8.0 eq) in methanol (15 ml) at O°C was added dropwise a
solution of 2,4-hexadienal (449; 1.49 g, 15.50 mmol, 1.0 eq) over 20 minutes. The resulting
mixture was further stirred for 30 minutes and allowed to warm up to ambient temperature and
was added portion wise to an ice-water (15 ml) mixture. The reaction was acidified with 2M HCI
to pH 2 and extracted with ethyl acetate (3x IS rnl). The organic phase was dried (MgS04),
filtered and the solvent was removed in vacuo. The crude was purified by flash column
chromatography (eluent: PE:EtOAc 2:3) to yield the hex-2,4-dien-l-ol (450; l.125 g, 74% yield)
as a thick yellow oil.
7.2.2 Synthesis of J-bromo-La-hexadtene'?"
OH PBr), ether Br
~ I~ ooe ~ I~
Me~~ ---;__., Me~~
450 451
To a stirring solution of hex-2,4-dien-l-ol (450, 1.82 g, 21.85 mmol, 1.0 eq), in anhydrous
dichloromethane (10 ml) was added dropwise a solution of phosphorus tribromide (7.26 ml, 76.49
mmol, 3.5 eq) at O°C, under an atmosphere of dry nitrogen. The resulting mixture was further
stirred for 1 hr at O°C, quenched at O°Cwith ice-water (15 ml) and allowed to warm to ambient
temperature. The mixture was extracted with dichloromethane (3x 10 ml) and the organic phase
was dried (MgS04), filtered and the solvent was removed in vacuo. The crude l-bromo-Z.s-
hexadiene (451; 1.54 g, 44% yield), was used without purification at the next stage.
166
Chapter 7 Experimental Part IIzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.2.3 Synthesis of cyclisation precursor (386)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAEt3N, DCM
2 Br
~ ~e~~
~"TT NH2 451
NH2
~NH2
~N~Me
HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
386
To a stirring suspension of2-aminobenzamide (0.540 g, 3.966 mmol, 1.0 eq), in anhydrous
DMF (8 ml) was added triethylamine (0.72 ml, 5.156 mmol, 1.3 eq) dropwise at ambient
temperature. Stirring of the reaction mixture was continued for a further 30 minutes at ambient
temperature, followed by dropwise addition of a solution I-bromo-2,4-hexadiene (451; 0.70 g,
4.362 mmol, 1.] eq) in anhydrous dichloromethane (5 ml) and the whole reaction was stirred at
ambient temperature for 3 hr. The reaction was quenched with saturated ammonium chloride
solution (10 ml) and extracted with dichloromethane (2x 10 ml). The organic phase were
combined, dried (MgS04)' filtered and the solvent was removed in vacuo and the crude was
purified by flash column chromatography (eluent PE:EtOAcl 3:2) to yield the cyc1isation precursor
(386, 0.279 g, 32% yield) as a yellow oil.
bH (400 MHz, CDCh): 1.76 (3H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.7, CH3), 3.86 (2H, d, J 5.5, NHCH2), 5.60-5.71
(2H, m, 2x =Cl!), 5.97 (2H, s, br, NH2), 6.00-6.14 (1H, m, =Cl!), 6.23 (lH, dd, J 15.0, 10.3,
=Cl!), 6.59 (tH, t, J 7.3, Arl!), 6.69 (1H, d, J 8.6, Arl!), 7.32 (tH, td, J 8.4, 1.2, Arl!), 7.40 (lH,
dd, J7.7, 1.1, Arl!). be (100 MHz, CDCb): 18.0 (CH3), 44.6 (CH2), 112.1 (CH), 113.1 (q), 114.5
(CH), ]27.2 (CH), 128.2 (CH), 129.1 (CH), 130.8 (CH), 131.7 (CH), 133.3 (CH), 150.1 (q), 172.3
(q). Vrnax (thin :film ern"): 3397 (br, s), 3333 (br, s), 3163 (br, s), 2932 (m), 2877 (m), 1663 (s),
1615 (s), 1586 (s), 1514 (s), 1489 (m), 1437 (m), 1411 (s), 1328 (m), 1296 (s), 1216 (s), 1166 (s),
1128 (s), 1048 (s), 986 (s), 909 (s), 846 (m), 747 (s). ES+ mass spectrum (m/z, %): 271 ([M+Ht,
16%),226 ([Mt, 85%),198 (31%), 184 (75%),172 (33%),170 (100%),156 (68%),130 (48%),
119 (84%), 92 (48%),81 (77%),77 (81%), 65 (59%), 53 (64%),41 (67%). HRMS (EI+): found
[M+Ht 271.1328 CI3H17N20 requires 271.1326.
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Experimental-PartzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAIII
7.3.t Synthesis of t-(2-aminobenzenesulfonyl)pyrroles
400a: RI=R2=H
400b: R1=H, R2=Me
400c: RI=R2=Me
455a: RI=R2=H
455b: RI=H, R2=Me
455c: RI=R2=Me
To a rapidly stirring solution of triethylamine (0.15-0,40 ml, 1.0 eq) and trimethylphosphite
(0.25-0.68 ml, 2.0 eq) in anhydrous methanol (10 ml) was added the 2-(2-azidobenzenesulfonyl)-
3,6-dihydro-l,2-thiazine l-oxide (400a-c; 0.30-0.50 g, 1.0 eq) in one portion and the mixture was
stirred at room temperature under an atmosphere of dry nitrogen for 2 hrs. The volatiles were
removed in vacuo and the crude mixture was purified by flash column chromatography (eluent
PE:EtOAcl 40:60 + 10% triethylamine). The 1-(2-aminobenzenesuljonyl)pyrroles (455a-c) were
obtained as follows:
1-(2-aminobenzenesuljonylJpyrrole (455a)97 was obtained as pale yellow oil (0.277 g,
50% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide (400a; 0.660 g,
2.21 mmol)
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 5.21 (2H, br s, NH2), 6.29 (2H, t, J2.3, pyrrole-H), 6.67 (1H, d, J
8.2, ArH), 6.74 (lH, t, J 7,4, ArH), 7.20 (2H, t, J 2.3, pyrrole-H), 7.29 (1H, td, J 8.5, ],4, ArH),
7.70 (1H, dd, J8.3, 1,4, ArH). be (100 MHz, CDCh): 112.8 (2 x pyrrole-CH), 1]7.5 (CH), 117.9
(CH), 119.2 (q), 120.2 (2 x pyrrole-CH), 129.1 (CH), 135,4 (CH), 145.8 (q). Vmax (thin film ern"):
3456 (s), 3347 (s), 2954 (s), 2851 (m), 1590 (s), 1486 (s), 1458 (s), 1373 (s), 1282 (m), 1186 (s),
1161 (s), 1106 (s), 1029 (s), 815 (s), 734 (s), 677 (m). EI+ mass spectrum (rn/z, %): 222 ([Mt,
22%), 156 (17%), 130 (4%), 108 (25%), 92 (100%), 65 (97%). HRMS (ESI+): Found [M+Ht
223.0537, CJQHJ1N202Srequires 223.0536. Identical to that in the literature."
1-(2-aminobenzenesuljonyl)-3-methylpyrrole (455b) was obtained as a pale yellow oil
(0,495 g, 73% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-5-methyl-] ,2-thiazine l-oxide
(400b; 0.901 g, 2.88 mmol).
bH (400 MHz, CDCh): 2.03 (3H, s, CH3), 6.05 (2H, dd, J 1.6,1.3, NH2), 6.75 (1H, t, J8.0,
ArH), 6.89 (lH, d, J8.2, ArH), 6.93 (lH, s, pyrrole-H), 7.13 (lH, t, J2.6, pyrrole-H), 7.26 (IH, td,
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JzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA8.5, 1.5,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAArH), 7.41 (IH, dquartet, J 4.7, 1.6, Ar ). be (lOO MHz, CDCh): 11.7 (CH3), 113.1
(CH), 117.8 (CH), 118.5 (CH), 121.6 (CH), 121.8 (q), 124.5 (CH), 128.7 (CH), 129.8 (q), 134.2
(CH), 147.5 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVrnax ( hin fil cm"): 3477 (m), 3342 (m), 2999 (m), 2954 (s), 2850 (s), 1591 (s),
1487 (s), 1356 (s), 1291 (m), 1263 (s), 1172 (s), 1031 (s), 914 (m), 816 (s), 760 (s), 732 (s), 677
(s), 607 (s). EI+ mass spectrum (m/z, %): 236 ([Mt, 15%), 156 (19%), 108 (37%), 93 (100%),65
(84%). HRMS (ESI+): Found [M+Ht 237.0734, CI1HJ3N202S requires 237.0732.
1-(2-aminobenzenesuljonyl)-3,4-dimethylpyrrole (455c) was obtained as a pale yellow oil
(0.135 g, 50% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-4,5-dimethyl-l ,2-thiazine 1-
oxide (400c; 0.350 g, 1.07 mmol).
bH (400 MHz, CDCh): 1.91 (6H, s, 2 x CH3), 4.50-4.70 (2H, br s, NH2), 6.63 (IH, d, J 8.2,
ArH) 6.71 (lH, t, J 7.6, ArH), 6.84 (2H, s, 2 x pyrrole-H), 7.25 (IH, t, J 7.4, ArH), 7.61 (lH, d, J
8.1, ArH). be (100 MHz, CDCh): 9.6 (CH3), 10.1 (CH3), 117.4 (CH), 1] 7.6 (CH), 117.8 (CH),
120.0 (q), 124.2 (q), 129.2 (CH), 135.0 (CH), ]45.6 (q). Vmax (thin film ern"): 3457 (s), 3377 (s),
2966 (m), 2919 (m), ]599 (m), 1484 (s), 1455 (m), 1348 (m), 1296 (m), 1068 (s), 1034 (s), 829 (s),
744 (m), 699 (m), 610 (m), 588 (m). EI+ mass spectrum (m/z, %): 250 ([Mt, 70%), ]85 (25%),
]56 (20%), 108 (35%), 94 (l00%), 65 (80%),39 (50%). HRMS (ESI+): Found [M+Ht 251.0845,
C12H 14N202Srequires 251.0849.
7.3.2 Synthesis of 1-(2-formamidobenzenesulfonyl)pyrroles
CHO
I
o
'COMe
THF
0)( --:C(S-N~2
NH
IzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
eHO
456a: Rl=R2=H
456b: Rl=H, R2=Me
456c: Rl=R2=Me
455a: Rl=R2=H
455b: Rl=H, R2=Me
455c: RI=R2=Me
Formic acid (0.036-0.] 93 g, 2.25 eq) was added to acetic anhydride (0.070-0.381 g, 2.0 eq)
at O°C and the solution was stirred at room temperature for 2 hrs. This solution was added to a
solution of the 1-(2-aminobenzenesutfonyl)pyrrole (455a-c; 1.0 eq) in anhydrous tetrahydrofuran
(5 ml) and the reaction mixture was stirred at room temperature for 20 h. The volatiles were
removed in vacuo and the crude mixture was purified by flash column chromatography (eluent
PE:EtOAcl 40:60). The 1-(2-Jormamidobenzenesuljonyl)pyrroles (456a-c) were obtained as
follows:
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1-(2-jormamidobenzenesuljonyl)pyrrolezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(455a) was obtained as pale yellow oil (0.083 g,
98% yield) from 1-(2-aminobenzenesulfonyl)pyrrole (456a; 0.076 g, 0.343 mmol), and was
identical to that reported by Artico in all respects."
1-(2-jormamidobenzenesuljonyl)-3-methylpyrrolezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(455b) was obtained as pale yellow oil
(0.383 g, 77% yield) from 1-(2-aminobenzenesulfonyl)-3-methylpyrrole (456b; 0.440 g, 1.864
mmol).
6zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 2.05 (3H, s, CH3), 6.16 (IH, s, pyrrole-H), 6.85 (IH, s, pyrrole-H),
7.05 (IH, t, J2.6, pyrrole-H), 7.23 (IH, t, J7.7, ArH), 7.31 (IH, d, J7.4, ArH), 7.59 (IH, t, J7.7,
ArH), 7.79 (IH, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.0, ArH), 8.54 (IH, s, CHO), 9.40 (IH, br s, NH). 6c (100 MHz, CDCh):
11.8 (CH3), 116.5 (CH), 117.4 (CH), 120.5 (CH), 123.2 (CH), 124.6 (CH), 125.4 (q), 126.0 (q),
128.8 (CH), 129.9 (CH), 135.3 (CH), 158.9 (CHO). Vmax (thin film ern"): 3299 (s), 2953 (s), 1705
(s), 1677 (s), 1580 (s), 1517 (s), 1467 (s), 1433 (s), 1406 (s), 1361 (s), 1291 (m), 1261 (s), 1174
(s), 1096 (s), 1038 (s), 913 (s), 829 (s), 735 (s), 692 (s), 608 (s). EI+ mass spectrum (m/z, %): 264
([Mt, 50%), 184 (77%), 156 (45%), 120 (59%), 92 (81%), 81 (100%), 65 (95%), 53 (83%).
HRMS (CI+NH3): Found [M+NH4t 282.0905, CI2HI6N303S requires 282.0907.
1-(2-jormamidobenzenesuljonyl)-3,4-dimethylpyrrole (455c) was obtained as pale yellow
oil (0.120 g, 83% yield) from 1-(2-aminobenzenesulfonyl)-3,4-dimethylpyrrole (456c; 0.130 g,
0.523 mmol).
6H (400 MHz, CDCh): 1.97 (6H, s, 2 x CH3), 6.85 (2H, s, 2 x pyrrole-H), 7.23 (lH, t, J7.7,
ArH), 7.61 (IH, t, J 7.7, ArH), 7.77 (1H, d, J 8.0, ArH), 8.52 (IH, d, J 7.9, ArH), 8.56 (IH, s,
CHO), 9.45 (1H, br s, NH). 6c (100 MHz, CDCh): 10.1 (CH3), 117.5 (CH), 123.0 (CH), 124.2
(CH), 125.7 (q), 125.8 (q), 126.1 (q), 128.8 (CH), 135.1 (CH), 158.8 (CHO). Vmax (thin film ern"):
3290 (m), 3020 (w), 2921 (w), 1706 (s), 1674 (s), 1579 (m), 1514 (m), 1403 (m), 1358 (m), 1290
(m), 1216 (s), 1160 (s), 1071 (m), 669 (m), 611 (m). EI+ mass spectrum (m/z, %): 278 ([M]+'
60%),250 (10%), 228 (60%), 184 (85%), 156 (20%), 120 (50%), 95 (100%), 65 (85%). HRMS
(Cl+NH3): Found [M+N~r 296.1063, C13H14N203Srequires 296.1063.
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7.3.3 Synthesis of pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 5,5-dioxides
O~{? (~/Rl dichloroethanezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~ -N,,=\ POCI3,Ll
~_ R2
NH
1
CHO
456a: Rl=R2=H
456b: Rl=H, R2=Me
456c: Rl=R2:Me
457a: Rl=R2=H
457b: R1=H, R2=Me
457c: Rl=R2=Me
A solution of the 1-(2-formamidobenzenesulfonyl)pyrrole (456a-c; 1.0 eq) and phosphorus
oxychloride (0.67-0.93 ml, 21.6 eq) in dichloroethane (2 ml) was heated at reflux temperature for
3 hrs. Saturated sodium hydrogen carbonate solution (4 ml) and ethyl acetate (4 ml) was added and
the organic layer was separated and dried over NaS04. Evaporation of the solvent gave a residue,
which was purified by flash column chromatography (eluent PE:EtOAcl 40:60). The pyrrolo[1,2-
bJ[1,2,5Jbenzothiadiazepine 5,5-dioxides (457a-c) were obtained as follows:
Pyrrolo[1,2-bJ[1,2,5Jbenzothiadiazepine 5,5-dioxide (457a) was obtained as pale yellow
oil (0.043 g, 55% yield) from 1-(2-formamidobenzenesulfonyl)pyrrole (456a; 0.083 g, 0.331
mmol).
t5H (400 MHz, CDCb): 6.45 (IH, t, J3.3, pyrrole-H), 6.86 (lH, dd, J3.6, 1.2, pyrrole-H),
7.43 (lH, t, J 7.6, ArH), 7.48 (lH, dm, J 8.1 pyrrole-H), 7.63 (lH, d, J 8.0, ArH), 7.66 (tH, t, J
7.7, ArH), 8.05 (IH, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.0, ArH), 8.63 (tH, s, N=CH). t5c (lOO MHz, CDCh): 112.6 (CH),
120.3 (CH), 123.2 (CH), 125.6 (CH), 126.6 (CH), 128.2 (q), 130.0 (q), 130.3 (CH), 134.7 (CH),
144.4 (q), 150.0 (N=CH). Vmax (thin film ern"): 2926 (s), 1605 (s), 1583 (s), 1463 (s), 1406 (s),
1366 (s), 1289 (m), 1236 (m), 1191 (s), ] 145 (s), 1125 (m), 1069 (s), 1051 (s), 909 (s), 823 (m),
765 (m), 732 (s), 696 (s), 594 (s). EI+ mass spectrum (m/z, %): 233 ([M+Ht, 10%), 102 (100%),
74 (6%). HRMS (ESI+): Found [M+Ht 233.0381, CIIH9N202S requires 233.0379.
l-methyl-pyrrolo[1,2-bJ[1,2,5Jbenzothiadiazepine 5,5-dioxide (457b) was obtained as pale
yellow oil (0.067 g, 59% yield) from 1-(2-formamidobenzenesulfonyl)-3-methylpyrrole (456b;
0.121 g, 0.462 mmol).
t5H (400 MHz, CDCI3): 2.37 (3H, s, CH3), 6.36 (1H, d, J2.9, pyrrole-H), 7.44 (IH, t, J7.4,
ArH), 7.51 (IH, d, J 2.9, pyrrole-H), 7.66-7.75 (2H, m, 2 x ArH), 8.07 (IH, d, J 7.9, ArH), 8.66
(lH, s, N=CH). t5c (lOOMHz, CDCh): 11.5 (CH3), 1]4.8 (CH), 123.0 (q), 123.1 (CH), 124.6 (q),
125.5 (CH), 126.5 (CH), 129.9 (CH), 133.0 (q), 134.6 (CH), 143.9 (q), 148.6 (N=CH). Vmax (thin
film ern"): 2927 (w), 1603 (s), 1580 (s), 1466 (m), 1365 (s), 1259 (m), 1187 (s), 1149 (m), 1069
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(m), 910 (s), 829 (m), 765 (m), 733 (m). ES+ mass spectrum (m/z, %): 247zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA([M+Ht, 100%), 172
(54%), 130 (45%), 112 (33%), 88 (15%), 58 (15%). HRMS (ES+): Found [M+Ht 247.0532,
CI2HIIN202S requires 247.0536.
1,2-dimethyl-pyrrolo[zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA1,2-bJ [1,2,5 J benzothiadi zepine 5,5-dioxide (zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA457 c) was obtained as
pale yellow oil (0.040 g, 43% yield) from 1-(2-formamidobenzenesulfonyl)-3,4-dimethylpyrrole
(456c; 0.100 g, 0.360 mmol).
OH (400 MHz, CDCh): 2.06 (3H, s, CH3), 2.26 (3H, s, CH3), 7.33 (1H, s, pyrrole-B), 7.42
(1H, dt, J 8.0, 1.0, ArB), 7.60-7.73 (2H, m, 2 x ArB), 8.04 (lH, dd, J 7.9, 1.2, ArB), 8.62 (1H, s,
N=CB). oe (100 MHz, CDCh): 9.6 (CH3), 9.9 (CH3), 120.8 (CH), 123.6 (q), 124.9 (q), 125.3
(CH3), 126.2 (CH), 129.9 (CH), 130.] (q), 132.5 (q), 134.4 (CH), 144.1 (q), 148.6 (N=CH). Vmax
(thin film ern"): 2924 (w), 1603 (s), 1582 (s), 1458 (m), 1365 (s), 1294 (m), 1181 (s), ] 137 (m),
1107 (m), 910 (s), 832 (m), 767 (m), 733 (m). ES+ mass spectrum (m/z, %): 261 ([M+Ht,
100%), 86 (4%), 58 (25%). HRMS (ESI+): Found [M+Ht 261.0691, C13HI2N202S requires
261.0692.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.3.4 Synthesis of ll-phenyl-[l,2,4-oxadiazolo]pyrrolo[l,2-b] [l,2,S]benzothia-
diazepine S,S-dioxides
1. Et3N, THF
2. N-OH
PhACI
457b: R1=H, R2=Me
457c: RI=R2=Me
477a: R1=H, R2=Me
477b: RI=R2:Me
A solution of benzohydroximoyl chloride (0.l81 g, 1.163 mmol, 2.4 eq)in tetrahydrofuran
(l0 ml) was added dropwise over (10-12 h) with stirring to a mixture of I-methylpyrrolo[1,2-
b][1,2,5]benzothiadiazepine 5,5-dioxide (457b; 0.121 g, 0.491 mmol, 1.0 eq) and triethylamine
(16 ml, 1.171 mmol, 2.4 eq) in anhydrous terahydrofuran (10 ml) at ambient temperature, under an
atmosphere of dry nitrogen for a total of 15-22 h. Upon completion, the volatiles were removed in
vacuo and the crude residue was purified by flash column chromatography (eluent: PE:EtOAc I
1:2) to yield the ll-phenyl-[1,2,4-oxadiazoloJpyrrolo[l,2,-bJ[1,2,5Jbenzothiadiazepine 5,5-
dioxides (477b-c) as follows:
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Il-phenyl-[1,2,4-oxadiazoloJ-l-methylpyrrolo[1,2-bJ[1,2,5Jbenzothiadiazepine 5,5-
dioxidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(477a) was obta ned as pale yellow oil (0.085 g, 47% yield).
t5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH(400 MHz, CDCh): 2.21 (3H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH3), 6.14 (IH, d, J3.2, pyrrole-H), 6.85 (IH, d, 7.6,
pyrrole-H), 7.10 (IH, s, CH), 7.20-7.30 (2H, m, 2 x ArH), 7.30-7.50 (4H, m, 4 x ArH), 7.57 (2H,
d, J 7.7,2 x ArH), 7.94 (1H, dd, J 7.9, 1.4, ArH). t5c(100 MHz, CDCh): 11.8 (CH3), 91.9 (CH),
115.5 (CH), 119.5 (q), 122.3 (CH), 124.4 (q), 125.5 (CH), 127.4 (CH), 127.7 (CH), 127.8 (q),
128.5 (2 x CH), 128.8 (2 x CH), 131.1 (CH), 132.8 (q), 134.4 (CH), 135.9 (q), 155.6 (q). Vmax
(thin film ern"): 3145 (w), 3087 (w), 3066 (w), 2927 (m), 1721 (m), 1660 (m), 1585 (s), 1477 (s),
1444 (m), 1408 (m), 1358 (s), 1258 (s), 1179 (s), 1156 (s), 1089 (m), 908 (s), 836 (s), 730 (s), 694
(s), 648 (s), ES+ mass spectrum (m/z, %): 366 ([M+Ht, 27%), 191 (21%),132 (35%),117
(26%),85 (100%). HRMS (ESI+): Found [M+Ht 366.0905, CI9HI6N303S requires 366.0907.
Il-Phenyl-[1,2,4-oxadiazoloJ-l,2-dimethylpyrrolo[1,2-bJ[I, 2,5Jbenzothiadiazepine 5,5-
dioxide (477b) was obtained as pale yellow oil (0.201 g, 69% yield) in the same way from 1,2-
dimethyl-pyrrolo[I,2-b][I,2,5]benzothiadiazepine 5,5-dioxide (4S7c; 0.202 g, 0.776 mmol).
t5H(400 MHz, CDCh): 1.93 (3H, s, CH3), 2.10 (3H, s, CH3), 6.81 (lH, d, J 8.0, CH), 7.07
(lH, s, pyrrole-H), 7.23 (lH, t, J7.23, ArH), 7.30-7.40 (3H, m, 3 x ArH), 7.45 (lH, t, J7.5, ArH),
7.56 (2H, d, J 7.9, 2 x ArH), 7.90 (lH, d, J 7.9, ArH). t5c (lOO MHz, CDCh): 9.5 (CH3), 10.0
(CH3), 92.0 (CH), 119.6 (q), 119.8 (CH), 124.2 (q), 124.5 (q), 125.3 (CH), 127.3 (CH), 127.5
(CH), 128.2 (q), 128.4 (2 x CH), 128.7 (q), 128.8 (2 x CH), 131.1 (CH), 132.6 (q), 134.2 (CH),
135.9 (q). Vmax (thin film cm"): 3145 (w), 3090 (w), 3070 (w), 1610 (w), 1584 (m), 1573 (m),
1500 (m), 1446 (m), 1409 (s), 1365 (s), 1308 (m), 1269 (s), 1197 (s), 1185 (s), 1174 (s), 1130 (m),
1085 (s), 905 (s), 842 (s), 774 (s), 699 (s), ES+ mass spectrum (m/z, %): 380 ([M+Ht, 100%),
303 (10%), 277 (13%), 261 (35%), 249 (18%), 175 (10%), 141 (12%), 105 (18%), 89 (11%).
HRMS (ESI+): Found [M+Ht 380.1063, C20H1SN303Srequires 380.1067.
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7.3.5 Synthesis of ethyl[l,2,4-oxadiazolo]pyrrolo[l,2-h] [l,2,5]benzothiadiazepine
5,5-dioxide carboxylateszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
I.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAEt3N, THF
2. N-OH
Et02C)lCI
457b: R1=H, R2=Me
457c: Rl=R2=Me
A solution of ethylchloroximidoacetate (0.291 g, 1.920 mmol, 2.4 eq) in tetrahydrofuran
(10 ml) was added dropwise over (10-12 h) with stirring to a mixture of 1-methylpyrrolo[I,2-
b][I,2,5]benzothiadiazepine 5,5-dioxide (457b; 0.203 g, 0.824 mmol, 1.0 eq) and triethylamine
(0.27 ml, 1.951 mmol, 2.4 eq) in anhydrous terahydrofuran (10 ml) at ambient temperature, under
an atmosphere of dry nitrogen for a total of 15-22 h. Upon completion, the volatiles were removed
in vacuo and the crude residue was purified by flash column chromatography (eluent: PE:EtOAczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI
1:2) to yield the ethyl[1,2,4-oxadiazoloJpyrrolo[1,2-bJ [1,2,5Jbenzothiadiazepine 5,5-dioxide
carboxylates (479a-b) as follows:
Ethyl[1,2,4-oxadiazoloJ-1-methylpyrrolo[J,2-bJ[J,2,5Jbenzothiadiazepine 5,5-dioxide 11-
carboxylate (479a) was obtained as pale yellow oil (0.190 g, 66% yield).
bH (400 MHz, CDCI): 1.28 (3H, t, J 7.1, C02CH2CH3), 2.12 (3H, s, CH3), 4.25 (2H, m,
C02CH2CH3), 6.13 (1H, s, Clf), 7.11 (lH, s, pyrrole-lf), 7.33 (1H, d, J3.0, pyrrole-lf), 7.54 (lH,
t, J7.6, Arlf), 7.63 (lH, d, J7.7, Arlf), 7.70 (lH, t, J7.6, Arlf), 7.95 (lH, d, J7.8, Arlf). be (100
MHz, CDCh): 11.2 (CH3), 13.8 (CH3), 62.7 (CH2), 91.3 (CH), 114.0 (CH), 121.1 (q), 123.9 (CH),
127.1 (CH), 129.0 (CH), 130.2 (q), 133.6 (CH), 134.5 (CH), 137.8 (q), 147.8 (q), 156.6 (q). Vrnax
(thin film ern"): 3159 (m), 3]00 (m), 3020 (m), 2926 (s), 1736 (s), 1574 (s), 1485 (s), 1444 (m),
1416 (m), 1362(s), 1287 (m), 1259 (m), 1214 (s), 1193 (s), 1153 (s), 1094 (s), 1020(m),913 (m),
763 (s). ES+ mass spectrum (m/z, %): 362 ([M+Ht, 100%), 316 (10%), 282 (16%), 247 (15%),
89 (24%), 59 (16%). HRMS (ESI+): Found [M+Ht 362.0804, CI6HI6N30SS requires 362.0805.
Ethyl[1,2,4-oxadiazoloJ-l,2-dimethylpyrrolo[1,2-bJ[1,2,5Jbenzothiadiazepine 5,5-dioxide
l l-carboxylate (479b) was obtained as pale yellow oil (0.101 g, 58% yield) from 3,5-dimethyl-
pyrrolo[I,2-b][1,2,5]benzothiadiazepine 5,5-dioxide (457c; 0.120 g, 0.461 mmoJ).
OH (400 MHz, CDCh): 1.30 (3H, t, J 7.1, C02CH2CH3), 1.93 (3H, s, CH3), 2.01 (3H, s,
CH3), 4.23-4.31 (2H, m, C02CH2CH3), 7.10 (IH, s, pyrrole-lf), 7.14 (tH, s, Clf), 7.52 (IH, td, J
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7.7, 1.2,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAArH), 7.60 (lH, dd, J 7.9, 1.0, ArH), 7.68 (lH, td, 7.7, 1.5, ArH), 7.95 (IH, dd, J 7.8,
1.4,ArH). be (lOO MHz, CDCI3): 9.3 (CH3), 9.9 (CH3), 13.8 (CH3), 62.7 (CHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2), 91.6 (CH), 121.0
(q), 121.5 (CH), 122.7 (q), 127.0 (CH), 128.9 (CH), 130.5 (q), 133.5 (CH), 134.2 (CH), 138.0 (q),
147.9 (q), 156.6 (q). Vmax (thin film ern"): 1733 (s), 1582 (s), 1362 (s), 1310 (m), 1275 (m), 1205
(s), 1186 (s), 1130 (m), 1080 (s), 1018 (m), 903 (m), 818 (m), 786 (m), 764 (s). ES+ mass
spectrum (m/z, %): 376 ([M+Ht, 41%), 262 (17%), 261 (100%),74 (14%). HRMS (ESI+):
Found [M+Ht 376.0962, C17HISN30SSrequires 376.0966.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.3.6 Synthesis of 1-(2-phosphoramidobenzenesulfonyl) pyrroles
400a: Rl=R2=H
400b: Rl=H, R2=Me
400c: Rl=R2=Me
462a: Rl=R2=H
462b: Rl=H, R~Me
462c: Rl=R2=Me
To a rapidly stirring solution of triethylamine (0.061-0.070 g, ~ eq) and trimethylphosphite
(0.28-0.33 ml, 2.0 eq) in anhydrous methanol (10 ml) was added the 2-(2-azidobenzenesulfonyl)-
3,6-dihydro-1,2-thiazine I-oxide (400a-c; 0.30-0.50 g, 1.0 eq) in one portion and the mixture was
stirred at room temperature under an atmosphere of dry nitrogen for 2 h. Upon completion of the
reaction (TLC), the mixture was washed with aqueous hydrochloric acid (10 ml) and extracted
with ethyl acetate (3x 10 ml). The organic phase was dried over anhydrous MgS04, filtered under
gravity and the volatiles were removed in vacuo. The crude product was purified by flash column
chromatography (eluent: PE:EtOAc/ 3:2). The 1-(2-phosphoramidobenzenesuljonyl)pyrroles were
obtained as follows:
1-(2-phosphoramidobenzenesuljonyl)pyrrole (462a) was obtained as pale yellow oil (0.291
g, 64% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-l ,2-thiazine I-oxide (400a; 0.411 g,
1.378 mmol)
bH (400 MHz, CDCh): 3.72 (3H, s, OCH3), 3.75 (3H, s, OCH3), 6.31 (2H, t, J2.3, pyrrole-
H), 7.08 (lH, td, J 8.1, 1.0, ArH), 7.17 (2H, t, J2.2, pyrrole-H), 7.38 (IH, s, br, NH), 7.42 (IH, d,
J 8.5, ArH), 7.50 (lH, td, J 8.0, 1.3, ArH), 7.85 (lH, d, J 8.], ArH). be (100 MHz, CDCh): 53.5
(OCH3), 53.6 (OCH3), ] 13.6 (2x pyrrole-CH), 119.4 (CH), 120.5 (2x pyrrole-CH), 121.9 (CH),
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124.2 (q), 129.4 (CH), 135.8 (CH), 138.8 (q). Vmax (thin film ern"): 3338 (s), 3017 (s), 2956 (m),
2854 (m), 1600 (s), 1578 (s), 1492 (s), 1456 (s), 1412 (m), 1362 (s), 1310 (m), 1281 (s), 1216 (s),
1187 (s), 1162 (s), 1135 (m), 1057 (s), 1033 (s), 950 (s), 843 (m), 831 (m), 752 (s, br), 668 (s), 617
(s). ES+ mass spectrumzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(mlz, %): 331 ([M+H]+' 83%), 265 (11%),264 (100%), 130 (10%), 102
(85%),59 (13%). HRMS (ES1+): Found [M+Ht 331.0512, CI2HI6N20SPS requires 331.0512.
1-(2-phosphoramidobenzenesuljonyl)-3-methylpyrrole (462b) was obtained as pale yellow
oil (0.285 g, 69% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-5-methyl-l ,2-thiazine 1-
oxide (400b; 0.375 g, 1.200 mmol).
t5H (500 MHz, CDCb): 1.97 (3H, s, CH3), 3.66 (3H, s, OCH3), 3.69 (3H, s, OCH3), 6.06
(IH, dd, J 3.1, 1.5, NH), 6.82 (IH, s, pyrrole-H), 6.96-7.03 (2H, m, ArH + pyrrole-H), 7.31-7.38
(2H, m, ArH + pyrrole-H), 7.41 (IH, td, J 8.0, 1.6, ArH), 7.73 (IH, dt, J 8.1, 1.5, ArH). t5c (100
MHz, CDCh): 11.7 (CH3), 53.6 (OCH3), 53.6 (OCH3), 116.0 (CH), 117.5 (CH), 119.3 (CH), 120.6
(CH), 121.8 (CH), 124.5 (q), 124.7 (q), 129.3 (CH), 135.5 (CH), 138.7 (q). Vmax (thin film cm"):
3346 (s), 2957 (m), 1599 (s), 1577 (s), 1490 (s), 1463 (s), 1411 (m), 1357 (s), 1279 (m), 1257 (m),
1162 (s), 1094 (s), 1060 (s), 1018 (s), 944 (s), 830 (s), 765 (s), 730 (s). E1+ mass spectrum (mlz,
%): 367 ([M+Nat, 9%), 296 (2%), 242 (16%), 192 (3%), 158 (4%). HRMS (ES1+): Found
[M+Nat 367.0488 C13H17N2NaOsPS.
1-(2-phosphoramidobenzenesuljony/)-3,4-dimethylpyrrole (462c) was obtained as pale
yellow oil (0.347 g, 75% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-4,5-dimethyl-l,2-
thiazine l-oxide (400c; 0.421 g, 1.290 mmol).
t5H (400 MHz, CDCb): 1.88 (6H, s, 2 x CH3), 3.71 (3H, s, OCH3), 3.74 (3H, s, OCH3), 6.57
(lH, s, br, NH), 6.83 (2H, s, 2x pyrrole-H), 7.01 (lH, t, J7.6, ArH), 7.36 (lH, d, J 8.3, ArH), 7.43
(lH, t, J 8.6, ArH), 7.73 (lH, d, J 8.1, ArH). t5c (100 MHz, CDCzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAh): 9.8 (2x CH3), 53.3 (2x
OCH3), 117.4 (2x pyrrole-CH), 119.0 (CH), 121.6 (CH), 124.4 (q), 125.0 (2x q), 129.0 (CH),
135.2 (CH), 138.3 (q). Vmax (thin film cm"): 3332 (s), 2954 (s), 2926 (s), 2855 (s), 1599 (s), 1578
(s), 1492 (s), 1461 (s), 1412 (m), 1357 (s), 1280 (m), 1224 (m), 1164 (s), 1135 (s), 1059 (s), 1032
(s), 951 (s), 911 (s), 843 (s), 733 (s), 706 (m), 611 (s), 587 (s), E1+ mass spectrum (mlz, %): 359
([M+H]+, 65%), 264 (100%), 192 (15%), 130 (10%), 102 (45%), 59 (10%). HRMS (ES1+):
Found [M+H]+ 359.0843 CI4H20N20SPSrequires 359.0842.
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7.3.7 Synthesis of N-[o-(N' ,N'-dimethylformamidinyl)benzenesulfonyl] formyl-
pyrrole
o 0 0
"S'_N~Me DMF, POCl3 o"S'_NAyMeex '=\ DCM,r.t. ex r".zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA+
.6- NH Me .6- NH CHOMe
I I
O=P,-OMe O=P,-OMe
OMe OMe
462c 470
0)( ~MeexS-N -c-N CHOMe
Me'NJJ
I
Me
471
To a stirring solution of N,N-dimethylforamide (0.09 mI, 1.127 mmol, 2.0 eq) in anhydrous
dichloromethane (2 ml) was added phosphorus oxychloride (0.11 ml, 1.127 mmol, 2.0 eq)
dropwise over the course of 2 mins atzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAODC under an atmosphere of dry nitrogen. The stirring was
continued for] 5 mins, followed by dropwise addition of 1-(2-phosphoramidobenzenesulfonyl)-
3,4-dimethylpyrrole (462c; 0.202 g, 0.564 mmol, 1.0 eq) in dichloromethane (2 ml) over an
additional 5 mins. Stirring was continued for 18 hrs, during which time the reaction mixture was
allowed to warm up to ambient temperature. The reaction mixture was washed with aqueous
NaOH (5 ml) and extracted with ethyl acetate (3x 10 ml). The organic phase was dried over
anhydrous MgS04, filtered under gravity and the volatiles were removed in vacuo. The crude
product was purified by flash column chromatography (eluent: PE:EtOAcl 3:2) to provide two
products as follows:
1-(2-phosphoramidobenzenesuljonyl) jormylpyrrole (470; 0.081 g, 38% yield) was
obtained as a yellow oil.
bH (400 MHz, CDCI3): 2.00 (3H, s, CH3), 2.27 (3H, s, CH3), 3.77 (3H, s, OCH3), 3.80 (3H,
s, OCH3), 7.04 (lH, t, J 7.5, Arl!), 7.38-7.57 (3H, m, 2xArH + pyrrole-l!), 7.68 (IH, d, J 8.1,
ArH), 10.1 (lH, s, CHO). be (lOO MHz, CDCh): 9.9 (CH3), 10.8 (CH3), 54.1 «OCH3)2), 120.0
(CH), 122.2 (CH), 123.8 (q), 124.5 (q), 127.3 (CH), 129.5 (q), 130.0 (CH), 136.2 (CH), 139.8 (q),
139.9 (q), 179.0 (CHO). Vmax (thin film cm"): 3348 (s), 3105 (s), 3018 (s), 2957 (m), 2928 (m),
2854 (m), 1662 (s), 1600 (s), 1578 (s), 1497 (s), 1468 (s), 1418 (m), 1378 (m), 1361 (s), 1318 (m),
1281 (s), 1263 (s), 1232 (m), 1216 (m), 1165 (s), 1130 (s), 1111 (m), 1051 (s), 1033 (s), 970 (s),
858 (m), 850 (s), 830 (m), 757 (s), 728 (m), 704 (s), 668 (s), 613 (m), 587 (m). ES+ mass
spectrum (m/z, %): 387 ([M+Ht, 100%), 369 (30%), 359 (10%), 264 (25%), 124 (5%), 1] 7
(18%),96 (23%). HRMS (ESI+): Found [M+Ht 387.0768, CISH2oN206PS requires 387.0774.
N-[o-{N',N'-dimethyljormamidinyl)benzenesuljonyl] jormylpyrrole (471; 0.]01 g, 54 %
yield) was obtained as a pale yellow oil.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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c5HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(400 MHz, CDCh): 1.99 (3H, s, CH3), 2.28 (3H, s, CH3), 3.01 (3H, s, NCH3), 3.02 (3H,
s, NCH3), 6.76 (lH, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.0,0.7, ArH), 7.10 (lH, td, J 8.2, 1.1, ArH), 7.29 (lH, s, pyrrole-H),
7.42 (lH, s, N=CH), 7.46 (lH, td, J 8.4, 1.5, ArH), 8.03 (lH, dd, J 8.0, 1.5, ArH), 9.98 (lH, s,
CHO). c5e (100 MHz, CDCh): 9.5 (CH3), 10.9 (CH3), 34.4 (CH3), 40.3 (CH3), 120.6 (q), 121.6
(CH), 121.9 (CH), 128.2 (CH), 128.7 (q), 129.9 (CH), 130.2 (q), 135.5 (CH), 135.9 (q), 151.7 (q),
152.8 (CH), 180.5 (CHO). Vrnax (thin film cm"): 2924 (m), 1660 (m), 1631 (s), 1581 (s), 1558 (m),
1489 (m), 1469 (s), 1432 (m), 1414 (m), 1370 (s), 1280 (s), 1160 (s), 1132 (m), 1102 (s), 1061
(m), 998 (m), 907 (s), 857 (s), 760 (m), 726 (s). EI+ mass spectrum (m/z, %): 335 (20%), 334
([M+Ht, 100%),211 (8%), 102 (8%). HRMS (ESI+): [M+Ht 334.1224, C16H20N303PSrequires
334.1220.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.3.8 Synthesis of 1-(2'-aminobenzenesulfonyl)-2-formylpyrrole (472)
455c 472
o
CCO~S-.N::::r:MeMe
NH2
OMF, POCl3
OCM,r.t.
o 0
~II ~MeCCS-N - +CHOMeNH2
To a stirring solution of N,N-dimethylforamide (0.05 ml, 0.628 mmol, 1.2 eq) in anhydrous
dichloromethane (1 ml) was added phosphorus oxychloride (0.06 ml, 0.628 mmol, ].2 eq)
dropwise over the course of 2 mins at O°Cunder an atmosphere of dry nitrogen. The stirring was
continued for 15 mins, followed by dropwise addition of the pyrrole (455c; 0.131 g, 0.523 mmol)
in dichloromethane (2 ml) over additional 5 mins. The reaction mixture was allowed to warm up
to ambient temperature and was stirred for 3 hrs. Upon completion the reaction mixture was
washed with aqueous NaOH (5 ml) and extracted with ethyl acetate (3x 10 ml). The organic phase
was dried over anhydrous MgS04, filtered under gravity and the volatiles were removed in vacuo.
The crude residual product was purified by flash column chromatography (eluent: PE:EtOAc/ 3:2)
to provide two products as follows:
1-(2 '-aminobenzenesuljonyl)-2-Jormylpyrrole (472; 0.082 g, 57% yield) was obtained as a
yellow oil.
bH (400 MHz, CDCh): 2.02 (3H, s, CH3), 2.29 (3H, s, CH3), 4.79 (2H, br s, NH2), 6.83
(lH, d, J8.0, ArH), 6.97 (lH, t, J7.8, ArH), 7.41 (IH, s, pyrrole-H), 7.75 (lH, t, J7.6, ArH), 7.97
(lH, d, J 8.1, ArH), 10.5 (lH, s, CHO). be (lOOMHz, CDCh): 9.7 (CH3), 10.8 (CH3), 122.1 (CH),
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123.4 (CH), 124.5 (q), 125.6 (q), 128.8 (CH), 130.1 (q), 131.3 (CH), 137.1 (CH), 140.5 (q), 140.9
(q), 180.3 (CHO).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin fil cm"): 3454 (s), 3380 (s), 2967 (m), 2928 (m), 1680 (s), 1600 (s),
1488 (s), 1461 (s), 1357 (m), 1318 (m), 1232 (m), 1216 (m), 1165 (s), 1130 (s), 1049 (s), 1033 (s),
839 (m), 755 (s), 710 (m), 668 (s), 587 (m). ES+mass spectrum (rn/z, %): 279 ([M+Ht, 30%),
250 (10%), 185 (5%), 156 (35%), 122 (5%), 108 (25%), 94 (83%). HRMS (ESI+):Found [M+Ht
279.0821, Cl3HISN203S requires 279.0819.
N-[o-{N',N'-dimethylformamidinyl)benzenesulfonyl] Jormylpyrrole (471; 0.074 g, 43%
yield) was obtained as pale yellow oil.
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Experimental- Part IV
7.4.1 Synthesis of 2-amino-N-(but-3-enyl)benzenesulfonamidezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
402a: Rl=R2=H
402b: Rl=H, R~Me
402c: Rl=R2=Me
480a: RI=R2=H
480b: Rl=H, R2=Me
480c: RI=R2=Me
A stirring solution the of 2-(2-aminobenzenesulfonyl)-3,6-dihydro-1 ,2-thiazine l-oxide
(402a-c; 1.0 eq) in aqueous hydrochloric acid! tetrahydrofuranzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(l :I; -10-20 ml) was heated un er
reflux for 3 hrs. On cooling the mixture was washed with brine (l0 ml) and extracted with ethyl
acetate (3x 10 ml). The organic phase was dried over anhydrous MgS04, filtered under gravity
and the volatiles were removed in vacuo. The crude residual product was purified by flash silica
column chromatography (eluent: PE:EtOAc/ 3:2). The 2-amino-N-(but-3-enyl)benzenesulJon-
amides were obtained as follows:
2-Amino-N-(but-3-enyl)benzenesulJonamide (480a) was obtained as a pale yellow oil
(0.470 g, 47% yield) from 2-(2-aminobenzenesulfonyl)-3,6-dihydro-l ,2-thiazine l-oxide (402a;
1.050 g, 3.855 mmol).
bH (400 MHz, CDCh): 2.13 (2H, q,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.5, CH2), 2.92 (2H, q, J 6.5, NCH2), 4.67 (2H, s, br,
NH2), 5.01 (2H, d, J 10.9, =CH2), 5.18 (IH, t, J 6.1, -cui, 5.60 (lH, ddd, J 17.0, 9.9, 3.3, Nl!),
6.75 (2H, m, 2x Arl!), 7.28 (IH, t, J 7.8, Arl!), 7.67 (lH, d, J 7.8, Arl!). be (lOO MHz, CDCb):
31.9 (CH2), 42.0 (CH2), 117.7 (CH), 117.8 (CH), 117.9 (CH2), 123.0 (q), 129.0 (CH), 132.7 (CH),
133.1 (CH), 144.5 (q). Vmax (thin film cm"): 3479 (s), 3378 (s), 3298 (s, br), 2978 (m), 2939 (m),
1621 (s), 1600 (s), 1568 (s), 1484 (s), 1455 (s), 1318 (s), 1154 (s), 1076 (s, br), 1028 (m), 992 (m),
920 (s), 755 (s), 696 (s), 657 (s). ES+ mass spectrum (m/z, %): 226 ([M+], 35%), 214 (15%), 187
(4%), 157 (9%), 108 (24%), 92 (7%), 80 (10%). HRMS (ESI+): found [M+Ht 227.0825,
CIOHISN202Srequires 227.0824.
2-Amino-N-(3-methylbut-3-enyl)benzenesulJonamide (480b) was obtained as pale yellow
oil (0.270 g, 51% yield) from 2-(2-aminobenzenesulfonyl)-3,6-dihydro-5-methyl-I,2-thiazine 1-
oxide (402b; 0.630 g, 2.201 mmol).
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OH (400 MHz, CDCh): 1.52 (3H, s, CH3), 2.05 (2H, t,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.9, NHCH2CH2), 2.93 (2H,
quartet, J 6.6, NHCH2), 4.60 (IH, s, =CH-H), 4.71 (lH, s, =CH-H), 5.00 (2H, s, br, NH2), 5.22
(lH, t, br, J 6.1, NH), 6.70 (IH, t, J 7.7, ArH), 6.75 (lH, d, J 8.1, ArH), 7.24 (lH, td, J 7.7, 1.5,
ArH), 7.64 (IH, dd, J 8.0, 1.3, ArH). Oc (lOOMHz, CDCh): 21.4 (CH3), 36.6 (CH2), 40.4 (CH2),
112.4 (CH2), 116.9 (CH), 117.4 (CH), 120.5 (q), 129.1 (CH), 133.8 (CH), 141.3 (q), 145.1 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Vmax (thin film ern"): 3477 (s), 3376 (s, br), 3285 (s, br), 2961 (s), 2933 (s), 2872 (m), 1620 (s),
1599 (s), 1568 (s), 1483 (s), 1455 (s), 1319 (s, br), 1154 (s, br), 1092 (s), 1043 (s), 910 (s), 840
(m), 755 (s), 733 (s), 697 (m). ES+ mass spectrum (m/z, %): 241 ([M+Ht, 12%), 240 ([~],
80%),227 (5%), 186 (5%), 156 (25%), 108 (16%), 93 (5%), 80 (l3%), 65 (4%). HRMS (ESI+):
found [M+Ht 241.1036, CllH17N202S requires 241.1040.
2-Amino-N-(2,3,-dimethylbut-3-enyl)benzenesulfonamide (480c) was obtained as yellow oil
(0.280 g, 58% yield) from 2-(2-aminobenzenesulfonyl)-3,6-dihydro-4,5-dimethyl-l ,2-thiazine 1-
oxide (402c; 0.570 g, 1.897 mmol).
OH (400 MHz, CDCh): 0.95 (3H, d, J 6.9, CH3), 1.53 (3H, s, CH3), 2.25 (IH, sextet, J 7.0,
CH), 2.73 (IH, ddd, J 13.0, 8.8,4.3, CH-H), 2.90 (IH, ddd, J 12.5, 7.5, 2.1, CH-H), 4.71 (2H, s,
br, =CH2), 4.82 (IH, s, br, NH), 4.86 (2H, s, br, NH2), 6.78 (UI, d, J 8.1, ArH), 6.82 (IH, t, J 7.6,
ArH), 7.34 (lH, td, J 8.4, 1.4, ArH), 7.71 (IH, dd, J 8.0, 1.4, ArH). Oc (100 MHz, CDCh): 16.8
(CH3), 18.6 (CH3), 40.5 (CH), 46.2 (CH2), 112.5 (CI-h), 117.6 (CH), 117.7 (CH), 121.3 (q), 129.6
(CH), 134.1 (CH), 145.0 (q), 146.0 (q). Vmax (thin film cm"): 3476 (br, s), 3378 (br, s), 2974 (m),
2922 (m), 1621 (s), 1600 (s), 1484 (s), 1455 (s), 1319 (s), 1144 (s), 1088 (s), 1027 (s), 911 (s), 755
(s), 735 (s). ES+ mass spectrum (m/z, %): 255 ([M+Ht, 5%), 254 ([~], 12%), 253 (69%), 227
(4%), 187 (5%), 139 (6%), 80 (11%). HRMS (ESI+): found [M+Ht 255.1137, CI2HI9N202S
requires 255.1136.
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7.4.2 Synthesis of aziridino 1,2,6-benzothiadiazocine l,l-dioxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
480a: RI=R2=H
480b: R1=H, R2=Me
480c: RI=R2=Me
496a: RI=R2=H
496b: R'=H, R2=Me
496c: RI=R2=Me
To a stirred mixture of the 2-amino-N-(but-3-enyl)benzenesulfonamides (480a-c; 1.0 eq)
and sodium hydrogen carbonate (0.159-0.336 g, 3.0 eq) in anhydrous acetonitrile (-10 ml) was
added finely powdered iodine (0.479-1.014 g, 3.0 eq) portionwise at ambient temperature. The
resulting mixture was further stirred until cyclisation was complete according to TLC analysis.
The mixture was quenched with saturated aqueous sodium thiosulfate, which was added until
decolorisation occurred, and the resulting mixture was extracted with dichloromethane (3 x 10 ml).
The combined organic extracts were dried over anhydrous MgS04, filtered and the solvent
evaporated in vacuo to give a crude product which was purified by flash column chromatography
(eluent: PE:EtOAcl 3:2). The aziridino 1,2,6-benzothiadiazocine-I,1-dioxides were obtained as
follows:
Aziridino-ti-methyl-lZ, ti-benzothtadiazoctne-I, l-dioxide (496b) was obtained as yellow oil
(0.161 g, 49% yield) from 2-amino-N-(3-methylbut-3-enyl)benzenesulfonamide (480b; 0.320 g,
1.332 mmol).
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.35 (3H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH3), 1.51 (lH, t, 11.2, NHCH-H), 2.02 (lH, ddd, J
8.4, 5.9, 2.5, CH3CCH-H), 2.11 (IH, s, aziridino CH), 2.31 (IH, s, aziridino Cll), 3.34 (lH, m, br,
CH3CCH-H), 3.80 (lH, m, br, NHCH-H), 5.25 (lH, t, J 6.2, NH), 6.85 (IH, d, J 7.9, Arll), 6.98
(lH, t, J 7.3, ArH), 7.34 (lH, td, J 8.4, 1.4, Arlf), 7.82 (lH, dd, J 7.9, 1.3, ArH). be (100 MHz,
CDCb): 20.2 (CH3), 35.8 (CH2), 39.2 (CH2)' 40.2 (CH2), 44.0 (q), 121.7 (CH), 122.0 (CH), 128.6
(CH), 133.0 (CH), 135.0 (q), 147.8 (q). Vmax (thin film ern"): 3101 (s), 3021 (m), 2990 (m), 2953
(m), 2896 (m), 1591 (s), 1566 (s), 1472 (s), 1439 (m), 1418 (m), 1382 (m), 1363 (m), 1333 (s),
1285 (m), 1258 (s), 1216 (s), 1158 (s), 1109 (s), 1069 (m), 1048 (m), 995 (m), 935 (m), 878 (s),
866 (s), 758 (s, br), 702 (s), 669 (s). ES+ mass spectrum (m/z, %): 241 (6%), 240 (15%), 239
([M+Ht, 100%), 192 (9%), 156 (6%), 123 (5%), 84 (6%), 59 (7%), 58 (72%). HRMS (ES+):
found [M+Ht 239.0845, CIIHISN202S requires 239.0849.
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Aziridino-4, 5-dimethyl-l,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2,6-benzothiadiazocine-l, I-dioxide (496c) was obtained as
yellow oil (0.048 g, 30% yield) from 2-amino-N-(2,3-dimethylbut-3-enyl)benzenesulfonamide
(480c; 0.160 g, 0.629 mmol)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
bH (400 MHz, CDCh): 0.74 (3H, d, J7.0, CHCH3), 0.93 (3H, s, CCH3), 2.01 (lH, sextet, J
7.2, CHCH3), 2.24 (lH, s, aziridino CH), 2.40 (lH, s, aziridino CH), 3.26 (2H, m, br, NHCH2),
6.96 (lH, d, J8.0, ArH), 7.07 (lH, t, J7.6, ArH), 7.43 (lH, t, J8.2, ArH), 7.67 (lH, m, NH), 7.76
(lH, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 7.7, ArH). be (100 MHz, CDCh): 14.9 (CH3), 22.0 (CH3), 35.3 (CH2), 35.7 (CH), 47.5
(q), 48.0 (CH2), 120.0 (q), 120.6 (CH), 121.8 (CH), 129.2 (CH), 132.4 (CH), 146.9 (q). Vmax (thin
film cm"): 3317 (s), 3068 (m), 3020 (m), 2968 (m), 2935 (m), 1587 (s), 1471 (s), 1421 (s), 1381
(s), 1342 (m), 1313 (s), 1278 (m), 1215 (s), 1]54 (s), ]] 16 (m), 1094 (m), 1076 (s), 1035 (m), 934
(m), 852 (m), 827 (s), 756 (s), 693 (m), 668 (m), 600 (m). ES+ mass spectrum (m/z, %): 255
(6%), 254 (14%), 253 ([M+Ht, 100%), 188 (5%), 185 (34%), 98 (3%), 69 (4%), 59 (45%).
HRMS (ES+): found [M+Ht 253.1006, C12H17N202Srequires 253.1005.
7.4.3 Synthesis of 2-azido-N-(but-3-enyl)benzenesulfonamides
crO~lNriRI R2 aq. HCI/THFzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA~_/ d,4h ..Ii
N3zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA0
400a: RI=R2=H
400b: RI=H, R2=Me
400e: RI=R2=Me
RI
d~~'t-R'
N3
SOla: RI=R2=H
50tb: RI=H, R2:Me
SOle: RI=R2:Me
A stirring solution of the 2-(2-azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine ]-oxide
(400a-c; l.0 eq) in aqueous hydrochloric acidl tetrahydrofuran (1:1; -10-20 ml) was heated under
reflux for 3 h. On cooling the mixture was washed with brine (10 ml) and extracted with ethyl
acetate (3x 10 ml). The organic phase was dried over anhydrous MgS04, filtered under gravity
and the volatiles were removed in vacuo. The crude residual product was purified by flash silica
column chromatography (eluent: PE:EtOAcl 3:2). The 2-azido-N-(but-3-enyl)benzenesulJon-
amides were obtained as follows:
2-Azido-N-(but-3-enyl)benzenesulJonamide (SOla) was obtained as pale yellow oil (0.108
g, 71% yield) from 2-(2-azidobenzenesulfonyl)-3 ,6-dihydro-] ,2-thiazine l-oxide (400a; 0.183 g,
0.613 mmol).
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t5H (400 MHz, CDCh): 2.12 (2H, q, J 6.7, CH2), 2.97 (2H, q, J 6.5, NCH2), 5.07 (2H, d, J
11.1, =CH2), 5.18 (lH, t, J 5.9, =CH), 5.65 (IH, ddd, J 17.2, 10.3, 3.4, NH), 7.24 (lH, t, J 7.7,
ArH), 7.30 (IH, d, J 8.1, ArH), 7.61 (lH, t, J 7.7, ArH), 7.96 (IH, d, J 7.9, ArH). t5c (lOO MHz,
CDCh): 33.4 (CH2), 42.3 (CH2), 117.8 (CH2), 119.3 (CH), 124.7 (CH), 129.6 (q), 120.5 (CH),
133.9 (CH), 134.2 (CH), 137.4 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin fil ern"): 3368 (s), 2934 (m), 2134 (s), 1620 (s),
1599 (s), 1565 (s), 1483 (s), 1455 (s), 1437 (s), 1318 (s), 1154 (s), 1089 (s), 1028 (m), 996 (m),
908 (s), 755 (s), 694 (s). ES+ mass spectrum (mlz, %): 253 ([M+Ht, 8%), 252 ([~], 40%), 224
(5%), 198 (7%), 183 (11%), 104 (20%), 90 (25%), 80 (3%). HRMS (ESI+): found [M+Ht
253.0761, CIOH13N402Srequires 253.0759.
2-Azido-N-(3-methylbut-3-enyl)benzenesuljonamide (50Ib) was obtained as pale yellow oil
(0.325 g, 81% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-5-methyl-l ,2-thiazine I-oxide
(400b; 0.471 g, 1.508 mmol).
t5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.52 (3H, s, CH3), 2.12 (2H, t, J 6.8, NHCH2CH2), 2.94 (2H,
quartet, J6.5, NHCH2), 4.62 (lH, d, JO.9, =CH-H), 4.75 (IH, d, J 1.4, =CH-H), 5.21 (lH, t, br, J
5.9, NH), 7.19 (IH, td, J 7.9, 1.0, ArH), 7.24 (IH, dd, J 8.1, 0.9, ArH), 7.55 (IH, td, J 7.7, 1.2,
ArH), 7.89 (lH, dd, J 7.8, 1.5, ArH). t5c(100 MHz, CDCh): 21.3 (CH3), 36.7 (CH2), 40.5 (CH2),
112.4 (CH2), 119.1 (CH), 124.4 (CH), 129.3 (q), 130.2 (CH), 133.8 (CH), 137.2 (q), 141.4 (q).
Vmax (thin film cm"): 3308 (s, br), 2937 (s, br), 2135 (s), 1650 (m), 1575 (s), 1472 (s), 1445 (s),
1332 (s), 1164 (s), 1126 (m), 1066 (s), 897 (s), 820 (s), 759 (s), 652 (s). Cl+(NH3) mass spectrum
(mlz, %): 284 (23%), 267 ([M+Ht, 7%), 259 (13%), 258 (100%), 256 (28%), 241 (90%), 239
(63%),202 (18%), 190 (48%), 173 (41%), 94 (56%),84 (76%). HRMS (EI+): found 266.0837,
CIIHI4N402S requires 266.0837.
2-Azido-N-(2,3-dimethylbut-3-enyl)benzenesuljonamide (50Ie) was obtained as yellow oil
(0.575 g, 78% yield) from 2-(2-azidobenzenesulfonyl)-3,6-dihydro-4,5-dimethyl-l ,2-thiazine' 1-
oxide (400e; 0.860 g, 2.635 mmol).
t5H (400 MHz, CDCh): 1.00 (3H, d, J6.9, CH3), 1.56 (3H, s, CH3), 2.35 (tH, sextet, J7.0,
CH), 2.73 (tH, ddd, J 12.6, 9.0, 4.3, CH-H), 2.94 (IH, ddd, J 12.4, 7.5, 2.2, CH-H), 4.76 (tH, s,
=CH-H), 4.89 (lH, s, =CH-H), 4.99 (IH, m, br, NH), 7.24-7.35 (2H, m, ArH), 7.63 (IH, td, J 8.8,
1.3, ArH), 8.00 (IH, dd, J 7.9, 1.2, ArH). t5c (lOO MHz, CDCh): 16.9 (CH3), 18.6 (CH3), 40.6
(CH), 46.4 (CH2), 112.3 (CH2), 119.2 (CH), 124.8 (CH), 129.5 (q), 130.8 (CH), 134.0 (CH), 137.5
(q), 146.1 (q). Vmax (thin film cm"): 3305 (w, br), 2925 (s, br), 2133 (s), 1612 (m), 1575 (m), 1471
(s), 1445 (m), 1332 (s), 1289 (m), 1264 (s), 1164 (s), 1066 (m), 895 (s), 819 (m), 733 (s). ES+
mass spectrum (m/z, %): 281 ([M+Ht, 72%), 253 (39%), 224 (9%), 188 (24%), 183 (100%), 174
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(14%), 156 (6%), 108 (23%), 92 (46%). HRMS (EI+): found 281.1026, C12H17N4zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA02S requires
266.1026.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.4.4 Synthesis ofpyrrolo-l,2,4-benzothiadiazine l,l-dioxides
SOla: RI=R2=H
50lb: RI=H, R2=Me
SOle: RI=R2=Me
516a: RI=R2=H
517b: RI=H, R2=Me
517e: RI=R2=Me
A solution of 2-azido-N-(but-3-enyl)benzenesulfonamide (501a-c; 1.0 eq) in
dimethylformamide (~5-15 ml) was heated under reflux for 2-3 hrs. On cooling, the solvent was
removed in vacuo and the crude product was purified by flash column chromatography (eluent:
PE:EtOAc/3:2). Thepyrrolo-i,2,4-benzothiadiazine l.l-dioxides were obtained as follows:
Pyrrolo-lZvt-benzothiadiazine l.l-dioxide (516a) was obtained as a yellow oil (0.017 g,
18% yield) from 2-azido-N-(but-3-enyl)benzenesulfonamide (SOla; 0.103 g, 0.407 mmol).
bH (400 MHz, CDCb): 1.91-2.01 (lH, m, CH-H), 2.09-2.24 (2H, m, CH2), 2.26-2.41 (lH,
m, CH-H), 3.16-3.23 (lH, m, CHCH-H), 3.45-3.61 (lH, m, CHCH-H), 4.28 (lH, s, CH), 5.47
(lH, d, J 4.4, NH), 6.62 (IH, d, J8.3, ArH), 6.81 (lH, t, J7.5, ArH), 7.28 (IH, t, J7.8, ArH), 7.65
(IH, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 7.9, ArH). be (100 MHz, CDCb): 21.7 (CH2), 33.6 (CH2), 46.9 ( H2), 71.2 (CH), 115.4
(CH), 117.4 (q), 118.1 (CH), 125.3 (CH), 133.4 (CH), 142.3 (q). Vmax (thin film ern"): 3371 (br,
m), 3269 (br, w), 2922 (s), 1599 (m), 1482 (s), 1453 (s), 1317 (s), 1242 (s), 1153 (s), 1101 (m),
1047 (m), 986 (m), 873 (m), 760 (s). ES+ mass spectrum (m/z, %): 225 ([M+Ht, 96%), 214
(8%),188 (27%),174 (16%),156 (9%),118 (27%),92 (17%),85 (16%), 70 (12%). HRMS (ES+):
found [M+Ht 225.0689, CIOH13N202S requires 225.0692.
Pyrrolo-lZi-t-benzothiadiazine Ll-dioxide (517b) was obtained as yellow oil (0.076 g,
45% yield) 2-azido-N-(3-methylbut-3-enyl)benzenesulfonamide (501b; 0.190 g, 0.713 mmol).
bH (400 MHz, CDCh): 1.78 (3H, s, CH3), 1.85-2.03 (2H, m, CH3CCH2), 2.04-2.10 (lH, m,
CH-H), 2.17-2.27 (lH, m, CH-H), 3.37 (IH, ddd, J 15.4, 9.7, 4.0, CH-H), 3.67 (1H, ddd, J 14.7,
10.0,3.7, CH-H), 4.56 (lH, s, NH), 6.63 (lH, d, J 8.3, ArH), 6.78 (lH, t, J7.7, ArH), 7.25 (IH, t,
J 8.5, ArH), 7.62 (IH, d, J 7.9, ArH). be (lOO MHz, CDCh): 19.9 (CH2), 26.9 (CH3), 42.5 (CH2),
50.9 (CH2), 79.0 (q), 115.8 (CH), 117.8 (CH), 125.3 (CH), 133.2 (CH), 142.0 (q), 145.0 (q). Vmax
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(thin film ern"): 3364 (s), 2930 (s), 1674 (m), 1606 (s), 1576 (m), 1502 (s), 1484 (s), 1451 (s),
1324 (s), 1260 (m), 1216 (m), 1159 (s), 1071 (m), 1037 (m), 982 (m), 911 (m), 750 (m). ES+
mass spectrum (m/z, %): 240 (15%), 239 ([M+H]\ 100%),237 (19%), 214 (7%), 185 (6%), 85
(6%), 84 (68%), 74 (13%). HRMS (ES+): found [M+Ht 239.0850, CIIHISN202S requires
239.0849.
Pyrrolo-i,2,4-benzothiadiazine i,l-dioxide (S17c) was obtained as yellow oil (0.076 g,
45% yield) 2-azido-N-(2,3-dimethylbut-3-enyl)benzenesulfonamide (SOlc; 0.130 g, 0.464 mmol).
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.73 (3H, s, CH3), 1.78 (3H, s, CH3), 1.88 (lH, dd, J 12.9, 10.2,
CH3CH-HCH3), 2.21 (1H, dd, J 13.0,7.1, CH3CH-HCH3), 2.41-2.48 (1H, m, CH3CHCH2N), 3.23
(1H, dd, J 10.3,7.0, NCH-H), 3.58 (lH, t, J 10.0, NCH-H), 4.56 (lH, s, NH), 6.61 (IH, d, J 8.3,
ArH), 6.76 (tH, t, J 7.9, ArH), 7.24 (lH, td, J 8.4, 1.3, ArH), 7.68 (lH, dd, J 8.0, 1.3, ArH). be
(lOO MHz, CDCh): 18.6 (CH3), 27.2 (CH3), 28.3 (CH), 51.0 (CH2), 57.9 (CH2), 79.8 (q), 115.3
(CH), 117.5 (CH), 129.3 (CH), 133.2 (CH), 142.3 (q), 145.0 (q). Vmax (thin film cm"): 3479 (m),
3366 (s), 2965 (s), 2932 (s), 2875 (m), 1707 (m), 1677 (m), 1605 (s), 1484 (s), 1453 (s), 1322 (s),
1261 (m), 1224 (m), 1157 (s), 1072 (m), 1037 (m), 995 (m), 751 (s). ES+ mass spectrum (m/z,
%): 271 (20%),253 ([M+Ht, 100%), 188 (5%), 185 (10%), 173 (11%), 98 (35%), 59 (23%).
HRMS (ES+): found [M+Ht 253.1008, C12H17N202Srequires 253.1005.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.4.5 Synthesis of 2-triphenylphosphoranyl-N-(3-methylbut-3-enyl)benzenesulfon-
amide (502b)
o 0 0
O~II ~ aq. HCIITHF ~II ~
('YS-N'c,JMe Ll,4h ('YI~ S-~ ,r-Me
~- I~ ~.NON
II II
PPh3 PPh3
40th S02h
A stirring solution of the 2-(2-N-(triphenylphosphoranylidene)sulfonyl)-3,6-dihydr0-1,2-
thiazine l-oxide (401b; 0.631 g, 1.154 mmol, 1.0 eq) in aqueous hydrochloric acid/
tetrahydrofuran (1:1; 15 ml) was heated under reflux for 3 hrs. On cooling the mixture was
washed with brine (10 ml) and extracted with ethyl acetate (3x 10 ml). The organic phase was
dried over anhydrous MgS04, filtered under gravity and the volatiles were removed in vacuo. The
crude residual product was purified by flash silica column chromatography (eluent: PE:EtOAcl
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3:2). The 2-triphenylphosphoranyl-N-(3-methylbut-3-enyl)benzenesuljonamide (502b) was
obtained as pale yellow solid (0.478 g, 83% yield).
£5zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCl)): 1.53 (3H, s, CH3), 2.04 (2H, t,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA6.9, NHCH2CH2), 2.93 (2H, m,
NHCH2CH2), 4.40 (2H, s, =CH2), 6.47 (lH, d, J8.2, ArH), 6.66 (IH, s, br, NH), 6.72 (IH, t, J7.S,
ArH), 7.03 (lH, td, J 8.9, 1.6, ArH), 7.40-7.62 (9H, m, 9x ArH), 7.70-7.80 (6H, m, 6x ArH), 7.89
(lH, dd, J8.6, 1.4, ArH). be (lOOMHz, CDCh): 22.1 (CH3), 37.4 (CH3), 41.5 (CH), 111.9 (CH2),
116.5 (CH), 122.0 (CH), 115.3 (CH), 128.9 (q), 129.0 (CH, PPh3), 129.1 (CH, PPh3), 129.6 (q),
129.7 (q), 129.9 (CH), 132.3 (CH), 132.3 (CH), 132.4 (CH, PPh3), 132.5 (CH, PPh3), 132.6 (q),
142.1 (q), 149.1 (q). Vmax (thin film cm"): 3227 (br, m), 3059 (m), 3020 (s), 2973 (m), 2936 (m),
1649 (m), 1585 (s), 1552 (m), 1465 (s), 1438 (s), 1341 (s), 1289 (m), 1216 (s), 1155 (s), 1109 (s),
1064 (m), 1043 (m), 1016 (m), 999 (m), 754 (s). ES+ mass spectrum (m/z, %): 503 (10%), 502
(30%), 501 ([M+Ht, 90%), 279 (8%), 174 (3%), 152 (3%), 85 (5%), 59 (6%). HRMS (ES+):
found [M+Ht 501.1777, C29H30N202PSrequires 501.1760.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.4.6 Synthesis of 2-nitro-N-(but-3-enyl)benzenesulfonamides
O
X-ND-M aq. HCVTHF OX-N. ~M
's ezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA~,4h ... I '-'::: H ;r e
// ..--:;
N020 N02
507a: X=S02
507b: X=CO
508a: X=S02
508b: x=CO
A stirring solution of the 2-(2-nitroaryl)-1,2-thiazine l-oxide (507a or 507b; 1.0 eq) in
aqueous hydrochloric acid/ tetrahydrofuran (1: 1; ~ 10-20 ml) was heated under reflux for 3 h. On
cooling the mixture was washed with brine (l0 ml) and extracted with ethyl acetate (3x 10 ml).
The organic phase was dried over anhydrous MgS04, filtered under gravity and the volatiles were
removed in vacuo. The crude product was purified by flash silica column chromatography (eluent:
PE:EtOAc/3:2). The homoallylic nitro were obtained as follows:
2-Nitro-N-(3-methylbut-3-enyl)benzenesuljonamide (508a) was obtained as pale yellow oil
(0.165 g, 43% yield) from 2-(2-nitrobenzenesulfonyl)-3,6-dihydro-5-methyl-l ,2-thiazine I-oxide
(507a; 0.451 g, 1.422 mmol).
bH (400 MHz, CDCh): 1.63 (3H, s, CH3), 2.25 (2H, t, J 6.7, NHCH2CH2), 3.24 (2H,
quartet, J 6.4, NHCH2), 4.69 (tH, s, =CH-H), 4.82 (tH, s, =CH-H), 5.34 (lH, t, br, J 5.3, NH),
7.74-7.82 (2H, m, ArH), 7.84-7.93 (lH, m, ArH), 8.12-8.18 (IH, m, ArH). be (lOOMHz, CDCI3):
21.6 (CH3), 37.2 (CH2), 41.3 (CH2), 113.4 (CH2), 125.4 (CH), 131.0 (CH), 132.7 (q), 132.8 (CH),
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133.7 (CH), 141.0 (q), 148.0 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVrnax (thin fil ern"): 3281 (br, s), 2928 (m), 1659 (s), 1620 (s),
1562 (s), 1528 (s), 1447 (m), 1348 (s), 1319 (m), 1247 (m), 1144 (s), 1087 (m), 910 (m), 849 (m),
755 (s), 696 (m). ES+ mass spectrumzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(m/z, %): 271 ([M+Ht, 3%), 226 (5%), 202 (15%), 186
(75%), 141 (33%), 92 (10%), 76 (50%). CI+ mass spectrum (m/z, %): 288({M+NH4t, 100%),
271 ([M+Ht, 15%). HRMS (EI+): found [M+Ht 271.0719 CIIHISN204S requires 271.0722.
2-Nitro-N-(3-methylbut-3-enyl)benzamide (508b) was obtained as yellow oil (0.127 g, 51%
yield) from 2-(2-nitrobenzeneamide )-3,6-dihydro-5-methyl-l ,2-thiazine l-oxide (507b; 0.301 g,
1.070 mmol).
bH (400 MHz, CDCh): 1.78 (3H, s, CH3), 2.35 (2H, t, J 6.8, CH2CH2NH), 3.58 (2H, quart,
J 6.9, CH2NH), 4.79 (IH, s, MeC=CH2), 4.85 (tH, s, MeC=CH2), 6.00 (lH, s, br, NH), 7.49 (lH,
dd, J 7.5, 1.5, ArH), 7.56 (tH, td, J 7.8, 1.5, ArH), 7.65 (lH, td, J 7.5, 1.3, ArH), 8.03 (tH, dd, J
8.1, 1.1, ArH). be (100 MHz, CDCh): 21.9 (CH3), 36.9 (CH2), 37.6 (CH2), 112.5 (CH2), 124.5
(CH), 128.7 (CH), 130.3 (CH), 133.0 (q), 133.6 (CH), 142.3 (q), 146.5 (q), 166.3 (q, CONH). Vrnax
(thin film cm"): 3278 (bs), 3089 (m), 2939 (m), 1682 (s), 1660 (s), 1562 (s), 1528 (s), 1447 (m),
1348 (s), 1318 (m), 1247 (m), 1077 (m), 915 (m), 859 (m), 756 (s), 669 (m). ESI+ mass spectrum
(m/z, %): 257 ([M+Nat, 20%), 235 ([M+Ht, 60%).
7.4.7 Synthesis of N-(2-nitrobenzoyl)-3-iodo-3-methylpyrrolidine
f\__ NaHC03 .~
~x-~ rMe I2,MeCN ~X-N~ .. 1
~. ~. Me
N02 N02
508a: X=S02 509a: X=S02
508b: X=CO 509b: X=CO
To a stirred mixture of the 2-nitro-N-(but-3-enyl)benzamide (508a or 508b; ].0 eq) and
sodium hydrogen carbonate (0.226-0.326 g, 3.0 eq) in anhydrous acetonitrile (-10 ml) was added
finely powdered iodine (0.682-0.986 g, 3.0 eq) portionwise at ambient temperature. The resulting
mixture was further stirred until cyclisation was complete according to TLC analysis. The mixture
was then quenched with saturated aqueous sodium thiosulfate, which was added until
decolorisation occurred, and the resulting mixture was extracted with dichloromethane (3 x 10 ml).
The combined organic extracts were dried over anhydrous MgS04, filtered and the solvent
evaporated in vacuo to give a crude product which was purified by flash column chromatography
(eluent: PE:EtOAcl 3:2). The 3-iodo-3-methyl pyrrolidine were obtained as follows:
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N-(2-nitrosulfonyl)-3-iodo-3-methylpyrrolidinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(509a) was obtained as yellow oil (0.270 g,
53% yield) from 2-nitro-N-(3-methylbut-3-enyl)benzenesulfonamide (508a; 0.350 g, 1.295 mmol).
OH (400 MHz, CDCh): 1.27 (3H, s, CH3), 1.80 (lH, m, ICCH3CH-H), 1.97 (lH, m,
ICCH3CH-H), 3.18 (IH, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 10.0, NCH-H), 3.29 (lH, d, J 10.0, NCH-H), 3.59 (lH, m, NCH-
HCH2), 3.84 (lH, m, NCH-HCH2), 7.81 (3H, m, 3x ArH), 8.13 (lH, d, J7.0, ArH). Oc (lOOMHz,
CDCh): 19.6 (CH2), 25.1 (CH3), 31.8 (CH2), 42.4 (CH2), 52.7 (q), 125.0 (CH), 131.1 (CH), 132.3
(CH), 133.2 (q), 134.6 (CH), 146.8 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin film ern"): 2934 (s), 2914 (m), 1590 (s), 1578
(s), 1532 (s, br), 1440 (s), 1367 (s, br), 1315 (s), 1253 (m), 1175 (m), 1122 (s), 1084 (s), 1025 (m),
990 (m), 853 (s), 756 (m), 659 (m), 626 (m).
N-(2-nitrobenzoyl)-3-iodo-3-methylpyrrolidine (509b) was obtained as yellow oil (0.295 g,
91% yield) from 2-nitro-N-(3-methylbut-3-enyl)benzeneamide (508b; 0.210 g, 0.896 mmol).
OH (400 MHz, CDCh): 1.46 (3H, s, CH3), 1.83 (IH, dt, J 13.8, 5.9, ICCH3CH-H), 2.06
(IH, dt, J 13.9, 6.3, ICCH3CH-H), 3.27 (IH, d, J 10.5, NCH-H), 3.34 (lH, d, J 10.5, NCH-H),
3.53 (2H, t, J 6.1, NCH2), 7.47 (IH, t, J 7.7, ArH), 7.55 (IH, t, J 7.5, ArH), 7.67 (lH, d, J 7.6,
ArH), 7.75 (IH, d, J 8.0, ArH). Oc (lOO MHz, CDCh): 13.3 (CH2), 24.8 (CH3), 29.8 (CH2), 40.8
(CH2), 75.6 (q), 123.5 (CH), 129.3 (q), 130.1 (CH), 130.4 (CH), 132.2 (CH), 148.5 (q), 153.7 (q).
Vmax (thin film cm"): 2980 (s), 2934 (s), 2865 (s), 1733 (m), 1668 (s, br), 1611 (s), 1578 (s), 1532
(s, br), 1445 (s), 1356 (s, br), 1300 (s), 1253 (m), 1122 (s), 1084 (s), 1025 (m), 913 (m), 859 (s),
784 (s), 761 (m), 722 (s), 701 (s), 679 (m), 648 (m). ES+ mass spectrum (m/z, %): 362 (l5%),
361 ([M+Ht, 100%),235 (10%), 211 (4%), 179 (l5%), 150 (17%). HRMS (ES+): found [M+Ht
361.0040, CI2HI4N203I requires 361.0044.
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Experimental-Part V
7.5.1 Synthesis of N-Fmoc protectedzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBApyrrolidine-z-methanol'P
Fmoc-Cl
NaHC03zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~OH _D_CM__:,_r,t.,~OH
N N
I I
H FmoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
522 523
To a solution of the (S)-prolinol (522; 2.00 g, 19.773 mmol, 1.0 eq) in anhydrous
dichloromethane (30 ml) was added sodium hydrogen carbonate (3.500 g, 41.522 mmol, 2.1eq)
and 9-fluorenylmethyl chloroformate (5.00 g, 41.522 mmol, 2.1 eq) under an atmosphere of dry
nitrogen. The reaction mixture was stirred at ambient temperature for 12 hrs, and distributed
between dichloromethane/water (1: 1; 30 ml) and extracted with dichloromethane (3x 15 ml), dried
over MgS04, and filtered under gravity. Evaporation of the solvent gave the crude product as a
orange oil, which was purified by flash chromatography (eluent: PE:EtOAcl 3:2) to yield N-Fmoc
protected pyrrolidine-2-methanol (523; 5.263 g, 82% yield) as a colourless oil.
bH (400 MHz, CDCh): 1.63-2.00 (4H, m, CHCH2CH2), 3.00 (lH, s, br, Ol!), 3.30-3.52
(2H, m, CHCH20H), 3.60-3.70 (2H, m, NCH2), 3.99 (IH, m, CHCH20H), 4.22 (1H, t,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 6.8,
Fmoc Cl!), 4.35-4.60 (2H, m, Fmoc CH2), 7.32 (2H, t, J7.4, 2x Arl!), 7.40 (2H, t, J7.3, 2x Arl!),
7.60 (2H, d, J7.2, 2x Arl!), 7.75 (2H, d, J7.4, 2x Arl!). be (100 MHz, CDCh): 23.6 (CH2), 28.0
(CH2), 46.8 (CH2), 46.9 (CH), 60.1 (CH), 65.5 (CH2), 67.1 (CH2), 119.6 (2x CH), 124.5 (2x CH),
126.7 (2x CH), 127.4 (2x CH), 140.9 (q), 143.6 (q), 143.7 (q), 154.8 (q), 156.3 (q). Vmax (thin film
cm"): 3428 (br, s), 2953 (s), 2879 (s), 1682 (s), 1418 (s), 1356 (s), 1246 (s), 1194 (s), 1049 (s),
985 (m), 908 (s), 878 (m), 759 (s), 739 (s), 647 (s).
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7.5.2 Synthesis of N-Fmoc protected (S)-prolinal
Dess-Martin
period inane
r=; ,H DCM,r.t. ~
"",~OH --_ 0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN N c-:
I I
Fmoc FmoczyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
524523
To a solution of N-Fmoc protected (S)-prolinol (523; 0.863 g, 2.669 mmol, 1.0 eq) in
anhydrous dichloromethane (5 ml) was added finely powdered Dess-Martin periodinane (1.245 g,
2.935 mmol, 1.1 eq) at ambient temperature under an atmosphere of dry nitrogen for 1 h.
Evaporation of the solvent gave a residue, which was purified by flash column chromatography
(eluent PE:EtOAc/ 3:2). The N-Fmoc protected (S)-prolinal (524) was obtained as yellow oil
(1.653 g, 92% yield).
£5H (400 MHz, CDCh): 1.75-2.01 (2H, m, CH2CHCHO), 2.02 (2H, m, NCH2CH2), 3.55
(2H, m, NCH2), 4.02/4.21 (IH, 2x t, J 6.1, Fmoc CH), 4.25-4.37 (IH, m, CHCHO), 4.39-4.60 (2H,
m, Fmoc CH2), 7.30-7.45 (2H, m, 2x ArH), 7.50-7.70 (2H, m, 2x ArH), 7.73-7.85 (2H, m, 2x
ArH), 9.25/9.58 (1H, 2x s, CHO). £5c (100 MHz, CDCh): 23.5/24.4 (CH2), 26.5/27.7 (CH2), 46.6
(CH2), 47.1 (CH), 64.7/65.1 (CH), 67.2/67.4 (CH2), 119.9 (2x CH), 124.6 (CH), 124.7 (CH), 124.9
(CH), 125.0 (CH), 127.0 (CH), 127.6 (CH), 141.1 (q), 141.2 (q), 143.6 (q), 143.8 (q), 1541155.2
(q), 199.7/199.8 (q). Vmax (thin film ern"): 2980 (s), 2884 (s), 2812 (m), 2714 (w), 1736 (s), 1702
(s), 1580 (m), 1478 (m), 1451 (s), 1418 (s), 1372 (m), 1355 (s), 1243 (s), ] 187 (m), 1124 (s), 1047
(s), 992 (m), 760 (s), 741 (s). El+ mass spectrum (m/z, %): 322 ([M+Ht, 26%), 282 (16%), 180
(15%), 179 (100%), 158 (43%), 144 (23%), 142 (13%), 114 (44%), 89 (70%), 59 (10%). HRMS
. +(ESI+): found [M+H] 322.1434 C20H20N03requires 322.1433.
7.5.3 Synthesis of (2S)-N-(9'-fluorenylmethoxycarbonyl)-pyrrolidine-2-ethene
~O
I
Fmoc
524
Ph3P=CH2
THF
-78°C to r.t. n ,H
---"N~
I
Fmoc
525
To a stirring suspension of methyltriphenyl phosphonium bromide (0.709 g, 1.985 mmol) in
anhydrous THF (15 ml) was added n-BuLi (1.6 M solution in hexane, 1.24 ml, 1.985 mmol,)
]9]
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dropwise at -78°C under an atmosphere of dry nitrogen. Stirring of the reaction mixture was
continued for a further 30 minutes at _lOoC, followed by dropwise addition of a solution N-Fmoc-
(Sj-prolinal (524; 0.581 g, 1.808 mmol) in anhydrous THF (8 ml) and the whole reaction mixture
was allowed to stir at ambient temperature for 4 hr. The reaction mixture was quenched with
saturated ammonium chloride solution (20 ml) and extracted with ethyl acetate (2x 20 ml). The
organic phase was collected, dried (MgS04), filtered and the solvent was removed in vacuo and
the crude product was purified by flash column chromatography (eluent: PE:EtOAc/ 2:3) to yield
the (28)-N-(9' -fluorenylmethoxycarbonyl)-pyrrolidine-2-ethene as a mixture of rotamers (525;
0.182 g, 31 % yield) in the form of a yellow oil.
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.75-2.14 (4H, m, CHCH2CH2), 3.50 (2H, m, NCH2), 4.15-4.61
(4H, m, CHCH=CH2, Fmoc CH & CH2), 4.90-5.25 (2H, m, =CH2), 5.77 (IH, m, =CH), 7.28-7.36
(2H, m, 2x ArH), 7.37-7.50 (2H, m, 2x ArH), 7.58-7.70 (2H, m, 2x ArH), 7.73-7.85 (2H, m, 2x
ArH). be noo MHz, CDCh): 22.4/23.5 (CH2), 31.2/32.0 (CH2), 46.4/46.7 (CH2), 47.4 (CH),
59.0/59.5 (CH), 66.9 (CH2), 114.11114.3 (CH2), 119.9 (2x CH), 120 (CH), 124.9 (q), 125.1 (2x
CH), 126.9 (2x CH), 127.6 (2x CH), 137.9 (q), 138.3 (q), ]41.3 (q), 144.2 (q). Vmax (thin film cm'
I): 2981 (s), 2882 (m), 2281 (m), 1736 (s), 1663 (s), 1478 (m), 1433 (s), 1378 (s), 1307 (m), 1256
(m), 1182 (m), 1125 (s), 1070 (m), 1027 (m), 915 (m), 743 (s).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.5.4 Synthesis of (S)-(-)-1-ethoxycarbonylpyrrolidine-2-methanol
4MNaOH
n ,H CIC02Et
""T~OHN
BzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
522
To a stirred solution of (S)-prolinol (522; 3.00 g, 29.68 mmol, 1.0 eq) in 4M NaOH (20 ml)
was added ethyl chloroformate (3.4 ml, 38.56 mmol, 1.2 eq) over 10 min at OOCand the mixture
was stirred at the same temperature for 30 min, followed by ambient temperature for further 30
min. The reaction mixture was neutralized with 2M HCI and extracted with dichloromethane (3x
lOml). The extract was dried (MgS04), filtered and the solvent was removed in vacuo. The crude
residue was purified by flash column chromatography (eluent: Pe:EtOAcl 2:3) to yield the (8)-(-)-
l-ethoxycarbonylpyrrolidine-2-methanol (531; 4.80 g, 93% yield) as a thick yellow oil.
Vmax (thin film ern"): 3433 (s, br), 2979 (s), 2880 (s), 1749 (m), 1677 (s), 1425 (s), 1383
(m), 1337 (m), 1265 (m), 1194 (m), 1110 (s), 1052 (m), 908 (m), 773 (s).
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7.5.5 Synthesis of (S)-(-)-1-ethoxycarbonylpyrrolidine-2-carbaldehydezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
n"H OR__[O_]_.n ,R°
"N~ "N~
I I
C02Et C02Et
531 532
Method A
To a stirred solution of (S)-(-)-I-ethoxycarbonylpyrrolidine-2-methanol (531; 3.50 g, 20.20
mmol, 1.0 eq) and triethylamine (20 ml, 141.45 mmol, 7.0 eq) in DMSO (20 ml) and
dichloromethane (2 ml) was added portionwise sulfur trioxide pyridine complex (12.90 g, 80.83
mmol, 4.0 eq) at O°C. The reaction mixture was stirred at O°C for 1 hr and diluted with diethyl
ether (l0 ml). The ethereal solution was washed with brine (l5 ml) and extracted with
dichloromethane (3x IS ml), dried (MgS04), and filtered. The volatiles were removed in vacuo
and the residue was purified by flash column chromatography (eluent: PE:EtOAcl 3:2) to yield the
(S)-(-)-1-ethoxycarbonylpyrrolidine-2-carbaldehyde (532; 2.88 g, 83% yield) as a yellow oil.
Method B
To a solution of (S)-(-)-1-ethoxycarbonylpyrrolidine-2-methanol (531; 3.79 g, 21.88 mmol,
1.0 eq) in anhydrous dichloromethane (40 ml) was added pyridinium chlorochromate (8.02 g,
37.20 mmol, 1.7 eq) and the whole was stirred vigorously for 3 hours under an atmosphere of dry
nitrogen. The dark reaction mixture was quenched with ether (lOO ml) and the supernatant liquid
was removed by decantation. The black tar residue was washed thoroughly with ethyl acetate (3x
30 ml) and the combined organic layers were collected, dried (MgS04), and filtered under gravity.
Evaporation of the solvent gave the crude product as a brown oil, which was purified by flash
chromatography (eluent: PE:EtOAcl 3:2) to yield (S)-(-)-1-ethoxycarbonylpyrrolidine-2-
carbaldehyde (532; 2.10 g, 56% yield) as an yellow oil.
Method C
A solution of oxalyl chloride [2M solution in dichloromethane] (5.2 ml, 10.39 mmol, ].2
eq) in anhydrous dichloromethane (l5 ml) was cooled to -78°C. Following the dropwise addition
of a solution of anhydrous dimethylsulfoxide (l.5 ml, 20.77 mmol, 2.4 eq) in anhydrous
dichloromethane (5 ml), the reaction mixture was stirred for 5 min. A solution of (S)-(-)-I-
ethoxycarbonylpyrrolidine-2-methanol (531; ] .50 g, 8.66 mmol, 1.0 eq) in dichloromethane (5 ml)
was added to the reaction mixture. After 5 min of stirring diisopropylethylamine (7.5 ml, 43.28
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mmol, 5 eq) was added, and the reaction mixture was allowed to warm to ambient temperature for
1 hr. Upon completion the reaction mixture was diluted with diethyl ether/water (l: 1; 10 ml)
mixture and extracted with dichloromethane (3x 15 ml), dried (MgS04), and filtered under gravity.
Evaporation of the solvent gave the crude product as a orange oil, which was purified by flash
column chromatography (eluent: PE:EtOAc/ 3 :2) to yield (S)-(-)-1-ethoxycarbonylpyrrolidine-2-
carbaldehyde (532; 1.13 g, 76% yield) as a yellow oil.
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.09-1.27 (3H, m, CH3), 1.68-2.15 (4H, m, 2x CH2), 3.36-3.57 (2H,
m, CH2), 4.00-4.15 (3H, m, CH2CH3 + Cll), 9.47 (1H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 12.0, CHO). be (lOO MHz, CDCh):
13.9/14.0 (CH3), 23.1123.9 (CH2), 25.9/27.2 (CH2), 45.9/46.4 (CH2), 60.9 (CH2), 64.1164.5 (CH),
154.11154.9 (q), 199.6 (CH). Vrnax (thin film cm"): 2980 (s), 2917 (m), 2849 (m), 1736 (s), 1699
(s, br), 1466 (m), 1420 (s), 1382 (s), 1347 (s), 1266 (s), 1186 (m), 1121 (s), 1022 (m), 772 (s). EI+
mass spectrum (m/z, %): 173 (3%), 172 ([M+Ht, 65%), 142 (30%), 127 (7%), 100 (15%), 99
(90%). HRMS (ESI+): found [M+Ht 172.0943 CgHI4N03 requires 172.0941.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.5.6 Synthesis ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(S)-( -)-2-ethenyl-l-ethoxycarbonylpyrrolidine
Ph3P=CH2
THF
-78°Cto r.t. n.H
---"N~
I
C02EtzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
533
Method A
A suspension ofNaH (60% mineral oil dispersion; 0.201 g, 1.1 eq) in dry hexane (3 ml)
was stirred under an atmosphere of dry nitrogen for 10 min, after which the hexane was removed
by syringe and the sodium hydride was washed in the same manner with three further aliquots of
hexane (3 ml). Anhydrous DMSO (3 ml) was added to the flask containing neat NaH, and the
mixture was heated with stirring at 65-75°C until the evolution of hydrogen ceased. The mixture
was cooled to O°C, and a solution of methyltriphenylphosphonium bromide (2.50 g, 1.1 eq) in
DMSO (8 rnl) was added over 10 min, and the mixture was allowed to warm to ambient
temperature for l~ hr. A solution of (S)-(-)-I-ethoxycarbonylpyrrolidine-2-carbaldehyde (532;
1.10 g, 6.43 mmol, 1.0 eq) in DMSO (5 ml) was added to the above solution and the mixture was
stirred at ambient temperature for 2 hr. Upon completion the reaction mixture was diluted with
water (30 ml) and extracted with hexane (3x 10m]), dried over MgS04 and filtered under gravity.
Evaporation of the solvent gave the crude product as a pale yellow oil, which was purified by flash
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chromatography (eluent: PE:EtOAcl 3:2) to yield the (S)-(-)-2-ethenyl-I-ethoxycarbonyl-
pyrrolidine (533; 0.55 g, 50% yield) as a yellow oil.
Method B
To a stirring suspension of methyltriphenylphosphonium bromide (2.70 g) in anhydrous
THF (20 ml) was added n-BuLi (1.6 M solution in hexane, 7.26 mmol, 4.54 ml) dropwise at -78°C
under an atmosphere of dry nitrogen. Stirring of the reaction mixture was continued for a further
30 minutes at -l O''C, followed by dropwise addition of a solution (S)-(-)-I-ethoxycarbonyl-
pyrrolidine-2-carbaldehyde (532; 1.13 g, 6.60 mmol, 1.0 eq) in anhydrous THF (5 ml) and the
whole reaction mixture was allowed to stir at ambient temperature for 4 hr. The reaction mixture
was quenched with saturated ammonium chloride solution (20 ml) and extracted with ethyl acetate
(2x 20 ml). The organic phase was collected, dried (MgS04), filtered and the solvent was
removed in vacuo and the crude product was purified by flash column chromatography (eluent:
PE:EtOAcl 2:3) to yield the (S)-(-)-2-ethenyl-l-ethoxycarbonyl-pyrrolidine as a mixture of
rotamers (533; 0.55 g, 49 % yield) in the form of a yellow oil.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
t5H (400 MHz, CDCh): 1.24 (3H, m, br, CH3), 1.72 (lH, s, br, CH2CH-HCH2), 1.84 (2H,
m, br, NCHCH2), 2.00 (IH, m, br, CH2CH-HCH2), 3.44 (2H, s, br, NCH2), 4.13 (2H, q, br, OCH2),
4.32 & 4.39 (IH, m, br, NCH), 5.09 (2H, m, =CH2), 5.74 (lH, s, br, =CH). t5c (100 MHz, CDCh):zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
14.0/14.1 (CH3), 22.4/23.3 (CH2), 31.1/31.8 (CH2), 46.1146.3 (CH2), 57.9/58.7 (CH), 60.6 (CH2),
113.7/114.0 (CH2), 138.1/138.4 (CH), 154.6/155.0 (q). Vmax (thin film cm"): 3448 (w), 2981 (s),
2882 (m), 2281 (m), 1736 (s), 1698 (s, br), 1467 (m), 1421 (s), 1382 (s), 1346 (s), 1266 (m), 1173
(m), 1124 (s), 1068 (m), 1023 (m), 912 (m), 772 (s), ES+ mass spectrum (mlz, %): 171 (5%), 170
([M+Ht, 25%), 142 (36%), 127 (17%), 99 (13%), 98 (100%). HRMS (ESI+): found [M+Ht
170.1176, C9HI6N02 requires 170.1176.
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7.5.7 Synthesis of (2S)-1-(2' -azidobenzoyl)-pyrrolidine-2-ethenezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
533zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA526 527
To a vigorously stirred suspension of finely ground KOH (2.59 g, 46.12 mmol, 26 eq) in
ethylene glycol (8 ml) and hydrazine hydrate (0.28 ml, 8.87 mmol, 5.0 eq) under an atmosphere of
dry nitrogen was added (S)-(-)-2-ethenyl-l-ethoxycarbonylpyrrolidine (533; 0.30 g, 1.77 mmol,
1.0 eq), and the mixture was heated under reflux (~195DC) for 4 hr. The reaction mixture was
cooled to ambient temperature and diluted with (lzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAi l ) diethyl e her/water (8 ml) mixture an
extracted with diethyl ether (3x 5 ml), and dried over finely ground NaOH. Triethylamine (0.37
ml, 2.66 mmol, 1.5 eq) was added to the above ethereal solution containing the amine (526) at ODC
under an atmosphere of dry nitrogen and the mixture was stirred for 10 min, followed by a
dropwise addition of a solution of the acid chloride (0.48 g, 2.643 mmol, 1.5 eq) in diethyl ether (5
ml) and the whole reaction mixture was allowed to stir at ambient temperature for 18 hr. The
reaction mixture was diluted with water (20 ml) and extracted with diethyl ether (2x ]0 ml). The
organic phases were combined, dried over MgS04, and filtered under gravity. The volatiles were
removed in vacuo and the crude product was purified by flash column chromatography (eluent:
PE:EtOAc/ 2:3) to yield the (2S)-1-(2 '-azidobenzoyl)-pyrrolidine-2-ethene as a mixture of
rotamers (527; 0.2] g, 49% yield) in the form of a yellow oil.
bH (400 MHz, CDCh): 1.62&1.87 (3H, m, CHrCHH), 1.93&2.05 (1H, m, CH2-CHH),
3.07&3.24 (IH, 2x m, CHH), 3.48&3.69 (lH, 2x m, CHH), 4.00&4.7] (lH, 2x m, br, CH),
4.55&5.22 (lH, 2x d, J 17.0&]7.], =CH-H), 4.77&5.06 (lH, 2x d, J 10.3&10.4, =CH-H),
5.43&5.76 (tH, 2x ddd, J 16.6, ]0.2,4.] & J 16.1,10.4,5.6, =CH), 6.94-7.23 (3H, m, ArH), 7.2]-
7.34 (IH, m, ArH). be (100 MHz, CDCh): 21.6/23.1 (CH2), 30.4/31.8 (CH2), 45.3/47.7 (CH2),
57.9/60.6 (CH), 113.91114.4 (CH2), 118.0 (CH), 124.21124.7 (CH), 127.4/127.7 (CH), 129.2 (q),
129.6/129.8 (CH), 135.5 (q), 136.5/137.1 (CH), 166.31166.9 (q). Vmax (thin film cm"): 2974 (s),
2879 (s), 2128 (s), ]718 (m), ]633 (s, br), 1598 (s), 1578 (m), 1480 (s), 1449 (s), 1415 (s), 1293
(s), 1148 (m), 1089 (m), 1041 (m), 990 (m), 920 (s), 753 (s). ES+ mass spectrum (m/z, %): 243
([M+Ht, 32%), 215 (67%),177 (24%),147 (15%), 146 (50%),120 (57%),118 (13%), 81 (29%),
79 (70%). HRMS (ESI+): found [M+Ht 243.12403, Cl3HlSN40 requires 243.12403.
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7.5.8 Synthesis ofzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAI la-hydroxyl-l I-methyl-pyrrolo[2,1-c] [1,4]benzodiazepine-5-onezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
d<~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN3 \_'HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
527
_D_MF_/_~.. cC;QH
Me
539
A solution of (2S)-N-(2-azidobenzoyl)-pyrrolidine-2-ethene (527; 0.271 g, 1.11 mmol) in
DMF (20 ml) was heated at reflux for 3 hr. The reaction mixture was cooled, and evaporation of
the solvent gave the crude product as an orange oil, which was purified by flash chromatography
(eluent: PE:EtOAcl 3:2) to yield the pyrrolo[2,1-c][1,4]benzodiazepine (539; 0.091 g, 38% yield)
as a pale yellow oil.
t5H (400 MHz, CDCh): 1.52 (3H, s, CH3), 1.91-2.05 (lH, m, CH2), 2.08-2.19 (lH, m, CH2),
2.70 (2H, q,J8.6, 5.0, CH2), 3.18 (lH, td,JI4.5, 3.0, CH2), 4.68 (IH, dt,JlOA, 3.7, CH2), 5.24
(lH, s, Oll), 6.70 (IH, d, J 8.0, Arll), 6.82 (lH, t, J 7.5, Arll), 7.30 (lH, t, J7.8, Arll), 7.89 (IH,
d, J7.8, Arll). t5c (lOO MHz, CDCh): 22.1 (CH3), 22.2 (CH2), 35.6 (CH2), 37.5 (CH2), 75.1 (q),
114.2 (q), 114.7 (CH), 118.8 (CH), 128.6 (CH), 133.9 (CH), 143.3 (q), 163.2 (q), 203.7 (q). Vmax
(thin film ern"): 3315 (br), 3009 (m), 2972 (m), 2929 (m), 2871 (m), 1729 (s), 1628 (s, br), 1507
(s), 1421 (m), 1389 (m), 1319 (m), 1294 (m), 1217 (m), 1158 (m), 1029 (m), lOll (m), 892 (s),
754 (s). E8+ mass spectrum (m/z, %): 253 (25%), 231 (85%), 213 (l9%), 201 (18%), 120
(100%), 112 (17%), 89 (17%), 84 (12%). HRM8 (E81+): found [M+Ht 231.1129, C13HISN202
requires 231.1128.
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7.5.9 Synthesis of aziridinopyrrolobenzodiazepin-5-one (538)zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
0 0 0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAclN8 M,CNrDCM ell.? +elXI fi 'H fi _ H
N3 ~ N H N
H "'H
MezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
527 538 540
Method A
A solution of (2S)-N-(2-azidobenzoyl)-pyrrolidine-2-ethene (527; 0.131 g, 0.541 mmol) in
anhydrous acetonitrile (20 ml) under an atmosphere of dry nitrogen was heated at refluxed for 20
hr. Upon completion (TLC) the reaction mixture was cooled, and evaporation of the solvent gave
the crude product as a yellow oil, which was purified by flash chromatography (eluent: PE:EtOAcl
3:2) to yield the aziridinopyrrolobenzodiazepin-5-onezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA538 as an inseparable mixture (- 3: 1 a:b)
with 540 (0.078 g, 60% yield) as a pale yellow oil.
bH (400 MHz, CDCh): 2.0 (lH, d, .1 3.4, aziridine CH2), 2.04-2.16 (3H, m, CH2+CHH),
2.18-2.26 (IH, m, CHH), 2.53 (lH, d, .1 4.5, aziridine CH2), 2.78 (ddd, .1 9.5,4.1,3.9, aziridine
CH), 3.34 OH, ddd, .19.4,2.9, 1.6, pyrrolidine CH), 3.62-3.69 (lH, m, NCH2), 3.81-3.95 (lH, m,
NCH2), 7.01 (lH,dt,J7.9,0.7,ArH), 7.11 (lH,d,J8.l,ArH), 7.44-7.52 (lH,m, ArH), 7.74(lH,
d, .17.9, ArH). be (lOO MHz, CDCh): 23.1 (CH2), 29.4 (CH2), 32.7 (CH2), 44.8 (CH), 46.1 (CH2),
58.1 (CH), 122.0 (CH), 122.9 (CH), 126.8 (q), 129.7 (CH), 131.2 (CH), 145.6 (q), 150.3 (q). Vmax
(thin film cm"): 3317 (s, br), 3063 (m), 2979 (s), 2877 (s), 1625 (m), 1456 (s), 1405 (s), 1340 (m),
1287 (m), 1248 (m), 1203 (m), 1100 (m), 1039 (m), 922 (m), 766 (s), 730 (s), 704 (s). ES+ mass
spectrum (m/z, %): 288 (14%), 251 (15%), 242 (17%), 215 (l00%), 201 (9%), ] 87 (5%), 145
(5%), 122 (33%), 88 (5%). HRMS (ESI+): found [M+Ht 215.] 178, C13HISN20 requires
215.1179.
Method B
A solution of (2S)-N-(2-azidobenzoyl)-pyrrolidine-2-ethene (527; 0.300 g, ] .242 mmol) in
anhydrous chloroform (30 ml) under an atmosphere of dry nitrogen was heated at reflux for 20 hr.
Upon completion (TLC) the reaction mixture was cooled, and evaporation of the solvent gave the
crude product as a yellow oil, which was purified by flash chromatography (eluent: PE:EtOAcl
3:2) to yield the aziridinopyrro!obenzodiazepin-5-one (538) as a 1:1 mixture with (540); 0.171 g,
66% yield) in the form of a yellow oil.
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7.5.10 Synthesis of (2S)-N-(2-azidoaroyl)-2-hydroxymethylpyrrolidinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
N
I
HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
522
1. aq. K2C03
2.DCMQ:~"CC:N~
OH
541
Potassium carbonate (0.331 g, 2.0 eq) dissolved in water (5 ml), was added in one portion
to a stirring solution of (S)-prolinol (522; 0.12 ml, 1.0 eq) in dichloromethane (l ml). After
stirring for 5 min, a solution of 2-azidobenzoyl chloride (0.220 g, 1.0 eq) in dichloromethane (5
ml) was added to the reaction mixture and the resultant mixture was stirred at ambient temperature
for 4 hr. The reaction mixture was diluted with water (l0 ml) and extracted with dichloromethane
(2x 10 ml). The organic phase was collected, dried over MgS04, and filtered under gravity. The
volatiles were removed in vacuo and the crude product was purified by flash column
chromatography (eluent: PE:EtOAc/ 2:3) to yield the (2SJ-l-(2'-azidobenzoyIJ-2-hydroxymethyl
pyrrolidine (541; 0.182 g, 61% yield) as a yellow oil.
OH (400 MHz, CDCh): 1.51-1.82 (3H, m, CH2+CHH), 1.87-1.99 OH, m, CHH),zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA2.96-3.14
(2H, m, CH2), 3.57 (2H, d, J 4.9, OCH2), 4.07-4.18 (lH, m, CH), 4.77 OH, s, br, OH), 6.94-7.06
(2H, m, ArH), 7.12 OH, d, J 7.5, ArH), 7.25 (IH, t, J 7.8, ArH). oe (lOO MHz, CDCI3): 23.7
(CH2), 27.6 (CH2), 48.8 (CH2), 60.0 (CH), 64.6 (CH2), 117.9 (CH), 124.6 (CH), 127.1 (CH), 128.7
(q), 130.0 (CH), 135.2 (q), 167.9 (q). Vmax (thin film cm"): 3396 (s, br), 2972 (s), 2879 (s), 2129
(s), 1736 (s), 1616 (s, br), 149] (s), 1452 (s), 1428 (s), l373 (m), 1294 (s), 1243 (m), 1161 (m),
1149 (m), 1090 (m), ]049 (s), 755 (s), ES+ mass spectrum (m/z, %): 269 ([M+Nat, 100%),247
([M+Ht, 65%),219 (98%), 201 (12%), 177 (11%),133 (13%), ]22 (17%),120 (45%), 85 (18%),
59 (30%). HRMS (ESI+): found [M+Nat 269.1008, Cl2H14N402Na requires 269.]009.
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7.5.11 Synthesis of (2S)-N-(2-azidoaroyl)-pyrrolidine-2-carbaldehydezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
PCCzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
DeMzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
541 542
To a solution of (2S)-N-(2-azidoaroyl)-2-hydroxymethylpyrrolidine (541; 2.283 g, 9.270
mmol, 1.0 eq) in anhydrous dichloromethane (50 mJ) was added pyridinium chlorochromate
(3.337 g, 15.481 mmol, 1.67 eq) and the whole was stirred vigorously for 3 hours under an
atmosphere of dry nitrogen. The dark reaction mixture was quenched with ether (50 ml) and the
supernatant liquid was removed by decantation. The black tar residue was washed thoroughly with
ethyl acetate (3x 30 ml) and the combined organic layers were collected, dried (MgS04), and
filtered under gravity. Evaporation of the solvent gave the crude product as a brown oil, which was
purified by flash chromatography (eluent: PE:EtOAc/ 3:2) to yield (2S)-N-(2-azidoaroyl)-
pyrrolidine-l-carbaldehyde (542; 0.983 g, 43% yield) as an yellow oil.
bH (400 MHz, CDCh): 1.85-1.98 (2H, m, NCH2CH2), 2.00-2.13 (IH, m, CHCH-H), 2.13-
2.25 (IH, m, CHCH-H), 3.29-3.45 (2H, m, NCH2), 4.63 (lH, m, NCHCHO), 7.10-7.28 (2H, m,
2x ArH), 7.30-7.50 (2H, m, 2x ArH), 9.70 (lH, s, CHO). be (lOOMHz, CDCh): 22.2/24.3 (CH2),
25.9/27.2 (CH2), 46.1/48.1 (CH2), 64.2/65.9 (CH), 118.1 (CH), 124.61124.7 (CH), 127.5 (CH),
128.0 (q), 130.4 (CH), 135.7 (q), 166.81167.0 (q), 197.5/198.9 (q). Vmax (thin film cm"): 2958 (s),
2869 (s), 2125 (s), 1725 (s), 1598 (s), 1579 (s), 1487 (s), 1447 (s), 1299 (s), 1255 (s), 1166 (m),
1129 (s), 1077 (m), 952 (m), 894 (m), 754 (s), 693 (s), 649 (s).
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7.5.12 Synthesis of N-protected dibromoalkenezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~O
I
R
532: R=COzEt
552: R=Boc
t-BuOK
THFzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
+ -
Ph)PCHBrz·Br n,H~r
"N~Br
I
R
543: R=COzEt
553: R=Boc
General Procedure:
A solution of t-BuOK (2.8 eq) in anhydrous THF (5 ml) was added dropwise to a stirring
suspension of dibromomethyltriphenylphosphonium bromide (3.0 eq) in anhydrous TRF (-20 ml)
at ambient temperature under an atmosphere of dry nitrogen. Stirring of the reaction mixture was
continued for a further 5 min, followed by dropwise addition of a solution of the N-protected
aldehyde (532 or 552; 1.0 eq) in anhydrous THF (5 ml) and the whole reaction mixture was
allowed to stir at ambient temperature for Y2 - 1 hr. Upon completion the reaction mixture was
quenched with water (-20 ml) and extracted with ethyl acetate (2x 10 ml). The organic phase was
collected, dried over MgS04, and filtered under gravity. Evaporation of the volatiles in vacuo
provided the crude product, which was purified by flash column chromatography (eluent:
PE:EtOAc/ 2:3) to yield the N-protected dibromoalkene (543 or 553) as follows:
(S)-(-)-1-ethoxycarbonylpyrrolidine-2-(1, l-dibromoprop-l-ene) (543) was obtained as a
rotameric mixture in the form of a yellow oil (0.531 g, 65% yield) from (S)-(-)-1-
ethoxycarbonylpyrrolidine-2-carbaldehyde (532; 0.430 g, 2.51 mmol, 1.0 eq).
bH (400 MHz, CDCh): 1.05 (3R, m, br, CH3), 1.56 (1R, m, br, Cll), 1.63-1.70 (2H, m, br,
CH2), 1.91-2.03 (lH, m, br, CH2), 3.18-3.30 (2H, m, br, CH2), 3.88 (2R, m, br, C02CH2), 4.18-
4.30 (IR, m, br, CH2), 6.15 (IR, m, =Cll). be (100 MHz, CDCI3): 13.3/13.9 (CH3), 21.9/22.6
(CH2), 29.4/30.1 (CH2), 43.9/44.7 (CH2), 57.5/58.5 (CH), 59.0/59.4 (CH2), 87.4 (q), 137.7/137.9
(CH), 152.7/153.1 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (thin fil cm"): 2980 (s), 2883 (s), 1735 (s), 1698 (s), 1470 (s), 1435
(s), 1389 (s), 1356 (s), 1250 (m), 1168 (m), 1115 (s), 1080 (m), 910 (m), 772 (s). ES+ mass
spectrum (m/z, %): 328 ([M+Rt, 8%), 316 (16%), 289 (7%), 288 (31%), 256 (9%),186 (9%),156
(11%), 142 (100%), 128 (13%), 98 (7%), 70 (15%). HRMS (EST+): HRMS (ESI+): found
[M+Rt 328.9321, C9R14Br2N02 requires 328.9320.
(S)-(-)-1-t-butoxycarbonylpyrrolidine-2-(l, l-dibromoprop-I-ene) (553) was obtained in
rotameric form as a yellow oil (0.321 g, 89% yield) from (S)-(-j-l-r-butoxycarbonyfpyrrolidine-z-
carbaldehyde (552; 0.201 g, 1.00 mmol, 1.0 eq).
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bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 1.47 (9H, s, (CH3)3), 1.74 (IH, m, C 2), 1.80-1.94 (2H, m, CH2),
2.11-2.24 (lH, m, CH2), 3.20-3.60 (2H, m, CH2), 4.30-4.50 (lH, m, CH), 6.37 (lH, m, =CH). be
(lOO MHz, CDCh): 22.8 (CH2), 29.4 ((CH3)3), 31.2 (CH2), 46.2 (CH2), 60.4 (CH), 80.0 (q), 88.5
(q), 140.2 (CH), 154.5 (q). Vrnax (thin film cm"): 2976 (s), 2930 (m), 2877 (m), 1698 (s, br), 1614
(m), 1477 (s), 1456 (s), 1393 (s), 1366 (s), 1248 (s), 1165 (s), 1110 (m), 910 (m), 860 (m), 796 (s),
772 (s). ES+ mass spectrum (m/z, %): 355 ([M+], 27%), 299 (15%), 276 (4%), 254 (7%), 220
(4%), 197 (2%), 115 (7%),97 (l0%), 85 (9%), 71 (2%). HRMS (ESI+): found [M+Ht, 356.9637,
CIIH17Br2N02 requires 356.9635.
7.5.13 Synthesis of N-protected alkyne
B I-BuOKn ,H It THF, r.t.
"N~Br
I
R
543: R=C02Et
553: R=Boc
~
I
R
544: R=C02Et
554: R=Boc
General Procedure:
A solution of t-BuOK (2.5 eq) in anhydrous THF (3 ml) was added dropwise to a stirring
solution of N-protected dibromoalkene (543 or 553; 1.0 eq) in anhydrous THF (-10 ml) at ambient
temperature under an atmosphere of dry nitrogen. Stirring of the reaction mixture was continued
for a further 30 min, and the reaction mixture was quenched with water (-20 ml) and extracted
with ethyl acetate (2x 10 ml), The organic phase was collected, dried over MgS04, and filtered
under gravity. Evaporation of the volatiles in vacuo gave the crude product which was purified by
flash column chromatography (eluent: PE:EtOAcl 2:3) to yield the N-protected alkyne (544 and
554) as follows:
(Sj-(-j-l-ethoxycarbonylpyrrolidine-2-prop-I-yne (544) was obtained as a rotameric
mixture in the form of a yellow oil (0.270 g, 100% yield) from (S)-(-)-l-ethoxycarbonyl-
pyrrolidine-2-(l, l-dibromoprop-l-ene) (543; 0.530 g, 1.63 mmo!, 1.0 eq).
bH (400 MHz, CDCh): 1.18 (3H, t, J 7.8, CH2CH3), 1.86 (IH, m, br, NCH2CH-H), 2.00
(lH, m, br, NCH2CH-H), 2.19 (lH, m, br, CHCH-H), 2.54 (lH, m, br, CHCH-H), 3.30 (lH, m, br,
NCH2), 3.45 (IH, m, br, NCH2), 4.00-4 ..20 (2H, q, J 7.9, CH2CH3), 4.42&4.49 (IH, 2x m, br,
alkyne CH), 5.53 (lH, dd, J 4.1, 2.0, CH). be (100 MHz, CDC13): 14.6 (CH3), 28.0 (CH2), 47.2
(CH2), 61.2 (CH2), 75.5 (CH2), 81.5 (CH), ]20.8 (CH), 124.2 (q), ]52.6 (q). Vrnax (thin film cm"):
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3286 (s), 3243 (s), 2981 (s), 2933 (m), 2110 (m), 1698 (s, br), 1606 (s), 1467 (m), 1415 (s), 1384
(s), 1333 (s), 1268 (m), 1172 (m), 1135 (s), 1062 (s), 932 (s), 765 (s).
(SJ-(-J-I-t-butoxycarbonylpyrrolidine-2-prop-I-yne (554) was obtained as a yellow oil
(0.110 g, 100% yield) from (S)-(-)-I-t-butoxycarbonylpyrrolidine-2-(1, l-dibromoprop-l-ene)
(553; 0.201 g, 0.563 mmol, 1.0 eq).
bH (400 MHz, CDCI)): 1.50-1.70 (3H, m, CHCH2CH-H), 1.94-2.07 (lH, m, CHCH2CH-
ll), 3.00-3.30 (2H, m, NCH2), 4.18&4.30 (2x m, br, alkyne Cll), 5.34 (lH, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 4.0, 1.8, Cll). be
(lOO MHz, CDCI)): 26.9 (CH2), 27.4 ((CH3)3), 46.0 (CH2), 59.3 (CH2), 80.9 (CH), ] 19.3 (CH),
123.8 (q), 169.8 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax ( hin fil ern"): 3306 (m), 3258 (m), 2977 (s), 2929 (s), 2857 (m), 2108
(m), 1694 (s, br), 1604 (s), 1477 (m), 1456 (m), 1393 (s), 1366 (s), 1269 (m), 1254 (m), 1170 (s),
1140 (s), 1092 (m), 1049 (m), 1004 (m), 933 (s), 862 (m) 768 (s), 733 (m).
Both compounds were used without further characterization due to their noticeable
instability at room temperature.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.5.14 Synthesis of (2S)-N-(2'-azidobenzoyl)-2-ethynylpyrrolidinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
544 545 546
Method A
To a vigorously stirred suspension of finely ground KOH (1.70 g, 31.] 0 mmol, 26 eq) in
ethylene glycol (5 ml) and hydrazine hydrate (0.20 mI, 5.98 mmol, 5.0 eq) under an atmosphere of
dry nitrogen was added (S)-(-)-I-ethoxycarbonylpyrrolidine-2-prop-l-yne (544; 0.20 g, 1.20
mmoI, 1.0 eq), and the mixture was heated under reflux (-195°C) for 3 hr. The reaction mixture
was cooled to ambient temperature and diluted with (l :1) diethyl ether/water mixture (8 ml) and
extracted with diethyl ether (3x 5 ml), and the combined organic extracts were dried over finely
ground NaOH. Triethylamine (0.25 ml, 1.79 mmol, 1.5 eq) was added to the above ethereal
solution containing the amine (545) at O°Cunder an atmosphere of dry nitrogen and was stirred for
10 min, followed by a dropwise addition of a solution of the acid chloride (0.50 g, 1.5 eq) in
diethyether (5 ml) and the whole reaction mixture was allowed to stir at ambient temperature for
18 hr. Upon completion, the reaction mixture was diluted with water (20 ml) and extracted with
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diethyl ether (2x 10 ml). The organic phase was collected, dried over MgS04, and filtered under
gravity. The volatiles were removed in vacuo and the crude product was purified by flash column
chromatography (eluent: PE:EtOAc/ 2:3) to yield the (2S)-I-(2-azidobenzoyl)-2-ethynylpyrrolidine
(546; 0.032 g, 11% yield) as a rotameric mixture in the form of yellow oil.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Method BzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
1. Et3N
diethyl ether
CK TFA,DCM [CK.. ,H 12CC:~zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBArSN~-;.
N N ~"Nr HI I 3
Boc HzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
547 544 546
Trifluoroacetic acid (0.36 ml, 4.632 mmol, 4.5 eq), was added to a solution of (S)-(-)-I-t-
butoxycarbonylpyrrolidine-2-prop-l-yne (547; 0.201 g, 1.029 mmol, 1.0 eq) in anhydrous
dichloromethane (5 ml) under an atmosphere of dry nitrogen. The reaction mixture was stirred at
ambient temperature for 3 hr, and neutralized with aqueous sodium hydroxide to pH 7 and
extracted with dichloromethane (2x 5 ml), dried over MgS04, and filtered under gravity.
Triethylamine (0.25 ml, 1.79 mmol, 1.5 eq) was added to the above ethereal solution containing
the amine (544) at O°Cunder an atmosphere of dry nitrogen and was stirred for 10 min, followed
by a dropwise addition ofa solution of the acid chloride (0.51 g, 1.5 eq) in dichloromethane (5 ml)
and the whole reaction mixture was allowed to stir at ambient temperature for 18 hr. Upon
completion, the reaction mixture was diluted with water (20 ml) and extracted with diethyl ether
(2x 10 ml). The organic phase was coIlected, dried over MgS04, and filtered under gravity. The
volatiles were removed in vacuo and the crude product was purified by flash column
chromatography (eluent: PE:EtOAc/ 2:3) to yield the (2S)-1-(2-azidobenzoyl)-2-ethynylpyrrolidine
(546; 0.093 g, 37% yield) as a rotameric mixture in the form of yellow oil.
bH (400 MHz, CDCh): 1.63-1.79 (IH, m, CH-H), ] .83-2.05 (lH, m, CH-H), 3.02-3.26 (2H,
m, CH2), 3.36-3.63 (lH, m, NCH-H), 3.66-3.79 (lH, m, NCH-H), 4.37 (lH, dd, J, 7.9,4.0, CH),
7.07-7.17 (2H, m, 2x ArH), 7.20 (IH, s, alkyne-CH), 7.29-7.38 (lH, m, ArH), 7.40-7.51 (IH, m,
ArH). be (100 MHz, CDCh): 22.2/24.2 (CH2), 28.0/29.6 (CH2), 45.8/48.8 (CH2), 56.3/58.4 (CH),
114.6 (q), 118.51119.6 (CH), 124.9/125.1 (CH), ]27.6/127.9 (CH), 129.9/130.1 (CH), 132.1/133.4
(CH), 136.] (q), 139.9 (q), 167.8 (q). Vmax (thin film cm"): 3394 (m, br), 3058 (m), 2971 (s),2922
(s), 2877 (m), 2435 (m), 2127 (s, br), 1717 (s), 1634 (s, br), 1598 (m), 1579 (m), 1488 (s), 1448
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(s), 1418 (s), 1293 (s, br), 1256 (m), 1164 (m), 1148 (m), 1132 (m), 1074 (s, br), 897 (m), 754 (s),
734 (m), 682 (m). EH mass spectrum (m/z, %): 242 (6%), 241zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA([M+Ht, 4%), 240 ([Mt, 4%),
212 (16%), 186 (60%), 114 (20%), 88 (100%), 77 (25%). HRMS (EI+): found [M+Ht 241.1084,
C13H13N40requires 241.1 086.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
7.5.15 Synthesis of 1,2,3-triazolopyrrolo[2,1-c][1,4]benzodiazepine (547)
Toluene,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAL'1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
546
A solution of (2S)-1-(2'-azidobenzoyl)-2-ethynylpyrrolidine (546; 0.093 g, 0.39 mmol) in
anhydrous toluene (8 ml) under an atmosphere of dry nitrogen was heated at reflux for 4 hr. Upon
completion (TLC) the reaction mixture was cooled, and evaporation of the solvent gave the crude
product as an orange oil, which was purified by flash column chromatography (eluent: PE:EtOAcl
2:3) to yield the 1,2,3-triazo[opyrro[o[2,1-cj[1,4jbenzodiazepine (547; 0.015 g, 16% yield) as a
pale yellow oil.
bH (400 MHz, CDCh): 2.09-2.18. (2H, m, CH2),2.50-2.60 (2H, m, CH2), 3.69-3.86 (2H, m,
NCH2), 4.76 (lH, dd, J7.2, 4.9, CH), 7.56 (1H, td, J7.6, 1.0, ArH), 7.64 (1H, s, triazolo CH), 7.69
(1H, td, J 7.7, 1.5, ArH), 7.99 (IH, dd, J 8.1, 1.0, ArH), 8.11 (1H, dd, J 7.9, lA, ArH). be (100
MHz, CDCh): 22.7 (CH2), 2904 (CH2), 47.6 (CH2), 49.6 (CH), 123.0 (CH), 127.2 (q), 128.8 (CH),
129.0 (CH), 132.0 (CH), 132.7 (CH), 133.1 (q), 138.9 (q), 164.0 (q). Vmax (thin film cm"): 3113
(m), 3031 (m), 3007 (s), 2877 (m), 1637 (s, br), 1607 (s), 1579 (m), 1488 (s), 1473 (s), 1433 (s),
1412(5), 1350(m), 1244(5), 1217 (s), 1180(m), 1151 (m), 1129 (m), 1090(m), 1048 (m), 987 (s),
974 (m), 884 (m), 820 (m), 788 (5), 755 (s, br). EI+ mass spectrum (m/z, %): 240 ([Mt, 7%), 211
(12%),184 (30%),143 (50%),115 (85%),114 (22%), 89 (22%), 88 (100%), 77 (21%),76 (60%),
75 (21%),63 (39%), 62 (20%), 50 (50%). HRMS (EH): found [M+Ht 241.1088, C13H13N40
requ ires 241. 1084.
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7.5.16 Synthesis of (S)-(-)-I-ethoxycarbonylpyrrolidine-2-carbonitrile
~OHzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
N
I
C02EtzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
531
Q.;_H
~ C~N
C02Et
557
Finely ground iodine (1.095 g, 8.645 mmol, 3 eq) was added portionwise to a stirred
mixture of (2S)-1-(2'-azidobenzoyl)-2-hydroxymethyl pyrrolidine (531; 0.498 g, 2.875 mmol, 1.0
eq) and ammonia/water solution (10 ml; 7:3 cone. ammonia:water) at ambient temperature. After
stirring for 10 min, the resultant mixture was heated at 65-75°C for 20 hr. The reaction mixture
was cooled to ambient temperature, and was diluted with aqueous sodium sulphite (10 ml) and
extracted with diethyl ether (2x 10 ml). The organic phase was collected, dried over MgS04, and
filtered under gravity. The volatiles were removed in vacuo and the crude residue was purified by
flash column chromatography (eluent: PE:EtOAc/ 2:3) to yield the (S)-(-)-l-ethoxycarbonyl-
pyrrolidine-Z-carbonitrile (557; 0.289 g, 60% yield) as a yellow oil.
t5H (400 MHz, CDCI3): 1.16 (3H, t, J9.2,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOCH2CH3),1.21 (IH, m, NCH2CH-H), 2.04 (IH,
m, NCH2CH-H), 2.20 (1H, m, CHCH-H), 3.34 (lH, m, CHCH-H), 3.48 (lH, m, NCH-H), 4.03
(2H, q, J7.1, OCH2CH3), 4.]2 (lH, m, NCH-H), 4.52 (1H, m, NCHCN). t5c (100 MHz, CDCh):
13.8/14.2 (CH3), 23.4/24.3 (CH2), 30.4/31.4 (CH2), 45.5/45.8 (CH2), 46.6/47.0 (CH), 61.5/61.6
(CH2), 118.6 (q), 170.7 (q). Vmax (thin film ern"): 2984 (s), 2896 (s), 224] (s), 1707 (s), ]528 (s),
1415 (s), ]382 (s), 1346 (s), 1244 (s), 1184 (s), 1123 (s), 1096 (m), 1039 (m), 1014 (m), 914 (s),
877 (s), 773 (s).
7.5.17 Synthesis of (2S)-I-(2'-azidobenzoyl)-pyrrolidine-2-carbonitrile
12, aq. NH3
65-70oc
o
clNNQ
3 C
II/
N
559541
Method A
Finely ground iodine (0.390 g, 1.52 mmol, 1.1 eq) was added portionwise to a stirred
mixture of (2S)-1-(2'-azidobenzoyl)-2-hydroxymethyl pyrroJidine (541; 0.340 g, 1.38 mmol, 1.0
eq) and ammonia/water solution (10 ml; 7:3 cone. ammonia:water) at ambient temperature. After
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stirring for 10 min, the resultant mixture was heated at 65-75°C for 20 hr. The reaction mixture
was cooled to ambient temperature, and was diluted with aqueous sodium sulphite (10 ml) and
extracted with diethyl ether (2x 10 ml). The organic phase was collected, dried over MgS04, and
filtered under gravity. The volatiles were removed in vacuo and the crude residue was purified by
flash column chromatography (eluent: PE:EtOAc/ 2:3) to yield the (2S)-1-(2 'razidobenzayl)-
pyrrolidine-2-carbonitrile (559; 0.271 g, 36% yield) as a yellow oil.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
Method BzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
1. aq. K2C03IDCM
2.DCMzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
r(YCOCl 0zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
~N ~N~
NH2 3 ~"T X
I N3 C
HO.
N
567 559
Potassium carbonate (1.03 g, 4.0 eq) dissolved in water (5 ml), was added in one portion to
a stirring solution of (L)-prolinamide (567; 0.201 g, 1.0 eq) in dichloromethane (5 ml). After
stirring for 5 min, a solution of 2-azidobenzoyl chloride (0.64 g, 2.0 eq) in dichloromethane (5 ml)
was added to the reaction mixture and the resultant mixture was stirred at ambient temperature for
20 hr. Upon completion the reaction mixture was diluted with water (IO ml) and extracted with
dichloromethane (2x 10 ml). The organic phase was collected, dried over MgS04, and filtered
under gravity. The volatiles were removed in vacuo and the crude residue was purified by flash
column chromatography (eluent: PE:EtOAc/ 2:3) to yield the (2S)-1-(2 '< aztdobenzoyl)-
pyrrolidine-2-carbonitrile (559; 0.202 g, 48% yield) as a yellow oil, as a mixture ofrotamers.
bH (400 MHz, CDCh): 2.02 (lH, m, CH-H), 2.15 (IH, m, CH-H), 2.32 (JH, m, CH-H),
3.28 (lH, m, CH-H), 3.39 (IH, m, NCH-H), 3.72 (lH, m, NCH-H), 4.87 (JH, dd, J 8.0, 4.0,
CHCN), 7.19 (2H, m, ArH), 7.31 (lH, dd, J8.0, 4.0, ArH), 7.45 (lH, td, J8.0, 4.0, ArH)' be (100
MHz, CDCh): 23.0-24.8 (CH2), 30.2-32.0 (CH2), 46.0 (CH), 45.6-47.5 (CH2), 118.1 (q), 118.5
(CH), 125.1 (CH), 127.6 (q), 127.9 (CH), 131.0 (CH), 136.2 (q), 166.9 (q). Vrnax (thin film ern"):
2984 (m), 2958 (m), 2884 (m), 2424 (m), 2242 (m), 2131 (s), 1645 (s), 1599 (s), 1578 (m), 1488
(s), 1449 (s), 1408 (s), 1292 (s), 1163 (m), 1148 (m), 904 (m), 756 (s), 732 (m). ES+ mass
spectrum (m/z, %): 242 ([M+Ht, 2%), 215 (l7%), 214 (24%), ]86 (14%),104 (100%), 76 (30%).
HRMS (ES1+): found [M+Ht 242.1036, CI2H12NsOrequires 242.1036.
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7.5.18 Synthesis of 1,2,3,4-tetrazolopyrrolo[2,1-c] [1,4]benzodiazepinezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
559
A solution of (2S)-I-(2'-azidobenzoyl)-pyrrolidine-2-carbonitrile (559; 0.100 g, 0.41
mmol) in anhydrous toluene (10 ml) under an atmosphere of dry nitrogen was heated at reflux for
6 hr. The reaction mixture was cooled, and evaporation of the solvent gave the crude product as a
yellow oil, which was purified by flash chromatography (eluent: PE:EtOAcl 2:3) to yield the
1,2,3,4-tetrazolopyrrolo[2,1-cJ[1,4Jbenzodiazepine (560; 0.099 g, 99% yield) as a pale yellow oil.
bzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400 MHz, CDCh): 2.19 (2H, m, CH2), 2.59 OH, m, CH-H), 3.18 (lH, m, CH-B), 3.72
(lH, m, NCH-B), 3.85 (lH, m, NCH-H), 4.84 (lH, dd,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 8.3,3.1, CHCN), 7.64 (lH, t, J 8.0,
ArB), 7.75 (1H, t, J 8.0, ArB), 7.94 (lH, d, J 8.0, ArB), 8.17 (1H, d, J 8.0, ArB). be (100 MHz,
CDCh): 23.5 (CH2), 28.2 (CH2), 48.2 (CH2), 49.7 (CH), 122.5 (CH), 127.2 (q), 129.9 (CH), 130.4
(q), 132.3 (CH), 133.2 (CH), 154.6 (q), 163.4 (q). Vmax (thin film ern"): 2957 (m), 2927 (m), 2884
(m), 1733 (m), 1639 (s, br), 1606 (s), 1579 (m), 1490 (s), 1471 (s), 1411 (s), 1241 (m), 1152 (m),
1125 (m), 1095 (m), 832 (m), 785 (m). ES+ mass spectrum (m/z, %): 268 (23%), 242 ([M+H]\
100%),236 (63%), 214 (14%), 140 (9%), 122 (7%). HRMS (ESI+): found [M+Ht 242.1040,
C12HI2NsO requires 242.1036.
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The synthesis of pyrrolo[l,2-b][1,2,5]benzothiadiazepines from
1,2-thiazine l-oxides-sulfonamide analogues of the
pyrrolobenzodiazepine antitumour natural products
Karl Hemming" and Nilesh PatelzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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Abstract-Pyrrolo[2, l-c][1,4]benzodiazepines (PBDs) and the corresponding pyrrolobenzothiadiazepines (PBTDs) are attractive tar-
gets as natural and synthetic antitumour antibiotics and as non-nucleosidic reverse transcriptase inhibitors. A concise synthesis of
the PBTD class is presented, which starts from o-azidobenzenesulfonamide and its conversion into 2-(0-azidobenzenesulfonyl)-1,2-
thiazine l-oxides via Diels-Alder reaction. After a one-pot ring contraction, desulfurisation and aromatisation process, accompa-
nied by concomitant same pot conversion of the azide group into a primary amine via the Staudinger reaction, these I,2-thiazine-
l-oxides yield a I-(o-aminobenzenesulfonyl)pyrrole. N-Formylation of the amine and Bischler-Napieralski ring closure onto the
pyrrole completes the PBTD synthesis.
© 2004 Elsevier Ltd. All rights reserved.
The pyrrolo[2, I-e][! ,4]benzodiazepines (PBDs) are of
interest'r' due the antitumour antibiotic activity of the
PBD natural products, of which DC-8I 1 and prothra-
carcin 2 (Fig. 1) are typical, and synthetic analogues of
which are in clinical development.' The related
pyrrolo[I,2-b][1,2,5]benzothiadiazepines (PBTD) 3 have
received much less interest, but are attractive as sulfon-
amide analogues of the antitumour antibiotic PBDs,4
and also as non-nucleosidic inhibitors of reverse tran-
scriptase." The 1,2,5-benzothiadiazepines have also
attracted attention for the range of activities that they
possess as analogues of the CNS-active l,4-benzodiaze-
pines'' and also as tumour necrosis factor-alpha convert-
ing enzyme (TACE) inhibitors, and as inhibitors of
metalloproteinases in general.6c,7 Almost all reported
syntheses of the PBDs and PBTDs use proline as the
source of the five-membered ring,I-5 with only a few
methods relying on a de novo pyrrole construction
methodology.P and there are no methods, which con-
struct the pyrrole from a diene. Although relatively
unexploited, the synthesis of simple (unfused) pyrroles
Keywords: Pyrrolobenzodiazepine; Pyrrolobenzothiadiazepine; Pyr-
role; 1,2-Thiazine-1-oxide; Azide .
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from dienes has proven its importance to the synthetic
chemist." In this letter we report that 2-arylsulfonyl sub-
stituted 1,2-thiazine-I-oxides 4 (see Fig. I), which are
easily constructed from a diene via a Diels-Alder reac-
tion, can be transformed in a one-pot process into the
l-arylsulfonyl-substituted pyrroles 5, which can then
be easily converted into the PBTD nucleus.
Our interest in this area came about as part of a pro-
gramme of studies aimed at exploring the uses of 1,2-
thiazine-l-oxides in heterocyclic synthesis.10-12 We
previously reported that 2-(0-azidobenzenesulfonyl)-
1,2-thiazine-l-oxides 4 are precursors for the synthesis
of unsaturated bicyclic 1,2,5-benzothiadiazepines via
conversion into ct,ro-iminophosrhoranyl ketones and
subsequent aza-Wittig reaction. I One of the key trans-
formations in this process was the construction of 1-(0-
azidobenzenesulfonyl)-1,2-thiazine-l-mddes 4 via a
Diels-Alder reaction, which relied upon the in situ gen-
eration of the unstable N-sulfinyl dienophile 6 (see Fig.
1) by treating the sulfonamide with pyridine and thionyl
chloride. The Diels-Alder reaction was high yielding but
gave, 011 occasion, the l-(o-azidobenzenesulfonyl)pyr-
role 7 (Fig. 1) as a minor product «5%). We became
interested in optimising the yield of this pyrrole as it is
a potential intermediate for the synthesis of PBTDs.
The origin of this pyrrole product wouJd seem to be base
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Figure 1.
Scheme 1.
catalysed ring opening of the 1,2-thiazine-l-oxide 4, sub-
sequent closure to a pyrrolidine 8 and loss of HSOH to
give the pyrrole 7, as shown in Scheme I. Indeed, Harr-
ington?" has also observed the low yielding formation of
pyrroles from 1,2-thiazine- I-oxides under similar basic
conditions, and went on to optimise the sequence to
great effect?"via the addition of a thiophile, trimethyl
phosphite, in a synthetic approach to simple (unfused)
l-(p-toluenesulfonyl)pyrroles.
The use of trimethyl phosphite in this conversion was
attractive to us as we anticipated that we could under-
take concurrent conversion of the azide group in com-
pound 7 into an amine via the hydrolysis of an
intermediate iminophosphorane [ArN=P(OMe)3],
formed after Staudinger reaction of the azide with the
phosphite.'! Our retrosynthetic strategy for the PBTD
nucleus 3 is shown in Scheme 2 and relies upon the
installation of the imine bond as the final step, giving
the formylated precursor 9 or 10, and hence leading to
RI
CC~:_N~R2 ~R3
NH2
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Scheme 2.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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the l-(o-aminobenzenesulfonyl)pyrrole 11 as the key tar-
get for formylation. Functional group interconversion
(azide to amine) leads back to compound 7, and the
key transformation of 1,2-thiazine-I-oxide into pyrrole
gives the readily available (see below) 2-(o-azido-
benzenesulfonyl)-1,2-thiazine-l-oxides 4 as starting
materials.
The 2-(o-azidobenzenesulfonyl)-1,2-thiazine-l-oxides 4
were constructed using a hetero Diels-Alder reaction 14
between the appropriate diene and the N-sulfinyl hetero-
cumulene'P 6, derived from o-azidobenzenesulfonamide
12, as shown in Scheme 3. o-Azidobenzenesulfonamide
12 was obtained from o-aminobenzenesulfonamide in
over 90% yield via diazotisation and treatment with so-
dium azide. o-Aminobenzenesulfonamide could not be
used directly as the starting material for the sulfinylation
reaction as this resulted in the formation of the dithiad-
iazine 13. The N-sulfinyl 6 was best formed from a 1:1:2
ratio of sulfonamide 12, thionyl chloride and pyridine,
7
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Scheme 3. Reagents and conditions: (i) NaN02, HCl(aq) then NaN3. (ii) SOCI2, pyridine, THF, QOC,3h. (iii) R1HC=CR2-CR3=CH2. (iv)
P(OMeh, Et3N, MeOH, 25°C, then 2M NaOH(aq). (v) HCl(g), THF, room temp. (vi) HC02H, (MeCOhO, THF. (vii) P(O)CI3, (CH2Cl)2'
and had to be formed in situ, as attempted isolation
resulted in its hydrolysis back to the sulfonamide.
Thus, the 2-(o-azidobenzenesulfonyl)-1,2-thiazine-I-oxi-
des 4a-c were obtained from o-azidobenzenesulfona-
mide in yields of 78%, 82% and 93%, respectively, and
were next treated with a 2: I molar equivalent mixture
of trimethyl phosphite:triethylamine in methanol. The
desired l-(o-aminobenzenesulfonyl)pyrroles lla-c were
isolated in yields of 50%, 73% and 50%, respectively,
after basic aqueous (2M NaOH) work-up, good yields
considering the multi-step nature of the process. The
phosphoramidates 14a-c were the only other products
of this reaction and were isolated in yields of 23%,
10% and 18%, respectively, and are probably the result
of partial basic hydrolysis of the iminophosphorane.
The phosphoramidateszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA14 could be converte into the
amine 11 in 85-90% yields using gaseous hydrogen chlo-
ride in THF.16
The conversion of the I-(o-aminobenzenesulfonyl)pyr-
roles 11 into the PBTD nucleus required the introduc-
tion of a single carbon. Vilsmeier formylation of the
pyrrole ring in compound 11 gave the desired product
9 (shown in Scheme 2) but, in the event, this would
not cyclise, probably due to the deactivation of the alde-
hyde by delocalisation into the pyrrole ring. However,
N-formylation using a preformed mixture of acetic
anhydride and formic acid!" gave the N-formylated
products lOa-c (Scheme 3) in yields of 98%, 77% and
83%, respectively. The final ring closure was effected
by the Bischler-Napieralski reaction using phosphorus
oxychloride in 1,2-dichloroethane and gave the desired
PBTDs 3a-c in 55%, 59% and 43% yields,
respectively.Pi'?
To conclude, a concise route to the pyrrolobenzothia-
diazepine (PBTD) nucleus has been reported via the
one-pot conversion of 2-(o-azidobenzenesulfonyl)-1,2-
thiazine-l-oxides into 1-(o-amino benzenesulfonyl)pyr-
roles followed by formylation and Bischler-Napieralski
ring closure. The PBTDs are attractive as sulfonamide
analogues of the synthetic and natural antitumour pyr-
rolobenzodiazepines (PBDs). We are now adapting this
route to allow access to such PBDs.
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ArH), 8.01 (lH, dd, J 8.0, 0.9, ArH). Dc (IOOMHz,
CDCI3): 16.9 (Me), 19.7 (Me), 42.9 (CH2), 55.5 (CH2),
115.0 (q), 120.3 (CH), 123.5 (q), 124.6 (CH), 127.5 (q),
131.6 (CH), 135.1 (CH), 139.0 (q). Vmax (chloroform,
cm "): 3006 (w), 2918 (w), 2134 (s, N3), 1585 (m), .1575
(m), 1472(s), 1444(m), 1351(s), 1291 (m), 1171 (s), 1102
(s), 885 (m), 758 (s), 614 (m). EI+ mass spectrum (mlz, %):
326 ([Mr, 9%), 298 (12%), 278 (10%), 156 (10%), 116
(25%),104 (20%),90 (40%), 76 (35%), 64 (50%), 54 (30%),
39 (100%). HRMS (ESI+): found [M+H+] 327.0587,
CI2H 14N403S2 requires 327.0585.
Preparation of 1-(2-aminobenzenesulfonyl)pyrroles 11: to
a rapidly stirring solution of triethylamine (1 equiv) and
trimethylphosphite (2 equiv) in anhydrous methanol
(IOmL) was added the 1,2-thiazine I-oxide 4 (0.30-
0.50 g, I equiv) in one portion and the mixture was stirred
at room temperature under an atmosphere of dry nitrogen
for 2 h. The volatiles were removed by rotary evaporation
and the crude mixture was purified by silica column
chromatography (petroleum ether-ethyl acetate
40:60+10% triethylamine). For example, compound He
(0.135 g, 50%) was obtained as pale yellow oil from 1,2-
thiazine I-oxide 4e (0.350g, 1.07mmol). OH (400MHz,
CDCh): 1.91 (6H, s, 2 x Me), 4.5-4.7 (2H, br s, NH2), 6.63
(IH, d, J 8.2, ArH), 6.71 (I H, t, J 7.6, ArH), 6.84 (2H, s,
2xpyrrole-H), 7.25(IH,t,J7.4,ArH), 7.61 (lH,d,J8.1,
ArH). ocClOOMHz, CDCh): 10.1 (Me), 117.4 (CH), 117.6
(CH), 117.8 (CH), 120.0 (q), 124.2 (q), 129.2 (CH), 135.0
(CH), 145.6 (q), vmax(thin film, cm "): 3457 (5, NH2), 3377
(s, NH2), 2966 (m), 2919 (m), 1636 (s), 1599 (m), 1484 (s),
1455 (m), 1348 (m),1296 (m), 1068 (s), 1034 (s), 829 (s),
744 (m), 699 (m), 610 (m), 588 (m). EJ+ mass spectrum
(mlz, %): 250 ([Mt, 70%), 185 (25%), 156 (20%), 108
(35%), 94 (100%), 65 (80%), 39 (50%). HRMS (ESI+):
Found [M+H+] 251.0845, C12H14N202S requires 251.0849.
Preparation of 1-(2-formamidobenzenesulfonyl)pyrroles
10: formic acid (2.25 equiv) was added into acetic anhy-
dride (2equiv) at O°C and the solution was stirred at room
temperature for 2h. This solution was added to a solution
of the 1-(2-aminobenzenesulfonyl)pyrrole 11 (0.10-0.20g,
I equiv) in anhydrous tetrahydrofuran (5mL) and the
reaction mixture was stirred at room temperature for 20h.
The crude product was purified by silica column chroma-
tography (petroleum ether-ethyl acetate 40:60). As an
example, compound tOe (0.120 g, 83%) was obtained as a
pale yellow oil from 1-(2-aminobenzenesulfonyl)pyrrole
lle (O.l30g, 0.52mmol). OH (400MHz, CDCI3): 1.97 (6H,
s, 2 x Me), 6.85 (2H, s, 2 x pyrrole-H), 7.23 (1H, t, J 7.7,
ArH), 7.61 (IH, t, J 7.7, ArH), 7.77 (IH, d, J 8.0, ArH),
8.52 (I H, d, J 7.9, ArH), 8.56 (IH, s, CHO), 9.45 (!H, br s,
NH). Oc (lOOMHz, CDCI3): 10.1 (Me), 117.5 (CH), 123.0
(CH), 124.2 (CH), 125.7 (q), 125.8 (q), 126.1 (q), 128.8
(CH), 135.1 (CH), 158.8 (CHO). Vmax (thin film, cm "):
3290 (m, NH), 3020 (w), 2921 (w), 1706 (s), 1674 (s), 1579
(m), 1514 (m), 1403 (m), 1358 (m), 1290 (m), 1216 (s), 1160
(s), 1071 (m), 669 (m), 611 (m). EJ+ mass spectrum (mlz,
%): 278 ([M+], 60%), 250 (10%),228 (60%), 184 (85%),156
(20%),120 (50%), 95 (100%), 65 (85%). HRMS (CJ+NH3):
Found [M+NHt] 296.1063, CI3HI4N203S requires
296.1063.
Preparation of pyrrolobenzothiadiazepines 3: A solution
of 1-(2-formamidobenzenesulfonyl)pyrrole 10 (",,0.10 g,
1equiv) and phosphorus oxychloride (21.6 equiv) in 1,2-
dichloroethane (2mL) was heated at reflux temperature
for 3 h. Evaporation of the solvent gave a residue, which
was purified by silica column chromatography (petroleum
ether-ethyl acetate, 40:60). For example, compound 3e
(0.040 g, 43%) was obtained from 1-(2-forma-
midobenzenesulfonyl)pyrrole 10e (0.100 g, 0.36mmol) as
a bright orange oil. DH (400MHz, CDCh): 2.06 (3H, s,
Me), 2.26 (3H, s, Me), 7.33 (IH, 5, pyrro1e-H), 7.42 (IH,
dt, J 8.0, 1.0, ArH), 7.60-7.73 (2H, m, 2 x ArH), 8.04 (I H,
dd, J 7.9, 1.2, ArH), 8.62 (l H, s, N=CH). Oc (lOOMHz,
CDCI3): 9.6 (Me), 9.9 (Me), 120.8 (CH), 123.6 (q), 124.9
(q), 125.3 (CH), I26.2(CH), I 29.9(CH), 130.1 (q), 132.5
(q), 134.4 (CH), 144.1 (q), 148.6 (CH). Vmax (cm-I): 2924
(w), 1603 (s), 1582 (s), 1458 (m), 1365 (s), 1294 (m), 1181
(s), 1137 (m), 1107 (m), 910 (s), 832 (m), 767 (m), 733 (m).
HRMS (EST+): Found [M+H+] 261.0691, C13H12N202S
requires 261.0692.
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The synthesis of 1,2,5-benzothiadiazepine l,l-dioxides from
1,2-thiazine I-oxides
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tDepartment of Chemical and Biological Sciences, University of Huddersfield,
Huddersfield, WestYorkshire, HDI 3DH, UK
:j:Departmentof Chemistry, University College Dublin, Belfield, Dublin 4, Ireland
§Departement Chimie, I.U.T de Poitiers, 6 allee Jean Monnet, 86010 Poitiers cedex, France
(Received 12 September 2005; infinalform 14 November 2005)
This paper presents a new approach to the synthesis of 1,2,5-benzothiadiazepine J, l-dioxides,
sulfonamide analogues of the 'privileged' I ,4-benzodiazepine pharmacophore. The key steps during
this synthesis are the hetero Diels-Alder reaction of anzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN -sul finylamine dienophile with a diene to give
a 1,2-thiazine l-oxide which is then convened into a N -(o-azidobenzenesulfonyl)-I,2-amino alcohol
via a [2, 3)-sigmatropic rearrangement involving an intermediate allylic sulfoxide and sulfenate ester.
Staudinger reaction of the o-azido group and hydrolysis of the intermediate iminophosphorane gave
the corresponding N-(o-aminobenzenesulfonyl)-I,2-amino alcohols. Fmoc protection at nitrogen,
oxidation of the alcohol, and Fmoc deprotection furnished directly the 1,2,5-benzothiadiazepine
I,I-dioxides in 57-69% yield. An alternative method which uses triazene chemistry is also pre-
sented, but was consistently lower yielding. A second route to 1,2,5-benzothiadiazepine Ll-dioxides
using 2-nitrobenzenesulfonamide as the dienophile precursor proceeded without incident to give
N -(o-nitrobenzenesulfonyl)-I,2-amino ketones which underwent reductive cyclisation to furnish the
target heterocycle.
Keywords: Azide; 1,2-Thiazine I-oxide; Benzodiazepine; Benzothiadiazepine; Allylic sulfoxide;
N -sulfinyJamine
1. Introduction
The synthesis and biological applications of the 1,4-benzodiazepine pharmacophore 1continue
to attract considerable attention in the literature [1-8]. The related 1,2,5-benzothiadiazep.ine
I .l-dioxides 2, however, have been subject to much less scrutiny [9-12]. Early interest in
1,2,5-benzothiadiazepine 1, l-dioxides was inspired by their potential use as eNS active com-
pounds [13-14]. More recently it has been shown that, whilst 1,2,5-benzothiadiazepines
continue to attract attention as eNS active antidepressives [15-17], they have also exhib-
ited activity as antiarrhythmic agents [18], as inhibitors of metalloproteinase and farnesyJ
protein transferases [19-21], and as potent tumour necrosis factor-Cl! (TNF-Cl!) converting
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enzyme (TACE) inhibitors [22]. Tricyclic 1,2,5-benzothiadiazepines have attracted partic-
ular attention as non-nucleosidic reverse transcriptase inhibitors (NNRTIs) [23-28], a class of
compounds that includes the pyrrolo fused system 3 [23-25] and other tricycles such as the
heterocycle system 4, where the latter is the sulfonamide analogue of the well known class of
NNRTIs that includes the clinically used nevirapine [26-28]. Benzothiadiazepine analogues 5
of the anti-HIV drug TIBO with specific anti-HIV type 1 activity have also been reported [29]
(figure 1). Finally, it is of note that the pyrrolo fused 1,2,5-benzothiadiazepines 3 have also
attracted attention [30-32] as sulfonamide analogues of the minor groove DNA-interactive
antitumour antibiotic natural and synthetic pyrrolobenzodiazepines [33].
The synthetic routes to the 1,2,5-benzothiadiazepine 1,] -dioxide nucleus include
many approaches to the pyrrolobenzothiadiazepines 3 which proceed via 3,4- or 4,5-
bond formation of the 1,2,5-benzothiadiazepine ring. These include reductive cycli-
sation of (2-nitrobenzenesulfony 1)-1H -pyrrole derivatives [23, 34], the cyclisation of
1-(2-formamidobenzenesulfonyl)pyrrole with phosphorus oxychloride [30,34], the reac-
tion of 2-(1 H -pyrrol-l-yl)benzenesulfonamide with triphosgene [35,36], the cyclisation of
1-(2-amino-5-chlorobenzenesulfonyl)pyrrole-2-carbohydrazide with loss of hydrazine [37],
the cyclisation of 1-(2-fluorobenzenesulfonyl)-1zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH -pyrrole-2-carboxyamides [23], and the
reaction of 1-(2-aminobenzenesulfonyl)pyrrole with ethyl glyoxylate [14]. Approaches to
simple bicyclic 1,2,5-benzothiadiazepine I. l-dioxides 2 include synthesis by ring expansion
of 1,2,4-benzothiadiazines [38], 1,2-bond formation by intramolecular sulfonamide forma-
tion [39, 40], and 2,3-bond formation by intramolecular elimination of ethanol from N-~,
~-diethoxyethyl-N-alkylanilines [41]. 4,5-Bond formation is a common approach to this sys-
tem, and has been achieved by cyclisation of 2-(2-aminobenzenesulfonamido) propanoic acid
[25]; by reductive cyclisation of 2-nitro-w-phenacylbenzenesulfonamide [42]; by the use of
2-N -[(2-aminobenzenesulfonyJ)methylamino]acrylate in an intramolecular Michael reaction
[43]; via the use of an intramolecular aza-Wittig reaction [44]; via the ozonolysis and sub-
sequent ring closure of N-(2-nitrobenzenesulfonyl) N-allyJic systems [22]; and from the
cyclisation of N -(2-aminobenzenesulfonyl) N -ethylbromo systems [22]. 5,6-Bond formation
by intramolecular SNAr reaction has also been reported [23].
In the current paper, we report a new approach to the 1,2,5-benzothiadiazepine l .l-dioxide
nucleus that begins with a I,3-diene. Our methodology is the only route that allows this
important heterocyclic system to be accessed from dienes, and also provides access to hitherto
unreported I,2,5-benzothiadiazepines.
As part of an ongoing programme of work directed towards the use of I,2-thiazine
l-oxides as building blocks in heterocyclic synthesis, we have already reported routes to
l,4-benzodiazepines [7,44] and isoxazolo-fused benzothiazines [45]. Herein we report the
conversion of 1,2-thiazine l-oxides into a series of 1,2,5-benzothiadiazepine l,l-dioxides.
Our original plan is shown in scheme 1. Hence, the 1,2-thiazine 1-oxides 8 (XzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA= synthetic
equivalent of NH2) that are central to our methodology would be accessible from a hetero-
Diels-Alder reaction involving the N-sulfinylamine dienophiles 7 which are in turn easily
R' O2 R'
cc~}:I O2 O2 R'CC_) CC:}R' CC:b C''qS-N'--- I b _)-R2N- NN
HN-{I I R2 H X-R R
S
2 3 4, X = CH or N 5
Figure I. Examples of some important benzothiadiazepines,
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9
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SCHEME I Planned route to I,2,5-benzothiadiazepines_
available from the action ofthionyl chloride upon the benzenesulfonamides 6_Subsequent ring
opening of the I,2-thiazine l-oxides 8 would give an allylic sulfoxide 9 which is ideally set up
for a [2, 3]-sigmatropic, Evans-Mislow, rearrangement [46-53]. Desulfurisation of the resul-
tant sulfenate esterzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA10 and oxidation of th alcohol 11 should then form the ketone 12, which
is the precursor for an envisaged straightforward cyclisation into the 1,2,5-benzothiadiazepine
nucleus 2. We present the results of this endeavour herein and report the successful syn-
thesis of the alcohols 11 (X = NH2; R3, R4, R5 = Me/H) from 2-aminobenzenesulfonamide
(6, X = NH2) via selective functionalization of the sulfonamide nitrogen in 58 to 63% overall
yield. The successful conversion of the alcohols 11 (X = NH2; R3, R4, R5 = Me/H) into the
I,2,5-benzothiadiazepine I,I-dioxide nucleus is also discussed. This paper also presents a
concise second route to the I,2,5-benzothiadiazepine Ll-dioxide nucleus which relies upon
the conversion of 2-nitrobenzenesulfonamide (6, X = N02) into I,2,5-benzothiadiazepine
l.J-dioxides via alcohols 11 (X = N02; R3, R4, R5 = Me/H) using a similar strategy.
2. Results and discussion
ThezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAN -sulfinyl gr up that we required as the dienophile is best accessed via sulfinylation
[48-53] of the corresponding sulfonamide. We observed that the greater reactivity of the
2-amino nitrogen of 2-aminobenzenesulfonarnide (6, X = NH2; scheme 2) towards thionyl
chloride precluded reaction at the sulfonamide nitrogen in 2-aminobenzenesulfonamide. We
elected, therefore, to diazotise the 2-amino nitrogen and convert it into an azide, with a view
to the subsequent conversion of the azide back into an amine at a later stage in the syn-
thesis. Thus, diazotisation of 2-aminobenzenesulfonarnide 6 under standard conditions (5M
HCI, NaN02• 0 0c) followed by reaction with sodium azide gave a reproducible 90% yield of
2-azidobenzenesulfonamide 13, as shown in scheme 2. Reaction of compound 13 with thionyl
458zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAC.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBALoukou et al.
(i)
--90%
(ii)
-- lO::~N=s=°l
14
(iii)
6, X = NH2 13
(iv) (v)
--
15
(vi)
188 (R5 = R4 = R3 = H)
lab (R5 = R3 '" H; R4 = Me)
lSc (R5= R3", Me; R4= H)
SCHEME 2 Synthesis of key intermediate 18 via a triazene. Reaction conditions:
(i) HCI(aq.), NaN02, 0 -c. NaN3. (ii) SOCh (1.5 equiv.), benzene, reflux, 72 hours; or SOCI2,
pyridine, THF, room temperature, 3-4 hours. (iii) R3CH=CH-CR4=CHR5, THF, 25°C,
16 hours. (iv) PhMgBr (2 equiv.), THF, -40°C, 2 hours; NH4CI(aq.). (v) piperidine (5 equiv.),
anhydrous MeOH, 60°C, 12 hours (inert atmosphere) [54-56]. (vi) MeOH (wet), reflux,
5 hours (open air).
17
chloride gave the N -sulfinyl dienophile 14 which was noted to be unstable upon exposure to
the moisture in air, and was hence generated and used in situ. Hetero Diels-Alder reaction [48-
53] of the N -sulfinyl dienophile 14 gave the 2-(o-azidobenzenesulfonyl)-1,2-thiazine l-oxides
ISa-c in ",,80% yield from compound 13 (see table 1) after chromatography. Compound ISc
was isolated as a single diastereoisomer with "cis" R3/R5 stereochemistry in line with that
expected from thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(E, E)-diene that was used. The stereochemistry at sulfur was not deter-
mined due to the fact that this chiral centre was soon to be lost (see below). The treatment
of 2-(o-azidobenzenesulfonyl)-I ,2-thiazine l-oxides 15 with an excess of PhMgBr followed
by aqueous work-up, and then [2,3]-sigmatropic rearrangement/piperidine mediated desul-
furisation [54-56] of the intermediate allylic sulfoxides 16 (scheme 2) gave the (l,3-diaryl
triazenyl) allylic alcohols 17 in 59-67% yield starting from the I,2-thiazine l-oxides 15 (see
table 1). The triazene moiety arises as the result of the ring opening of the thiazine l-oxide
with PhMgBr accompanied by the expected [57] reaction of PhMgBr at the azide group to
form the triazene. The treatment of the triazenes 17 with boiling aqueous methanol gave the
corresponding amines 18 in 60 to 70% yield, a hydrolysis of triazenes which has parallels in
the literature [58-61].
The relative stereochemistry of compounds 17c and 18c (R3 = Me) was not determined as,
at the next stage, the alcohol chiral centre was to be oxidised. It is of interest to note, however,
that others have reported that such reactions proceed with a high degree of stereoselectivity
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Table 1. % Yields for isolated. purified products.
%yield % yield %yield % yield
15 (scheme 2) 17 (scheme 2) 21 (scheme 3) 18 (scheme 3)
Entry R3 R4 R5 (from 13) (from 15) (from 15) (from 21)
azyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH H H 82 67 99 86
b H Me H 78 64 >99 89
c Me H Me 80 59 >99 82
when performed with other substrates [48,49,51-53), a point reflected by the fact that we
found compounds 17e and 18e to be single diastereoisomers. In the one situation where it is
appropriate, i.e. also for compounds 17e and 18e (R4 = H, R5 = Me), the alkene geometry
was found to bezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(E). This can be explained by invoking a 5-membered ring envelope transition
state for the [2, 3)-sigmatropic rearrangement, in which the methyl group that occupies position
6 (see figure 2) in the allylic sulfoxide 16e is in a pseudo-equatorial position leading to
(E)-alkene geometry in the intermediate sulfenate ester 19, geometry which is carried through
to compounds 17e and 18e.
Using the procedure shown in scheme 2, the highest overall yield that was obtained for
compound 18 was that for 18a (R3 = R4 = R5 = H), which was obtained in only 34% yield
from 2-aminobenzenesulfonamide 6. An improved procedure for the conversion of the 2-
(o-azidobenzenesulfonyl)-1,2-thiazine l-oxides 15 into the desired amines 18 was therefore
sought.
Our improved procedure is set out in scheme 3. The reaction of the azide group in compounds
15 with triphenylphosphine resulted in a quantitative Staudinger reaction [62] to give the
iminophosphoranes 20. The in situ hydrolysis [63-66) of the iminophosphoranes 20 with
wet THF at reflux gave the 2-(o-aminobenzenesulfonyl)-1,2-thiazine l-oxides 21a-c in near
quantitative yields from the azides 15 (see table 1) after column chromatographic removal
of triphenylphosphine oxide. It is noteworthy that these hydrolytic conditions were selective
for the irninophosphorane group, and that no competing hydrolysis (see later - scheme 6)
of the 1,2-thiazine I-oxide rings was observed. In the next step, ring opening of the thiazine
l-oxides 21 with PhMgBr gave the phenyl allylic sulfoxides 22. Conversion of the crude
phenyl aUylic sulfoxides 22 into the desired N-(o-aminobenzenesulfonyl)-I,2-vicinal amino
alcohols 18 was best achieved by treatment with hot methanolic trimethyl phosphite, a process
which occurs via a [2, 3)-sigmatropic rearrangement to give the intermediate sulfenate esters
1. PhMgBr
2. W H
2 3
ArS02HN Me
H
-
16c
19
Figure 2. Origin of (Er-alkene geometry.
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(ii) (iii)
-
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~ H OH
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SCHEME 3 Synthesis of key intermediate 18 using iminophosphoranes. Reaction condi-
tions: (i) PPh3 (1 equiv.), THF, 25°C, 3-4 hours (inert atmosphere), then H20 (8 equiv.), THF,
reflux, 15-20 hours (open air). (ii) PhMgBr (2 equiv.), THF, -40°C, 2 hours; NH4Cl(aq.).
(iii) P(OMeh, MeOH, 60°C, 10-15 hours.
18a (Rs = R4 = R3 = H)
18b (Rs = R3 = H; R4 = Me)
lac (RS = R3 = Me: R4 = H)
23, which then undergo desulfurisation with the trimethyl phosphite [46-53]. Products 18a-c
were obtained in 82-89% yield from the 2-(o-aminobenzenesulfonyl)-1,2-thiazine l-oxides
21 (see table 1). The next step in the sequence was to be an alcohol oxidation, and hence the
relative stereochemistry of the two chiral centres in compound 18c (R4 = H, R5 = R3 = Me)
was not determined, but it was again noted (see above) to be a single diastereoisomer, as
expected [48,49,51-53]. Compound 18c was also noted to have (E)-alkene geometry, as
discussed above. By this procedure, the highest yield that was obtained for this multi-reaction
sequence was again that of compound 18a (R3 = R5 = R4 = H), which was now obtained
in 63% overall yield starting from 2-aminobenzenesulfonamide 6. Compounds 18b and 18c
were obtained in similarly acceptable overall yields of 62% and 58%, respectively, from
2-aminobenzenesulfonamide 6.
With a higher yielding and reproducible synthesis of compounds 18a-c now in hand, we
next set about to convert them into the desired 1,2,5-benzothiadiazepine Ll-dioxides, a pro-
cess that we anticipated would be trivial. In the event, all attempts to affect the oxidation of the
N-(o-aminobenzenesulfonyl)-1,2-amino alcohols 18a-c into the corresponding ketones
proved unsuccessful under a variety of conditions (for example, Dess-Martin, Swern, TPAP,
Corey's reagent, Mn02, etc), possibly due to a competing reaction at the primary amine.
Fortunately, Fmoc protection of the primary amine group (72-81 %) allowed the successful
oxidation (Dess-Martin, 76-85%) to give the Fmoc protected derivatives 24a-c, as shown in
scheme 4. Standard Fmoc deprotection methods (using secondary amines such as piperidine,
diethylamine and dicyclohexylamine) resulted in a multi-spot TLC profile in all cases from
which the only identifiable products implied that the amine had undergone Michael addition
to the O!, ,B-unsaturated ketone moiety. Such a reaction has been noted by other workers whilst
attempting to remove Fmoc with piperidine in the presence of a Michael acceptor [43]. We
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therefore found that a tertiary amine base, triethylamine (TEA), could be used to bring about
the removal of Fmoc. These conditions also turned out to be rigorous enough to bring about
cyclisation. Thus, treatment of the Fmoc protected ketone derivatives 24a-c with excess TEA
in anhydrous dichloromethane at reflux resulted in the complete disappearance by Tl.C of the
starting material after 15 hours and in the isolation, in each case, of a major new product. The
new products were not the deprotected compounds 25 (scheme 4), nor the expected cyclisa-
tion products 26, but were in fact the 3-hydroxy-l ,2,5-benzothiadiazepines 27a-c which were
isolated in yields of 57-69%.
With regards to a possible mechanism, it is plausible that the 3-hydroxy-I,2,5-
benzothiadiazepines 27 may arise as a result of a series of tautomerisms in starting material
24 to give enol tautomer 28, followed by the formation of tautomer 29 as shown in scheme 5.
Deprotection of tautomer 29 then produces the corresponding amine 30. Clearly, the exact
sequence of events leading to intermediate 30 could be ordered differently so that deprotec-
lion occurs first and is followed by the tautomerism sequence. In any event, cyclisation of
intermediate 30 would give the carbinol amine 31 which could then give the isolated product
27, possibly via an intramolecular process such as that involving the intermediate epoxide 32,
as outlined in scheme 5. Alternatively, loss of water across the C4-N5 bond of compound 31,
and the subsequent intermolecular re-addition of water across the N2-C3 double bond of the
sulfonirnine, would give the isolated product 27.
In the final part of this work, as shown in scheme 6, we investigated the use of
2-nitrobenzenesulfonamide as a precursor for a shorter synthesis of I,2,5-benzothiadiazepine
1, l-dioxides. In this respect, we were surprised to find that, whilst we were able to convert
2-nitrobenzenesulfonamide into the dienophile 33 and isolate the Diels-Alder adduct 34c
derived from hexadiene, we were unable to isolate the butadiene or isoprene adducts 34a and
34b. This was due to their ready conversion into the corresponding homoallylic sulfonamides
36 (R4 = H or Me) in the presence of atmospheric moisture. The formation of homoallylic
sulfonamides 36 is due to attack of water at the 1,2-thiazine sulfur atom in compounds 34a
and b, followed by ring opening of the 1,2-thiazine to give an allylic sulfinic acid 35 with sub-
sequent retro-ene loss of S02, an overall process that has precedent in the literature [48-53].
We believe that the presence of a methyl group at the 6-position of the 1,2-thiazine ring in
the hexadiene adduct 34c (R5 = Me) offers sufficient steric hindrance to prevent the initial
18zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
27a (R5 '" R4", R3", H), 69%
27c (R5 = R3 = H. R4 = Me), 62%
27c (R5 '" R3 '" iII1e; R4 '" H), 57%
1. Fmoc-CI
2. [OJzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
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[not formedl
26
[not formedl
SCHEME 4 Synthesis of 3-hydroxy-l ,2.5-benzothiadiazepines.
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SCHEME 5 Suggested mechanism for the formation of 3-hydroxy-I,2,5-benzothia-
diazepines 27.
attack of water at sulfur, hence allowing this adduct to be isolated, whereas adducts 34a and
b (R5 = H) are able to accommodate ready access of water to the sulfur and can thus go
on to produce the homoallylic sulfonamides 36. Hexadiene adduct 34c was isolated in 60%
yield and was converted into the alcohol 37c in 89% yield and thence into the correspond-
ing ketone 38c in 84% yield, again with the expected (see above) (E)-alkene geometry, as
shown in scheme 6. The treatment of this ketone with zinc in acetic acid gave access to the
4-alkenyl-I,2,5-benzothiadiazepine 1.l-dioxide 39c in 45% yield. Interestingly, we were able
to show that the air sensitive isoprene and butadiene adducts 34a and 34b could be convertedzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
in situ into the alcohols 37a and 37b using the PhMgBr/P(OMeh sequence in overall yields
of 38% and 45%, respectively, for the four step process from 2-nitrobenzenesulfonamide.
The same 'in situ' process when applied to the hexadiene system gave another method for
accessing the alcohol 37c which was obtained in 44% overall yield for the four steps from
2-nitrobenzenesulfonamide. Finally, oxidation of alcohols 37a and b was achieved in yields
of 78% and 89% to give the ketones 38a and b. Ring closure using zinc in acetic acid gave
the 4-alkenyl-I,2,5-benzothiadiazepine l.J-dioxides 39a and 39b in 50% and 49% yields,
respectively.
3. Summary
In conclusion, two efficient entries (3 examples of each) into the 1,2,5-benzothiadiazepine
Ll-dioxide system have been reported which rely upon the synthesis of N-(o-
aminobenzenesulfonylj-I ,2-vicinal amino alcohols or N -(o-nitrobenzenesulfonyl)-l ,2-vicinal
amino alcohols from I,2-thiazine I-oxides, which are derived in tum from
2-aminobenzenesulfonamide and 2-nitrobenzenesulfonamide, respectively. A hetero-Diels-
Alder reaction between a diene and a N -sulfinyl dienophile was used to install the I,2-thiazine
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SCHEME 6 1,2,5-Benzothiadiazepines from 2-nitrobenzenesulfonamide. Reaction
conditions: (i) SOCI2, pyridine, THF or SOCI2 (1.5 equiv.), benzene, reflux, 72 hours.
(ii) diene. (iii) PhMgBr. THF, -40°C then H20. (iv) P(OMeh, MeOH, heat. (v) Dess-Martin
periodinane. (vi) Zn/AcOH, reflux.
I-oxide grouping which, after conversion into an allylic sulfoxide, underwent a [2.3]-
sigmatropic rearrangement and desulfurisation to produce the 1,2-amino alcohol functionality.
For the 2-aminobenzenesulfonamide series, the conversion of the o-amino group into an
azide allowed the selective functionalization of the sulfonamide nitrogen. The azide could
be converted back into the amine very efficiently via the hydrolysis of an intermediate
iminophosphorane, or, less efficiently, via the hydrolysis of an intermediate triazene. ThezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
N -(o-aminobenzenesulfonyl)-l ,2-vicinal amino alcohols so obtained proved to be useful pre-
cursors for the synthesis of 3-hydroxy substituted 1.2.5-benzothiadiazepine 1, l-dioxides, For
the 2-nitrobenzenesulfonamide series, the Diels-Alder-[2,3]-sigmatropic rearrangement -
desulfurisation sequence gave N -(o-nitrobenzenesulfonyl)-l ,2-vicinal amino alcohols which
served as useful precursors for the synthesis of 4-alkenyl substituted 1.2,5-benzothiadiazepine
lI-dloxides.
4. Experimental section
4.1 General considerations
All starting materials and reagents were used as commercially available. Pyridine.
triethylamine. piperidine, diisopropylamine, and N ,N -diisopropylethylamine, were dried over
4 A molecular sieves prior to use. Solvents for chromatography were of analytical grade.
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Petroleum ether used for chromatography was of the 40-60°C boiling point range. Anhy-
drous grade solvents were used as supplied. without additional drying, except where stated.
Unless otherwise stated, all reactions were conducted using oven-dried glassware under a
positive pressure of dry, oxygen-free nitrogen. All reactions were monitored by thin-layer
chromatography using aluminium plates coated with silica gel with F2s4 fluorescent indicator.
Various mixtures of petroleum ether (40-60 "C) and ethyl acetate were used as the eluent and
visualisation of the plates was achieved using ultraviolet light and/or vanillin stain. Flash col-
umn chromatography was performed using flash grade silica gel (70-230 mesh; 60 .A) using
the eluent described in the experimental protocol.
IHand 13CNMR spectra were recorded on a Bruker DPX-400 or Bruker AC-250 spectro-
meter operating at 400 MHz (or 100 MHz) and 250 MHz (or 63 MHz) frequency, respectively.
Coupling constantszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(J) are reported in Hertz (Hz) nd resonances are designated as follows:
singlet (s); doublet (d); triplet (1); quartet (q); quintet (quint). Broad signals in IH NMR
are denoted as 'br' and signals corresponding to quaternary carbon atoms in 13C NMR are
indicated as 'q', Low resolution mass spectra (LRMS) were recorded on a Micromass Quattro
II Triple Quadrupole or a VG Micromass 7070 H mass spectrometer operating at a positive ion
mode under electron impact (El), chemical ionisation (Cl), or electrospray ionisation (ESI)
methods. Molecular ions are reported as their mass, with the percentage abundance quoted in
brackets. High resolution mass spectra (HRMS) were recorded on a Finnegan MAT 900 XTL
instrument operated by the EPSRC National Mass Spectrometry service at the University of
Wales Swansea, UK, and are reported for compounds of >99% purity (NMR) which were
single spot pure by TLC. Infrared spectra (IR) were recorded on a Perkin Elmer Paragon 1000
FT-IR instrument as thin films between NaCI plates (oils) or as KBr disks (solids). Absorptions
are listed as wavenumber (cm='), with their absorption intensity indicated parenthetically as
broad (b), strong (s), medium (m) or weak (w).
4.2 Synthesis of 2-(0-azidobenzenesuljonyl)-3,6-dihydro-I,2-thiazine l-oxides (15)
4.2.1 General procedure, Method A. To a suspension of e-azldobenzenesulfonamide
(13; 5-8 mmol, 1.0 eq) in anhydrous benzene (30-50 ml) [CAUTION: SUSPECTED
CARCINOGEN - see Method B for an alternative] was added, under an atmosphere of dry
nitrogen, thionyl chloride (1.5 eq), and the whole was heated at reflux in an oil bath for 3 days
('" 72 hours). or until the sulfonamide had completely dissolved. The reaction mixture was
allowed to cool to room temperature and the solvent and excess thionyl chloride were
removed in vacuo to yield the N -sulfinyl-c-azidobenzenesulfonarnlde (14) as a brown
oil. To the crude N -sulfinyl-o-azidobenzenesulfonamide (14) in anhydrous tetrahydrofu-
ran (20-30 ml) was added, under nitrogen, the diene .(1.6 eq), and the reaction mixture
was stirred at room temperature for 6-16 hours, whilst being monitored by TLC. After
completion of the reaction, the solvent was removed in vacuo and the crude product
was purified by flash silica column chromatography (eluent: PE:EtOAc/I:I) to yield the
2-(o-azidobenzenesulfonyl)-3,6-dihydro-I ,2-thiazine l-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(15), as follows:
2-(o-Azidobenzenesu/fonyl)-3.6-dihydro-l.2-thiazine l-oxide (15a) was obtained as a
yellow solid (1.235 g, 82% yield) from o-azidobenzenesulfonamide (13; 1.000 g. 5.05 mmol)
and 1,3-butadiene (large excess, -10 eq), mp: 122-124°C.
OH (400MHz. CDCh): 3.45 (1H, ddd, J 16.5,6.2,2.3, CB2S=O), 3.61 (1H, ddd, J 16.5,
5.1,2.5, CB2S=O), 3.83 (1H, ddd, J 17.4,5.2,2.3, CB2N), 4.11-4.17 (1H, m, CB2N),
5.73-5.79 (1H, m, HC=CB), 5.96-6.01 (1H. m, BC=CH), 7.28 (1H, td, J 7.8,0.9. ArB),
7.34 (1H, dd, J 8.0, 0.8, ArB), 7.66 (1 H, td, J 7.8, 1.5, ArB), 8.01 (1H, dd, J 8.0, 1.5,
ArB).oc (lOOMHz, CDCh): 39.0 (CH2), 50.6 (CH2), 114.6 (CH), 120.3 (CH), 124.3 (CH),
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124.6 (CH), 127.7 (q), 131.6 (CH), 135.1 (CH), 139.1 (q).zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAVmax (cm "): 30tO (w), 2919 (w),
2133 (s), 1575 (m), 1470 (s), 1433 (m), 1352 (s), 1282 (s), 1170 (s), lt03 (s), 1060 (s),
1003 (m), 868 (m), 771 (s), 653 (m). EI+ mass spectrum (m/z, %): 298 ([M]+, 4%), 282
([M-O]+, 1%),270 ([M-N2]+, 2%), 250 ([M-SO]+, 3%),172 (5%),156 (10%),116 (25%),
104 (20%), 90(40%), 76(35%), 64(50%), 54(30%), 39 (100%). CH mass spectrum (m/z, %):
316 ([M+Nf4]+, 100%),299 ([M+H]+, 6%). HRMS (ESI+): found [M+Nf4]+ 316.0534,
ClOHlON403S2 requires 316.0538. C, H, N(%): found C 40.4, H 3.4, N 18.6; ClOHlON403S2
requires C 40.3, H 3.4, N 18.8.
2-( o-Azidobenzenesu/fonyl)-3.6-dihydro-5-methyl-I,2-thiazine I-oxide (ISh) was obtained
as a yellow solid (1.845 g, 78% yield) from o-azidobenzenesulfonamide (13; 1.500 g,
7.57mmol) and isoprene (1.21 ml, 12.11 mmol), mp: 146-148 DC.
8H (400MHz, CDCh): 1.80 (3 H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH3), 3.23 (1 H, dd, J 16.2,1.8, CH2S=O), 3.57-3.62
(1 H, dm, J 16.2, CH2S=O), 3.75-3.82 (1 H, dm, J 17.0, CH2N), 4.05-4.tO (1 H, dm, J
17.0, CH2N), 5.66 (1 H, d, J 1.9, MeC=CH), 7.24 (1 H, t, J 7.7, ArH), 7.32 (1 H, d, J 8.1,
Ar H), 7.64 (1 H, td, J 7.8, 1.4, Ar H), 7.99 (1 H, dd, J 8.0, 1.4, Ar H). 8c (100 MHz, CDCh):
24.2 (CH3), 39.3 (CH2), 54.3 (CH2), 117.6 (CH), 120.2 (CH), 122.6 (q), 124.5 (CH), 127.7
(q), 131.5 (CH), 135.1 (CH), 139.0 (q). Vmax (cm "): 3011 (w), 2916 (w), 2134 (s), 1575
(m), 1473 (s), 1444 (m), 1350 (s), 1293 (m), 1172 (s), 1103 (s), t064 (m), 10tO (w), 832
(m), 757 (s), 655 (m). EI+ mass spectrum (m/z, %): 312 ([M]+, 2%), 296 ([M-O]+, 1%),
284([M-Nz]+,3%),264([M-SO]+,I%),183(5%),171 (to%),156(15%),130(10%),108
(15%),104 (15%), 90 (55%), 84 (45%), 76 (35%), 68 (100%). CI+ mass spectrum (m/z, %):
330 ([M+Nf4]+, 97%), 313 ([M+H]+, 15%),284 ([M-N2]+, 90%). HRMS (ESH): found
[M+H]+ 313.0425, CllHIZN403S2 requires 313.0429. C, H, N(%): found C 42.4, H 3.7, N
17.8; CllHI2N403S2 requires C 42.3, H 3.9, N 17.9.
2-( o-Azidobenzenesu/fonyl)-3,6-dihydro-3,6-dimethyl-I,2-thiazine I-oxide (lSe) was obtai-
ned as a yellow solid (1.580 g, 80% yield) from o-azidobenzenesulfonamide (13; 1.200 g,
6.054 mmol) and (E, E)-2,4-hexadiene (1.10 ml, 9.69 mmol), mp: 137-139 DC.
8H (250 MHz, CDCh): 1.27 (3 H, d, J 7.0, CH3CHS=O), 1.46 (3 H, d, J 7.4, CH3CHN),
3.29-3.41 (1 H, m, MeCHS=O), 4.55-4.68 (1 H, m, MeCHN), 5.45 (1H, ddd, J 11.0,2.5,
1.5, HC=CH), 5.91 (1 H, dt, J 11.0,3.2, HC=CH), 7.25-7.35 (2H, m, 2xArH), 7.62-7.69
(1 H, m,ArH), 8.06(1 H,dd, J 8.0,O.9,ArH). 8c (63MHz, CDCl): 15.9 (CH3), 22.2 (CH3),
51.2 (CH), 53.3 (CH), 119.8 (CH), 120.1 (CH), 124.8 (CH), 129.7 (CH), 130.4 (q), 131.1
(CH), 135.0 (CH), 138.7 (q). Vmax (cm "): 3020 (w), 2929 (w), 2131 (s), 1575 (m), 1472
(s), 1441 (m), 1353 (m), 1262 (s), 1166 (s), 1121 (s), 1060 (m), 1003 (m), 877 (m), 752 (s),
657 (m). EH mass spectrum (m/z, %): 327 ([M+H]+, 2%), 310 ([M-O]+, 2%), 298 ([M-
N2]+, 4%), 278 ([M-SO]+, 3%), 208 (10%),198 (5%),183 (5%),171 (10%), 154 (8%),144
(10%),105 (15%), 96 (20%), 90 (30%),82 (100%), 76 (25%), 67 (60%). CI+ mass spectrum
(m/z, %): 344 ([M+Nf4]+, 100%), 327 ([M+H]+, 55%), 298 ([M-N2]+' 20%). HRMS
(ESI+): found [M+H]+ 327.0585, CI2HI4N403S2 requires 327.0585. C, H, N(%): found C
44.4, H 4.4, N 17.0; CI2HI4N403S2 requires C 44.2, H 4.3, N 17.2.
4.2.2 Method B (avoiding the use of benzene). To a solution of o-azidobenzenesulfo-
namide (13, "-'5-10mmol, 1.0eq) and anhydrous pyridine (2.0eq) in anhydrous tetrahydro-
furan (30-60 ml), under an atmosphere of dry nitrogen, was added, dropwise with stirring
over a period of 3 hours, a solution of thionyl chloride (1.0eq) in anhydrous tetrahydrofuran
(5-8 ml). Stirring of the reaction mixture was continued for a further 30 minutes, followed
by dropwise addition of the appropriate 1,3-diene (1.6eq), and the whole was allowed to
stir at room temperature for 6-16 hours whilst being monitored by TLC. In the case of the
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1,3-butadiene adduct (lSa), the diene was condensed at low temperature (-20°C) and sub-
sequently added to the mixture, maintaining the low temperature of the reaction forzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA4-6
hours. After completion of the reaction, the solvent was removed in vacuo and the crude
product was purified by flash column silica chromatography (eluent PE:EtOAc/l:l). The
2-(0-azidobenzenesu/fonyl)-3,6-dihydro-l,2-thiazine l-oxides (15) were obtained as follows:
2-(0-Azidobenzenesu/fonyl)-3,6-dihydro-l,2-thiazine l-oxide (lSa) was obtained as a yel-
low solid (0.8720 g, 58% yield) from o-azidobenzenesulfonamide (13; 1.000 g, 5.05 mmol)
and 1,3-butadiene (large excess, '" 10 eq).
2-( o-Azidobenzenesu/fonyl)-3,6-dihydro-5-methyl-l,2-thiazinel-oxide (lSb) was obtained
as a yellow solid (1.512 g, 60% yield) from o-azidobenzenesulfonamide (13; 1.600 g,
8.07 mmol) and isoprene (1.29 ml, 12.92 mmol).
2-( o-Azidobenzenesulfonyl )-3, 6-dihydro-3,6-dimethyl-l ,2-thiazine l-oxide (lSc)was obtai-
ned as a yellow solid (1.720 g, 70% yield) from o-azidobenzenesulfonamide (13; 1.500 g,
7.57 mmol) and 2,4-hexadiene (1.38 ml, 12.11 mmol). [For full characterization data of these
compounds, see Method A, above].zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4.3 Synthesis o!(o-aminobenzenesuljonamidyl)alkenols (18)
4.3.1 Method 1. Synthesis via the triazene route (see scheme 2). Synthesis of
[3'-(0-benzenesulfonamidyl)-I'-phenyltriazene] alkenols (17). A solution of phenylmag-
nesium bromide (3 M in ether, 3.0 eq) was added to a stirred solution of the 2-(0-
azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide (15; "'1.0-3.5 mmol, 1.0eq) in
anhydrous tetrahydrofuran (10-20 ml) at -78°C, under an atmosphere of dry nitrogen. The
reaction mixture was kept at low temperature (<-40 QC)for 3-4 hours, whilst being monitored
by TLC. Upon completion of the reaction, the mixture was quenched at -20°C with saturated
ammonium chloride solution (15 ml) and allowed to warm to room temperature. The mixture
was extracted with ethyl acetate (2 x 20 ml) and the combined organic layers were washed
with water (2 x 20 ml) and brine (10 ml). The organic phase was collected, dried (MgS04),
filtered and the solvent evaporated off to yield the phenyl allylic sulfoxide (16), which was
not purified further. To a solution of the crude allylic sulfoxide (16) in anhydrous methanol
(10-20 ml) was added anhydrous piperidine (5.0 eq), under an atmosphere of dry nitrogen,
and the whole was heated under reflux for a total of 10-15 hours, whilst being monitored
by TLC. Upon completion of the reaction, the solvent was removed in vacuo and the crude
product was purified by flash column chromatography (eluent: PE:EtOAc/5:2) to yield the
[3' -(o-benzenesulfonamidylj-I '-phenyltriazene] alkenols (17) as follows:
4-[3' -(o-Benzenesulfonamidyli-I '-phenyltriazene J-but-l-en-3 -01 (17a) was obtained as
a yellow oil, which solidified to give a waxy solid (0.7770 g, 67% yield), from
2-(0-azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide (lSa; 1.000 g, 3.35 mmol), mp
172-174°C.
8H (400MHz, CDCh): 2.92 (1 H, dd, J 12.8,8.2, CH2NH), 3.19 (1 H, dd, J 12.8,3.3,
CH2NH), 4.37 (1 H, s, br, CHOH), 5.17 (1 H, d, J 10.6, HC=CH2), 5.33 (1 H, d, J 17.2,
HC=CH2), 5.81 (1 H, ddd, J 16.6, 10.8,5.6, H2C=CH), 7.11-7.13 (3H, m, 3 x ArH), 7.25
(2H, t, J 7.7, 2 x ArH), 7.31 (1 H, t, J 7.6,ArH), 7.54 (1 H, t, J 7.8, ArH), 7.71 (1 H, d, J
8.1, ArH), 8.02 (1 H, d, J 7.8, ArH). 8c (100MHz, CDCh): 48.7 (CH2), 71.1 (CH), 117.0
(CH2), 117.5 (CH), 124.9 (CH), 125.3 (CH), 129.2 (CH), 129.3 (CH), 129.7 (q), 133.9 (CH),
135.4 (q), 136.9 (CH), 144.0 (q). Umax (neat oil, cm "): 3476 (bm), 3291 (m), 3231 (m), 2987
(m), 2928 (m), 2306 (m), 1602 (s), 1527 (m), 1466 (s), 1441 (s), 1421 (s), 1327 (s), 1155 (s),
1126 (m), 1087 (m), 909 (s), 728 (s), EI+ mass spectrum (m/z, %): 346 ([M]+, 1%), 149
(15%),105 (20%), 91 (20%),84 (75%), 77 (60%), 69 (35%), 65 (25%), 57 (40%). ESI+ mass
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spectrum (m/z, %): 715 ([2M+Na]+,25%),693 ([2M+H]+,2%), 369([M+Na]+, 100%),347
([M+H]+, 10%). HRMS (ESI+): found [M+H]+ 347.1174, CI6HISN403S requires 347.1178.
C, H, N(%): found C 55.4, H 5.4, N 16.4; CI6HISN403S requires C 55.5, H 5.2, N 16.2.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
4-[3 '-(o-Benzenesulfonamidyl)-l '-phenyltriazeneJ-2-methyl-but-I-en-3-01 (17b) was ob-
tained as a yellow oil which solidified on standing to give a waxy solid (0.3690 g, 64% yield)
from 2-(0-azidobenzenesulfonyl)-3,6-dihydro-5-methyl-l,2-thiazinel-oxide (ISb; 0.5000 g,
1.60mmol), mp 122-128 "C,
8H (400MHz, CDCh): 1.67 (3 H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACB3), 2.80 (1 H, s, br, OH), 2.93 (1 H, dd, J 12.7,
8.3, CB2NH), 3.24 (1 H, dd, J 12.7, 3.3, CB2NH), 4.26 (1 H, dd, J 5.2, 1.6, CHOH), 4.90
(1H, s, MeC=CB2), 5.03 (1H, s, MeC=CB2), 6.05 (1H, s, br, NH), 7.19-7.21 (3H, m,
3 x ArB), 7.28-7.32 (3 H, m, 3 x ArB), 7.55 (1 H, td, J 7.8, 1.3, ArH), 7.74 (1 H, d, J
8.2,ArB), 8.01 (1 H, dd, J 7.9, 1.3, ArB), 11.0 (1 H, s, br, NH). 8c (100MHz, CDCh): 18.5
(CH3), 47.5 (CH2), 73.5 (CH), 112.5 (CH2), 117.1 (q), 117.4 (CH), 123.0 (q), 123.2 (q), 125.1
(CH), 125.3 (CH), 129.2 (CH), 129.4 (CH), 133.9 (CH), 144.0 (q). Vmax (cm "): 3468 (bm),
3290 (m), 3229 (m), 2987 (m), 2927 (m), 2306 (m), 1602 (s), 1526 (m), 1466 (s), 1441 (s),
1420 (s), 1327 (s), 1154 (s), 1123 (m), 1098 (m), 910 (m), 730 (s). EI+ mass spectrum (m/z,
%): 360 ([M]+, 1%), 156 (10%), 105 (25%), 92 (40%), 84 (20%), 77 (100%), 69 (25%), 65
(45%),57 (25%). ESI+ mass spectrum (m/z, %): 743 ([2M+Na]+, 30%), 721 ([2M+H]+,
5%),383 ([M+Na]+,loo%),361 ([M+H]+,15%). HRMS (ESI+): found [M+H]+ 361.1333,
C17H20N403S requires 361.1334. C, H, N(%): found C 56.9, H 5.8, N 15.2; C17H20N403S
requires C 56.7, H 5.6, N 15.5.
(E)-5-[ 3'-( o-Benzenesulfonamidylt-I '-phenyltriazenel-hex-l-en-t-ol (17c) was obtained
as a yellow waxy solid (0.4740 g, 59% yield) from 2-(0-azidobenzenesulfonyl)-3,6-dihydro-
3,6-dimethyl-l,2-thiazine l-oxide (ISc; 0.7000 g, 2.15 mmol), mp: 149-153 "C.
8H (400MHz, CDCh): 1.07 (3H, d, J 6.7, CH3CHNH), 1.62 (3H, dd, J 6.5, 1.4,
CB3CH=CH), 3.00 (1 H, s, br, OB), 3.34 (1H, dq, J 15.3,6.4, MeCHNH), 3.94 (1 H, t,
J 6.5, CBOH), 5.39 (1H, ddd, J 15.3,7.3, 1.5, MeHC=CB), 5.71 (1 H, dq, J 14.9,6.6,
CH=CBMe), 5.90 (1 H, s, br, NB), 7.13 (1 H, t, J 7.1, ArB), 7.16-7.21 (2H, m, 2 x ArB),
7.25-7.30 (3H, m, 3 x ArB), 7.53 (1 H, td, J 7.8, 1.4, ArH), 7.75 (1 H, d, J 8.1, ArB),
8.01 (1 H, dd, J 7.9, 1.1, ArB), 11.2 (1 H, s, br, NB). 8c (lOOMHz, CDCh): 17.4 (CH3),
17.7 (CH3), 54.9 (CH), 75.7 (CH), 117.2 (CH), 117.3 (CH), 122.7 (q), 125.1 (CH), 125.3
(CH), 129.1 (CH), 129.8 (CH), 130.1 (CH), 132.3 (q), 133.7 (CH), 141.3 (q). Vmax (cm'"):
3470 (bm), 3289 (m), 3230 (m), 2987 (m), 2928 (m), 2305 (m), 1601 (s), 1527 (m), 1465
(s), 1441 (s), 1422 (s), 1327 (s), 1155 (s), 1123 (m), 1087 (m), 896 (m), 739 (s). EI+ mass
spectrum (m/z, %): 374 ([M]+, 1%),303 (2%),149 (15%), 105 (40%),92 (30%), 84 (65%),
77 (100%), 69 (65%), 65 (35%), 56 (70%). ESI+ mass spectrum (m/z, %): 771 ([2M+Na]+,
25%),749 ([2M+H]+, 3%), 397 ([M+Na]+, 100%),375 ([M+H]+, 10%). HRMS (ESI+):
found [M+H]+ 375.1486, CIsH22N403S requires 375.1491. C, H, N(%): found C 57.4, H
5.8, N 15.1; CIsH22N403S requires C 57.7, H 5.9, N 15.0.
Synthesis of (o-aminobenzenesulfonamidyl)alkenols (18) from triazenes (17). A solution
of the [3' -(o-benzenesulfonamidyl)-I' -phenyltriazene] alkenol (17) (-0.5-1.5 mmol) in stan-
dard laboratory reagent grade methanol was heated at reflux in the open air for a total of 5 hours.
The reaction mixture was allowed to cool to room temperature, the solvent was removed in
vacuo and the crude product was purified by column chromatography (eluent: PE:EtOAc/5:2)
to yield the 4-(0-aminobenzenesulJonamidyl)-but-l-en-3-0Is (18) in 60-70% yield. As a typ-
ical example, 4-(0-aminobenzenesulJonamidyl)-but-l-en-3-01 (18a) was obtained as a yellow
oil (0.2450 g, 70% yield) from 4-[3' -(o-benzenesulfonamidyl)-I' -phenyltriazene]-but-l-en-3-
01 (17a; 0.5000 g, 1.44 mmol). [Data for compounds (18a-c) were identical to that provided
via the more efficient Method 2, details of which are listed immediately below].
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4.3.2 Method 2. Synthesis via the hydrolysis ofiminophosphorane (20) (see scheme 3).
Synthesis of 2-(0-aminobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxides (21). To a solu-
tion of the 2-(o-azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide (15; .......3-6mmol,
1.0 eq) in anhydrous tetrahydrofuran (10-20 ml) was added, dropwise with stirring over
a period of 1 hour, a solution of triphenylphosphine (1.0eq) in anhydrous tetrahydro-
furan (5-8 ml) under an atmosphere of dry nitrogen. The mixture was stirred for 3-4
hours, after which analysis by TLC showed a single new spot, assumed to be the 2-[o-N-
(tripheny Iphosphorany lidene )benzenesulfony 1]-3,6-dih ydro-I ,2-thiazine l-oxides (20).Water
(.......8 eq) was added to the mixture and the whole was heated at reflux in the open air for a total
of 15 hours, at which stage TLC showed disappearance of the assumed intermediate (20) and
the presence of a single new spot together with base-line material which was later identified
as triphenylphosphine oxide. The reaction mixture was allowed to cool to room temperature,
the solvent was removed in vacuo and the crude product was purified by gravity column
chromatography on silica (eluent: PE:EtOAcj2:1) to yield the 2-(o-aminobenzenesulJonyl)-
3,6-dihydro-i,2-thiaZine I-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(21) as light yellow oils, which darkened on standing and
which were used immediately in the next step. Data for samples of compounds (21a-c) were
as follows:
2-(o-AminobenzenesulJonyl)-3.6-dihydro-i.2-thiazine l-oxide (21a) was obtained as a yel-
low oil (0.900 g, 99%) from 2-(o-azidobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide
(15a; 1.000 g. 3.35 mmol).
8H (250MHz, CDCh): 3.39 (1 H, ddd, J 16.5,6.3.2.4.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH2S=O), 3.61 (1 H, d d, J 1604,
5.2,2.8. CH2S=O), 3.80 (1 H, ddd, J 17.1,5.3,2.3, CH2N), 3.99-4.10 (1 H, dm, J 17.1,
CH2N), 5.12 (2H, s, br, NH2), 5.71 (1 H, dddd, J 12.8.8.6,4.5,2.1, HC=CH). 5.92-6.00
(1 H, m, HC=CH), 6.72-6.81 (2H, m, 2 x ArH), 7.33 (1 H. td, J 7.7,1.6, ArH), 7.67 (1 H.
dd, J 8.1, 1.5, ArH). 8c (63 MHz, CDCI): 39.0 (CH2), 50.6 (CH2). 114.5 (CH), 117.6 (CH),
117.7 (q), 118.1 (CH), 12404(CH), 130.1 (CH), 135.4 (CH), 146.2 (q). 31p spectroscopy
showed the sample to be free of phosphorus. Vmax (cm'): 3432 (m), 3339 (m), 2960 (m),
2918 (m), 1617 (s), 1560 (m), 1484 (s), 1454 (m), 1342 (s), 1166 (s), 1075 (s), 1002 (m), 869
(m), 773 (s), 630 (s). EI+ mass spectrum (mjz, %): 273 ([M+H]+, 3%), 272 ([M]+, 15%),
224 ([M-SO]+, 15%),218 (30%), 172 (5%), 156 (40%), 140 (10%),116 (10%),108 (30%),
92 (100%), 65 (80%), 54 (10%). CI+ mass spectrum (mjz, %): 290 ([M+N~]+, 100%),
273 ([M+H]+, 60%). HRMS (ESI+): found [M+H]+ 273.0367, CIOH12N203S2 requires
273.0367.
2 -(o-Aminobenzenesulfonylt-B, 6-dihydro-5-methyl-i.2-thiazine I-oxide (2Ib) was obtai-
ned as a yellow oil (1.454 g, >99%) from 2-(o-azidobenzenesulfonyl)-3,6-dihydro-5-methyl-
1,2-thiazine l-oxide (ISb; 1.600 g, 5.12 mmol, 1.0 eq).
8H (400MHz, CDCh): 1.83 (3 H, s, CH3), 3.22 (1H, dd, J 16.2, 1.9, CH2S=O). 3.61 (1 H.
dt, J 16.2.1.2. CH2S=O). 3.80 (1 H. ddq, J 16.6.5.8.2.1. CH2N). 4.00 (1 H. dt. J 16.6.2.1,
CH2N). 5.14 (2H. s, br, NH2). 5.67 (1 H. m, MeC=CH). 6.75 (1 H. ddt J 8.1. 0.6.ArH). 6.80
(1 H. dt. J 7.6. 0.8. ArH), 7.35 (1 H. td, J 7.7. lA. ArH). 7.70 (1 H. ddt J 8.1, 1.4. ArH). 8c
(100MHz. CDCi): 24.3 (CH3). 39.3 (CH2). 54.3 (CH2). 117.6 (CH). 117.8 (CH). 117.9 (q),
118.0 (CH). 122.6 (q), 130.2 (CH). 135.4 (CH). 146.1 (q). Vmax (cm "): 3462 (m). 3338 (m).
2961 (m). 2928 (s), 1625 (m), 1598 (m). 1483 (s). 1438 (s). 1343 (s), 1158 (s), 1093 (s), 1027
(w), 927 (m). 758 (s), 668 (s). EI+ mass spectrum (mjz, %): 286 ([M]+. 4%).238 ([M-SO]+,
8%).218 (15%).172 (10%).156 (30%).140 (10%).108 (35%). 92 (100%). 65 (25%). ESI+
mass spectrum (mjz. %): 309 ([M+Na]+. 8%),287 ([M+H]+, 20%). HRMS (ESI+): found
[M+H]+ 287.0524. CIIHI4N203S2 requires 287.0524.
2-( o-AminobenzenesulJonyl)-3.6-dihydro-3.6-dimethyl-i.2-thiazine J -oxide (21e) was
obtained as a yellow oil (1.650 g, >99%) from 2-(o-azidobenzenesulfonyl)-3.6-dihydro-3.6-
dimethyl-Lz-thiazine I-oxide (ISe; 1.800 g. 5.52 mmol).
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OH (250MHz, CDCh): 1.41 (3 H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 7.0, CH3CHS=O), 1.44 (3 H, d, J 7.5, CH3CHN),
3.42 (1 H, dq, J 7.6,1.9, MeCHS=O), 4.33 (1 H, dq, J 6.8, 3.4, MeCHN), 4.91-4.95 (2H, br,
NH2), 5.38 (1 H, ddd, J 11.0,2.1,2.1, HC=CH), 5.84 (1 H, ddd, J 11.0,3.3,3.3, HC=CH),
6.75 (1 H, d, J 8.3, ArH), 6.78-6.83 (1 H, m, ArH), 7.34 (1 H, td, J 7.7, 1.5, ArH), 7.75
(1 H, td, J 7.5, 1.5, ArH). oc (63 MHz, CDCh): 15.8 (CH3), 22.9 (CH3), 50.8 (CH), 52.9
(CH), 117.8 (CH), 118.0 (CH), 119.8 (CH), 120.8 (q), 129.5 (CH), 129.9 (CH), 135.1 (CH),
145.3 (q). Vmax (cm='): 3476 (w), 3373 (w), 2968 (m), 2928 (m), 1621 (m), 1566 (w), 1483
(s), 1455 (m), 1342 (s), 1157 (s), 1100 (s), 942 (m), 880 (s), 755 (s), 669 (s). EI+ mass
spectrum (m/z, %): 300 ([M]+, 2%), 252 ([M-SO]+, 4%),218 (15%), 172 (4%),156 (6%),
140 (5%), 108 (20%), 92 (100%),82 (80%), 77 (20%), 65 (85%). CI+ mass spectrum (m/z,
%): 318([M+N14]+, 70%), 301 ([M+H]+,40%). HRMS (ESI+): found [M+H]+ 301.0675,
C12H16N203S2 requires 301.0680.
Synthesis of (o-aminobenzenesulfonamidyl)alkenols (18) from compounds (21). A solu-
tion of phenylmagnesium bromide (3 M in ether, 2.0 eq) was added to a stirring solution of
the 2-(o-aminobenzenesulfonyl)-3,6-dihydro-1 ,2-thiazine I-oxide (21; "'2-5 mmol, 1.0 eq) in
anhydrous tetrahydrofuran (10-20 ml) at -78°C, under an atmosphere of dry nitrogen. The
reaction mixture was kept at low temperature (zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA< -40 "C) for 3-4 hours, whilst being moni-
tored by TLC. Upon completion of the reaction, the mixture was quenched at -20°C with
saturated ammonium chloride solution (15 ml) and allowed to warm to room temperature.
The mixture was extracted with ethyl acetate (2 x 20 ml) and washed with water (2 x 20 ml)
and brine (10 ml). The organic phase was collected, dried (MgS04), filtered and the solvent
evaporated off to yield the phenyl allylic sulfoxide (22), which was not purified further. To
a solution of the crude allylic sulfoxide (22) in anhydrous methanol (10-20ml) was added
trimethyl phosphite (2.0 eq), under an atmosphere of dry nitrogen, and the whole was heated
under reflux for a total of 10-15 hours. Upon completion of the reaction (TLC), the solvent was
removed in vacuo and the crude product was purified by flash silica column chromatography
(eluent: PE:EtOAc/5:2) to yield the (o-aminobenzenesulJonamidyl)alkenols (18) as yellow
oils which darkened on standing at room temperature, but which were stored without detri-
ment at -15°C and used after 24 hours in the next step. Data for samples of compounds
(18a-e) were as follows:
4-(o-AminobenzenesulJonamidyl)-but-l-en-3-ol (lSa) was obtained as a yellow oil
(0.6120 g, 86% yield) from 2-(o-aminobenzenesulfonyl)-3,6-dihydro-l,2-thiazine l-oxide
(21a; 0.8000 g, 2.94 mmol).
OH (400MHz, CDCh): 2.85 (1 H, ddd, J 13.1,8.0,5.2, CH2NH), 3.08 (1 H, ddd, J 13.1,
7.6,3.7, CH2NH), 4.15-4.17 (1 H, m, CHOH), 4.75 (2H, s, br, NH2), 5.17 (1 H, dt, J 10.5,
1.0, HC=CH2), 5.28 (1 H, dt, J 17.2, 1.2, HC=CH2), 5.44 (1 H, t, br, J 5.9, S02NH), 5.73
(1H,ddd, J 17.1, 1O.6,5.7,H2C=CH),6.78-6.84(2H,m,2 x ArH), 7.34(1 H, td, J 7.7, 1.5,
ArH), 7.71 (1 H, dd, J 8.0, 1.4,ArH). Oc (100MHz, CDCh): 48.2 (CH2), 71.1 (CH), 117.0
(CH2), 117.8 (CH), 117.9 (CH), 121.5 (q), 129.6 (CH), 134.3 (CH), 137.0 (CH), 145.0 (q).
Vmax (cm "): 3476 (bm), 3377 (bm), 2987 (m), 2928 (m), 1620 (m), 1600 (m), 1573 (w), 1483
(s), 1456 (s), 1332 (s), 1156 (s), 1073 (m), 896 (m), 747 (s), EH mass spectrum (m/z, %): 242
([M]+, 5%),224 ([M-H20]+, 5%), 185 (35%), 168 (15%), 156 (50%), 108 (35%),92 (100%),
65 (98%), 57 (90%). CH mass spectrum (m/z, %): 260 ([M+N14]+, 95%), 243 ([M+H]+,
100%). HRMS (ESH): found [M+H]+ 243.0804, ClOHI4N203S requires 243.0803.
4-(o-AminobenzenesulJonamidyl)-2-methyl-but-l-en-3-ol (18b) was obtained as a yellow
oil (1.115 g, 89% yield) from 2-(o-aminobenzenesulfonyl)-3,6-dihydro-5-methyl-1 ,2-thiazine
I-oxide (21b; 1.400 g, 4.89 mmol).
OH (400MHz, CDCh): 1.66 (3H, s, CH3), 2.88 (1 H, ddd, J 12.9,8.0,3.5, CH2NH), 3.15
(1 H, ddd, J 13.1,8.0,3.6, CH2NH), 4.06 (1 H, dd, J 7.8, 3.6, CHOH), 4.88 (2H, s, br, NH2),
4.93 (1 H, bs, MeC=CH2), 5.00 (1 H, d, J 0.9, MeC=CH2), 5.11 (1 H, s, br, S02NH), 6.80
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(1 H, d, J 8.2,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAArB), 6.85 (1 H, td, J 7.7, 1.0, ArB), 6.85zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA(1H, dd, J 7.7, 1.0, ArB), 7.36
(1H, td, J 7.7,1.7,ArB), 7.74 (1 H, dd, J 8.0, 1.5,ArB). 8c (100MHz, CDCh): 18.3 (CH3),
47.0 (CH2), 73.4 (CH), 112.4 (CH2), 117.8 (CH), 118.1 (CH), 121.7 (q), 129.7 (CH), 134.3
(CH), 144.1 (q), 145.0 (q). Vmax (cm"): 3477 (bm), 3378 (bm), 2986 (m), 2926 (m), 1619
(m), 1600 (m), 1573 (w), 1483 (s), 1456 (s), 1331 (m), 1155 (s), 1090 (m), 910 (m), 756
(s). EH mass spectrum (m/z, %): 256 ([M]+, 3%), 238 ([M-H20]+, 4%), 185 (30%), 168
(15%),156 (50%),108 (35%), 92 (100%), 71 (35%),65 (90%). CI+ mass spectrum (m/z, %):
274 ([M+N~]+, 100%),257 ([M+H]+, 90%). HRMS (ESH): found [M+H]+ 257.0956,
CllH16N203S requires 257.0960.
(E)-5-(o-AminobenzenesulJonamidyl)-hex-2-en-4-01 (lSe) was obtained as a yellow
oil (0.8900 g, 82% yield) from 2-(0-aminobenzenesulfonyl)-3,6-dihydro-3,6-dimethyl-l,2-
thiazine l-oxide (21e; 1.200 g, 4.00 mmol).
8H (400MHz, CDCh): 1.02 (3H, d, J 6.7, CB3CHNH), 1.62 (3H, dd, J 6.5, 1.3,
CB3CH=CH), 3.13-3.18 (1 H, m, CHMe), 3.80 (1 H, t, J 6.6, CHOH), 3.99 (2H, s, br,
NH2), 5.22 (1 H, d, br, J 8.1, S02NB), 5.31 (1H, ddd, J 15.3,7.5, 1.6, MeHC=CB), 5.67
(1H, dq, J 15.3,6.6, CH=CBMe), 6.78 (1 H, d, J 8.0, ArB), 6.80 (1 H, t, J 7.5, ArB),
7.32 (1 H, td, J 7.7, 1.5, ArB), 7.72 (1 H, dd, J 8.0, 1.4, ArB). 8c (lOOMHz, CDCh): 17.7
(CH3), 17.8 (CH3), 54.2 (CH), 75.7 (CH), 117.7 (CH), 117.8 (CH), 122.3 (q), 129.5 (CH),
129.7 (CH), 130.0 (CH), 134.0 (CH), 144.9 (q). Vmax (cm"): 3474 (bm), 3374 (bm), 2975
(m), 2931 (m), 1621 (m), 1600 (m), 1568 (w), 1483 (s), 1455 (m), 1318 (s), 1155 (s), 1080
(m), 968 (m), 755 (s). EH mass spectrum (m/z, %): 270 ([M]+' 1%),252 ([M-H20]+, 6%),
199 (25%), 182 (20%), 172 (25%), 156 (30%), 108 (35%), 92 (98%), 71 (10%),65 (100%).
CH mass spectrum (m/z, %): 288 ([M+N~]+, 20%), 271 ([M+H]+, 25%). HRMS (ESH):
found [M+H]+ 271.1116, CI2HlSN203S requires 271.1116.
4.4 Synthesis of {0-[(9'-jluorenylmethoxycarbonyl)amino]benzenesuljonamidylj
aiken ones (24)
4.4.1 Stage 1. Synthesis of the {o-[(9'-ftuorenylmethoxycarbonyl)amino]benzenesul-
fonamidyl} alkenols. To a solution of the o-(aminobenzenesulfonamidyl)alkenol (18;
"'0.8-1.6 mmol, 1.0 eq) in anhydrous dichloromethane (10 ml) was added solid sodium hydro-
gen carbonate (2.1 eq) and 9-fluorenylmethyl chloroformate (2.1 eq) and the reaction mixture
was left stirring at room temperature under nitrogen for a total of 6-8 hours, whilst being mon-
itored by TLC. Upon completion of the reaction, the solvent was removed in vacuo and the
crude product was purified by column chromatography (eluent: PE:EtOAc/3:1) to yield the
desired {o-[ (9'-fiuorenylmethaxycarbonyliamino [aenzenesulfonamtdyl} alkenols, as follows:
4-{0-[(9' -Fluorenylmethoxycarbonyl)amino lbenzenesulfonamidyll-but-I-en-B -01 was ob-
tained as a colourless solid (0.3085 g, 81% yield) from 4-(0-aminobenzenesulfonamidyl)-but-
l-en-3-ol (18a; 0.2000 g, 0.82 mmol), mp 204-205 "C.
8H (400MHz, CDCh): 2.90 (1 H, ddd, J 12.8,8.0,4.7, CB2NH), 3.15 (1 H, ddd, J 11.7,
8.0,3.7, CB2NH), 3.57 (1 H, s, br, OH), 4.05-4.12 (1 H, m, CHOH), 4.33 (1 H, t, J 7.1,
CBCB20CONH), 4.52 (2H, d, J 7.2, CHCH20CONH), 5.02 (1 H, q, J 5.7, S02NB), 5.18
(1 H, d, J 10.5, HC=CH2), 5.25 (1 H, d, J 17.3, HC=CH2), 5.71 (1 H, ddd, J 17.1, 10.8,
5.7, H2C=CH), 7.22 (1 H, t, J 7.7, ArB), 7.36 (2H, t, J 7.5, 2 x ArB), 7.45 (2H, t, J
7.5, 2 x ArH), 7.59 (1 H, t, J 7.8, ArH), 7.65 (2H, d, J 7.4, 2 x ArH), 7.81 (2H, d, J
7.5,2 x ArB), 7.90 (1 H, dd, J 8.0, 1.0, ArB), 8.15 (1 H, d, br, J 7.8, ArB), 8.69 (l H, s,
br, C02NB). 8c (lOOMHz, CDCl3): 46.9 (CH), 47.9 (CH2), 67.7 (CH2), 70.9 (CH), 111.3
(CH2), 117.5 (q), 118.0 (q), 120.1 (CH), 122.3 (CH), 123.5 (CH), 125.1 (CH), 127.2 (CH),
127.9 (CH), 129.4 (CH), 134.3 (CH), 136.8 (CH), 141.4 (q), 143.6 (q), 153.3 (q, C02NH).
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Vmax (cm "): 3512 (bw), 3355 (bm), 2925 (m). 2853 (m). 1735 (s), 1588 (s), 1530 (s), 1469
(m). 1458 (s), 1329 (s), 1291 (m). 1250 (m), 1154 (s), 1132 (m). 1082 (m). 1047 (m). 933 (w),
757 (s), 668 (m). ESI+ mass spectrum (m/z. %): 487 ([M+Na]+. 55%).465 ([M]+. 20%).
HRMS (CI+): found [M+N14]+ 482.1747.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAC2SH24N20SSrequ res 482.1750. C. H, N(%):
found C 64.4. H 5.1. N 5.9; C2SH24N20SSrequires C 64.6, H 5.2, N 6.0.
4-{o- [(9'- Fluorenylmethoxycarbonyl )amino 1benzenesulfonamidyl} -2-methyl-but-l-en-3 -01
was obtained as a colourless solid (0.5675 g. 76% yield) from 4-(0-aminobenzenesulfona-
midylj-z-methyl-but-l-en-Lol (18b; 0.4000g. 1.56mmol). mp 198-200 QC.
OH (400MHz. CDCh): 1.60 (3 H. s. CH3). 1.94 (1 H. d. J 3.7. OH). 2.93 (1 H. ddd, J 12.7.
8.4.4.1. CH2NH). 3.18 (1 H. ddd, J 12.3.8.2.4.1. CH2NH). 3.95 (1 H. ddd, J 12.5. 11.9.3.9.
CHOH). 4.32 (1 H. t. J 7.1. CHCH20CONH). 4.52 (2H. d. J 7.2. CHCH20CONH). 4.88
(1 H. s, HC=CH2). 4.93 (1 H. s. HC=CH2). 5.07 (1 H. dd, J 8.1.3.9. S02NH). 7.21 (1 H.
t. J 7.8. ArH). 7.36 (2H. t, J 7.4.2 x ArH). 7.44 (2H, t, J 7.4.2 x ArH). 7.58 (1 H. t. J
7.2. ArH). 7.65 (2H. d. J 7.4.2 x ArH). 7.81 (2H. d. J 7.5.2 x ArH). 7.91 (1 H. dd, J 8.0.
1.4. ArH). 8.15 (1 H. d. br, J 8.0. ArH). 8.72 (1 H. s, br; C02NH). oc (100MHz. CDCh):
18.2 (CH3), 46.7 (CH2). 46.9 (CH). 67.7 (CH2). 73.2 (CH). 112.6 (CH2). 120.1 (CH). 122.2
(CH). 122.8 (q), 123.4 (CH). 125.1 (CH). 127.2 (CH). 127.9 (CH). 129.3 (CH). 134.3 (CH).
136.1 (q), 141.3 (q). 143.6 (q), 143.9 (q), 153.3 (q, C02NH). Vmax (cm'"): 3515 (bw), 3354
(bm), 2924 (m). 2851 (m). 1737 (s), 1588 (s). 1530 (s), 1470 (m). 1444 (s). 1328 (s), 1291
(m). 1249 (m). 1153 (s), 1133 (m). 1083 (m). 1049 (m). 910 (w). 757 (s), 668 (m). ESI+ mass
spectrum (m/z, %): 979 ([2M+Na]+. 5%), 957 ([2M]+. 15%).501 ([M+Na]+. 20%).479
([M]+, 70%). C. H. N(%): found C 65.5, H 5.4, N 5.9; C26H26N20SS requires C 65.2. H 5.5.
N5.9.
(E)-5- {o-[(9' -Fluorenylmethoxycarbonyltamino Ibenzenesulfonamidyll-hex-z -en-4-01 was
obtained as a colourless solid (0.3930 g. 72% yield) from (E)-5-(o-aminobenzene-
sulfonamidylj-hex-z-en-s-ol (18c; 0.3000 g. 1.11 mmol, 1.0 eq), mp 186-187 qc.
DH (400MHz. CDCh): 1.09 (3H, d, J 6.7. CH3CHNH), 1.59 (3H. dd. J 6.5,1.5.
CH3CH=CH). 1.88 (1 H, s, br, OH). 3.21 (1 H, q, J 6.0. MeCHNH). 3.80 (1 H. t, J 6.2.
CHOH), 4.32 (1H, t, J 6.7. CHCH20CONH). 4.51 (2H. d. J 7.2. CHCH20CONH). 5.12
(1 H, d. br. J 7.6. S02NH). 5.24 (1 H. ddd, J 15.3,7.5. 1.6. MeHC=CH). 5.64 (1 H. dq, J
15.3.6.6. HC=CHMe). 7.18 (l H, t. J 7.1, ArH). 7.36 (2H. t. J 7.5, 2 x ArH), 7.44 (2H.
t, J 7.4.2 x ArH). 7.55 (1 H. t, J 7.0. ArH). 7.64 (2H. t, J 6.8.2 x ArH). 7.80 (2H. d, J
7.5.2 x ArH). 7.91 (l H. dd. J 8.0. 1.5. ArH). 8.16 (1H. d. br, J 7.5. ArH). 8.79 (1H. s, br,
C02NH). DC (lOOMHz. CDCh): 17.7 (CH3). 18.1 (CH3), 46.9 (CH). 54.2 (CH), 67.6 (CH2),
75.3 (CH). 120.1 (CH), 121.8 (CH). 123.2 (CH). 125.0 (CH), 127.2 (CH). 127.8 (CH), 129.3
(CH). 129.5 (CH).130.4 (CH). 134.0 (CH), 136.0 (q).141.3 (q), 143.6 (q), 153.2 (q. C02NH).
Vmax (cm "): 3512 (bw), 3354 (bm), 2923 (m), 2850 (m). 1736 (s), 1589 (s), 1530 (s), 1470
(m), 1444 (s), 1329 (s), 1291 (s), 1247 (m). 1155 (s), 1133 (m). 1081 (m). 1049 (m). 967 (m).
758 (s), 668 (m). ESI+ mass spectrum (m/z. %): 515 ([M+Na]+. 100%). C. H. N (%): found
C 65.7. H 5.7, N 5.8; C27H2SN20SS requires C 65.8, H 5.7, N 5.7.
4.4.2 Stage 2. Formation of {o-[(9' -fluorenylmethoxycarbonyl)amino]benzenesulfon-
amidyl} alkenones (24)by oxidation of the {0-[(9'-ftuorenylmethoxycarbonyl)amino [ben-
zenesulfonamidyl} alkenols. To a solution of Dess-Martin periodinane (1.1 eq)
in anhydrous dichloromethane (lOml) was added a solution of the 0-[N-(9-
fluorenylmethoxycarbonyl)aminobenzenesulfonamidyl] alkenol from Stage 1 in anhydrous
dichloromethane (5 ml) at room temperature and the reaction mixture was stirred for 1 hour,
whilst being monitored byTLC. Upon completion of the reaction the solvent was evaporated off
and the crude product was purified by flash column chromatography (eluent: PE:EtOAc/3:1)
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to yield the {0-[(9'-fluorenylmethoxycarbonyl)aminolbenzenesulJonamidylJ alkenones (24),
as follows:
4-{0-[(9'-Fluorenylmethoxycarbonyl)aminojbenzenesulJonamidylJ-but-l-en-3-one (24a)
was obtained as a slightly unstable (noticeable degradation after two days at room temperature)
pale yellow oil (0.0477 g, 78% yield) from 4-{0-[(9'-fluorenylmethoxycarbonyl)amino]ben-
zenesulfonamidylj-but-l-en-Lol (0.0600 g, 0.13 mmol).
eSH (400MHz, CDCI3): 4.05 (2H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 4.7, CH2NH), 4.36 (1 H, t, J 7.3, CHCH20CONH),
4.52 (2H, d, J 7.4, CHCH20CONH), 5.73 (1 H, t, br, J 4.5, S02NH), 5.93 (1 H, dd, J 9.8,
1.5, H2C=CH), 6.21-6.34 (2H, m, HC=CH2), 7.19 (1 H, t, J 7.6, ArH), 7.37 (2H, t, J
7.4,2 x ArH), 7.45 (2H, t, J 7.4, 2 x ArH), 7.58 (1 H, t, J 7.8, ArH), 7.77 (2H, d, J 7.4,
2 x ArH), 7.81 (2H, d, J 7.5, 2 x ArH), 7.89 (1 H, dd, J 8.0, 1.3, ArH), 8.23 (1 H, d, br,
J 8.1, ArH), 8.82 (1 H, s. br, C02NH). eSc (1ooMHz, CDCh): 46.9 (CH), 49.2 (CH2), 67.7
(CH2), 120.0 (CH), 121.9 (CH), 123.1 (CH), 125.1 (CH), 125.9 (q), 127.2 (CH), 127.8 (CH),
129.2 (CH), 130.8 (CH2), 132.7 (CH), 134.5 (CH), 136.4 (q), 141.3 (q), 143.6 (q), 153.1 (q,
C02NH), 192.1 (q, C=O). Vmax (cnr"): 3355 (bm), 2920 (s), 2850 (s), 1735 (s), 1589 (s),
1529 (s), 1470 (m), 1459 (s), 1330 (s), 1291 (m), 1240 (m), 1155 (s), 1133 (m), 1079 (m),
1048 (m), 756 (s), 667 (m). ESI+ mass spectrum (m/z, %): 485 ([M+Na]+, 40%); Cl mass
spectrum (m/z, %): 480 ([M+NH4]+, 50%).
4-{ 0-[( 9' -Fluorenylmethoxycarbonyl)aminojbenzenesulJonamidyl }-2-methyl-but-I-en-3-
one (24b) was obtained as a pale yellow oil which solidified on standing (0.1700 g, 85% yield)
from 4-{ 0-[(9' -fluorenylmethoxycarbonyl)amino]benzenesulfonamidyl }-2-methyl-but-I-en-
3-01 (0.2000 g, 0.42 mmol), mp 176-178 QC.
eSH (400 MHz, CDCh): 1.84 (3 H, s, CH3), 4.18 (2H, d, J 4.6, CH2NH), 4.36 (1 H, t, J 7.3,
CHCH20CONH), 4.51 (2H, d, J 7.4, CHCH20CONH), 5.70 (1 H, t, J 4.4, S02NH), 5.84
(2H, dd, J 5.0, 1.5, MeC=CH2), 7.19 (1 H, td, J 8.0,0.8, ArH), 7.37 (2H, td, J 7.6,0.9,
2 x ArH), 7.45 (2H, t, J 7.3, 2 x ArH), 7.58 (1 H, td, J 8.4, 1.2, ArH), 7.68 (2H, d, J 7.4,
2 x ArH), 7.81 (2H, d, J 7.5, 2 x ArH), 8.00 (1 H, dd, J 7.8, 1.6, ArH), 8.24 (1 H, d, br,
J 8.2, ArH), 8.86 (1 H, s, br, C02NH). eSc (100MHz, CDCh): 17.2 (CH3), 46.9 (CH), 47.5
(CH2), 67.8 (CH2), 120.0 (CH), 121.8 (CH), 123.1 (CH), 125.1 (CH), 126.0 (CH2), 126.3
(q), 127.2 (CH), 127.8 (CH), 129.2 (CH), 134.4 (CH), 136.4 (q), 141.3 (q), 141.7 (q), 143.6
(q), 153.1 (q, C02NH), 193.3 (q, C=O). Vmax (cm "): 3349 (bm), 2924 (s), 2851 (s), 1733
(bs), 1587 (s), 1530 (s), 1470 (m), 1444 (s), 1330 (s), 1291 (m), 1236 (m), 1154 (s), 1133 (m),
1083 (m), 1048 (m), 757 (s), 668 (m). ESI+ mass spectrum (m/z, %): 499 ([M+Na]+, 65%),
478 ([M+H]+, 6%). C, H, N (%): found C 65.7, H 5.0, N 6.0; C26H24N20SS requires C 65.5,
H 5.1, N 5.9.
( E)-5-{ 0- [( 9' -Fluorenylmethoxycarbonyl) amino lbenzenesulfonamidyl l-hex-Z-en-t-one
(24c) was obtained as a pale yellow oil which solidified on standing (0.2650 g, 76%
yield) from (E)-5-{0-[(9'-fluorenylmethoxycarbonyl)amino]benzenesulfonamidyl}-hex-2-
en-4-01 (0.3500g, 0.71 mmol), mp 173-176 QC.
c5H (400MHz, CDCh): 1.31 (3H, d, J 7.2, CH3CHNH), 1.86 (3H, dd, J 6.9, 1.6,
CH3CH=CH), 4.17 (1 H, dq, J 7.4,7.2, MeCHNH), 4.37 (1 H, t, J 7.4, CHCH20CONH),
4.47-4.58 (2H, m, CHCH20CONH), 5.92 (1 H, d, J 7.1, S02NH), 6.04 (1 H, dq, J 14.1,
1.5, HC=CHMe), 6.90 (1 H, dq, J 13.7,6.9, MeHC=CH), 7.16 (1 H, td, J 7.8, 1.0, ArH),
7.37 (2H, td, J 7.4, 1.1,2 x ArH), 7.45 (2H, t, J 7.4,2 x ArH), 7.55 (1 H, td, J 7.9, 1.4,
ArH), 7.69 (2H, t, J 7.4, 2 x ArH), 7.81 (2H, d, J 7.5,2 x ArH), 7.86 (1 H, dd, J 8.0, 1.5,
ArH), 8.22 (1 H, d, br, J 8.1, ArH), 8.81 (1 H, s, br, C02NH). eSc (100MHz, CDCI3): 18.5
(CH3), 19.5 (CH3), 46.9 (CH), 55.2 (CH), 67.7 (CH2), 120.0 (CH), 121.7 (CH), 123.0 (CH),
125.1 (CH), 126.7 (CH), 127.2 (CH), 127.8 (CH), 129.1 (CH), 134.3 (CH), 136.4 (q), 141.3
(q), 141.7 (q), 143.5 (q), 146.4 (CH), 153.0 (q, C02NH), 195.5 (q, C=O). Vmax (cm""): 3347
(bm), 2929 (m), 2851 (m), 1740 (s), 1587 (s), 1530 (s), 1470 (m), 1442 (s), 1332 (s), 1291
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(s), 1240 (s), 1154 (s), 1132 (m), 1079 (s), 1048 (s), 759 (s), 668 (m). ESI+ mass spectrum
(m/z, %): 1003 ([2M+Na]+, 15%),513 ([M+Na]+, 100%),491 ([M+H]+, 15%). C, H, N
(%): found C 6604, H 504, N 5.8; C27H26N205S requires C 66.1, H 5.4, N 5.7.
4.5 Synthesis of 2,3-dihydro-3-hydroxy-I,2,S-benzothiadiazepine I.l-dioxides (27)
A solution of thezyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA{o-[ (9' -fluoreny methoxycarbonyl)amino ]benzenesulfonamidyl} alkenone
(24; ""0.4-0.5 mmol) in a mixture of triethylamine and anhydrous dichloromethane (1: 1 V/V,
10ml) was heated at reflux under an atmosphere of dry nitrogen whilst being monitored by
TLC. Upon completion (approx. 15 hours) of the reaction, the solvent was evaporated off and
the crude residue was purified by flash silica column chromatography (eluent: PE:EtOAc/1: 1)
to yield the 1,2,5-benzothiadiazepine l.I-dioxides (27) as follows:
4-Ethyl-2,3 -dihydro-3 -hydroxy- J ,2,5-benzothiadiazepine J, J -dioxide (27a) was obtained
as a light yellow oil which solidified on standing (0.0716g, 69% yield) from 4-{0-[(9'-
fluoreny1methoxycarbonyl) amino]benzenesulfonamidyl] }-but-1-en-3-one (24a; 0.2000 g,
0043 mmol), mp: 89-92 QC.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
8H (400MHz, CDCh): 1.06 (3H, t, J 704, CH3), 1.87 (1 H, dq, J 704, 3.8, MeCH2), 2.08
(1 H, m, MeCH2), 3.6-3.8 (1 H, bs, OH), 4049 (1 H, d, J 3.8, CHOH), 7.12 (1 H, d, J 8.2,
ArH), 7045 (1 H, t, J 7.7, ArH), 7.57 (1 H, t, J 7.7, ArH), 7.96 (1 H, d, J 8.0, ArH). 8c
(100MHz, CDCh): 9.1 (CH3), 28.5 (CH2), 72.3 (CHOH), 117.0 (CH), 121.6 (q), 124.7
(CH), 127.2 (CH), 132.9 (CH), 133.6 (q), 16004 (q). Umax (cm "): 3475 (bm), 3277 (bm),
2963 (m), 2927 (m), 1604 (m), 1560 (w), 1525 (m), 1481 (m), 1440 (w), 1297 (m), 1261 (s),
1158 (s), 1079 (s), 1020 (s), 801 (s), 759 (s). ESI+ mass spectrum (m/z, %): 743 ([3M+Na]+,
5%),503 ([2M+Na]+, 30%), 481 ([2M+H]+, 6%), 263 ([M+Na]+, 70%), 241 ([M+H]+,
100%). HRMS (ESI+): found [M+H]+ 241.0642, ClOHI2N203S requires 241.0647. C, H,
N(%): found C 49.9, H 5.1, N 11.9; ClOH12N203S requires C 50.0, H 5.0, N 11.7.
2,3 -Dihydro-3 -hydroxy-4-( i-propyl)- J ,2,5-benzothiadiazepine J, J -dioxide (27b) was sim-
ilarly obtained as a yellow solid (0.0830g, 62% yield), mp: 117-119 QC from 4-{0-
[(9' -fluorenylmethoxycarbonyl) aminobenzenesulfonamidyl }-but-1-en-3-one (24b; 0.2500 g,
0.53mmol).
8H (400 MHz, CDCh): 0.87 (3 H, d, J 6.9, CH3), 1.07 (3 H, d, J 6.9, CH3), 2.34 (1 H,
qq, J 6.8, 6.7, Me2CH), 3.4-3.5 (1 H, bs, OH), 4.33 (1 H, d, J 3.3, CHOH), 7.13 (1 H, d, J
8.2, ArH), 7.43 (1H, t, J 7.6, ArH), 7.54 (1 H, t, J 7.8, ArH), 7.92 (1H, d, J 7.9, ArH),
9.40 (1 H, s, br, S02NH). 8c (100MHz, CDCh): 15.3 (CH3), 19.0 (CH3), 32.8 (CH), 75.1
(CH), 117.2 (CH), 121.6 (q), 124.5 (CH), 127.1 (CH), 133.0 (CH), 133.6 (q), 160.8 (q). Umax
(cm "): 3477 (bm), 3261 (bm), 2965 (m), 2930 (m), 1602 (m), 1560 (w), 1523 (m), 1482
(m), 1442 (w), 1297 (s), 1260 (s), 1161 (s), 1082 (s), 1028 (s), 800 (s), 756 (m). EI+ mass
spectrum (m/z, %): 254 ([M]+, 2%), 237 ([M-OH]+, 4%), 212 ([(M-CHMez)+H]+, 25%),
196 (20%), 147 (70%), 119 (50%), 108 (15%), 91 (45%), 77 (15%),64 (25%). ESI+ mass
spectrum (m/z, %): 785 ([3M+Na]+, 4%),763 ([3M+H]+, 2%), 531 ([2M+Na]+, 35%),
509 ([2M+H]+, 10%),277 ([M+Na]+, 35%), 255 ([M+H]+, 100%). HRMS (ESI+): found
[M+H]+ 255.0803, Cl1HI4N203S requires 255.0803. C, H, N (%): found C 51.8, H 5.6, N
10.8; CIIHI4N203S requires C 52.0, H 5.5, N 11.0.
2,3-Dihydro-3 -hydroxy-3-methyl-4-propyl- J ,2,5-benzothiadiazepine J, J -dioxide (27c) was
obtained as a yellow solid (0.0621 g, 57%), mp: 107-111 QC from (E)-5-fo-
[(9' -fluorenylmethoxycarbonyl)aminolbenzenesulfonamidylJ-hex-2-en-4-one (24c, 0.2000 g,
0.41 mmol).
8H (400MHz, CDCh): 1.32 (3 H, t, J 10.2, CH3), 1.63 (2H, m, CH2CH2Me), 1.80 (1H,
m, CH2CH2Me), 2.02 (3 H, s. CH3), 2.08 (1 H, dt, J 10A,7.8, CH2CH2Me), 3.2-3.4 (1 H,
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bs,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAOH), 4.83 (1 H, bs, CHOH), 6.87 (1 H, dt, J 14.8,6.9, ArH), 7.11 (1 H, s, br, S02NH),
7.35 (1 H, dt, J 7.9, 1.4, ArH), 7.55 (1 H, dd, J 5.6, 2.2, ArH), 7.73 (1 H, dd, 5.6, 2.2,
ArH), 7.79 (1 H, dd, J 8.0, 1.2, ArH). de (100MHz, CDCh): 14.0 (CH3), 23.7 (CH3), 28.1
(CH2), 31.7 (CH2), 79.0 (q, C(OH)Me), 128.4 (CH), 128.8 (q), 128.8 (CH), 130.9 (CH),
134.2 (CH), 144.6 (q), 167.8 (q). Vrnax (cm ", chloroform): 3377 (bs), 3100 (bs), 2965 (m),
1624 (m), 1482 (w), 1314 (w), 1482 (m), 1154 (m), 1107 (m), 1088 (w). EH mass spectrum
(m/z, %): 268 ([M]+, 2%), 253 ([M-CH3]+, 10%),250 ([M-H20]+, 14%),217 (25%), 169
(100%), 154 (70%), 108 (15%), 91 (45%), 77 (15%), 64 (25%). ESI+ mass spectrum (m/z,
%): 269 ([M+H]+, 100%),291 ([M+Na]+, 20%), 537 ([2M+H]+, 10%). HRMS (ESH):
found [M+H]+ 269.0960, CI2HI6N203S requires [M+H+] 269.0960. C, H, N (%): found C
54.0, H 5.8, N 10.4; CI2HI6N203S requires C 53.7, H 6.0, N 10.4.
4.6 Synthesis of(o-nitrobenzenesulfonamidyl)alkenols (37)
4.6.1 Method 1. Synthesis of compounds (37a/b/c) from o-nitrobenzenesulfonamide
('in situ' method). To a solution of o-nitrobenzenesulfonamide (-5-10 mmol, 1.0 eq) and
anhydrous pyridine (2.0 eq) in anhydrous tetrahydrofuran (15 ml), under an atmosphere of dry
nitrogen, was added, dropwise with stirring over a period of 3 hours, a solution of thionyl
chloride (1.0 eq) in anhydrous tetrahydrofuran (5 ml), to yield the crude N -sulfinyl compound
(33). Stirring of the crude reaction mixture was continued for a further 30 minutes, followed
by dropwise addition of the appropriate 1,3-diene (isoprene and hexadiene used 1.6 eq at room
temperature; butadiene used 10 eq at - 20°C), and the whole was left stirring at room temper-
ature for 12-16 hours (isoprene and hexadiene) or at -20°C for6-8 hours (butadiene), whilst
being monitored by TLC. Upon completion of the reaction, stirring was ceased and, under an
atmosphere of dry nitrogen, the supernatant solution was transferred into a second dry flask
via a syringe leaving the unwanted pyridinium hydrochloride precipitate behind, which was
washed with anhydrous tetrahydrofuran (5 x 10 ml) and the washings transferred to the second
flask. To the crude adduct solution was added, with stirring, a solution of phenylmagnesium
bromide (3M in ether, 2.0 eq) at -78°C under an atmosphere of dry nitrogen. The reaction
mixture was kept at low temperature « -40 QC) for 3-4 hours, whilst being monitored by
TLC. Upon completion of the reaction, the mixture was quenched at -20 QCwith saturated
ammonium chloride solution (15 ml) and allowed to warm to room temperature. The mixture
was extracted with ethyl acetate (4 x 50 ml) and the combined extracts washed with water
(2 x 10ml) and brine (10ml). The organic phase was collected, dried (MgS04), filtered and
the solvent evaporated off to yield the crude phenyl allylic sulfoxide which was not purified
further. To a solution of the crude allylic sulfoxide in anhydrous methanol (10 ml) was added
trimethyl phosphite (2.0 eq), under an atmosphere of dry nitrogen, and the whole was heated
under reflux for a total of 10-15 hours. Upon completion of the reaction (TLC), the solvent was
removed in vacuo and the crude product was purified by flash silica column chromatography
(eluent: PE:EtOAc/5:2) to yield the (o-nitrobenzenesulfonamidyltalkenols (37) as follows:
4-( o-NitrobenzenesulJonamidyl)-but-l-en-3-ol (37a) was obtained as a light yellow solid
(1.0230 g, 38% yield) over the four steps from o-nitrobenzenesulfonamide (2.000 g,
9.90mmol); mp 189-191 QC.
dH (400MHz, CDCh): 3.08 (1 H, ddd, J 12.2,7.3,4.7, CH2NH), 3.31 (1H, ddd, J 12.4,
7.1,4.6, CH2NH), 4.33 (1 H, m, CHOH), 5.11 (1 H, d, J 10.5, HC=CH2), 5.19 (1 H, d, J
14.8, HC=CHz), 5.74 (1 H, ddd, J 15.1,10.7,6.6, HC=CH2), 5.97 (1 H, s, br, NH), 7.72-
7.77 (2H, m, 2 x ArH), 7.87 (1 H, dt, J 7.8, 1.2, ArH), 8.08 (1H, dd, J 8.2,0.9, ArH). de
(100MHz, CDCh): 45.3 (CH2), 69.7 (CHOH), 112.6 (CHz), 118.1 (CH), 127.8 (CH), 129.0
(CH), 131.1 (CH), 134.8 (CH), 140.6 (q), 147.9 (q). Vrnax (cm "): 3576 (bm), 3301 (bm),
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3111 (m), 2928 (w), 1588 (m), 1547 (s), 1236 (m), 1166 (s), 1108 (m), 1086 (m), 1008 (m).
ESI+ mass spectrum (m/z, %): 295 ([M+Na]+, 14%),273 ([M+H]+, 34%). C, H, N (%):
found C 44.4, H 4.6, N 10.2; ClOHI2N20SS requires C 44.1, H 4.4, N 10.3.
2-Methyl-4-(o-nitrobenzenesuljonamidyl)-but-l-en-3-o1 (37b) was obtained as a yellow
waxy solid (0.6330 g, 45% yield) over the four steps from o-nitrobenzenesulfonamide (1.000 g,
4.95mmol).
8zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAH (400MHz, CDCh): 1.69 (3 H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH3), 2.40 (1 H, s, br, OH), 3.08 (1 H, ddd, J 12.6,
7.7,4.7, CH2NH), 3.27-3.38 (1 H, m, CH2NH), 4.17-4.19 (1 H, m, CHOH), 4.91 (1 H, s,
MeC=CH2), 5.01 (1 H, s, MeC=CH2), 5.78 (1 H, s, br, NH), 7.72-7.77 (2H, m, 2 x ArH),
7.83-7.93 (1 H, m, ArH), 8.11-8.15 (1 H, m, ArH). 8c (100MHz, CDCh): 18.3 (CH3), 47.5
(CH2), 73.4 (CHOH), 112.6 (CH2), 125.4 (CH), 130.9 (CH), 132.8 (CH), 133.6 (CH), 140.1
(q), 143.9 (q), 147.9 (q). Vmax (cm "): 3550 (bm), 3333 (bm), 3096 (m), 2953 (m), 1594 (m),
1539 (s), 1441 (m), 1410 (m), 1343 (s), 1239 (m), 1166 (s), 1126 (m), 1090 (m), 1024 (m),
912 (m), 854 (m), 783 (m), 741 (m). ESI+ mass spectrum (m/z, %): 309 ([M+Na]+, 45%),
287 ([M+H]+, 4%). C, H, N (%): found C 46.4, H 4.8, N 9.8; CIIHI4N20SS requires C 46.1,
H4.9, N9.8.
(E)-5-(o-Nitrobenzenesuljonamidyl)-hex-2-en-4-o1 (37c) was obtained as a yellow solid
(0.6490 g, 44% yield), mp: 163-166 °C, over the four steps from o-nitrobenzenesulfonamide
(1.000 g, 4.95 mmol).
8H (400MHz, CDCh): 1.14 (3H, d, J 6.8, CH3CH=CH), 1.55 (3H, dd, J 6.4, 1.0,
CH3CHNH), 2.35 (1 H, s, br, OH), 3.42-3.51 (1 H, m, MeCHNH), 3.92 (1 H, dd, J 6.8,5.3,
CHOH), 5.31 (1 H, ddd, J 15.3,7.3,1.5, CH=CHMe), 5.67 (1 H, dq, J 15.4,6.6, MeHC=CH),
5.70 (1 H, d, br, J 7.0,NH), 7.71-7.74 (2H, m, 2 x ArH), 7.84-7.87 (1 H, m,ArH), 8.12-8.14
(1 H, m, ArH). 8c (100MHz, CDCh): 17.6 (CH3), 18.1 (CH3), 54.8 (CH), 75.1 (CHOH),
125.2 (CH), 129.7 (CH), 129.9 (CH), 130.6 (CH), 132.8 (CH), 133.3 (CH), 134.7 (q), 147.6
(q). Vmax (cm'"): 3550 (bm), 3365 (bm), 3097 (m), 2955 (m), 1671 (w), 1594 (w), 1541 (s),
1442 (m), 1410 (m), 1362 (s), 1241 (m), 1169 (s), 1125 (m), 1061 (m), 1025 (m), 968 (m), 854
(m), 784 (m), 743 (m). CH mass spectrum (m/z, %): 318 ([M+N~]+, 100%),300 ([M]+,
45%). C, H, N (%): found C 48.3, H 5.2, N 9.3; C12HI6N20SS requires C 48.0, H 5.4, N 9.3.
4.6.2 Method 2. (E)-5-(o-Nitrobenzenesulfonamidyl)-hex-2-en-4-ol (37c) from the
thiazine I-oxlde (34c). Stage 1: Synthesis of 3,6-dihydro-3,6-dimethyl-2-(0-nitrobenzene-
sulfonyl)-l,2-thiazine l-oxide (34c). To a solution of o-nitrobenzenesulfonamide (1.000 g.
4.95 mmol, 1.0 eq) in anhydrous benzene (15 ml) [CAUTION: SUSPECTED CARCINO-
GEN - see above for an alternative synthesis of compound 37c] was added, under an
atmosphere of dry nitrogen, thionyl chloride (0.54 ml, 7.42 mmol), and the whole was
healed at reflux in an oil bath for 3 days (72 hours). The reaction mixture was allowed
to cool to room temperature and the solvent and excess thionyl chloride were removed
in vacuo to yield N -sulfinyl-o-nitrobenzenesulfonamide (33) as a brown oil. To the crude
N -sulfinyl-o-nitrobenzenesulfonamide (33) in anhydrous tetrahydrofuran (15 ml) was added
2,4-hexadiene (0.90 ml, 7.91 mmol) and the reaction mixture was stirred at room temperature
whilst being monitored by TLC. After completion of the reaction (16 hours) the solvent was
removed in vacuo and the crude product was purified by flash silica chromatography (eluent:
PE:EtOAc/2: 1) to yield 3,6-dihydro-3,6-dimethyl-2-( o-nitrobenzenesuljonyl)-1,2-thiazine
l-oxide (34c; 0.9830 g, 60% yield) as a pale yellow solid, mp: 110-112 DC.
8H (400MHz, CDCh): 1.39 (3 H, d, J 7.4, CH3CHS=0), 1.56 (3 H, d, J 7.0, CH3CHN),
3.30-3.38 (1 H, m, MeCHS=O), 4.57 (1 H, ddq, J 11.1, 3.4, 1.8, MeCHN), 5.45 (1 H, ddd,
J 11.0,2.5,2.0, HC=CH), 5.96 (1 H, ddd, J 11.0,3.4,2.9, HC=CH), 7.71-7.91 (3 H, m,
3 x ArH), 8.19 (1H, dd, J 8.3, 1.1, ArH). 8c (100MHz, CDCh): 15.7 (CH3), 23.5 (CH3),
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51.8 (CH), 53.1 (CH), 119.5 (CH), 124.8 (CH), 129.5 (CH), 131.3 (CH), 132.5 (CH), 133.0
(q), 134.8 (CH), 147.6 (q). Umax (cm "): 3106 (w), 2934 (w), 1593 (w), 1545 (s), 1442 (m),
1371 (s), 1301 (w), 1173 (s), 1131 (m), 1108 (m), 1059 (m), 990 (w), 853 (m), 758 (s), 658
(m), 626 (m). EI+ mass spectrum (m/z, %): 331 ([M+H]+, 2%), 282 ([M-SO]+, 2%), 186
(20%),144 (10%), 96 (10%), 82 (100%), 67 (85%), 64 (30%). CH mass spectrum (m/z, %):
348 ([M+N14]+, 100%),331 ([M+H]+, 15%). HRMS (ESH): found [M+H]+ 331.0419,
CI2HI4N20SS2 requires 331.0422. C, H, N(%): found C 43.7, H 4.3, N 8.6; CI2HI4N20SS2
requires C 43.6, H 4.3, N 8.5.
Stage 2. Synthesis of (E)-5-(0-nitrobenzenesulfonamidyl)-hex-2-en-4-01 (37c). A solution
of phenylmagnesium bromide (3 M in ether, 2.0 eq) was added with stirring to a solution
of 3,6-dihydro-3,6-dimethyl-2-(o-nitrobenzenesulfonyl)-1,2-thiazine l-oxide (34c; 1.000 g,
3.03 mmol) in anhydrous tetrahydrofuran (10 ml) at -78 DC, under an atmosphere of dry
nitrogen. The reaction mixture was kept at low temperature (zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA< -40 DC)for 3-4 hours, whilst
being monitored by TLC. Upon completion of the reaction, the mixture was quenched at
- 20 DCwith saturated ammonium chloride solution (15 ml) and allowed to warm to room
temperature. The mixture was extracted with ethyl acetate (2 x 10 ml) and washed with water
(2 x 10ml) and brine (10ml). The organic phase was collected, dried (MgS04), filtered and
the solvent evaporated off to yield the intermediate phenyl aUylic sulfoxide which was not
purified further. To a solution of the crude allylic sulfoxide in anhydrous methanol (10 ml) was
added trimethyl phosphite (2.0 eq), under an atmosphere of dry nitrogen, and the whole was
heated at reflux temperature for a total of 12-15 hours. Upon completion of the reaction (TLC),
the solvent was removed in vacuo and the crude product was purified by flash silica column
chromatography (eluent: PE:EtOAc/5:2) to yield (E)-5-(o-nitrobenzenesulJonamidyl)-hex-2-
en-4-o1 (37c) as a yellow oil (0.8100g, 89% yield), which solidified on standing and was
identical in all aspects to that obtained in Method 1, above.
4.7 Synthesis of(o-nitrobenzenesulfonamidyl)alkenones (38) by oxidation ofalkenols
(37)
To a solution of Dess-Martin periodinane (1.1 eq) in dry dichloromethane (10 ml) was added
a solution of the allylic alcohol (37; 1-2 mmol, 1.0 eq) in dry dichloromethane (5 ml) at room
temperature and the reaction mixture was stirred for 1 hour, whilst being monitored by TLC.
Once the reaction was complete, the solvent was evaporated off and the crude product was
purified by flash silica column chromatography (eluent: PE:EtOAc/5:2) to yield the following
products:
4-( o-NitrobenzenesulJonamidyl)-but-l-en-3-one (38a) was obtained as an unstable (decom-
poses in less than one day at room temperature), partially characterised yellow oil (0.1980 g,
78% yield) from 4-(o-nitrobenzenesulfonyl)-but-1-en-3-01 (37a; 0.3500 g, 1.29 mmol).
DH (400MHz, CDCh): 3.85 (2H, d,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBAJ 12.6, CH2NH), 5.71 (1 H, dd, J 9.1, 2.3, HC=CH2),
5.98 (1 H, dd, J 14.8, 2.5, HC=CH2), 6.34 (1 H, dd, J 14.6, 9.3, HC=CH2), 6.40 (1 H, s,
br, NH), 7.78-7.82 (2H, m, 2 x ArH), 7.81 (1 H, dt, J 7.8, 1.2,ArH), 8.10 (1 H, dd, J 8.1,
0.9, ArH). DC (100MHz, CDCh): 61.2 (CH2), 117.4 (CH2), 125.4 (CH), 130.9 (CH), 131.0
(CH), 132.8 (CH), 133.6 (CH), 136.8 (q), 146.3 (q), 185.1 (q, C = 0). Umax (cm""): 3462
(bm), 3330 (bm), 2945 (w), 1709 (s), 1598 (m), 1553 (s), 1170 (s), 1111 (m), 1008 (m). ESI+
mass spectrum (m/z, %): 293 ([M+Na]+, 100%),271 ([M+H]+,20%).
2-Methyl-4-(o-nitrobenzenesulJonamidyl)-but-l-en-3-one (38b) was obtained as a par-
tially characterised unstable (decomposed fully over two days at room temperature) yellow
oil (0.2200 g, 89% yield) from 2-methyl-4-(o-nitrobenzenesulfonyl)-but-1-en-3-01 (37b;
0.2500g,1.40mmol).
The synthesis of I.2.5-benzothiadiazepine l J-dioxtdes from I.2-thiazine I-oxideszyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA477zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
8H (400MHz, CDCh): 1.85 (3H, s,zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBACH3), 4.44 (2H, d, J 4.7, CH2NH), 5.90 (1 H, s,
MeC=CH2), 5.98 (1 H, s, MeC=CH2), 6.36 (1 H, s, br, NH), 7.71-7.82 (2H, m, 2 x ArH),
7.92 (1 H, dd, J 8.2, 2.1,ArH), 8.03 (1 H, d, J 7.7,ArH). 8c (100MHz, CDCh): 17.2 (CH3),
48.7 (CH2), 125.6 (CH), 126.3 (CH2), 128.0 (CH), 130.4 (q), 131.9 (q), 133.4 (CH), 133.6
(CH), 142.0 (q), 193.8 (q, C=O). Vrnax (cm "): 3097 (w), 2926 (m), 1732 (s), 1592 (w), 1543
(s), 1458 (s), 1375 (s), 1250 (m), 1171 (s), 1123 (m), 1024 (s), 930 (m), 757 (s), 669 (m).
ESI+ mass spectrum (m/z, %): 307 ([M+Na]+, 80%), 285 ([M+H]+, 45%).
(E)-5-(o-NitrobenzenesulJonamidyl)-hex-2-en-4-one (38c) was obtained as a more stable
yellow oil (0.4170 g, 84% yield) from (E)-5-(o-nitrobenzenesulfonamidyl)-hex-2-en-4-ol
(37c; 0.5000 g, 1.67 mmol).
8H (250MHz, CDCh): 1.42 (3H, d, J 7.2, CH3CH=CH), 1.91 (3H, dd, J 6.9, 1.6,
CH3CHNH), 4.42 (1 H, dq, J 7.2,7.2, CHMe), 6.16 (1 H, dd, J 15.6, 1.5, MeHC=CH),
6.48 (1 H, d, br, J 7.2, NH), 6.96 (1 H, dq, J 15.6,6.9, MeHC=CH), 7.70-7.72 (2H, m,
2 x ArH), 7.87-7.89 (1 H, m, ArH), 8.04-8.07 (1 H, m, ArH). 8c (63 MHz, CDCh): 18.5
(CH3), 19.5 (CH3), 56.5 (CH), 125.5 (CH), 127.0 (CH), 129.9 (q), 130.2 (CH), 132.7 (q),
133.5 (CH), 134.3 (CH), 146.3 (CH), 195.8 (q, C=O). Vmax (cm""): 3096 (w), 2925 (m),
1712 (s), 1594 (w), 1542 (s), 1442 (s), 1362 (s), 1250 (m), 1172 (s), 1124 (m), 1024 (s), 928
(m), 744 (s), 655 (m). EH mass spectrum (m/z, %): 299 ([M+H]+, 1%),229 (50%),186
(95%),156 (5%),109 (20%), 92 (15%), 77 (20%), 69 (100%), 64 (15%). CH mass spectrum
(m/z, %): 316 ([M+NRt]+, 100%),299 ([M+H]+, 3%). HRMS (CI+): found [M+NRt]+
316.0965, CI2H14N20SS requires 316.0967.
4.8 Synthesis of I,2,5-benzothiadiazepine Ll-dioxides (39)
To a solution of the freshly prepared allylic ketone (38, -0.2-0.4 mmol, 1.0 eq) in glacial acetic
acid (10 ml) was added gradually, with stirring, zinc powder ("'0.2-0.5 g) over a period of 1
hour at room temperature. After addition was complete, the mixture was heated under reflux
for an additional 2-4 hours, whilst being monitored by TLC. The crude mixture was filtered,
concentrated in vacuo, and purified by flash column chromatography (eluent: PE:EtOAc/l:1)
to yield the 1,2,5-benzothiadiazepine Ll-dioxides (39), as follows:
2,3,4,5-Tetrahydro-4-ethenyl-I,2,5-benzothiadiazepine I.l-dioxide (39a) was obtained as
a yellow solid (0.0413 g, 50% yield) from 4-(o-nitrobenzenesulfonamidyl)-but-1-en-3-one
(38a, 0.1000 g, 0.37 mmol), mp: 133-137 DC.
8H (400MHz, CDCh): 3.05 (1 H, ddd, J 15.1, 7.5, 4.6, CH2NH), 3.28 (1 H, m,
CHCH=CH2), 3.37 (1 H, ddd, J 13.1,7.6,3.6 CH2NH), 4.17 (1 H, dd, J 7.4, 3.4, CH2NH),
4.83 (1 H, d, J 10.3, HC=CH2), 4.95 (1 H, dd, J 16.2,0.7 HC=CH2), 5.70 (1 H, bd, J 9.8,
NHCH), 5.8 (1 H,ddd, J 15.9, 10.3, 7.9,HC=CH2)' 7.73-7.80(2H, m, 2 x ArH), 7.83 (1 H,
t, J 7.8, ArH), 8.10 (1 H, d, J 8.2, ArH). 8c (looMHz, CDCI3): 47.4 (CH2), 73.4 (CH),
112.6 (CH2), 125.3 (CH), 130.7 (CH), 133.0 (CH), 133.3 (CH), 133.9 (CH), 140.0 (q), 147.8
(q). Vmax (cm-I): 3450 (bm), 3363 (bm), 3225 (bm), 2986 (m), 2906 (m), 1604 (m), 1591
(w), 1479 (s), 1145 (s), 1066 (m). ESI+ mass spectrum (m/z, %): 225 ([M+H]+, 100%),247
([M+Na]+, 25%). C, H, N (%): found C 53.4, H 5.2, N 12.7; ClOH12N202S requires C 53.6,
H 5.4, N 12.5.
2,3,4,5-Tetrahydro-4-(2'-propenyl)-1,2,5-benzothiadiazepine I.l-dioxide (39b) was obtai-
ned as a yellow solid (0.0410 g, 49% yield) from 2-methyl-4-(o-nitrobenzenesulfonamidyl)-
but-1-en-3-one (38b, 0.1000 g, 0.35 mmol), mp: 165-167 DC.
8H (400 MHz, CDCh): 1.62 (3 H, s, CH3), 2.85 (1 H, ddd, J 12.9,8.1,4.7, CH2NH), 3.08-
3.12 (1 H, m, CH2NH), 4.04 (1H, d, J 5.6, CHNH), 4.88 (1 H, s, MeC=CH2), 4.96 (1H, s,
MeC=CH2), 5.00 (1H, s, br, NH), 5.49 (1 H, s, br, NH), 6.78-6.81 (2H, m, 2 x ArH), 7.33
478 C.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBALoukou e al.zyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA
(1H, t, JzyxwvutsrqponmlkjihgfedcbaZYXWVUTSRQPONMLKJIHGFEDCBA7.5,ArB), 7.70 (1H, d, J 7.9, ArB). 8c (lOOMHz, CDCh): 18.3 (CH3), 47.0 (CH2),
73.4 (CH), 112.3 (CH2), 117.8 (CH), 117.9 (CH), 121.4 (q), 129.6 (CH), 134.3 (CH), 144.0
(q), 145.0 (q). Vmax (cm"): 3478 (bm), 3379 (bm), 3250 (bm), 2970 (m), 2921 (m), 1621 (m),
1600 (m), 1570 (w), 1484 (s), 1455 (m), 1320 (s), 1154 (s), 1059 (m), 909 (m), 754 (s), 696
(m). ESH mass spectrum (m/z, %): 239 ([M+H]+, 30%). C, H, N (%): found C 55.4, H 6.0,
N 11.7; CllHI4N202S requires C 55.4, H 5.9, N 11.8.
2,3,4,5-Tetrahydro-3-methyl-4-( I'-propenyl)-I,2,5-benzothiadiazepine I.l-dioxide (39c;
.......1:1 mixture of diastereoisomers) was obtained as a yellow oil (0.03810 g, 45% yield) from
(E)-5-(o-nitrobenzenesulfonamidyl)-hex-2-en-4-one (38c, 0.1000 g, 0.34 mmol).
8H (400MHz, CDCh): 1.10 (3H, d, J 6.3, CB3CHNH), 1.14; 1.18 (3H, 2 x d, J 6.6,
HC=CHCB3), 3.54; 3.58 (1H, 2 x m, CBMe), 4.6-4.7 (1 H, s, br, NB), 4.92 (1 H, d, J 7.4,
NB), 5.01; 5.07 (1 H, 2 x s, CBNH), 5.31 (1 H, dq, J 15.1,6.8, MeHC=CB), 5.36-5.47 (1 H,
m, MeBC=CB), 6.76 (1H, d, J 8.5, ArB), 6.79 (1 H, t, J 8.0, ArB), 7.31 (1H, t, J 7.7,
ArB), 7.70 (1 H, d, J 7.9, ArB). 8c (100MHz, CDCh): 20.8; 20.9 (CH3), 21.8; 21.9 (CH3),
50.6 (CH), 50.8 (CH), 117.7 (CH), 117.8 (CH), 122.6; 122.7 (q), 129.4; 129.5 (CH), 132.3;
132.4 (CH), 132.5; 132.6 (CH), 134.0; 134.1 (CH), 134.5; 134.6 (q), 141.6; 144.9 (q). Vmax
(cm "): 3476 (bm), 3378 (bm), 3249 (bm), 2979 (m), 2932 (m), 1622 (m), 1601 (m), 1570
(m), 1484 (s), 1455 (s), 1332 (s), 1155 (s), 1061 (m), 971 (m), 755 (s), 698 (m). EH mass
spectrum (m/z, %): 253 ([M+H]+, 1%),252 ([M]+, 4%),172 (15%),156 (25%),112 (75%),
108 (30%), 92 (100%), 80 (45%), 65 (98%). ESH mass spectrum (m/z, %): 253 ([M+H]+,
40%). HRMS (ESH): found [M+H]+ 253.1012, CI2HI6N202S requires 253.1010.
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